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PPL24-001
BOWEL OBSTRUCTION MIMIKNG THE
CHILAIDITI’S SIGN FOLLOWING
HEPATECTOMY
Kuo-Shyang Jeng
Far East Memorial Hospital, Taiwan
Introduction: Demetrius Chilaiditi had been first
described in 1910, is a radiographic finding that the
bowels is interposed between the diaphragm and the
liver. The identification of this entity is important
because air under the diaphragm seen on plain radio-
graph usually represents pneumoperitoneum. We
report an uncommon case of this radiographic find-
ing.
Method: A 65-year-old man with a history of right
hepatectomy for hepatocellular carcinoma 11 months
ago, visited our Emergency Department with symptoms
and signs of mechanical ileus. A picture like a Chilai-
diti’s sign was demonstrated on computed tomographic
scan study.
Results: Following our active conservative treatment
for adhesion ileus, he recovered smoothly and dis-
charged 1 week later.
Conclusions: The common predisposing factors usually
are anatomical alterations of the intestine such as elon-
gation of the colon and a history of prior abdominal
surgery. The clinical symptoms were due to the intesti-
nal obstruction. This presentation may be attributed to
the adhesions among the diaphragm and the small
bowels because of an empty space following the due to
previous hepatectomy. It is different from those cases
published before.
PPL24-002
STAGING SYSTEMS FOR
HEPATOCELLULAR CARCINOMA: A
NOVEL PROPOSAL
Han Zhang1, Xing Huang2, Shu-Yang Dai2,
Yi-Nan Shen1, Shou-Xin Yuan1 and Tian Yang1
1Eastern Hepatobiliary Surgery Hospital, China;
2Second Military Medical University, China
Introduction: Clinical staging systems for cancer pro-
vide guidelines for patient assessments and treatments.
A proper staging is essential for objective comparison
between the outcomes of different treatments. While
the prognosis of most solid tumors is generally depen-
dent on tumor stage at presentation, prediction of
prognosis in hepatocellular carcinoma (HCC) patients
is somewhat more complicated due to various aspects
affecting patient survival including cirrhosis and
underlying liver function. Up to date, at least eight
staging systems have been proposed for HCC, but the
optimal staging system for HCC is still under intense
debate.
Method: Each existing staging system, characterized by
the patient population based on which it was con-
structed, may have different predictive power for HCC
patient in different area of the world, roughly the East
and the West. The lack of a consensus on HCC staging
systems is mostly in part related to the heterogeneity in
treatment modalities at diagnosis. Therefore, we hereby
propose a novel staging system for HCC, named as the
Eastern staging, based on the authors’ previous study
with a large cohort of Chinese patients undergoing sur-
gical resection.
Results: Compared with the six existing staging sys-
tems, including CLIP, TNM, JIS, BCLC, CUPI and
Okuda, the Eastern staging appears to have the best
predictive ability for mortality at 1, 3, and 5 years.
Conclusions: We believe the Eastern staging to be a
simple and practical system for prognostic factor evalu-
ation, risk level determination, and prognosis assess-
ment after surgical resection in patients with HCC.
PPL24-003
ADVANCES IN PROTON BEAM
THERAPY FOR HEPATOCELLULAR
CARCINOMA
Shu-Yang Dai2, Xing Huang2, Tian Yang1 and
Feng Shen1
1Eastern Hepatobiliary Surgery Hospital, China;
2Second Military Medical University, China
Introduction: Hepatocellular Carcinoma (HCC), one of
the most common malignancies with high prevalence
and mortality rate, usually results in poor prognosis
and limited survival duration.
Method: Combined and comprehensive analysis on
numbers and location of tumor, Child–Pugh grade, and
Barcelona Clinic Liver Cancer system will lead to
appropriate therapy and better prediction of prognosis.
A majority of patients are complicated with cirrhosis,
enlarged tumor, multiple lesions, vascular invasion and
even the cancer embolus in portal vein. Considering
this, with the growth knowledge about the radio toler-
ance of normal tissue and the advances in radiotherapy
techniques, radiotherapy plays a more significant role
in tumor degradation and cure.
Results: Thus, proton beam therapy (PTB) tend to be
a novel available approach for the management of
HCC among various radiotherapies, which, benefited
from the effect of Bragge Peak from PTB, effectively
decreased the toxicity of liver, barely do any harm to
the uninvolved liver tissue or the surrounding struc-
tures and intensify the destruction in targeted malig-
nant lesions. Furthermore, several previous results for
treatment of hepatocellular carcinoma with PBT
revealed excellent local control. In this review, we dis-
cuss the distinctive biophysical attributes in the treat-
ment of HCC. We also review the available literature
regarding clinical outcomes and toxicity of using PBT
for HCC.
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Conclusions: Current evidence provides a limited indi-
cation for PBT, which suggests that further study for
the relationship between liver function and PBT is
required for the sake of its indication and standardiza-
tion.
PPL24-004
COMBINED RESECTION FOR
HEPATOCELLULAR CARCINOMA AND
CONCOMITANT EXTRAHEPATIC
METASTASES: DOES IT BRING
SURVIVAL BENEFIT?
Tian Yang, Han Zhang, Jun-Hua Lu and Meng-Chao
Wu
Eastern Hepatobiliary Surgery Hospital, China
Introduction: Although recognized as poor prognostic
factor, concomitant EHM is no more considered an
absolute contraindication to surgery for patients with
HCC. However, the survival benefit of combined resec-
tion of HCC and EHM has remained unclear.
Method: From 881 patients who underwent hepatec-
tomy for HCC between 2001 and 2008, 51 (5.8%) also
underwent concomitant resection of EHM. We investi-
gated the pattern of resectable EHM, the surgical out-
come, and the prognostic factors of these patients who
underwent combined resection of HCC and EHM.
Results: Of the 51 patients, 20, 18, 5, 5, 2, 2, and 1
had metastatic lesions in lymph node, diaphragm, peri-
toneum and/or omentum, adrenal gland, lung, spleen,
and ovary, respectively. Less than 5 cm of intrahepatic
HCC seemed to have better outcomes when resected
than those with not <5 cm (5-year OS: 33.3% vs 8.7%,
p = 0.070, and 5-year DFS: 30.0% vs 2.4%,
p = 0.044, respectively). In the group of patients with
lymph node metastases, patients with adjuvant radio-
therapy after surgery experienced better survival than
those without(1-year OS: 80.0% vs 50.0%, p = 0.008,
and 1-year DFS: 60.0% vs 20.0%, p = 0.064, respec-
tively).
Conclusions: Combined resection of hepatectomy and
EHM, which is the only potentially curative treatment
of HCC patients with concomittant EHM, should be
actively considered if the HCC and EHM are com-
pletely resectable. The role of adjuvant radiotherapy
after complete resection of lymph node metastases and
HCC is worthy of exploring in the future.
PPL24-005
RISK FACTORS OF SURGICAL SITE
INFECTION AFTER HEPATECTOMIES:
A PROSPECTIVE STUDY OF 7388
PATIENTS
Tian Yang, Ping-An Tu, Han Zhang, Jun-Hua Lu,
Wan Yee Lau, Meng-Chao Wu, Jie-Wei Li and Feng
Shen
Eastern Hepatobiliary Surgery Hospital, China
Introduction: Surgical site infection (SSI) is a common
postoperative complication which is associated with
increased morbidities, hospital stay, and overall cost.
Determining the risk factors of SSI may provide infor-
mation on improving outcome.
Method: A prospective study was conducted on 7388
consecutive patients who underwent hepatic resection
between 2011 and 2012. The incidence and the risk fac-
tors of SSI were studied.
Results: The incidences of overall, incisional, and
organ/space SSI were 9.4%, 5.5%, and 4.9%, respec-
tively. Independent risk factors of overall SSI were
obesity, diabetes mellitus, American Society of Anes-
thesiologists (ASA) score ≥2, cirrhosis, repeat hepatec-
tomy, hepatoliathiasis, length of abdominal drainage ≥
5 days, and intraoperative blood transfusion. Although
independent risk factors of incisional SSI and organ/
space SSI differed, hepatolithiasis, cirrhosis and intra-
operative blood transfusion were common factors
between them.
Conclusions: SSI was common in patients after hepatic
resection. Patients with hepatolithiasis or cirrhosis
should be taken more cautious care for. Early removal
of abdominal drain, as well as minimizing intraopera-
tive blood transfusion, may lower SSI rates.
PPL24-006
PROGNOSTIC ANALYSIS OF
CURATIVE LIVER RESECTIONS FOR
LIVER MALIGNANCIES COMBINED
WITH BILE DUCT THROMBI
Hong Wang, Tian Yang, Jun-Hua Lu, Shou-Xin Yuan,
Guang-Shun Yang and Meng-Chao Wu
Eastern Hepatobiliary Surgery Hospital, China
Introduction: To evaluate the safety and effect of cura-
tive liver resections for primary liver cancer (PLC)
combined with bile duct thrombi (BDT), and to ana-
lyze prognostic risk factor affecting postoperative over-
all survival.
Method: From 2000 to 2008, a total of 48 patients with
PLC and BDT who underwent curative hepatectomy
were retrospectively analyzed.
Results: The overall morbidity and mortality were
31.3% and 0%, respectively. The 1-, 3- and 5-year
recurrence-free and overall survival rates were 42.8%,
20.2% and 8.1%, and 56.3%, 31.3% and 20.2%,
respectively. Survival analysis showed that more than
5 cm of maximum tumor size, portal vein tumor
thrombosis, multiple or diffuse tumor, involving
extrahepatic bile duct of BDT were independent risk
factors effecting long-term overall survival after
hepatectomy.
Conclusions: Curative hepatectomy appears to be a safe
and effective treatment modality for patients with PLC
and BDT. However, the overall prognosis is unsatisfac-
tory, and the survival rates after operation is low.
Involving extrahepatic bile duct of BDT is an
independent risk factor for postoperative overall
survival.
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PPL24-007
WORLDWIDE LAPAROSCOPIC
HEPATECTOMY FOR LIVER
MALIGNANCY: A SYSTEMATIC
REVIEW AND META-ANALYSIS
Xing Huang2, Han Zhang1, Shu-Yang Dai2, Eric C. H.
Lai1, Meng-Chao Wu1, Tian Yang1 and Feng Shen1
1Eastern Hepatobiliary Surgery Hospital, China;
2Second Military Medical University, China
Introduction: With the development of surgical tech-
nique, laparoscopic liver resection (LLR) is now
regarded as a feasible alternative to conventional open
liver resection (OLR). Nevertheless, short- and long-
term outcomes between LLR and OLR specifically for
liver malignancy remain to be investigated.
Method: A systematic literature search was conducted
to detect relevant studies comparing short- and long-
term outcomes between LLR and OLR for patients
with liver malignancies. Meta-analyses were performed
using fixed-effects model or random-effects model.
Odds ratio (OR) and weight mean difference (WMD)
were calculated with 95% confidence intervals (CI).
Results: Fifty-one studies reporting LLR for primary
and secondary liver malignancy were systematically
reviewed, and 26 studies reporting LLR versus OLR
for liver malignancy were included for a meta-analysis.
All included studies in the meta-analysis were non-ran-
domized control trials with no significant difference in
baseline characteristics. Compared with OLR, LLR
resulted in lower blood loss (WMD 189.14; 95% CI
266.11 to 112.17), fewer requirements for transfu-
sion (OR 0.35; 95% CI 0.21–0.59), decreased length of
hospital stay (WMD 4.23; 95% CI 5.83 to 2.64),
and reduced postoperative complications (OR 0.50;
95% CI 0.39–0.65). Negative tumor resection (R0
resection) was more frequently achieved in laparoscopic
group (OR 3.08; 95% CI 1.98–4.79). No statistical sig-
nificant difference was found between LLR and OLR
in hospital mortality, tumor recurrence rate, overall
survival and disease-free survival.
Conclusions: LLR, performed by experienced surgeons,
for selected patients with liver malignancy is superior
to OLR regarding relatively better short-term out-
comes, as well as equivalent long-term outcomes.
PPL24-008
THE OUTCOME OF REPEAT
HEPATECTOMY IN PATIENTS WITH
RECURRENT HEPATOCELLULAR
CARCINOMA
Ikuo Nakamura, Yuji Imuro, Seikain Hai, Shogo
Tanaka, Tadamichi Hirano, Nobukazu Kuroda,
Toshihiro Okada, Yashukane Asano and Yuichi
Kondo
Hyogo College of Medicine, Japan
Introduction: In recent studies, it was reported that
repeat hepatectomy is effective for treating intrahepat-
ic recurrent hepatocellular carcinoma (HCC) in
selected patients. The purpose of this study was to
investigate the outcome of the repeated hepatectomy
in patients with recurrence after curative resection of
HCC.
Method: From Jaunuary 2001 to December 2010, 325
patients underwent first operation (FOP) for HCC, and
26 received a 2nd operation (SOP) for recurrent HCC.
In FOP group, the 299 patients (Non surgical treat-
ment, NST) did not receive the operation. The survival
results in each group were analyzed, and prognostic
factors were determined using clinicopathological vari-
ables.
Results: There is no significant difference between FOP
and SOP groups in recurrence free and overall survival
after the first operation (p = 0.732). Between SOP and
NST groups, the rate of overall survival in SOP group
is high with marginal significant difference (p = 0.0732)
although the recurrence free survival after the first
operation shows no significant difference (p = 0.794).
The prognostic factors for the outcome of overall sur-
vival after the second operation are the duration
between the first and second operation (over 540 days,
p = 0.0387), the operation time in the second operation
(over 470 minutes, p = 0.0062), and the second opera-
tion method (p = 0.0387).
Conclusions: The second liver resection for recurrent
HCC can be performed safely and improve overall sur-
vival with marginal significance. The patients with
recurrence after the first operation may benefit from
repeat liver resection.
PPL24-009
LAPAROSCOPIC MAJOR
HEPATECTOMY: TECHNIQUE AND
OUTCOME
Kit Man Ho, Kai Chi Cheng and Yuk Pang Yeung
Kwong Wah Hospital, Hong Kong, China
Introduction: Laparoscopic liver resection (LLR) is
now a well-accepted treatment option for both benign
and malignant disease of the liver. While, laparoscopic
approach is widely adopted in minor resection, the role
in major hepatectomy remains to be established. The
objective of this study is to share our institutional expe-
rience in laparoscopic major hepatectomies and the
patient outcome.
Method: Laparoscopic liver resection was started in
our institution in 2006. All patients underwent LLR
from March 2006 to June 2013 were identified in a pro-
spectively collected database. Major hepatectomy was
defined as resection for more than or equal to 3 liver
segments and right posterior sectionectomy. The demo-
graphic data and operative outcome of patient who
underwent laparoscopic major hepatectomy were col-
lected and the result of earlier half and later half of the
period were compared.
Results: Between March 2006 and June 2013, 124 LLR
was performed for 108 patients in Department of Sur-
gery, Kwong Wah Hospital. They were 75 (69.4%)
male and 33 (30.6%) female and the median age was
64.5. For final histological diagnosis, 14 were benign
disease, 15 were colorectal liver metastases, 4 were int-
rahepatic cholangiocarcinoma and 75 were hepatocellu-
lar carcinoma (HCC). There were 34 laparoscopic
major hepatectomies including 14 right hepatectomies,
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11 left hepatectomies and 9 right posterior sectionecto-
mies.
Patients who underwent major hepatectomies were sep-
arated into two periods to compare the results. Laparo-
scopic-assisted procedures or conversion were lesser
performed in the later period. The median blood loss
(1200 mL vs 600 mL), complication rate (58.8% vs
41.2%), and hospital stay (10 days vs 7 days) were also
significantly reduced in the later period.
Conclusions: Totally laparoscopic major hepatectomies
are feasible with growing experience. The outcome of
patient improved over time and experience on major
LLR. Further refinements of surgical technique may be
required to further improve the outcome in major
LLR.
PPL24-010
SIMULTANEOUS SPLENECTOMY AND
HEPATECTOMY FOR PATIENTS WITH
HEPATOCELLULAR CARCINOMA AND
HYPERSPLENISM: SAFETY AND
OUTCOMES
Hong Zhao, Cong Li, Xinyu Bi, Jianjun Zhao, Zhen
Huang, Yefan Zhang, Zhiyu Li and Jianqiang Cai
Cancer Hospital, CAMS, China
Introduction: Traditionally hypersplenism was consid-
ered as a contraindication to liver resections in HCC
patients. The aim of this study is to evaluate the role of
simultaneous splenectomy and hepatectomy in patients
with hepatocellular carcinoma (HCC) in terms of
safety, and long-term outcomes.
Method: From January 1999 through February 2013,
182 patients associated with cirrhotic hypersplenism
underwent simultaneous hepatectomy and splenectomy
or hepatectomy alone. Patients were divided into two
groups non-randomly. 62 patients were performed
simultaneous hepatectomy and splenectomy (Sp group)
and the other 120 patients performed splenectomy
alone served as control (non-Sp group).
Results: Background characteristics were compared
between the two groups. Except for white blood cell
(WBC) count, there were no significant differences in
other variables. Estimated blood loss and cases needed
for transfusion were similar in two groups. Pathological
characteristics, postoperative morbidity, mortality, and
postoperative hospital stay did not show a statistical
significance between the two groups as well. No portal
vein or remnant splenic vein thrombosis was observed
in any patients. Liver function recovered after surgery
in both groups and showed no differences. The 1-, 3-,
5-year survival rates for the Sp and non-Sp groups
were 82.6%, 67.8%, 54.7% and 88.5%, 62.1%, 48.5%,
respectively. There was no difference in the cumulative
survival rates between the two groups (p = 0.657).
Conclusions: Simultaneous splenectomy and hepatec-
tomy is a safe and effective treatment strategy for
patients with HCC and cirrhotic hypersplenism. By
ameliorating liver function, patients with HCC and hy-
persplenism who undergo splenectomy and hepatec-
tomy may have superiority of long-term survival. Due
to the limits of nonrandom study design and sample
size, a prospective study with a larger sample will be
necessary in future.
PPL24-011
IS THERE AN IMPACT OF
NEOADJUVANT CHEMOTHERAPY ON
HYPERTROPHY OF THE FUTURE
LIVER REMNANT IN ALPPS?
Michael Kremer, Giulia Manzini, Hristov Branimir,
Theresa Mokry, Christoph Sommer, Arianeb Mehrabi,
J€urgen Weitz, Markus B€uchler and Peter Schemmer
University Hospital Heidelberg, Germany
Introduction: Associating liver partition and portal vein
ligation for staged hepatectomy (ALPPS) has been
demonstrated as feasible procedure in the clinical rou-
tine of extended liver resection to successfully increase
the volume of the future liver remnant (FLR). Chemo-
therapy is toxic to liver and may impair hepatic regen-
eration. Since most patients with colorectal liver
metastasis undergo neoadjuvant chemotherapy this
analysis was performed to assess its effect on hypertro-
phy of the FLR during ALPPS.
Method: Thirteen consecutive ALPPS patients were
prospectively analyzed between September 2011 and
September 2012. Patients included in the study pre-
sented with multifocal colorectal liver metastasis (54%),
cholangiocarcinoma in Klatskin position (38%) and
gallbladder carcinoma (8%). Hepatectomy was per-
formed within 6–12 days after hepatic partition.
Extended right hepatectomy was performed in 11 cases.
Right hepatectomy was needed in 2 patients with previ-
ous substantial hepatic resection. A hepatico-jejunosto-
my was performed in 5 the cases (39%) at the time of
hepatectomy. Volumetry was performed twice (before
liver partition and prior to hepatectomy).
Results: Liver partition and portal vein ligation
induced sufficient hypertrophy of the FLR with an
increased volume of the FLR of 73  39%. Patients
underwent hepatectomy after a median of 8 days. R0
resection was achieved in all cases. Neoadjuvant che-
motherapy significantly impaired hypertrophy: whereas
the volume of the FLR of patients without neoadjuvant
therapy increased by 104  35%, an increase of only
48  12% was observed after chemotherapy. Main sur-
gical complications included wound infection, fluid col-
lection and biliary leakage but did not differ between
the two groups.
Conclusions: Neoadjuvant chemotherapy impaired the
hypertrophy of the liver with no clinical consequences
in this series. Still, careful selection of patient is war-
ranted.
PPL24-012
EARLY EXPERIENCE WITH A NEW
HAEMOSTATIC PATCH IN LIVER
PROCEDURES
Darius Mirza, Sarah Hill, Ali Mukwamba, Robert
Sutcliffe and Ravi Marudanayagam
Consultant Surgeon, UK
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Introduction: VerisetTM haemostatic patch has received
CE Mark approval for use in open solid organ and soft
tissue procedures. This new technology is 100% free of
human or animal components. The objective of this
study is to evaluate its ease of use and effectiveness in
achieving haemostasis during liver procedures.
Method: Consecutive patients undergoing various liver
procedures were treated with a new haemostatic patch
after traditional means of achieving haemostasis were
applied. Bleeding severity and time to haemostasis were
assessed.
Results: Data for 6 procedures performed by one sur-
geon were collected. Procedures included hemihepatec-
tomy (n = 3) and right lobe liver transplants (n = 3).
Haemostasis was first attempted by electrocautery
(100%), sutures (100%), clips (67%), staples (33%),
Argon (33%), and Clamp (17%) prior to haemostatic
patch application. Intraoperative bleeding severity was
evaluated as oozing (n = 1), low (n = 2), and medium
(n = 3). All liver transplants had medium bleeding, and
as standard of care received blood, plasma, and platelet
transfusions prior to and after product application,
which occurred near the end of each procedure. After
patch application, haemostasis was successfully
achieved in 100% of patients with a mean of
42  13 seconds (range 25–80 seconds). One applica-
tion of a 5 cm by 10 cm patch was required in 5 of 6
(83.3%) patients with a maximum time to hemostasis
of 40 seconds in this patient subgroup. The one trans-
plant patient requiring 80 seconds for haemostasis
required a second application of the patch due to initial
compromised adherence. No patch repositioning was
required, although in all 3 transplant patients the bleed-
ing site was described as a hard to reach surface. Surgi-
cal and application techniques will be discussed with
accompanying procedural video clips.
Conclusions: In our early experience, VerisetTM hemo-
static patch is easy to apply and effective in obtaining
hemostasis during liver procedures.
PPL24-013
HEPATECOTOMY COMBINED WITH
MICROWAVE ABLATION OF SPLEEN
FOR TREATMENT OF SPLENOMEGALY
AND HYPERSPLENISM COMPLICATED
WITH HEPATOCELLULAR
CARCINOMA
Jianbo Han, Yongxiang Yi, Qiang Wei, Hai Ding,
Yufeng Zhang, Liang Hu, Liang Zhao and Chuanjun
Xu
Nanjing Second Hospital, China
Introduction: To investigate the security and curative
medium-term effect of hepatecotomy combined with
microwave ablation of spleen for treatment of spleno-
megaly and hypersplenism complicated with liver can-
cer.
Method: Retrospectively analysis of clinical characteris-
tics of 13 patients treated with microwave ablation of
spleen combined with hepatecotomy for hypersplenism
secondary to hepatitis cirrhosis complicated with liver
cancer. Splenic volume and ablated volume were calcu-
lated according to contrast-enhanced CT scan. Routine
blood test (WBC count and PLT count) and liver func-
tion (ALT, AST, T-Bil, ALB, ACE) test results were
examined before and after the operation. The complica-
tions and changes of routine blood test were observed
in the follow-up period (6 months).
Results: The proportion of destructed volume to the
total volume of spleen was (34.20  1.72) %; Alanine
aminatransferase and aspartate aminotransferase
increased in the first day after operation (p = 0.039,
0.001; p < 0.05), and recovered to normal level or base-
line in 1 week (p = 0.222, 0.303; p > 0.05); Total bili-
rubin increased slightly, albumin and cholinesterase
decreased mildly in the first day, and no statistically
significant differences were found compared with pre-
operative (p = 0.069, 0.073, 0.066; p > 0.05); The count
of white blood cell increased in the first day after oper-
ation, then decreased slightly, and it was still higher
compared with that after 1 week, 2 weeks, 1 month,
2 months, 6 months (p = 0.001, 0.001,0.028, 0.037,
0.034; p < 0.05); The count of blood platelet increased
no significantly in the first day and 1 week after opera-
tion (p = 0.908, 0.274; p > 0.05),and increased signifi-
cantly 2 weeks later (p = 0.005, p < 0.05), it also
increased significantly after 1 month, 2 months,
6 months compared with preoperative (p = 0.012,
0.016, 0.02; p < 0.05); No severe complications, such as
liver failure, hepatic encephalopathy, liver section errh-
ysis, upper gastrointestinal bleeding, spleen abscess,
spleen rupture, and portal vein thrombosis, developed
after operation. No upper gastrointestinal bleeding was
found in the postoperative follow-up period.
Conclusions: Hepatecotomy combined with microwave
ablation of spleen for treatment of splenomegaly and
hypersplenism complicated with liver cancer is safe and
the medium-term effect was excellent.
PPL24-014
MICROWAVE TERMAL ABLATION FOR
BREAST CANCER LIVER METASTASIS
Riccardo Boetto, Enrico Gringeri, Daniele Neri,
Alessandro Vitale, Francesco D’Amico, Domenico
Bassi, Maurizio Romano, Michele Finotti, Giacomo
Zanus and Umberto Cillo
Chirurgia Epatobiliare e Trapianto Epatico, Italy
Introduction: More than 50% of patients with breast
cancer will develop liver metastases but only 5% of
cases the liver is the only metastatic site. Chemotherapy
is the gold standard for metastatic breast cancer with
poor outcome, and selected patients could benefit from
metastasectomy of liver disease in association with che-
motherapy, leading to a median survival ranged from
27 to 63 months, with 5-year overall survival up to
61%. When resection is not possible, minimally inva-
sive liver ablation can be used in selected patients. We
evaluated technical success, and effectiveness following
percutaneous or videolaparoscopic microwave ablation
for breast cancer liver metastases.
Method: Twenty female patients (mean age 53 years,
range 32–72) breast cancer liver metastases) with pri-
mary cancer previously treated (time to metastases:
28.05 months, range 0–168) and 39 liver metastases
(diameter of 17.6 mm, range 6–40) treated with a
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microwave ablation under ultrasound guidance in 27
different procedures (14 percutaneous, 12 videolaparo-
scopic). The average ablation time was 7.2  3.2 min-
utes.
Follow-up with abdominal CT-scan at 1, 3 and
6 months after surgery. An analysis on mortality, peri-
operative complications (within 30 days), overall sur-
vival and disease free survival were also evaluated.
Results: In the radiological follow-up (mean
19.5 months) we achieved a complete ablation of
91.2%, 90%, 86.2%, respectively at 1, 3 and 6 months.
The overall survival after microwave ablation was
19.5 months (range 4–46) with a disease-free survival of
11 months (range 1–40); 6 of 20 patients died from sys-
temic progression of disease. No patient died in the
perioperative period. In the 26 procedures 3 minor
complications occurred (Clavien I).
Conclusions: Microwave liver ablation is safe and effec-
tive in selected cohorts of patients with liver metastases
from breast cancer, achieving good results in terms of
overall and disease-free survival after procedure in
patients with multiple previous treatment.
PPL24-015
PERCUTANEOUS APPROACH FOR
SIMULTANEOUS TREATMENT OF
COMBINED FISTULA OF BILE SYSTEM
AND DUODENUM AFTER MAJOR
SURGERY
Kwang-Woong Lee, Jeong-Moo Lee, Suk-Won Suh,
Tae You, Youngrok Choi, Nam-Joon Yi and Kyung-
Suk Suh
Seoul National University Hospital, Korea
Introduction: Symptomatic biliary fistulas in patients
undergoing hepatic resection heal spontaneously in
most cases, however, sometimes it persists, and associ-
ated with deterioration of the patient’s quality of life
and impaired metabolic status. Duodenal stump fistula
after gastrectomy is also a potentially devastating com-
plication with a high morbidity and mortality which
needs a very long period of hospitalization. Surgical
management of these postoperative complication poses
challenges to the surgeon because patients are often
septic or malnourished, may have a hostile abdomen,
and persistent leakage after reoperation is fairly fre-
quent. Therefore, we described an interesting case of a
patient who had persistent biliary fistula and duonemal
stump leakage, treated simultaneously by percutaneous
transhepatic biliary stent.
Results: A 43-year-old male diagnosed as infected
thrombosis within inferior vena cava (IVC) combined
with fistula between IVC and posterior wall of duode-
nal bulb that he underwent thrombectomy, fistulectomy
and subtotal gastrectomy with gastrogejunostomy. He
had no postoperative complication and discharged at
postoperative 1 month. After 5 months of operation,
he re-admitted with fever and general weakness for
complicated fluid collection suggesting duodenal stump
leakage. Percutaneous drainage (PCD) was performed
and combined biliary leakage from small caudate duct
to same cavity by tubography. Abscess cavity was
decreased during 5 months of drainage, then two
plastic stents were inserted from cavity to duodenum.
After 1 week later, cavity was near totally obliterated
and external PCD was removed. The patient discharged
without any complication and there was no evidence of
infected fluid collection for 3 months.
Conclusions: Percutaneous approach can be considered
for simultaneous treatment of combined fistula of bile
system and duodenum instead of deteriorate surgical
re-exploration.
PPL24-016
THE ASSOCIATION BETWEEN POST
HEPATECTOMY LIVER FAILURE AND
POST OPERATIVE INFECTION
Keith Roberts, Luisa Horstmann, Chiara Becchetti, Eu
Ling Neo, Robert Sutcliffe, John Isaac, Paolo Muiesan,
Ravi Marudanayagam, Simon Bramhall and Darius
Mirza
University Hospitals Birmingham NHS Trust, UK
Introduction: Post hepatectomy liver failure (PHLF) is
a feared complication following liver surgery and has
benefited from a recent stardardised definition. The aim
of this study was to explore the association between
post operative infection and the development of PHLF.
Method: Consecutive patients undergoing resection of
4 or more liver segments over a 9 year period were
identified from a prospectively maintained database.
All patient records were reviewed to identify all postop-
erative abdominal drain and blood culture results. The
ISGLS definition of PHLF was used; for the purpose
of this abstract all categories of PHLF (A, B and C)
were grouped together).
Results: PHLF affected 162/777 (20.8%) patients.
Increasing patient age and the number of resected
hepatic segments were associated with PHLF. Patient
sex, presence of diabetes, hypertension, use of Pringle
manoeuvre, underlying pathology, intraoperative trans-
fusion were not associated with PHLF.
A positive post operative drain culture was significantly
associated with the number of resected segments. No
other variable was significantly associated.
A positive intra-operative microbiology sample was not
significantly associated with the development of PHLF
(4.8% vs 3.7%, no-PHLF and PHLF groups respec-
tively, p = 0.568) though positive drain cultures follow-
ing the operation was (14.4% vs 42.6% p < 0.001) as
were blood cultures (19.2% vs 38.9%, p < 0.001).
There was no significant difference in the cultured
organisms taken from drain samples between the
groups. Enterococcus species were the most common
positive drain culture (185/246, 75.2%). In blood cul-
tures however enterococcus was less common in the
PHLF group (71/86 vs 138/146, p = 0.007) and
MRSA/VRE were more common (9/86 vs 0/146,
p < 0.001).
Conclusions: The development of abdominal infection
is strongly associated with PHLF. Institutional review
of microbiology data should be performed to optimize
antibiotic prophylaxis. Whether patients at risk of
PHLF would benefit from extended duration of antibi-
otic prophylaxis is unclear.
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PPL24-017
LAPAROSCOPIC LIVER RESECTION
FOR HEPATOCELLULAR CARCINOMA
Hiroyuki Nitta, Akira Sasaki, Tomohiro Fujita, Kenji
Makabe, Masahisa Ishibashi, Hirokatsu Katagiri,
Hidenori Itabashi, Yasushi Hasegawa, Takeshi
Takahara and Go Wakabayashi
Iwate Medical University School of Medicine, Japan
Introduction: We have continued to perform laparo-
scopic liver resection as a means of surgical therapy for
hepatocellular carcinoma (HCC).
Method: Between March 1997 and May 2013, 349
patients underwent laparoscopic and laparoscopy-
assisted liver resections in our institution for HCC,
metastatic liver cancer, benign diseases, and living
donor. Preoperative diagnoses were HCC (n = 118),
metastatic liver tumor (n = 146), other malignant dis-
ease (n = 18), benign disease (n = 27), and living donor
(n = 39). We evaluated the degree of invasiveness and
analyzed the outcomes of laparoscopic hepatectomy
compared with open hepatectomy for HCC.
Results: There were notable differences with respect to
blood loss and postoperative hospital stay compared
with open hepatectomy cases. Concerning the survival
rate and disease-free survival rate, there were no signifi-
cant differences between procedures.
Conclusions: Laparoscopic hepatectomy for HCC were
safe and feasible, and its survival rate was acceptable.
PPL24-018
FIRST TIPS EXPERIENCE IN THE
TRANSPLANT CENTER
Dmitriy Yurlevich, Aliaksei Shcherba, Alexander
Dzyadzko, Aliaksei Fedaruk, Elena Avdey, Yauhen
Santotski, Inessa Kulinkovich and Aleh Rumo
Minsk Center for Organ and Tissue transplantation,
Belarus
Introduction: Currently, the TIPS procedure is the one
of the methods of treatment of variceal bleeding, asci-
tes, Budd-Chiari syndrome and hepatic hydrothorax.
Method: Forty-two TIPS placement were done from
August 2010 to August 2013. Mean age was 46.4 years.
29 pts had Child–Pugh C and 13 B grade. The etiology
was: PBC (n = 1), HCV (n = 18), cryptogenic (n = 3),
alcohol (n = 20).
Indications: recurrent variceal bleeding (n = 9), refrac-
tory ascites (n = 4), ascites with recurrent hemorrhoidal
vein bleeding (n = 2), intractable ascites with recurrent
variceal bleeding (n = 24), nonocclusive portal vein
thrombosis (n = 3). The procedure was successful on
the first try in 40 patients, on the second try in 1
patient, and on the third try in 1 patient. The anasto-
mosis was formed between the right hepatic vein and
the right branch of portal vein (n = 28), the middle
hepatic vein and the right branch of portal vein
(n = 12), the left hepatic vein and the left branch of
portal vein (n = 2). Stent-grafts VIATORE, JAGUAR,
SMART, MarisPlus and Missago were used. To pre-
vent hepatic encephalopathy L-ornitin, lactulose and
rifaximin were used.
Results: The average duration of procedure was 2.5
(2.5–5), the average hospital stay was 10 days (2–45).
Overal survival is 91%. There were 2 hospital (8 and
17 days after TIPS) due to hepatic failure, and 2 late
(27 and 120 days) due to variceal bleeding. Hematobilia
occurred in 1 patient and was managed medically. Reb-
leeding occurred in six patients (14.3%) at 1–21 months
(mean 5.5 months) after TIPS. Six patients (14.3%)
underwent balloon angioplasty for anastomotic stenosis
at 1–21 months after TIPS. Four patients subsequently
underwent LT.
Conclusions: TIPS is an effective treatment of compli-
cations of portal hypertension and liver cirrhosis.
PPL24-019
CLINICAL ANALYSIS OF HEPATIC
EPITHELIOID
HEMANGIOENDOTHELIOMA
Joon Hyop Lee, Nam Joon Yi, Kwang-Woong Lee
and Kyung Suk Suh
Seoul National University College of Medicine, Korea
Introduction: Hepatic epithelioid endothelioma
(HEHE) is a rare tumor of vascular origin which dem-
onstrates a variable natural course. The rarity and vari-
able outcomes are the reasons for the lack of consensus
on diagnostic and treatment modalities of the disease.
Method: From 1994 to 2010, 17 HEHE patients had
been diagnosed in Seoul national university hospital
(SNUH) and National cancer center (NCC). Four
patients underwent surgery (one transplantation, right
hemihepatectomy, left lateral sectionectomy, and tu-
morectomy each), 5 administered with chemotherapy, 3
had transarterial chemoembolization (TACE), 2
received radiofrequency ablation (RFA) – five patients
received more than one modality of treatment. Six
patients did not receive any treatments at all; four
patients were terminally ill at diagnosis and 2 waited
for transplantation.
Results: Five patients are alive at the moment, 5 are
dead and 7 are lost to follow up.
Conclusions: The rare incidence of this entity renders
large scale study difficult – most studies on this disease
rely on cases or cases series. A large scale meta-analysis
is imperative in gathering an optimal and universal
medical treatment for inoperable tumors. In addition
we summarized all HEHE cases with outcome in the
English medical literature.
PPL24-020
PREDICTIVE FACTORS OF
PALLIATIVE RADIOTHERAPY
RESPONSE IN PATIENTS WITH SPINAL
METASTASES FROM
HEPATOCELLULAR CARCINOMA
Chihwan Choi and Jinsil Seong
Severance Hospital, Yonsei University, Korea
Introduction: The spine is the most common site of
bone metastases from hepatocellular carcinoma (HCC).
Spinal metastases often severely limit the quality of life
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by causing severe pain and neurological deficits. The
purpose of this study was to evaluate the palliative
effect of radiotherapy (RT) for spinal metastases from
HCC and to identify predictive factors of survival in
HCC patients with spinal metastases who received RT.
Method: A retrospective analysis was performed on
192 patients with spinal metastases from HCC who
received RT between April 1992 and February 2012.
Multivariate analyses were used to identify predictive
factors for pain response and overall survival (OS) after
diagnosis of spinal metastases.
Results: Of 192 patients with spinal metastases from
HCC, overall pain response to palliative RT occurred
in 187 (97.4%) patients. Higher biologically effective
dose (BED) and more advanced RT technique were
identified as predictive factors for complete pain
response (CR). The 1-year and 2-year OS rates were
18.1% and 6.3%, respectively, and the median survival
time was 4.5 months. Long OS was associated with
good performance status, a controlled primary HCC,
absence of extrahepatic metastases, and a higher BED.
Conclusions: RT provided effective palliation for
patients with painful spinal metastases from HCC. In
particular, RT with a higher BED was associated with
improved pain control and OS. Our results provide
information regarding pain control, survival outcomes,
and predictive factors for the prognosis of HCC
patients with spinal metastases treated with RT.
PPL24-021
AN ASSOCIATION STUDY BETWEEN
TRANSFORMING GROWTH FACTOR-b1
-509C>T AND +915G>C
POLYMORPHISMS AND CHRONIC
HEPATITIS B IN IRANIAN PATIENTS
Seyed Reza Mohebbi1, Armin Hosseini Razavi1,
Pedram Azimzadeh1, Seyed Masoud Hosseini2, Sara
Romani1, Mahsa Khanyaghma1, Yasin Hatami1,
Afsaneh Afsaneh1 and Mohammad Reza Zali1
1Gastroenterology and Liver Diseases Research Center,
Shahid Beheshti University of Medical Sciences, Iran;
2Faculty of Biological Sciences, Shahid-Beheshti
University, Iran
Introduction: Chronic hepatitis B is one of the world’s
health problems. The cause of this infection is hepatitis
B virus (HBV) which could escape from immune sys-
tem. Transforming growth factor beta 1 (TGF-b1) can
act against HBV by suppressing replication of this
virus. Also, TGF-b1 plays a role in preventing of liver
damage in patients with chronic hepatitis B.
The aim of this study was to evaluate the association
of +915G>C and -509C>T polymorphisms with chronic
hepatitis B in Iranian patients.
Method: A population-based case–control study was
conducted in Taleghani hospital. 220 patients with
chronic hepatitis B and the same number of healthy
control subjects formed patient and control group.
PCR-RFLP method was used for genotyping of both
polymorphisms. About 10% of control samples were
sequenced to confirm the results.
Results: There were no statically significant differences
in genotype distribution and allele frequency at both
polymorphisms between healthy control and patients
with chronic hepatitis B. The age range of case and
control groups were 11–88 and 14–83, respectively. The
mean age of case group was 46.62  17.105 and this
was 43.38  15.399 for control group.
Conclusions: There was no association between TGF-
b1 -509C>T and +915G>C polymorphisms with chronic
hepatitis B and may have no role in increasing the risk
of this infection in Iranian patients.
PPL24-022
LAPAROSCOPIC LIVER RESECTIONS:
OUR EARLY EXPERIENCE OF
30 MONTHS
M.N. Saravanan, Amit Javed, Nikhil Gupta, Raja
Kalayarasan and Anil Agarwal
GB Pant Hospital & MAM College, India
Introduction: Laparoscopic liver resection has evolved
and widened in its scope. We review our initial experi-
ence in laparoscopic liver resection to assess the early
outcomes and feasibility of the procedure.
Method: Retrospective analysis of prospectively col-
lected data of all laparoscopic liver resections for vari-
ous indications at our institute between January 2011
and July 2013. Liver and biliary pathologies, primary
gall bladder cancer (GBC) in selected fit patients, who
after evaluation and/or staging underwent laparoscopic
liver resection, were included. Duration, intraoperative
blood loss and postoperative outcomes were recorded.
Results: Of the 64 patients in whom laparoscopic liver
resection was attempted, majority were for GBC (26)
followed by hepatic hydatidosis (16), hepatocellular
carcinoma (HCC) (10), besides others. Five patients
with hydatid cyst were converted due to technical diffi-
culty and one patient with GBC was converted for
anesthesia considerations. Median duration of surgery
in minutes for GBC, hepatic hydatidosis and liver
tumour was 330 (240–1000), 240 (180–300) and 195
(150–270) respectively. The corresponding median
(range) blood loss in mL was 150 (100–300), 110 (50–
250) and 200 (100–300) respectively. The median hospi-
tal stay was 5 (3–8) days.
Median lymph node yield in GBC patients was 10 (4–
31). Liver resection margins were free in all patients.
No postoperative mortality was encountered. Morbid-
ity in GBC included Grade A (ISGLS) bile leak (1),
intraabdominal collection (1) and minor chyle leak (1).
No patient suffered postoperative liver failure. One
patient with HBV related CLD, who underwent a non-
anatomical resection of segment 6 HCC developed asci-
tes, which was diuretic-responsive.
At a median follow up of 12 (1–21) months, one
patient of GBC developed lymph nodal recurrence.
During a median follow up of 16 (1–23) months, one
patient with HCC had a locoregional recurrence
9 months post surgery, treated with TACE.
Conclusions: Laparoscopy liver resection is safe and
feasible in selected patients.
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PPL24-023
LAPAROSCOPIC MANAGEMENT OF
HYDATID CYST SHOULD BE AIMED
AT COMPLETE RESECTION!
Nilesh Sadashiv Patil, Nikhil Gupta, Raja
Kalayarasan, Amit Javed and Anil Agarwal
GB Pant Hospital & MAM College, India
Introduction: Total excision of hydatid disease of Liver
or resectional surgery (cystopericystectomy or formal
resection) is the treatment of choice as it reduces the
incidence of recurrence and also decreases the incidence
of cavity related complications. This is often performed
by conventional open surgery. To analyze our experi-
ence of radical resectional surgery for hydatid disease
of the liver performed laparoscopically.
Method: We analyzed the prospectively collected data
on hydatid cyst of the liver who were managed at our
centre with laparoscopic total excision (cystopericystec-
tomy, formal liver resection).
Results: Fourteen patients were planned for laparo-
scopic resectional surgery. There were 11 females.
Mean age was 34.14 years (19–56 years). In 5 patients,
the cysts were located in the right lobe, in 6 patients,
the cysts were located in the left lobe and in 3
patients, the cyst was involving both the lobes. Four
patients had Gharbi type I cysts, 4 patients had type II
cysts and 6 patients had type III cysts. Average size of
the cysts was 6.96 9 6.85 cm. Nine patients underwent
successful complete resection (4 left lateral hepatectomy
and 5 cystopericystectomy) and 5 patients were con-
verted to open surgery. Mean intra-operative blood loss
was 111.11 mL (50–250 mL) and mean operating time
was 243.33 minutes (180–300 minutes). Bile leak did
not occur in any of the patients. There were no wound
infections or post operative cavity related complica-
tions. Four out of five patients who were converted
had cysts located in the posterior segments of liver.
Anteriorly placed cysts had higher chances of being
completed laparoscopically compared to posteriorly
placed cysts (66.6% vs 12.5%). There has been no
recurrence till date.
Conclusions: Laparoscopic total excision/resection is a
feasible option with excellent post operative outcomes
for selected cases of hydatid cyst of liver. Anteriorly
placed cysts are better suited for laparoscopic resection.
PPL24-024
POSTOPERATIVE PLEURAL EMPYEMA
AFTER LIVER RESECTION: A RARE
BUT SERIOUS COMPLICATION
Claire Goumard1, David Fuks1, Safi Dokmak1, Yves
Castier2, Catherine Paugam-Burtz1 and Jacques
Belghiti1
1Beaujon Hospital, France; 2Bichat Hospital, France
Introduction: Postoperative pleural empyema following
liver resection has not been thoroughly described in lit-
erature yet. Hence, we aimed to describe characteristics
of patients experiencing this postoperative complica-
tion.
Method: Characteristics and outcomes of 19 patients
who developed pleural empyema after liver resection,
defined as a bacteriologically proven pleural infection
with clinical and biological inflammatory signs requir-
ing antiobiotherapy and thoracic drainage, from 1996
to 2013 were retrospectively analyzed.
Results: Overall incidence of pleural empyema was
0.96%. Eleven patients were males and median age was
53 years (range 18–69). Eighteen (95%) patients under-
went right or extended right hepatectomy (with hepat-
ojejunostomy n = 6). Major indication for liver
resection was malignant or benign biliary obstruction
(n = 7, 37%) requiring preoperative biliary drainage in
6 cases. All 19 patients developed postoperatively pleu-
ral effusion and 12 (63%) developed infected abdomi-
nal collection (biliary fistula n = 4 and infected ascites
n = 4). Sixteen (84%) patients required a percutaneous
pleural drainage and 9 (47%) an abdominal drainage
(repeat laparotomy n = 2), before diagnosis of pleural
empyema. The diagnosis was made in presence of a
persistent sepsis state with bacteriologically proven
pleural infection requiring thoracic drainage. Accidental
diaphragmatic effraction was observed in 4 patients
(intra-operatively n = 3, transdiaphragmatic drainage
n = 1). Treatment included 16 procedures of percutane-
ous drainage and 4 (21%) patients underwent a thora-
cotomy for surgical drainage after a median delay of
43 days (range 21–62). The median length of stay was
43 days (range 15–106) and postoperative mortality
was 16% including 3 patients who developed septic
shock. No patient treated by thoracotomy died postop-
eratively.
Conclusions: Postoperative pleural empyema is a rare
but serious complication occurring mostly after right
hepatectomy complicated with intraabdominal sepsis.
Late diagnosis in a context of general sepsis contributes
to its severity. Pleural paracentesis for diagnosis and
treatment should be rapidly considered for these
patients. Early thoracotomy for optimal drainage
would reduce postoperative mortality.
PPL24-025
TYPE II LEIOMYOSARCOMA OF
INFERIOR VENA CAVA
Surya Ramachandra Varma Gunturi, Prakash Valse,
Venu Madhav Thumma, Sandeep Mahapatra,
Rama Krishna Pinjala and Bheerappa Nagari
Nizams Institute of Medical Sciences, India
Introduction: Leiomyosarcoma of the inferior vena
cava (IVC) is a rare tumor that presents in an insidious
manner with non-specific symptoms. We are reporting
a case of leiomyosarcoma of IVC presenting as lump in
the right upper quadrant of abdomen. Given its rarity,
there are no consensus guidelines to its management.
Method: A 40-year-old lady presented with complaints
of right abdominal discomfort for 6 months and
vague palpable lump in right upper quadrant of abdo-
men for 3 months. On examination she had a hard
mass of approximate size of 8 9 7 cm in the right
hypochondrium.
Results: She was investigated with CECT abdomen
which was suggestive of Retroperitoneal mass. She was
investigated with FNAC which was suggestive of stro-
mal tumor. Intraoperatively we found a mass arising
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from Segment II of IVC. The tumor could be excised
and IVC repaired without graft. There was minimal
narrowing of IVC. An aortic cross clamping was done
for 30 minutes which facilitated the excision of mass
with minimal bleeding. Patient had uneventful post-
operative recovery. This case is being presented for its
rarity of occurrence and presentation.
Conclusions: IVC sarcoma can be considered in the dif-
ferential diagnosis of any mass around the IVC espe-
cially when it is not possible to separate the mass from
IVC intraoperatively. Aortic cross clamping will facili-
tate the resection of tumor with minimal bleeding.
PPL24-026
HASSAB’S OPERATION IN PATIENT
WITH HEPATOCELLULAR
CARCINOMA
Takayuki Shiraki
Dokkyo Medical University, Japan
Introduction: Hassab’s operation was introduced to
treat esophageal varices and hypersplenism secondary
to treat portal hypertension. Hassab’s operation con-
sists of splenectomy and devascularization of upper
part of stomach and lower part of esophagus. It is not
rare to have patients having esophageal varices and hy-
persplenism as well as hepatocellular carcinoma
(HCC). One interesting question in these patients is the
timing of Hassab’s operation. In this study, we retro-
spectively reviewed the clinical data and analyzed out-
come of patients with HCC, who underwent
hepatectomy and Hassab’s operation simultaneously,
and who underwent Hassab’s operation followed by
hepatectomy.
Method: Between July 2000 and April 2012, 18 patients
with HCC underwent Hassab’s operation and hepatec-
tomy at our department. There were 16 males and 2
females with a mean age of 61 years old. There were 2
HBV-positive, 7 HCV-positive, 7 HBV- and HCV-
positive, and 2 HBV- and HCV-negative patients.
Patients were divided into 2 groups, Group A (n = 11):
patients who underwent hepatectomy and Hassab’s
operation simultaneously, Group B (n = 7): patients
who underwent Hassab’s operation followed by hepa-
tectomy. Our indication for simultaneous operation is
the patients with HCC having preoperative platelet
count more than 5.0 9 10000/mm. Preoperative, opera-
tive and postoperative data were compared between the
2 groups.
Results: Mean preoperative platelet counts of Group A
and B were 6.22 9 10000/mm and 5.00 9 10000/mm,
respectively (p = 0.15). There were no significant differ-
ences between the two groups, in preoperative total
AST, ALT, bilirubin, and albumin. Mean blood loss
were 1136 and 769 mL (p = 0.18). No postoperative
complication, such as bleeding from surgical sites and
rupture of esophageal varices, were observed in the two
groups. In Group B, median interval between Hassab’s
operation and hepatectomy was 5 weeks.
Conclusions: Simultaneous operation of hepatectomy
and Hassab’s operation can be performed safely, as
long as the indication is observed and operation is per-
formed with meticulous techniques.
PPL24-027
INTRAOPERATIVE BILIARY
FLUORESCENCE IMAGING IN
LAPAROSCOPIC FENESTRATION FOR
GIANT LIVER CYST
Sachiyo Shirakawa, Shinobu Tsuchida, Masahide
Awazu, Yuki Ueda, Dongha Lee, Yuko Harada,
Tomoyuki Wakahara, Hiroshi Ashitani, Yasuyuki
Hasegawa and Akihiro Toyokawa
Yodogawa Christian Hospital, Japan
Introduction: Symptomatic giant liver cyst is considered
for interventional and surgical treatments because of no
effective medical therapy. Laparoscopic cyst fenestration
(LCF) is recently accepted as standard procedure.
Although LCF is less invasive and improves cosmetic
outcome, it is sometimes difficult to identify bile duct
with thinning by liver cyst expansion intraoperatively.
The case of intraoperative biliary injury was reported.
Recently, fluorescent cholangiography using indocyanine
green (ICG) for laparoscopic cholecystectomy and hepa-
tectomy has been developed. We used this technique for
LCF in two cases and describe the details in this paper.
Method: The two cases were 71-year-old man (case 1)
and 65-year-old woman (case 2), and approximately
10 cm diameter cysts were observed in both of the two
patients with biliary strictures, abdominal symptoms,
and abnormal hepatic function (case 2). The cysts indi-
cated for LCF were located in left lateral segment in
case 1 and liver segment 4 in case 2. In both of the two
cases, 2.5 mg of ICG injected intravenously after induc-
tion of anesthesia and laparoscopic fluorescence imag-
ing system (Karl Storz, Germay) was used for
conventional imaging and near-infrared fluorescence
imaging. Fluorescent cholangiography was conducted
to detect bile duct in thinning hepatic parenchyma
around giant liver cysts and identify good site for safe
puncture. After cyst fluid aspiration using SAND bal-
loon (Hakko, Japan), the cyst wall was dissected.
Results: Fluorescent cholangiography clearly visualized
intrahepatic bile duct around the cysts with illumina-
tion, and enable to identify the site where we could
safely dissect the cyst wall. After fenestration, fluores-
cent cholangiography also used to check for bile leak.
Operative times were 285 (case 1) and 301 (case 2) min-
utes and intraoperative blood loss was <10 mL. Post-
operative courses were uneventful in both cases.
Conclusions: Intraoperative fluorescent cholangiogra-
phy using intravenous ICG injection enables LCF
safely, and is useful for avoiding biliary injury.
PPL24-028
PORTAL VEIN ANEURYSM RESECTION
Ignacio M Gonzalez-Pinto1, Javier Casillas2, Seigo
Nishida3, Akin Tekin3, David Levi3, Jose Carlos
Fernandez1 and Andreas G Tzakis3
1Oviedo University, Spain; 2University of Miami, USA;
3University of Miami Transplant Institute, USA
Introduction: The surgical treatment of a case is pre-
sented. Aneurysms of the extrahepatic portal vein are
rare. Treatment is controversial, because symptoms are
frequently unspecific, and most patients have
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comorbidities. However, there is a risk of rupture and
thrombosis that should be balanced to decide surgical
treatment.
Method: A review of 26 years at a radiology depart-
ment in a tertiary care referral hospital, revealed only 8
cases.
A 30-year-old patient was found to have a portal vein
aneurysm of 7 cm in diameter. It seemed to be affect-
ing the whole circumference of the vein, but with a
lateral saccular shape.
Operation was planned with availability of a veno-
venous by-pass pump, which eventually was not used.
After dissection of the portal vein and aneurysm, soft
rubber tourniquets were applied below and above the
aneurysm. The circumferential involvement of the vein
was found smaller than it appeared in the preoperative
image studies.
The patient tolerated well the cross-clamp of the portal
vein, with maintenance of arterial blood pressure and
no significant signs of bowel edema. Thus, cannulation
for by-pass pump was not realized.
A complete resection of the aneurism was undertaken
including a short segment of involved portal vein, and
a venous anastomosis was performed end-to-end with
non-absorbable running sutures.
Results: Postoperative recovery was uneventful. There
were no long term complications.
Conclusions: Aneurysms of the extrahepatic portal vein
are extremely rare. Surgical resection must be consid-
ered if comorbidities do not contraindicate surgery.
Patients must be referred to a hospital with experience
in portal vein surgery, preferably with the facilities of a
liver transplant unit.
PPL24-029
RESECTION MARGIN STATUS AND
LONG-TERM OUTCOME USING
RADIOFREQUENCY ENERGY AS A
RESECTION TOOL FOR COLORECTAL
LIVER METASTASES
Madhava Pai, Ashish Shrestha, David Hunter, Vasilis
Constantinides, Thalis Christophides, Long Jiao, Nagy
Habib and Duncan Spalding
Imperial College London, UK
Introduction: Hepatic resection margin involvements in
colorectal liver metastases (CRLM) have poorer long-
term outcomes. The aim of this study was to evaluate
the long-term prognosis of patients with involved hepa-
tic resection margins following resection using radiofre-
quency energy (RFE) as a liver parenchymal resection
tool for CRLM.
Method: Between 2001 and 2012, 251 patients undergo-
ing RFE assisted hepatic resections for CRLM were
identified. Patients were grouped according to their
resection margin status (R0, R1 and R2) and their
overall survival (OS) and recurrence rates (RR) were
reviewed retrospectively.
Results: There were 130 (51.8%) R0, 89 (35.5%) R1 and
32 (12.7%) R2 resections. Median follow-up was 26 (1–
135) months. Large tumour size and multiple/bilobar
metastases were significantly higher in R2 resections.
Overall median survival was 34 (0.3–137) months,
significantly higher in the R0/R1 groups compared to the
R2 group (55.4, 34.6 and 27 months, p < 0.005). Five-
year OSs were 48.5%, 34.8% and 12.5% in R0, R1 and
R2 groups respectively, with a significantly lower OS in
the R2 group (p < 0.039). RRs were not significantly dif-
ferent amongst groups with a median time to recurrence
of 37.2 (1–137) months.
Conclusions: R2 resection margin status for CRLM
using RFE shows reasonable long-term prognosis com-
pared to R0/R1 resections. The possibility of an R2
resection margin should not lead to the abandonment
of a resection.
PPL24-030
DETERMINING COMPLETE CLINICAL
RESPONSE OF RADIOLOGICALLY
DISAPPEARING COLORECTAL LIVER
METASTASES AFTER
CHEMOTHERAPY AND HOW THEY
SHOULD BE MANAGED
Madhava Pai, David Hunter, Ashish Shrestha, Thalis
Christophides and Duncan Spalding
Imperial College London, UK
Introduction: The aim of this study was to determine if
radiologically disappearing liver metastases (DLMs)
after chemotherapy correspond to a complete clinical
response. The treatment of DLMs was also assessed to
determine whether they should be resected or left in situ.
Method: A retrospective review was carried out on 342
patients referred for surgery between January 2001 and
January 2012. Twenty-eight patients showed evidence
of at least one metastasis disappearing radiologically
after chemotherapy. Sixteen patients were subsequently
eligible for review with a median follow up of 27.6
(range 5.2–113.9) months.
Results: Thirty five metastases were identified in 16
patients. Twenty-eight metastases disappeared radiolog-
ically. Ten patients had 15 DLMs left in situ and 6
patients had 13 DLMs resected. Complete clinical
response was observed in 15 DLMs (53.6%) on follow
up. Five showed no recurrence within 1 year in those
left in situ (33.3%) and 10 showed complete pathologi-
cal response after resection (76.9%). A significantly
reduced recurrence free survival was observed in the in
situ group [6.3 months vs 19.4 months (p < 0.001)], but
overall survival was not significantly different between
the two groups (p = 0.12).
Conclusions: Radiologically DLMs do not necessarily
confer a complete clinical response. They should be
resected when possible but leaving them in situ can be
warranted.
PPL24-031
AETIOLOGY AND MANAGEMENT OF
SPONTANEOUS LIVER
HAEMORRHAGE
Sheng Qiu, Eyston Vaughan-Huxley, Sameh Mikhail
and Duncan Spalding
Imperial College London, UK
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Introduction: Spontaneous haemorrhage secondary to
non-traumatic rupture of the liver has life-threatening
consequences. Hepatocellular carcinomas (HCC) are
the commonest cause with an incidence of rupture <3%
and 12–14% in Western and Asian countries respec-
tively, the reported mortality being approximately 50%
in the latter. The aim of this study was to assess the
aetiology and management of patients with spontane-
ous liver haemorrhages based on the experience of a
single institution.
Method: Between 2002 and 2013, 39 patients with
spontaneous haemorrhage secondary to non-traumatic
rupture of the liver were identified. Their aetiology,
management and outcomes were reviewed retrospec-
tively.
Results: There were 24 men and 15 women of median
age 60 (range 17–82) years. Underlying liver pathology
was identified in 33 cases of which 22 were malignant
(17 HCCs, 2 intrahepatic cholangiocarcinomas and 3
hepatic metastases [choriocarcinoma, pancreatic neuro-
endocrine and yolksac tumour]). Eleven had benign
liver lesions (adenomas [7], liver cysts [3] and haemang-
ioma [1]). Six patients had no obvious underlying liver
pathology despite follow-up imaging. Nine of the 39
patients had coagulopathies secondary to either antico-
agulation therapy (6) or thrombocytopenia (3) (pre-
eclampsia [2] and leukaemia). Twenty seven patients
were successfully managed conservatively with fluid
resuscitation, blood transfusion and correction of coag-
ulopathy. Eight patients required transarterial emboli-
sation of which 7 were successful. Surgery was
necessary in 5 cases (hepatectomies [3], perihepatic
packing [2]). Bleeding was successfully stopped in all
cases with no recurrent bleeds but 1 mortalitiy.
Conclusions: Spontaneous liver haemorrhage secondary
to non-traumatic rupture of the liver is an uncommon
presentation. Conservative management alone may be
adequate provided there is access to multi-modality
treatment in a specialist centre. If no underlying liver
pathology is initially identified, then careful follow-up
imaging is required to detect a potentially treatable
cause.
PPL24-032
SUCCESSFUL SEPARATION OF
COJOINED TWINS OMPHALOPAGUSS
IN PERU
Victor Hugo Torres-Cueva, Eduardo Guillermo
Anchante-Castillo, Cecilia Marina Yeren-Paredes and
Juan Jose Nu~nez-Ju
Hepaatobiliary Service, Peru
Introduction: The cojoined twins are a rare condition
where identical twins birth joined by some parts of the
body and share one or two organs, we report a case of
cojoined twins omphalopagus girls born by cesharea at
Guillermo Almenara National Hospital Lima Peru;
The diagnosis was pre natal By MRI in a 41-year-old
woman; post natal studies confirmed that de cojoined
twins joined by upper and anterior abdominal wall the
only organ joined was the liver so we performed the
first successful separation of the cojoined twins, hepatic
bipartition and closure of the abdominal wall without
us in biological products.
Method: This is a retrospective study of a rare case of
cojoined twins omphalopagus, we use MRI, US dopler
to diagnosis pre and post natal to planify the surgery
of separation the bodies including the hepatic bipar-
tion.
Results: Abdominal MRI and Ultrasound showed two
livers joined only by parenchyma great vessels as IVC,
Portal vein, gold blader and Biliary Tree was indpen-
dent for each cojoined twin, we performed the surgery′s
separation and hepatic bipartition of the cojoined twins
when they were 2 months years old using intraoperative
ultrasound to cut the hepatic parenchyma with CUSA
excel (Ultrasonic Disector); the closure of the abdomi-
nal wall was without use of biological products to
expand the skin, the patients had good evolution and
they were discharged from hospital at PO 30 and con-
tinue they follow up at the outpatient clinic.
Conclusions: Multidisciplinary managements is the
principal action to treatment these rare anomalies; ana-
tomical studies by MRI and Ultrasound, use of intra-
operative ultrasound and ultrasonic disector were very
useful to get the hepatic bipartition with minimal lost
of blod and the closure of the abdominal wall without
tension; the evolucion was good.
PPL24-033
HEPATOCELLULAR CARCINOMA
MIMICKING LIVER ABSCESSES
Nadya Annane, Fatiha Alibenamara, Salah Berkane,
Karim Haddad and Larbi Abid
SAC, Algeria
Introduction: Cystic HCC in the context of a non cir-
rhotic liver is extremely rare. Also high fever and leu-
kocytosis have been well described as symptoms of
HCC.
Method: We describe two cases of cystic hepatocellular
carcinoma (HCC). Two ladies their age is above 60.
One of these patients has high fever 40°C, both of them
has hyperleukocytosis. TDM scanner showed a liver
hypoechogene images in both of the patients. One
patient was operated on for cholecistitis with abscess
around the gallbladder. The second patient was oper-
ated on for gallbladder cancer with liver necrosis exten-
sion. Per operatively the first patient has a small tumor
in the small bowel with carcinomatosis with cholecisti-
tis with bile collection around it, this patient underwent
cholecystectomy associated to resection of the collec-
tion with resection of the small intestine tumor. The
second patient underwent cholecystectomy with resec-
tion of the cyst or tumor necrosis around gallbladder.
Results: Histological study showed that was a HCC
with carcinomatosis associated to gallbladder cancer in
one patient and the other it was a HCC moderately dif-
ferentiated.
Conclusions: As the HCC has cyst- like structure, wich
were fiber and necrosis. The CT images of the liver
masses resemble abscesses or tumor necrosis. We must
think at HCC when we have hypoechogene, cyst lesion
even when we have fever and hyperleucocytosis.
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PPL24-034
MULTIDISCIPLINARY TREATMENT OF
HEPATOCELLULAR CARCINOMA AT
UNIVERSITY MEDICAL CENTER
LJUBLJANA, SLOVENIA:
COMPARISON OF TWO-FIVE-YEAR
PERIODS
Valentin Sojar1, Mihajlo Dokic
1, Dragoje
Stanisavljevic1, Miha Petric1, Deja Gnezda1, Ales
Tomazic1, Peter Popovic3, Rado Jansa2 and Blaz
Trotovsek1
1University Medical Centre Ljubljana, Slovenia,
Slovenia; 2University Medical Centre, Slovenia;
3University Medical Centre, Slovenia Republic of
Introduction: Hepatocellular carcinoma is the most
common type of primary liver carcinoma. We made a
retrospective analysis of patients with the diagnosis of
hepatocellular carcinoma that were surgically treated at
our medical center between 2003 and 2012 and the use-
fulness of BCLC classification in daily routine.
Method: One hundred and sixteen patients with hepa-
tocellular carcinoma were surgically treated from 2003
to 2012. We divided patients in two groups, group 1
(G1) from 2003 to 2007 and group 2(G2) from 2008 to
2012. Decision whether the patient should be operated
or not was made based on BCLC classification.
Results: In group 1 42 patients underwent surgical
treatment, 13 of them received combined therapy
(TACE or lipiodol pre/post operatively) in group 2 74
patients underwent surgical treatment, 21 of them
received combined therapy. Median age was 66.2 in
females (6 patients, 14.3%) and 61.3 in males (36
patients, 85.7%) for G1 and 59.6 years in females
(16.2%, 12 patients) and 63 years in male patients
(83.8%, 62) in G2. Predominant etiology factor, as
underlying liver disease, in both groups was alcoholic
liver cirrhosis (48%) followed by hepatitis C (25%).
More liver resection was performed in G1 69% cases
55.4% in G2, intraoperative RFA in 19% and 2.7%
respectively, liver transplantation in 4.8% and 20.3%,
exploration only was made in 7.2% (3 patients) and
17.6% (13). Hospital stay was 20.9 days for G1 and
18.4 in G2. 38.1% of patients in G1 developed postop-
erative complications, 33.8% in G2, 56% of them
developed Clavien-Dindo classification IIIa or more,
mortality rate was 4.6% and 6.7%.
Conclusions: In our study we showed that BCLC classi-
fication is still a gold standard for staging as well as for
treatment strategy for HCC. Survival rate was signifi-
cantly higner in group 2 by Kaplan–Meier curve.
PPL24-035
REPEAT HEPATECTOMY AND
EXTREME LONG-TERM SURVIVAL IN
PATIENTS WITH RECURRENT
NEUROENDOCRINE LIVER
METASTASES AFTER HEPATECTOMY
Carlos Castro Benitez1, Aldrick Ruiz4, Nicolas
Pedano3, Michele Tedeschi2, Denis Castaing2, Rene
Adam2 and Antonio Sa Cunha2
1CHB Paul Brousse & Hospital Mexico Costa Rica,
France; 2CHB Paul Brousse, France; 3CHB Paul
Brousse & Sanatorio Britanico de Rosario, France;
4CHB Paul Brousse & UMC Utrecht, France
Introduction: Neuroendocrine tumor is a rare and silent
cancer that is usually discovered when patients have
symptoms from systemic dissemination. Liver involve-
ment is accompanied by a steep decline in survival if
not treated. Due to advances in chemotherapy but also
in surgery, this disease has luckily become almost a
chronic disease. In this study we explore the possible
benefit of repeat liver resection for recurrent neuroen-
docrine liver metastases and look particularly at the
extreme long-term survival.
Method: Between 1981 and 2011, nineteen patients
underwent repeat hepatectomy for recurrent liver
metastases for neuroendocrine tumors at our center.
Clinicopathological data was retrospectively collected
and analyzed for overall survival and prognostic fac-
tors.
Results: A repeat hepatectomy after recurrence was
performed in nineteen patients after first hepatectomy.
This series consisted of 13 female and 6 male patients.
Median age at second hepatectomy was 54 years (range
30–71 years). Small intestine and pancreas were the
most frequent origin of the primary tumor; 6 (35%)
and 5 (29%) patients respectively. Sixty-four percent
had a carcinoid tumor. Halve of the patients had minor
and halve a mayor hepatectomy. Clavien dindo classifi-
cation was grade I, II, III in 5(29%), 5 (29%), 3 (18%)
patients respectively. Three patients died within
3 months of surgery. The median survival was
166 months. The 5-, 10-, 15-year survival was 93%,
93% and 45% respectively. No clinic pathological fac-
tor had a prognostic significance in our series.
Conclusions: We particularly noted an extreme long-
term survival in our series. Even though this study rep-
resents a highly selective and sometimes extreme group
of patients, repeat hepatectomy should be considered in
patients with recurrent neuroendocrine liver metastases.
PPL24-036
FOLFOX INDUCED SINUSOIDAL
OBSTRUCTION SYNDROME (SOS) IS A
POTENTIALLY REVERSIBLE
CONDITION
Stuart Robinson1, Jelena Mann2, Derek Manas1, Derek
Mann2 and Steven White1
1Freeman Hospital, UK; 2Newcastle University, UK
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Introduction: Chemotherapy associated liver injury is a
source of concern in heavily pretreated patients present-
ing for liver resection. It is not known what the impact
of a delay between cessation of chemotherapy and sur-
gery is on the extent of liver injury. We have attempted
to answer this question using a murine chemotherapy
model.
Method: C57BL6/j mice were treated with weekly
intraperitoneal FOLFOX, or vehicle control, for
5 weeks before being culled either 1 week or 5 weeks
after the final dose of chemotherapy (n = 6 per group).
Liver tissue was harvested and formalin fixed for histo-
logical assessment. Further liver biopsies were snap fro-
zen and used for extraction of mRNA for subsequent
qRT-PCR.
Results: FOLFOX treatment results in the develop-
ment of histological features of SOS which completely
resolve after 5 weeks of recovery. SOS is associated
with increased expression of the senescence markers
PAI-1 and p21, both of which return towards normal
after recovery (p < 0.001). Similar findings are observed
regarding the expression of the key matrix remodeling
gene MMP9 (p < 0.001) and the pro-inflammatory fac-
tor CXCL1 (p < 0.001).
Conclusions: This data support the hypothesis there is
benefit in allowing a reasonable delay between cessation
of chemotherapy and liver resection in heavily pretreat-
ed patients.
PPL24-037
SIMULTANEOUS OR STAGED
RESECTIONS FOR SYNCHRONOUS
COLORECTAL LIVER METASTASES:
EARLY AND LATE OUTCOMES
John Contis, Panagis Lykoudis, Dionysios Dellaportas,
Constantine Nastos, Dionysios Voros and Agathi
Kondi-Pafiti
University of Athens Medical School, Greece
Introduction: The optimal strategy for the treatment of
synchronous liver metastases has not been established
yet. We studied the outcomes and survival of patients
who underwent a simultaneous or a staged resection in
our institution.
Method: We performed a retrospective analysis of 168
consecutive liver resections for synchronous colorectal
metastases performed in our institution and focused on
early and late outcomes of patients who underwent
either a simultaneous or a staged resection.
Results: Only about a third of patients underwent a
simultaneous resection. Demographics of the patients,
site of the primary tumor and postoperative chemother-
apy regimen were similar in both groups. Duration of
surgery, blood loss and hospital stay were slightly
greater in the simultaneous resection group, but overall
hospital morbidity and mortality were similar. There
was a trend favoring the simultaneous resection for
right sided colon cancers but the analysis showed no
difference in outcomes regarding the type of hepatec-
tomy/metastasectomy and colectomy. Overall 5 years
survival was not statistically different between the two
groups, being 43% and 39% for the simultaneous and
staged groups respectively.
Conclusions: In our experience, there is no added risk
in simultaneous resections for synchronous colorectal
liver metastases. It is a safe approach resulting in simi-
lar early and late outcomes and should be offered to all
patients with this condition. An experienced oncologi-
cal service with a close collaboration of the hepatobilia-
ry and colorectal surgeons is though a requirement.
PPL24-038
DIABETES MELLITUS IS ASSOCIATED
WITH MORBIDITY AND MORTALITY
IN ELECTIVE LIVER SURGERY
Katharina Fedtke1, Konstantinos Kouladouros1,
Daniel G€artner1, Christoph Justinger1, Matthias
Bl€uher2 and Michael R. Sch€on1
1Klinikum Karlsruhe, Germany; 2University of Leipzig,
Germany
Introduction: The incidence of diabetes mellitus (DM)
has increased by 30% in the last 10 years. In large
parts this is the consequence of an increase in body
mass index. While it is well established in elective car-
diothoracic surgery that DM is an independent cofac-
tor for morbidity and mortality such studies are
missing for liver surgery.
Method: Between 2005 and 2013 414 patients under-
went elective liver surgery. In 52% of all cases a hemi-
hepatectomy or extended hemihepatectomy was carried
out. 69 patients were diagnosed to have DM. DM was
defined as fasting blood glucose higher than 126 mg/dL
or blood glucose higher than 200 mg/dL. The patient
cohort then was subdivided into three post op groups:
Group 1 included patients without or minor complica-
tions (wound infection, pleural effusions etc.), group 2
included patients with major complications (operative
revisions, liver failure, pneumonia etc.) and group 3
included patients that died within 30 days after surgery.
For statistical analysis the Chi2-test was used.
Results: Three hundred and sixty-three patients (88%)
had an uneventful course or minor complications after
elective liver surgery. 41 patients (9.9%) patients experi-
enced major complications and 10 (2.4%) patients died
within 30 days after surgery. Diabetes was diagnosed in
55 (15%) patients in group 1, in 8 (20%) patients in
group 2 and in 6 (60%) patients in group 3 (p < 0.001).
Conclusions: The risk of severe morbidity or mortality
after elective liver surgery increases significantly in
patients with DM. Our data are in line with similar
studies in cardiothoracic surgery. Further analyses are
needed with regard to DM treatment and perioperative
glucose level management.
PPL24-039
LIVER SURGERY AFTER SELECTIVE
INTERNAL RADIOTHERAPY (SIRT)
FOR LIVER METASTASIS
Christoph Justinger, Konstantinos Kouladouros,
Katharina Fedtke, Daria Wirch, Peter Reimer, Klaus
Tatsch, Thomas R€udiger, Martin Bentz, Daniel
G€artner and Michael R. Sch€on
Klinikum Karlsruhe, Germany
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Introduction: Selective internal radiotherapy (SIRT)
with yttrium 90 microspheres has emerged originally as
an effective liver directed therapy for patients with pri-
mary non resectable malignancies of the liver. How-
ever, tumor downstaging with significant reduction of
the hepatic tumor load and induction of hypertrophy
in the non-SIRT treated liver parts has been reported
previously. Based on these experiences we selected
patients with marginally resectable liver metastases for
a combination treatment with SIRT and subsequent
liver resection.
Method: Since 2010 all patients with liver malignancies
were evaluated in an interdisciplinary tumor board.
Fourteen patients (8 female, 6 male; median 76 years
(32–77) with marginally resectable liver metastasis
(colorectal carcinoma n = 12, breast cancer n = 2) were
treated with SIRT and subsequent liver resection.
Results: SIRT (mean 1461 MBq (600–1990)) was per-
formed in all patients without complications. In seven
patients (50%) additional in situ liver split with portal
vein ligation was performed before SIRT to increase
the volume of the future liver remnant. At re-evalua-
tion all patients showed a significant decrease in tumor
size and no new metatases. Thereupon, right hepatic
resection was performed in nine, extended left hepatic
resection in three and central liver resection in two
patients. The median time interval between SIRT and
liver resection was 82 days (38–150). Histological evalu-
ation showed advanced tumor necrosis and central
scaring. Liver resection was performed in all patients
with a morbidity rate of 26% and no mortality.
Conclusions: The combination of selective internal radi-
ation therapy (SIRT) with modern liver surgery can be
performed safely. This new treatment concept could
accomplish tumor control with good patient tolerability
and might offer curative therapy options for patients
with marginal resectable liver metastases.
PPL24-040
A CASE OF CAUDATE LOBE LIVER
ABSCESS – LAPAROSCOPIC DRAINAGE
AS PRIMARY TREATMENT
Hitesh Chavda, Amit Shah, Vismit Joshipura, Ashish
Parikh, Alankar Kumar Gupta and Kinjal Pandya
Sterling Hospital, Ahmedabad, India
Introduction: Radiologically guided percutaneous
drainage of liver abscess is effective and currently is
considered the gold standard of care with success rates
between 80% and 87% and low morbidity and mortal-
ity. In this approach the recovery time is longer and
the patients needs several sessions of percutaneous
drainage. Laproscopic drainage is employed for cases
where multi-loculated abscesses have failed percutane-
ous drainage therapy or concomitant biliary pathology
is present requiring surgery. We present her a case
where the laparoscopic approach was used as a primary
approach to treat the caudate lobe pyogenic liver
abscess.
Method: Case: A 53-year- old male was found to have
caudate lobe liver abscess on investigations for fever
and pain in the abdomen. His liver functions were
within normal limits and had leucocytosis. A CT Scan
showed 5.5 9 3.5 cm caudate live liver abscess with liq-
uefaction. The percutaneous approach was difficult due
to the location. He underwent laparoscopic drainage of
the abscess successfully. The operative time was
55 minutes. The abscess cavity was thoroughly drained
and the septas was brocken with the suction cannula
and lavage was given. A drainage tube was kept in the
abscess cavity. There was no perioperative complica-
tion.
Results: Post operatively patient recovered well. Drains
were removed on 4th post operative day and he was
discharged. His subsequent Ultrasound showed faster
resolution of the residual cavity and he did not require
further intervention.
Conclusions: Laproscopic drainage of caudate lobe
abscess is an effective method as it is deep seated, sur-
rounded by major vessels, and radiological guided per-
cutaneous approach is difficult. Endoscopic transgastric
drainage has been reported but requires high level of
technical expertise. Laproscopic method is commonly
available, effective and safe method for liver abscess
drainage as a primary treatment in selected cases.
PPL24-041
CLINICOPATHOLOGIC FEATURES
AND SURGICAL OUTCOMES OF
HEPATIC ANGIOMYOLIPOMA
Jae Hoon Lee, Kwang-Min Park, Young-Joo Lee,
Song Cheol Kim and Ki Byung Song
Asan Medical Center, Ulsan University, Korea
Introduction: Hepatic angiomyolipoma (HAML) is a
rare tumor containing a variable amount of fat, vessels
and smooth muscle. The aim of the study was to review
the main clinical, imaging and pathological features of
HAML.
Method: We retrospectively analyzed the imaging,
pathological and clinical features of 20 patients who
underwent surgical resection for HAML at our institute
between March 2000 and November 2011.
Results: Three males and 17 females with a median age
of 47 years (range: 23–73 years) were enrolled in the
study. HAML was seen as a well-defined, solitary mass
on imaging with 4.8 cm of median size (mean diameter,
7.3 cm). Of 20 patients, 4 showed large size of more
than 15 cm. Presenting symptoms consisted of abdomi-
nal discomfort in 4, indigestion in 2, and fever in one,
the others were asymptomatic. On preoperative imag-
ing, 12 patients had characteristic features of hepatocel-
lular carcinoma as well as HAML. Routine blood tests,
including those for a-fetoprotein and carcinoembryonic
antigen, were normal. No patient was positive for hepa-
titis B/C and liver cirrhosis. Thirteen lesions were
located in the right hepatic lobe, 5 in the left lobe, and
2 in both. All tumors were composed of varying pro-
portions of smooth muscle, adipose tissue, and blood
vessels, and showed positive immunohistochemical
staining for HMB-45. Seven tumors were positive for
smooth muscle actin (7/7) and negative for cytokeratin
(0/7) and S-100 protein (0/3). All patients underwent
curative resection and there was no evidence of recur-
rence after a median follow-up of 46 months.
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Conclusions: When the diagnosis of HAML is suspi-
cious or hypothesized, surgical resection remains the
recommended strategy due to the difficulty in diagnosis
preoperatively and the potentially invasive growth of
the lesion. The definitive diagnosis of HAML is chal-
lenging and depends on the presence of HMB-45-posi-
tive myoid cells. HAML is treated effectively with
surgery and the prognosis is good.
PPL24-042
EVALUATION OF LIVER AND
COLORECTAL RESECTIONS FOR
SYNCHRONOUS COLORECTAL LIVER
METASTASES IN OUR INSTITUTE
Ioannis Triantafyllidis, Vasileios Papadopoulos and
Charalampos Demertzidis
General Surgeon, Greece
Introduction: Liver metastasis of colorectal cancer is
common. The optimal surgical strategy for the treat-
ment of synchronous resectable colorectal liver metasta-
ses has not been defined. The aims of this study were
to review our experience with synchronous colorectal
liver metastases and to define the safety of simulta-
neous resection of the colon and liver.
Method: From August 2008 through August 2013, 78
patients were treated surgically for primary colorectal
adenocarcinoma and synchronous hepatic metastasis.
Clinicopathologic, operative, and perioperative data
were reviewed to evaluate selection criteria, operative
methods, and perioperative outcomes.
Results: Sixty one patients underwent wedge resec-
tions of hepatic metastasis and the remaining major
liver resections (3 Couinaud segments) along with
simultaneous colorectal resections mainly for right
colon primaries. Complication rate was 49% and 7
deaths occurred postoperatively. Median hospitaliza-
tion was 14 days. The recurrence rate was 68.6%.
Recurrences most frequently occurred in liver followed
by lung.
Conclusions: Simultaneous colon and liver resection is
safe and efficient in the treatment of patients with
colorectal cancer and synchronous liver metastases.
By avoiding a second laparotomy, the overall compli-
cation rate is reduced, with no change in operative
mortality. Given its reduced morbidity, short treat-
ment time, and similar cancer outcomes, simultaneous
resection should be considered a safe option in
patients with resectable synchronous colorectal
metastasis.
PPL24-043
SEQUENTIAL TRANSCATHETER
ARTERIAL CHEMOEMBOLIZATION
AND PORTAL VEIN EMBOLIZATION
FOR HCC RESECTION IN CIRRHOTIC
PATIENTS IMPROVES OUTCOME AND
INCREASES TUMOR NECROSIS: A
CASE MATCHED CONTROL STUDY
Daniele Sommacale1, Tullio Piardi1, Yohann Renard1,
Alexandra Heurgue-Berlot1, Thomas F Baumert2,
Gerard Thiefin1, Jacques Marescaux3, Reza
Kianmanesh1 and Patrick Pessaux3
1DUNE POLE, France; 2Pole Hepato-Digestive-
Hopitaux, France; 3Franceneral Surgeon, Greece
Introduction: Liver metastasis of colorectal cancer is
common. The optimal surgical strategy for the treat-
ment of synchronous resectable colorectal liver metas-
tases has not been defined. The aims of this study were
to review our experience with synchronous colorectal
liver metastases and to define the safety of simulta-
neous resection of the colon and liver.
Method: From August 2008 through August 2013, 78
patients were treated surgically for primary colorectal
adenocarcinoma and synchronous hepatic metastasis.
Clinicopathologic, operative, and perioperative data
were reviewed to evaluate selection criteria, operative
methods, and perioperative outcomes.
Results: Sixty one patients underwent wedge resections
of hepatic metastasis and the remaining major liver
resections (3 Couinaud segments) along with simulta-
neous colorectal resections mainly for right colon pri-
maries. Complication rate was 49% and 7 deaths
occurred postoperatively. Median hospitalization was
14 days.The recurrence rate was 68.6%. Recurrences
most frequently occurred in liver followed by lung.
Conclusions: Simultaneous colon and liver resection is
safe and efficient in the treatment of patients with col-
orectal cancer and synchronous liver metastases. By
avoiding a second laparotomy, the overall complication
rate is reduced, with no change in operative mortality.
Given its reduced morbidity, short treatment time, and
similar cancer outcomes, simultaneous resection should
be considered a safe option in patients with resectable
synchronous colorectal metastasis.
PPL24-044
PERIFERAL BILE LEAK
Ignacio M Gonzalez-Pinto, Jose Carlos Fernandez,
Carmen Garcia-Bernardo, Paul B Ugalde, Janet
Pagnozzi, Rocio R Cueva, Camilo A Lopez-Arevalo
and Alberto Miyar
Oviedo University/HUCA, Spain
Introduction: Peripheral bile leak, from an intrahepatic
duct disconnected of the main biliary tree, is a chal-
lenging condition which can produce serious complica-
tions and require complex treatment.
Method: Review of 2 cases of postoperative bile leak,
due to an isolated duct of a segment of liver, in which
resolution required prolonged treatment.
Results: Case 1: a 35-year-old patient was operated of
a giant liver hydatid cyst. Most of the right liver was
affected, and a partial pericystectomy was performed.
She developed postoperative biliary fistula. Endoscopic
papillotomy and biliary stent placement did not
resolved the fistula.
After 1 year, four operations and two completion right
hepatectomies, the bile fistula persisted, and it was
infected. She developed portal hypertension, that
resolved after drainage of a subphrenic abscess. RMN
showed a patent duct of a remnant of segment 5.
Case 2: a 56-year-old patient with Caroli’s disease
affecting right liver underwent a right hepatectomy.
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After a few days presented biliary fistula through the
suction drain. CT scan demonstared dilated ducts in a
remnant of segment 8. He had an episode of anicteric
cholangitis due to obstruction of the drain. Endoscopic
papillotomy was disregarded.
In both cases, suction with soft silicone bulb was chan-
ged to a rigid suction bottle. Fluid output decreased
steadily. When output fell to around 50 mL, the drain
was removed, and complete resolution was achieved.
Conclusions: Biliary fistulas of peripheral ducts repre-
sent a condition with potentially severe complications.
Endoscopic papillotomy does not seem to be effective.
First line treatment must be suction drainage, and anti-
biotic coverage. Although a completion hepatectomy
may be necessary, it can be very challenging, and per-
cutaneous treatments such as occlusion of the indepen-
dent duct, or of the portal branch irrigating the
isolated segment, should be evaluated.
PPL24-045
LAPAROSCOPIC RESECTION OF
COLORECTAL LIVER METASTASES
SHOULD BE PERFORMED BY HAND-
ASSISSTED LAPAROSCOPIC LIVER
SURGERY
Ricardo Robles, Asuncion Lopez Conesa, Roberto
Brusadin, Vıctor Lopez, Pilar Jimeno, Vicente Olivares,
Miriam Paredes and Pascual Parrilla
Virgen de la Arrixaca University Hospital, Murcia,
Spain
Introduction: Totally laparoscopic liver surgery (TLS)
allows only a visual and ultrasonography exploration
(US) of the liver. Some publications warning about the
existence of an underestimation with this technique
regarding the real number and localization of nodules,
especially in case of colorectal liver metastasis
(CRLM). We think that Hand-assisted laparoscopic
surgery (HALS) is more reliable than TLS to stage liver
disease in CRLM because the manual palpation of the
liver can detect hidden nodules. To analyze the results
of a prospective study comparing totally laparoscopic
staging versus hand hassisted laparoscopic staging in
patients diagnosed with CRLM.
Method: Since January 2003 we have performed 146
laparoscopic liver resection and 90 of them were for
CRLM. Each patient was staged preoperative with a
CT and PET scan. At the beginning of each operation
we performed an intraoperative staging: first we visual-
ized the peritoneal cavity and then we performed a lap-
aroscopic ultrasound through the Handport without
touch the peritoneal cavity. We wrote down the num-
ber, size and location of nodules. Then we repeated the
staging adding surface palpation of the liver and the
abdomen. The ultrasound probe was the same in all
cases. To assess the staging the number of nodules
founfd in the histological study was taken.
Results: Eight patients were excluded due to chirrosis
(6) or need of two stage liver resection (2). There was
no conversion neither mortality. When we added liver
and abdominal cavity palpation and an ultrasound
guided by palpation, in 8 patients (9.5%) we detected
more nodules than in TLS staging. Furthermore in one
case we detected a peritoneal implants.
Conclusions: The tumoral staging made by TLS could
understaging the number of nodules in CRLM. At our
surgical unit, to avoid this problem, we usually perform
a HALS.
PPL24-046
DO WE NEED FOR A MORE
STANDARDIZED DEFINITION OF BILE
LEAKAGE AFTER HEPATECTOMY?: AN
PROSPECTIVE OBSERVATIONAL
STUDY
Young-Dong Yu, Dong-Sik Kim, Sung-Won Jung and
Sung-Ock Suh
Korea University Anam Hospital, Korea
Introduction: Bile leakage after liver resection remains
a major cause of postoperative morbidity, often leading
to a prolonged hospital stay, and need for additional
diagnostic tests and interventions. The international
study group of liver surgery (ISGLS) had proposed a
uniform definition and severity grading of bile leakage
after hepatobiliary and pancreatic operative therapy.
The aim of this study was apply the definition pro-
posed by the ISGLS in clinical practice and search for
additional criteria for defining bile leakage after liver
resection.
Method: We collected clinical data from patients who
underwent liver resection between May, 2012 and
August, 2013. Data included drain amount, bilirubin
concentration in serum and drain fluid on the first and
third postoperative day. Bilirubin concentration in
serum and drain fluid was also checked on the day of
drain removal.
Results: There were 128 patients during the study per-
iod. The mean age was 59.4 years. The mean bilirubin
concentration in drain fluid on the first and third post-
operative day was 8.73 and 3.67 mg/dL, respectively.
There were 10 patients whose bilirubin concentration in
drain fluid on the first postoperative day exceeded 3
times the concentration in serum. All of these patients
eventually did not develop bile leakage and were dis-
charged within the tenth postoperative day. There were
3 patients with bile leakage according to the ISGLS cri-
teria. Two patients required radiologic intervention and
1 patient required reoperation. All three patients had
bilirubin concentration in drain fluid on the third
postoperative day above 3 times the concentration in
serum.
Conclusions: The bilirubin concentration in drain fluid
on the third postoperative day was more reliable to
predict bile leakage than on the first postoperative day.
The current definition of bile leak provided by the IS-
GLS was useful in clinical practice.
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PPL24-047
OUTCOMES OF SIMULTANEOUS
RESECTION COMPARING TO
DELAYED RESECTION IN
SYNCHRONOUS COLORECTAL LIVER
METASTASIS WITH THE SAME
EXTENT OF HEPATIC DISEASE
Bunthoon Nonthasoot, Boonchoo Sirichindakul,
Nitikun Booning, Jade Suphapol, Wipusit Taesombat,
Supanit Nivatvongs, Jirawat Pattana-arun, Choocheep
Sahakitrungruang, Charnjiroj Thiptanakit and Prapon
Karnjanasilp
Chulalongkorn University, Thailand
Introduction: There has been controversy in surgical
management of synchronous colorectal liver metastasis
(SCLM) between simultaneous resection (SR) and
delayed resection (DR). The recent meta-analysis
showed that the resection criteria between these 2
groups were different resulting in the greater extent of
metastatic disease severity in DR but the same post-
operative complications and overall survival (OS) and
concluded that SR can only be recommended in
patients with limited hepatic disease. In this study, the
SR and DR have the same extent of hepatic disease
and the outcomes were reported herein.
Method: The records of the patients with SCLM
between January 2000 and January 2012 were retro-
spectively reviewed. There were 42 SR and 48 DR.
Post-operative complications, disease free survival
(DFS), and OS were analyzed.
Results: There were 42 SR and 48 DR. The average
age were 57 and 59 years old respectively. The extent
of hepatic disease was not different between these 2
groups:- number of bilobar disease: 42% and 43%,
number of liver lesion: 2.78 and 3, maximal size of liver
lesion: 4.3 and 4.2 cm, CEA level: 318 and 120 ng/mL,
proportion of major liver resection: 36% and 55%
respectively. Liver related complications were also not
different. Five years DFS and OS were 20% and 42%
in SR and 20% and 40% in DR.
Conclusions: In SCLM, SR may be performed with
comparable outcomes with DR even in case of same
extent of hepatic disease.
PPL24-048
HEPATECTOMY WITHOUT
OPERATIVE MORTALITY. 20 YEARS
OF EXPERIENCE.
Mario A. Secchi, Lisandro Quadrelli and Leonardo
Rossi
HPB. Medical School. IUNIR and HIG, Argentina
Introduction: During the last decades, hepatic surgery
has developed dramatically and today hepatic resec-
tions can be performed safely, in well-trained and well-
equipped surgical units.
Safe hepatectomy implies no intraoperative blood loss,
a reasonable rate of morbidity (0–10%), no mortality
and a short hospital stay.
Method: The aim is to evaluate prospective data from
hepatectomies carried out at Hospital Italiano Rosario-
IUNIR, Medical School as from May 1993. These
hepatic resections were re-defined following the new
IHPBA Terminology: Brisbane 2000. And to point out
and set indications, technical aspects and results
obtained.
One hundred and Fifty patients underwent liver resec-
tions; 3 required another hepatic resection and 4 a two-
step resection. (157 liver resections were performed:
traumas were excluded) There were 81 men and 69
women, the mean age was 51  16 years.
Terminology: we used the French school, adapted to
the new “IHPBA-Brisbane 2000” terminology. 85
major hepatectomies (3 or more segments) and 65
minor hepatectomies were performed. 2 or 3 Standard
techniques were used.
Results: In major hepatectomies (n = 88), surgery time
was 3.50  2.7 hours. The Hospital stay was
5  3 days, 46% morbidity, mortality has been null
since 1993. Intraoperative blood transfusion demanded
the use of 2 U. (2) from 1993 to 2013.
In Minor hepatectomies (n = 69) surgery time was
2.20  1.5 hours, Hospital stay: 3  3 days, 15% mor-
bility, and 0% mortality. Intraoperative blood transfu-
sion demanded the use of 0.5 U (+0.5) from 1993 to
2013.
Conclusions: After our learning curve (84–92) a safe
hepatectomy can be performed in our non transplant
surgical center, with no operative mortality in the last
157 consecutive liver resections.
PPL24-049
EFFECT OF NEOADJUVANT
CHEMOTHERAPY ON
POSTOPERATIVE LIVER
REGENERATION FOLLOWING MAJOR
RESECTION
Takeshi Takahara, Hiroyuki Nitta, Daiki Takeda,
Hirokatu Katagiri, Syouji Kanno, Hidenori Itabashi,
Yasushi Hasegawa and Go Wakabayashi
Surgery, Japan
Introduction: In order to analyze postoperative liver
regeneration following hepatic resection after chemo-
therapy, we retrospectively investigated the differences
in liver regeneration by comparing changes of residual
liver volume in three groups: a living liver donor group;
and two groups of patients with colorectal liver metas-
tases, who did and did not undergo preoperative che-
motherapy.
Method: This study included 32 patients who had at
least segmental anatomical hepatic resection. Residual
liver volume, early postoperative liver volume, and late
postoperative liver volume were calculated to study the
changes over time. From the histopathological analysis
of chemotherapy-induced liver disorders, the effect on
liver regeneration according to the histopathology of
noncancerous liver tissue was also compared between
the two colorectal cancer groups using Kleiner’s score
for steatohepatitis grading and sinusoidal obstruction
syndrome (SOS) grading for sinusoidal obstructions.
Results: Assuming a preoperative liver volume of
100%, mean late postoperative liver volumes in the
three groups (the living liver donor group, and the
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colorectal cancer groups with or without chemother-
apy)were 91.1%, 80.8%, and 81.3%, respectively, with
about the same rate of liver regeneration among the
three groups. Histopathological analysis revealed no
correlation between either the Kleiner’s scores or the
SOS grading and liver regeneration.
Conclusions: As estimated by liver volume, the level of
liver regeneration was the same in normal livers,
tumor-bearing livers, and post-chemotherapy tumor-
bearing livers. Liver regeneration was not adversely
affected by the extent to which steatosis or sinusoidal
dilatation was induced in noncancerous tissue by che-
motherapy in patients scheduled for surgery.
PPL24-051
DOES THE LIVER REGENERATE
AFTER MINOR HEPATECTOMY?
Laurence Lacaze, Lilian Schwarz, Eglantine Voitellier
and Michel Scotte
Rouen University Hospital, France
Introduction: Liver regeneration (LR) is a physiological
mechanism which leads to restoration of the hepatic
parenchyma following hepatectomy. Although LR
allowed performing major liver resection, up to 80% of
liver volume in healthy liver, it can be deleterious,
inducing the growth of infraclinic tumors in the rem-
nant liver. LR following minor hepatectomy has not
been reported in the literature. Thus, the aim of this
study was to analyze whether the liver could regenerate
following a minor liver resection such as left lateral
lobectomy.
Method: This study analyzed LR in 18 men and 12
women operated on by left lateral lobectomy for he-
patocellullar carcinoma (19 pts), Liver metastasis (5
pts) or benign tumor (6 pts). Liver volumes were mea-
sured using OsiriX softwareO (version 5.5.2) before
and after hepatectomy. Total liver volume, right liver,
left liver and tumor volumes were assessed using MRI
or CT-scan. Post operative evaluation of LR was per-
formed between 3 months and 1 year after surgery. LR
was defined as an increased in right liver lobe volume
following hepatectomy.
Results: Preoperatively, mean volumes of total liver,
right lobe liver, left lobe liver (including tumor volume)
and tumor were 1767.6 mL (502), 1407 mL (349),
411.2 mL (315), 122.6 mL (230) respectively. Post-
operatively, LR was observed in 18 patients with an
increased volume of right liver lobe of 27  19%.
Among 12 patients without liver regeneration, 10
patients presented with underlying liver disease. No
relationship between tumor volume and LR was
observed.
Conclusions: Knowledge of liver regeneration is impor-
tant for operative decision in patients with MHCCR
and for repeated hepatectomy in patients with cirrhosis.
According to our study, in order to prevent growth of
metastasis in the remnant liver, local resection or abla-
tion seems preferable to left lateral lobe resection in
patients with liver metastasis.
PPL24-052
ACUTE ON CHRONIC EXTRAHEPATIC
PORTAL VEIN OBSTRUCTION: A
DISTINCT CLINICAL ENTITY
Raghavendra Havannavar, Salil Parida, Biju Pottakat
and Kalayarasan Raja
JIPMER, India
Introduction: Extrahepatic portal vein obstruction
(EHPVO) has been classified into recent and chronic
type according to Baveno V consensus statement. In
recent type, patients presents with abdominal pain,
ascites, or fever secondary to portal vein thrombosis in
the absence of portal cavernoma. In chronic EHPVO,
patients present with features of portal hypertension
and is associated with portal cavernoma. However, pre-
sentation with acute symptoms in chronic EHPVO is
not uncommon. Hence this study was done to analyse
the clinical presentation of patients with EHPVO and
to propose a new classification system.
Method: Retrospective analysis of prospectively col-
lected database of EHPVO patients managed at our
institute from June 2010 to July 2013. Clinical features
and imaging findings of these patients were analysed.
Results: Of the 58 chronic EHPVO patients with portal
cavernoma 4 patients had evidence of thrombosis
within portal cavernoma on ultrasound abdomen. Of
the 4 patients 3 were females and the median (range)
age at the time of presentation was 24 (21–28). Clinical
presentation included acute mesenteric ischemia in 2
patients and ascites in two patients. Patients with acute
mesenteric ischemia underwent emergency laparotomy.
Intraoperatively in both patients proximal 80 cm jeju-
num was spared with gangrene of the next 40–50 cm of
small bowel. Both underwent resection of gangrenous
bowel segment with end stomas. Postoperative recovery
was uneventful and both were planned for restoration
of bowel continuity. Two patients with ascites were
started on oral anticoagulants and high dose diuretics
and with medical treatment their ascites resolved
in 2 weeks. Proximal splenorenal shunt was performed
in one patient and other patient is awaiting shunt
surgery.
Conclusions: Chronic EHPVO patients with acute
thrombosis is a distinct entity and needs to be reclassi-
fied as “acute on chronic EHPVO.” Acute mesenteric
ischemia in the setting of chronic EHPVO tend to spare
proximal jejunum.
PPL24-053
HYPOXIC PRECONDITIONING OF
ADIPOSE-TISSUE DERIVED STEM
CELLS ENHANCES THE LIVER
REGENERATING POTENTIAL BY
RELEASING SECRETOME
Say-June Kim1 and Dong-Goo Kim2
1Catholic University of Korea, Daejeon St. Mary’s
Hospital, Korea; 2Catholic University of Korea, Seoul
St. Mary’s Hospital, Korea
Introduction: Recently, as the adverse effects of cell-
based therapy have been revealing, i.e. the potential of
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malignant transformation, the cell-free strategies based
on the property of the stem cell’s secretome have been
in the limelight. Hypoxic condition induces increased
release of cytokines and growth factors from stem cells;
therefore, the effects of hypoxic preconditioning on the
stem cell’s function should be determined.
Method: We therefore examined the effects of precul-
turing human adipose-derived stem cells (ASC) in hyp-
oxic conditions (1–3% oxygen for 24 hours) to
elucidate the best conditions that enhance their liver
regenerative potential.
Results: We demonstrated that ASC cultured in
hypoxia activate the Wnt/b-catenin signaling pathway
while maintaining their viability and cell cycle rates.
We also showed that ASC cultured in hypoxia induced
mRNA expression and extracellular release of pro-
inflammatory and liver-recovering mediators including
IL-6, TNFa, and hepatocyte growth factor. In vivo
experiment comparing the mice – control, secretome
administration, and hypoxic secretome administration –
mice with hypoxic secretome showed the highest liver
regenerating capacity estimated by BrdU, Ki67, and
PCNA immunohistochemical stains.
Conclusions: Collectively, these data suggest that pre-
culturing ASC under hypoxic conditions prior to trans-
plantation improves their liver regenerative potential by
way of recruitment of secretome content with higher
therapeutic potential.
PPL24-054
LIN’S CLAMP REVISITED: A SAFE
MODEL OF TRAINING OF LIVER
RESECTION
YiChia Chan, Chih-Chi Wang, Wei-Feng Li, Ting-
Lung Lin, Chao-Long Chen, Shih-Ho Wang, Chih-Che
Lin, Yueh-Wei Liu, Chee-Chien Yong and Yu-Hung
Lin
Kaohsiugn Chang Gung Memorial Hospital, Taiwan
Introduction: In 1973, Lin described a simplified tech-
nique of hepatic resection using a designed clamp and
crush method. It allowed regionally vascular control to
reduce blood loss during parenchymal transection. This
technique aimed at avoiding hilar dissection and vascu-
lar clamping thereby preventing ischemic-reperfusion
injury of remnant liver.
Method: The outcome of patients who underwent
hepatic resection using Lin’s technique was reviewed.
Multiple variables were used to statistically compare
outcomes between patients with cirrhotic and non-cir-
rhotic livers and cases performed by junior surgeon
(JS) and an experienced surgeon (ES).
Results: Lin’s technique was performed in 29 patients.
Eleven and 18 cases were operated by the JS and ES
respectively. Transection time was significantly longer
in the JS group. Thirteen patients had non-cirrhotic liv-
ers whereas 16 patients had cirrhosis. There was also
no statistically significant difference in the peri-opera-
tive outcomes between cases performed by the JS and
ES and between cases of patients with or without cir-
rhosis. There was no incidence of hepatic failure within
90 days.
Conclusions: Lin’s technique is an alternative and safe
approach for hepatic resection and useful to train
junior surgeons performing hepatectomy.
PPL24-055
A RARE CASE OF DUODENAL
METASTASES FROM
HEPATOCELLULAR CARCINOMA
Affirul Chairil Ariffin1, Azrin Waheedy Ahmad2, Zamri
Zuhdi2, Azlanuddin Azman2, Hairol Othman2 and
Razman Jarmin2
1Universiti Sains Islam Malaysia, Malaysia; 2Universiti
Kebangsaan Malaysia, Malaysia
Introduction: Hepatocellular carcinoma (HCC) is the
commonest primary tumor in the liver. It has been
shown to have a strong association with hepatitis B
and C. HCC not only commonly metastases to the
other part of the liver but also commonly metastases to
the lung. Involvements of upper gastrointestinal organs
are rare. We report a case of hepatocellular carcinoma
with duodenal metastases.
Method: A 58-year-old Chinese man with a back-
ground history of hepatitis B presented with right hy-
pochondrium pain. No jaundice or any constitutional
symptoms noted. Physical exams revealed irregular
right hypochondrium mass. No ascites palpable. Most
blood investigation was unremarkable except for a
raised Alpha fetoprotein of 2920. Imaging studies con-
firmed a diagnosis of a segment 4B HCC with
enlarged portal nodes and left portal vein thrombosis.
Despite his Child’s score A, he was deemed inoperable
and subjected to chemoembolization. During a subse-
quent follow up, he developed symptomatic anaemia
with hemoglobin level of 6.2 g/dL. He developed mul-
tiple episodes of anaemia and Upper GI endoscopy
shows a bleeding tumor at first part of duodenum
extending to the second. Biopsy revealed as metastatic
HCC.
Conclusions: Hepatocellular carcinoma is known to
spread via haematogenous, lymphatics or trancoelomic.
The usual sites of metastases are lung, regional lymph
nodes and bones. Metastases via direct spread are
uncommon hence the rarity of metastases to other
upper gastrointestinal organs especially small bowel.
This presentation imposed a treatment dilemma due to
the limited approach to both primary and the metasta-
ses lesion.
PPL24-056
BILIARY CYSTADENOMA AND
BILIARY CYSTADENOCARCINOMA, A
RARE TUMOR
Ho Joong Choi1, Gun Hyung Na2, Dong Do You3,
Kee Hwan Kim4 and Young Park II1
1Catholic University of Korea Bucheon St. Mary’s
Hospital, Korea; 2Catholic University of Korea, Seoul
St. Mary’s Hospital, Korea; 3Catholic University of
Korea, St. Vincent’s Hospital, Korea; 4Catholic
University of Korea, Uijeongbu St. Mary’s Hospital,
Korea
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Introduction: Biliary cystadenomas (BCA) or biliary
cystadenocarcinoma (BCAC) are rare intrahepatic cys-
tic neoplasm. The clinical feature is not marked but
abdominal fullness and mass are the most common
symptoms. The tumor is commonly a large multilocular
cystic mass which requires hepatectomy for cure. We
experienced five cases of BCA and two cases of BCAC.
Method: A retrospective review of seven cases of BCA
and BCAC who were treated at our department during
the last one decade was performed. The clinicopatho-
logic characteristics and surgical treatments are
described in detail.
Results: Data of 7 patients who underwent hepatec-
tomy for BCA and BCAC was evaluated. Mean age
was 57 years and composition of gender was 5 female
and 2 male. Abdominal pain was presented in 3
patients, palpable mass in 1 patient and no specific
symptom in 3 patients. Before the operation, 6 patients
were diagnosed with BCA and 1 patient was diagnosed
with simple cyst. Only 2 patients showed an increase of
CA 19-9. Three patients underwent right hepatectomy,
two performed left lateral sectionectomy, one patient
underwent left hepatectomy and the other one patient
performed right posterior sectionectomy. There were no
postoperative complications and mortality in our series.
Conclusions: The treatment of choice for a BCA or
BCAC is complete resection. We report seven cases of
BCA and BCAC.
PPL24-057
BENIGN LIVER NEOPLASM. OUR
EXPERIENCE IN 101 PATIENTS
Mario A. Secchi1, Leonardo Rossi2, Lisandro
Quadrelli2, Mario Cantaberta2, Ignacio Carossi2, Pablo
Bossa2 and Esteban Mateljan2
1Professor, Argentina; 2HPB Surgery, Argentina
Introduction: Benign liver tumors (solid and non-para-
sitic cystic) are a very common condition in our setting.
The purpose of this study is to evaluate the current ten-
dency to diagnosis and management in our practice.
Method: Benign tumors to be discussed include: hyper-
plasia, adenomas, hamartomas, hemangiomas and non-
parasitic cysts. Improvements in diagnosis and manage-
ment can be defined as: better understanding of the
natural history of each type of tumor, modern imaging
techniques in assuring a precise diagnosis of tumor nat-
ure, and safer liver resections. The difficulty in differen-
tiating an HCA from a well differentiated HCC (by
imaging techniques and by biopsies) should be kept in
mind.
We will present cases that underwent surgery: Resec-
tion (Res.) A tailored therapeutic strategy should be
used from a conservative approach for hemangioma
and FNH to Res. for HCA.
Results: Between 1990 and 2013, we diagnosed benign
liver tumors in 101 symptomatic patients in 2 special-
ized HPB units. 61 of these tumors (35 solid and 26
liquid) were operated (Res.) and 40 are clinically fol-
lowed (F.Up).
1). Focal Nodular Hiperplasia (FNH) symptomatic
and > 10 cm: 5 Res., 7 F.Up in small FNH
2). Hepatocellular adenoma (HCA): 27 Res. and
F.Up of 8 asymptomatic with multiple HCA.
3). Solid mesenchymal hamartoma: 1 Res.
4). HEMANGIOMAS: 3 Res. and 15 F.Up
5). Benign liquid
5.1). simple biliary cysts = type 1: 16 patients: 3
Res. (lobar cysts) and 13 laparoscopic Res. of
the dome.
5.2). Policystosis (PLC): 4 Res.: 3 symptomatic type
2 PLC and 1 type 3 PLC and 10 F.up
6). Cystadenomas: 5 Res.
There was no mortality from surgical treatment. Mor-
bidity was 10% (6/61).
Conclusions: Close imaging assessment is mandatory
due to the natural history of HCA. In some cases, the
laparoscopic biopsy with IO frozen in the section study,
is the method of choice which leads to an appropriate
decision about the tumor nature.
PPL24-058
ADULT UNDIFFERENTIATED
EMBRYONAL SARCOMA OF THE
LIVER: A CASE REPORT
Kunmoo Choi, Hyukjai Jang and Hosuk Oh
Gangneung Asan Hospital, Korea
Introduction: Undifferentiated embryonal sarcoma of
the liver (UESL) is a very rare tumor in adults, with a
poor prognosis. Although CT or MRI reveals a large
mass, UESL is a potentially treatable tumor. A combi-
nation of complete resection, chemotherapy and radio-
therapy may prolong the patient’s survival. We report
a case of UESL in a 54 year-old- man with no prior
medical history.
Method: The patient was admitted with vague abdomi-
nal pain. The physical examination findings were unre-
markable and the results of laboratory studies
including tumor markers were all within normal ranges.
Abdominal CT and MRI showed a 7.5 cm heteroge-
neous mass associated with a 5 cm hematoma in right
lateral side of tumor and hemoperitoneum in right peri-
hepatic, hepatorenal recess, perisplenic space and pelvic
cavity. The patient underwent left hepatectomy. After
surgery, the patient received two cycles of etoposide+
cisplatin (EP) therapy and an additional radiation ther-
apy to the remnant liver. After the second cycle of EP,
the follow-up CT showed 3.5 cm sized right perigastric
soft tissue density suggesting tumor recurrence. Subse-
quently, the soft tissue was excised, and then EP was
changed to cyclophosphamide+doxorubicin+ dacarb-
azine (CAD) therapy. The patient received the sixth
cycle of CAD. Follow-up imaging studies including
positron emission tomography showed no evidence of
recurrence of the disease. He is relatively healthy at
20 months follow-up.
Results: The pathology report of left hepatectomy was
UESL with rupture and free surgical margin. Immuno-
histochemical analysis showed that the tumor was dif-
fusely positive for vimentin, desmin, smooth muscle
actin and HMB45, but it did not express CK, C-kit,
CD31, S-100 protein. Recurred tumor mass was also
UESL, but the resection margin was not free of tumor.
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Conclusions: Although UESL is an aggressive tumor
and the standard therapy is still debating, a combina-
tion of complete resection, chemotherapy and radiation
therapy may prolong the patient’s survival.
PPL24-059
HOW TO TREAT LIVER METASTASES
FROM BREAST CANCER IN SURGICAL
ASPECT
Jung Woo Lee, Kwang-min Park, Young Joo Lee,
Song cheol Kim, Jae Hoon Lee, Ki Byung Song, Jeong
Soo Nam, Jong Hee Youn and Dong Joo Lee
Asan Medical Center, Ulsan University, Korea
Introduction: Liver resection offers the only chance of
cure in metastatic liver tumors. However, Breast cancer
liver metastases (BCLM) are generally considered as sys-
temic disease. So, the role of liver resection was limited
and controversial for liver metastases of breast cancer.
Method: We retrospectively reviewed 17 consecutive
patients who underwent hepatectomy for BCLM
between January 2008 and August 2013 at Asan Medi-
cal Center, Seoul.
Kaplan–Meier curves were used for the survival analy-
sis and the logrank method used for univariate survival
analysis.
Results: The mean age was 49 years. The liver resec-
tion was R0 in 13 patients. The disease free survival
and overall survivals were 14.2 and 26.1 months. Most
recurred event occurred between 6 and 12 months.
Only R0 resection (p = 0.021) was associated with bet-
ter survival outcomes on univariate analysis.
Conclusions: Liver metastases from breast cancer are
not an absolute contraindication of hepatectomy. With
R0 resection of breast cancer liver metastass, in a few
patients the chance of cure can be obtained. Also,
recent advances of surgical technique enabled R0 resec-
tion of liver metastased from breast cancer.
PPL24-060
LATE LIVER RECURRENCE OF
FIBROLAMELLAR HEPATOCELLULAR
CARCINOMA 11 YEARS AFTER
EXTENDED RIGHT HEPATECTOMY
Mauricio Ribeiro, Simone Angelo, Caio Aquino,
Nathalie Reigada, Fabio Ferreira and Luiz Szutan
Faculdade de Cie^ncias Medicas da Santa Casa de S~ao
Paulo, Brazil
Introduction: Fibrolamellar hepatocelular carcinoma
(FLC) is a rare histologic variant of hepatocellular car-
cinoma (HCC), was first described by Edmondson in
1956 and accounts for approximately 5% of HCC
cases. The diagnosis is often made incidentally and sur-
gical resection is a curative treatment. Recurrence of
FLC has been rarely reported after 10 years.
Method: Case report based on our files and literature
review.
Results: We present an unusual case of a 21-year-old
male underwent an extended right hepatectomy for a
large fibrolamellar hepatocellular carcinoma. After sur-
gery the patient was followed with routine check-up
scans performed every 6 months to 5 years, and every
1 year after.
After 11 years returned with obstructive jaundice. CT
with liver recurrence and MRI showed extrinsic com-
pression of the biliary tree. Underwent a nonanatomic
wedge liver resection. The pathological examination
showed the recurrence of fibrolamellar hepatocellular
carcinoma in liver with negative margin.
After 6 months showed new obstructive jaundice, the
recurrences were located in the liver, lymph nodes sub-
diaphragmatic and lung metastases. Percutaneous tran-
shepatic biliary drainage was performed. Died
13.37 years after the first surgery.
Conclusions: The late recurrence (more 10 years) of fi-
brolamellar hepatocellular to the liver carcinoma is
highly exceptional but possible. Patients should be fol-
lowed for more 10 years given that late recurrences
often occur.
PPL24-061
SURGICAL TREATMENT OF
SCIRRHOUS HEPATOCELLULAR
CARCINOMA IN NORMAL LIVER: A
CASE REPORT
Kwang-Ho Yang, Young-Mok Park, Je-Ho Ryu,
Ki-Myung Moon and Chong-Woo Chu
Pusan National University Yangsan Hospital, Korea
Introduction: Scirrhous hepatocellular carcinoma
(HCC) is an extremely rare variation of HCC. Most
scirrhous HCC lesions occur in patients with viral hep-
atitis and present as moderately differentiated carci-
noma, however clinical characteristics and prognosis of
this lesion remain unclear.
Method: We experienced surgical treatment for a scir-
rhous HCC that occurred in a normal liver. Herein, we
report the pathological findings of this case and review
the relevant medical literature.
Results: (CASE) A 55-year-old woman suffering from
abdominal pain referred to our institution. In blood
chemistry findings, liver enzyme was elevated Test for
hepatitis B and C virus were all negative. And serum
AFP level was highly elevated to 350 ng/mL. Abdomi-
nal computed tomography (CT) scan and magnetic res-
onance imaging (MRI) showed solitary mass at the left
hepatic lobe, and diagnosed intrahepatic cholangiocar-
cinoma. We performed left hepatectomy with regional
lymph node dissection. A diagnosis of scirrhous HCC
was made by pathologic findings. And there was no cir-
rhosis in the adjacent liver parenchyma. The patient
recovered uneventfully and discharged on postoperative
day 20. She remains well without recurrence for 4 years
after the operation.
Conclusions: We experienced a surgical treatment of
scirrhous HCC, the extremely rare sub-type of HCC
and achieved good result. Clinicians must pay attention
to the possibility of the scirrhous HCC when a hepatic
mass with atypical clinical findings is encountered.
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PPL24-063
LAPAROSCOPIC RESECTION OF
HEPATIC ADENOMA: SINGLE CENTER
EXPERIENCE
Paulo Herman, Marcos Perini, Fabrico Coelho, Jaime
Kruger, Gilton Fonseca, Luiz D’Albuquerque and Ivan
Cecconello
Liver Unit – Clinics Hospital – University of Sao Paulo,
Brazil
Introduction: Laparoscopic resection of benign liver
diseases has gained acceptance over conventional
approach due to the ability to provide adequate surgi-
cal treatment associated to a superior cosmetic result.
However, to date there are few studies reporting specifi-
cally the results of laparoscopic treatment of hepatocel-
lular adenoma (HA).The aim of this study is to discuss
treatment strategy and assess feasibility, safety and out-
comes of a series of pure laparoscopic resection
(PLLR) for patients with HA.
Method: From a prospective database, patients with
hepatocellular adenoma were retrieved. Indications for
resection were: lesions larger than 5 cm and selected
lesions larger than 3 cm in a favorable anatomic posi-
tion (anterior or lateral segments).
Results: Thirty eight PLLR were performed in 37
patients between September 2007 and July 2013. Mean
age was 34.5 years (28–46) and mean tumor size was
6.4 cm (3.4 cm). Thirty-four patients had a single
lesion, one had two, one had four and two had liver
adenomatosis. Mean tumor size was 6.4 cm (3.4 cm).
Three right hepatectomies, 13 left lateral sectionecto-
mies and one, six wedge resections, five segmentecto-
mies and 6/7 bisegmentectomy were performed. There
were no blood transfusions or conversions. Post-opera-
tive complications occurred in two (5.2%) patients.
Mean hospital stay was 3.8 days. All patients are alive
and after a mean follow-up of 24 months (range
3–42 months), no recurrences were observed.
Conclusions: PLLR is safe and feasible and should be
considered as new standard of care for the treatment of
HA when performed by surgeons with experience in
liver and laparoscopic surgery.
PPL24-064
TRANSARTERIAL RADIO
EMBOLISATION – OUR INITIAL
EXPERIENCE
Vivekanandan Shanmugam1, Sumati S2, Uthappa
Vipin7, Rajasekhar Perumalla3, Gomathy Narasimhan4,
Srinivas Reddy5, Thomas Cherian6, Rajesh
Rajalingam8, Anand Bharathan9 and Mohamed Rela10
1FRCS, India; 2DNB (Nuclear Medicine), DRM, India;
3MS, DNB, FRCS, India; 4MS, ASTS (USA), India;
5MS, DNB, FRCS, PhD, India; 6FRCS (General),
FRCS, India; 7FRCS, FRCR, India; 8M Ch (GI
Surgery), Postdoctoral fellowship in Liver
Transplantation, India; 9DNB (GI Surgery),
Postdoctoral fellowship in Liver Transplantation, India;
10MS, FRCS, India
Introduction: Transarterial Radio Embolisation
(TARE) is a new transarterial approach to manage
large inoperable hepatocellular carcinomas. Emerging
evidence suggests that Yttrium-90 internal radiation to
tumours is an effective way of tumour control and can
be performed even in the setting of portal vein throm-
bosis as this is not embolic like chemoembolisation. We
review our initial experience in a single centre.
Method: In this retrospective study we reviewed all our
patients who underwent TARE between March 2010
and March 2013.
Results: A total of 18 patients (M-17, Female-1) had
19 TARE procedures performed during this period
with age ranging from 28 to 69 years. Fourteen
patients were in Childs A and 4 in Childs B. Sixteen
patients had portal vein thrombosis (Main-11, Right
alone-4, Left alone-1). Twelve patients had bilobar dis-
ease and 6 had unilobar disease. The lung Shunt frac-
tion was <10% in 11 patients and 10–20% in 8.
A mean dose of 1.97 GBq was used. None had any
immediate adverse effects. Follow up data was avail-
able in 17/18 patients. Ten patients expired, with a
mean survival of 6.2 months ranging from 2 to
16 months. Seven patients are alive (range from 1 to
11 months) with an overall survival of 6 months. Seven
out of 10 patients who died had main portal vein
thrombosis and had mean survival of only 3.7 months.
Conclusions: The results of patients with HCC treated
with TARE had reasonable survival benefits and pro-
vided good palliation. Patient selection is of paramount
importance for achieving good results.
PPL24-065
POSTOPERATIVE LACTATE
CLEARANCE AFTER EXTENDED
HEPATECTOMIES: IS IT WORTHY?
Duilio Pagano1, Gabriel Cardenas2, Salvatore
Gruttadauria1, Pasquale Bonsignore1, Davide
Cintorino1, Sergio Li Petri1, Calogero Ricotta1,
Roberto Miraglia3, Bruno Gridelli1 and Marco Spada1
1Mediterranean Institute for Transplantation and
Advanced Specialized Therapies (ISMETT), University
of Pittsburgh Medical Center (UPMC) in Italy, Italy;
2Universidad Nacional Autonoma de Mexico, Mexico
City, Mexico; 3ISMETT, UPMC in Italy, Italy
Introduction: Postoperative plasma lactate has been
established as an important prognostic factor for
extended hepatectomy (EH) morbidity and mortality.
Method: In this single center retrospective study, a full
revision of 45 medical records was performed from
patients who underwent EH from 1999 to 2013. Post-
operative lactate clearance (DLAC) was defined as lac-
tate at postoperative day 5 minus lactate at ICU
presentation (hour 0). DLAC was analyzed in relation
to total hospital stay and 90 days’ perioperative mor-
bidity and mortality, using Clavien-Dindo classification,
and by presence or absence of previous portal vein
embolization (PVE).
Results: Forty-one right and 4 left EH were performed.
From these, 17 underwent previous PVE with a mean
of 44  29 days-to-surgery time and a 24  8% degree
of hypertrophy. In 39 cases (87%) a malignant etiology
was the indication for EH, surgery length was
486  122 minutes with a median of 300 mL of blood
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transfusion. In 25 patients a Clavien grade IIIa or
worst complication has been experienced, and in 3
cases the death occurred during the first 3 months after
EH. The median length of hospitalization was 11 days.
In patients with preoperative PVE a significative associ-
ation with an early post-resectional lactate clearance
was achieved (p = 0.01). Conversely, the univariate
analysis did not show any significative associations
between DLAC and a median time of hospital stay
major of 11 days (p = 0.08), or the onset of any com-
plications (p = 0.67) and of a Clavien’s grade of com-
plications ≥IIIa patients (p = 0.48). After adjusting for
co-variables, results of the multivariate logistic regres-
sion analyses confirmed that DLAC is not independent
or significant predictor for initial poor liver function
following EH.
Conclusions: The postoperative lactate clearance has
not been served as a prompt and accurate bedside pre-
dictor of severe complication after EH. In light of this
experience, the early lactate clearance could have a clin-
ical utility in the ICU statement, but in our facility was
dramatically reduced during the daily hospital stay
after EH.
PPL24-066
A CASE OF HEPATIC BILOMA AFTER
LAPAROSCOPIC PARTIAL HEPATIC
RESECTION FOR HEPATOCELLULAR
CARCINOMA USING MICROWAVE
PRE-COAGULATION TECHNIQUE
Hideyuki Takata, Yasuhiro Mamada, Nobuhiko
Taniai, Masato Yoshioka, Youichi Kawano, Tetuya
Shimizu, Junji Ueda and Eiji Uchida
Nippon Medical School, Japan
Introduction: In a laparoscopic hepatectomy, to control
bleeding from liver parenchyma is important. Micro-
wave pre-coagulation technique is effective to achieve
good hemostasis during hepatic resection. On the other
hand, there is a danger of causing bile leakage and bile
duct strangulation by the biliary damage after micro-
wave coagulation.
Method: We report a case of hepatic biloma after lapa-
roscopic partial hepatic resection for hepatocellular car-
cinoma using microwave pre-coagulation technique.
Results: A 73-year-old male was monitored for alco-
holic liver cirrhosis. During follow-up, an abdominal
CT identified a HCC 20-mm in diameter in S5 of the
liver. Laparoscopic partial resection of the liver S5
using microwave pre-coagulation technique was per-
formed. Blood loss was 20 mL. Seven months after the
procedure, an abdominal CT revealed recurrence of the
liver S5. Laparoscopic partial resection of the liver S5
was performed again. Then, biloma formation was
observed. The patient was discharged on the 16th post
op day.
Conclusions: Pre-coagulation method by microwave
coagulation for laparoscopic hepatectomy represents a
feasible technique with good control of bleeding. How-
ever, several reports have demonstrated that the bile
leakage occurred more frequently in patients with hepa-
tectomy using microwave pre-coagulation technique.
Therefore, it is concluded that adequate use of micro-
wave pre-coagulation technique recommended for lapa-
roscopic hepatectomy.
PPL24-067
THE AQUAMANTYS SYSTEM AS
ALTERNATIVE FOR PARENCHYMA
DIVISION AND HEMOSTASIS IN LIVER
RESECTION: A CLINICAL FEASIBILITY
STUDY
Giuseppe Curro, Salvatore Lazzara, Alberto Barbera,
EugenioDe Leo, Fabio Guccione, Valentina Rampulla
and Giuseppe Navarra
University of Messina, Italy
Introduction: The objective of this study was to evalu-
ate the clinical feasibility of a new technique for liver
resection based on a bipolar sealing device (Aquaman-
tys) that has shown high performance in the animal
setting in both parenchymal ablation and tissue necro-
sis.
Method: Fifteen patients with colorectal hepatic metas-
tasis and twelve cirrhotic patients with hepatocellular
carcinoma underwent partial hepatectomies using the
proposed technique for both parenchyma division and
hemostasis. Main outcome measures were blood loss
per transection area and transection speed, and post-
operative morbidity (biliary leakage, hemoperitoneum,
liver abscesses, etc).
Results: Twelve monosegmentectomies, eight bisegmen-
tectomies and seven atypical resections were performed.
No blood transfusion was required both intra-opera-
tively and post-operatively. No mortality was observed.
One biliary leakage occurred post-operatively and was
treated conservatively. One liver abscess after 6–7 bi-
segmentectomies occurred and was successfully treated
by ultrasound-guided drainage. The median blood loss
per transection area 0.8 mL/cm2 (range 0.1–1.9 mL/
cm2). Mean post-operative stay was 6 days (range 5–
16 days). No statistically significant differences were
found comparing resections in normal liver (secondary
tumors) and cirrhotic liver.
Conclusions: The proposed bipolar sealing device was
shown to be safe and to achieve effective parenchymal
division and hemostasis, resulting in reduced blood
loss. Comparative trials are needed to confirm our pre-
liminary results.
PPL24-068
“MAXIMAL DIAMETER NOT <3 CM”
AND “THREE OR MORE METASTASES”
AS A NEW INDICATION OF
PREOPERATIVE CHEMOTHERAPY
FOR RESECTABLE LIVER
METASTASES
Ryuta Nishitai, Dai Manaka, Sayuri Konishi, Shin-ya
Hamasu, Kenji Yoshino, Satoshi Kanto, Shun-pei
Kanai, Eisei Mitsuoka and Ryo Kudoh
Kyoto-Katsura Hospital, Japan
Introduction: Induction chemotherapy against unresec-
table colorectal liver metastases (CRLM) has been
widely conducted. However, the role of preoperative
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chemotherapy for initially resectable CRLM is still con-
troversial. We retrospectively examined the utility of
preoperative chemotherapy for CRLM in our hospital.
Method: Sixty-three consecutive cases of initially
resectable liver only colorectal metastases from 2000 to
2013 were evaluated. Twenty cases received preopera-
tive doublet chemotherapy which consisted of oxalipla-
tin or irrinotecan and fluorouracil (N group) and 43
cases underwent hepatectomy without preoperative ox-
aliplatin or irrinotecan (S group). The demographic of
the two groups were similar, and most of the patients
received fluorouracil based postoperative chemother-
apy. We compared progression free survival after hepa-
tectomy (PFS) and overall survival between the two
groups.
Results: PFS curves of the N and S group completely
overlapped. The overall survival curve of N group
showed tendency to be longer than that of S group
with no statistical significance. For further investiga-
tion, according to age, synchronous metastases or
metachronous, lymph node involvement of the primary,
the number of the metastases, the size of the largest
tumor, surgical margin, we divided 63 cases into two
subpopulations, and compared between PFS of N
group and that of S group within each subpopulations.
Among those subpopulations, PFS of N group was
shorter in the patients with <3 metastases or maximum
tumor size <3 cm, as compared to that of S group. On
the contrary, N group showed better PFS than S group
when the number of the tumor was three or more and
the maximum size not <3 cm. Other factors did not
show significant difference in relation to the preopera-
tive chemotherapy.
Conclusions: We propose “maximal diameter not
<3 cm” and “three or more metastases” as a new indi-
cation of preoperative chemotherapy for resectable liver
metastases.
PPL24-069
13 YEARS’ EXPERIENCE OF SURGICAL
MANAGEMENT AFTER EXTENDED
HEPATECTOMY IN A SOUTHERN
ITALIAN REFERRAL CENTER
Gabriel Cardenas2, Duilio Pagano1, Salvatore
Gruttadauria1, Pasquale Bonsignore1, Davide
Cintorino1, Sergio Li Petri1, Calogero Ricotta1,
Roberto Miraglia3, Bruno Gridelli1 and Marco Spada1
1Mediterranean Institute for Transplantation and
Advanced Specialized Therapies (ISMETT), University
of Pittsburgh Medical Center (UPMC) in Italy, Italy;
2Universidad Nacional Autonoma de Mexico, Mexico
City, Mexico; 3ISMETT, UPMC in Italy, Italy
Introduction: Extended liver resection implies a radical
procedure invariably carrying high rates of postopera-
tive morbidity and mortality. The aim of this study is
to perform a full revision of 45 patients submitted to
extended hepatectomy (EH), trisectionectomy according
to Birsbane 2000 classification.
Method: We examined demographics, preoperative
portal vein embolization (PVE), operative factors, and
early post-operative complications for procedures,
focusing on the results of patients who underwent EH
from 1999 to 2005 (P1) and from 2006 to 2013 (P2).
Results: The most common cause for EH was colorec-
tal liver metastasis (CRLM). Forty-one right and 4 left
EH were performed. From these, 17 underwent previ-
ous PVE with a mean of 44  29 days-to-surgery time
and a 24  8% degree of hypertrophy. Surgery length
was 486  122 minutes with a median of 300 (0–
3900) mL of blood transfusion. Histological findings:
39(87%) malignant etiologies, size of largest tumor
7.4  4.2 cm, 15 (42%) positive margins (10 CRLM),
20 (56%) vascular invasions and 9 (25%) perineural.
Ninety days’ morbidity and mortality was seen in 32
(72%) and 3 (7%) patients, respectively. Most common
complications were: 16 right pleural effusions (35%),
11 intra-abdominal collections (24%) and 11 biliary
leakages (24%). Mean hospital stay was 18 (5–107)
days, depending on Clavien’s grade of complications
[≥IIIa 25  24.6 vs <IIIa 10.4  5.6, p = 0.01]. Com-
paring periods (P1 vs P2) we found an important
increase in the number of PVE (p = 0.056), negative
margins (p = 0.007), and hospital stay (p = 0.008), and
a decrease in the need for blood transfusion (p = 0.04).
These variables analyzed in terms of complications
showed that not having PVE was significantly associ-
ated with having any complication (p = 0.003).
Conclusions: The increase in performing PVE in
selected patients and the lack of association between
short-term complications and positive margins espe-
cially on colorectal liver metastasis, suggest to strongly
consider this surgical option to expand selection criteria
and clinical management in these groups of patients.
PPL24-070
ISOLATED HEPATIC TUBERCULOSIS
MIMICKING METASTATIC DISEASE
Vivekanandan Shanmugam1, Anand Bharathan2,
Rajesh Rajalingam3, Manoj Shrivastav4, Kumar
Palaniappan5, Thomas Cherian9, Rajasekhar
Perumalla7, Srinivas Reddy8, Gomathy Narasimhan6
and Mohamed Rela10
1FRCS, India; 2DNB (GI Surgery), Postdoctoral
fellowship in Liver Transplantation, India; 3M Ch (GI
Surgery), Postdoctoral fellowship in Liver
Transplantation, India; 4DNB (General Surgery),
Postdoctoral fellowship in HPB Surgery, India; 5DNB
(GI Surgery), Fellowship (LT & HPB), India; 6MS,
ASTS (USA), India; 7MS, DNB, FRCS, India; 8MS,
DNB, FRCS, PhD, India; 9FRCS (General), FRCS,
India; 10MS, FRCS, India
Introduction: Liver metastasis from carcinoma breast
currently represents a relative contraindication for liver
resection. We present the case of a patient who pre-
sented with liver lesions consistent with metastasis,
7 years following treatment of carcinoma breast and
report the pathologic surprise encountered after resec-
tion of liver tumour.
Method: We have reviewed the case record of this
patient to present the pertinent facts.
Results: A 4-year-old woman presented to us with
diagnosis of liver tumour with high standard uptake
value (SUV) on PET-CT, 5 years following modified
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radical mastectomy and postoperative adjuvant chemo
radiotherapy for carcinoma of left breast (T2N0M0).
She was asymptomatic. Past history was remarkable
for total hip replacement for fibrous dysplasia of right
hip 5 years ago and right upper pole nephrectomy for
cystic disease 7 years ago. Clinical examination was
unremarkable. CT scan abdomen showed hypodense
lesions in segment 6 and segment 8 of liver of size
1.5 cm. Whole body PET-CT did not show any other
evidence of disease. Diagnosis of isolated liver metasta-
sis from carcinoma breast was made in view of history
and PET-CT findings. Biopsy was not considered as
there would be risk of tumour spillage and diagnosis
was considered fairly straightforward, given the clinical
situation. Diagnostic laparoscopy followed by right
hepatectomy was performed uneventfully. Cut surface
of the specimen showed multiple subcentimeter, pearly
white lesions which were firm to hard in consistency.
Biopsy of the lesion was reported as multiple caseating
granulomas, diagnostic of tuberculosis. She has been
started on antituberculous therapy.
Conclusions: Tuberculosis of liver is known to be PET
avid. Offering liver resection in this clinical scenario
seemed appropriate as opposed to preoperative fine
needle aspiration cytology of the lesion. Latter would
risk dissemination, in case these lesions were breast car-
cinoma metastasis.
PPL24-071
LIVER PARTITION AND PORTAL VEIN
LIGATION (ALPPS) FOR THE
TREATMENT OF A LARGE
PERIPHERAL
CHOLANGIOCARCINOMA. A GOOD
INDICATION FOR AN INNOVATIVE
PROCEDURE
Paulo Herman, Abe Emerson, Dumarco Rodrigo,
Fonseca Gilton and Kruger Jaime
University of Sao Paulo Medical School, Brazil
Introduction: In the last year there has been a huge
debate between liver surgeons about an innovative pro-
cedure proposed in Germany by Lange et al and popu-
larized by Santiba~nes and colleagues: in situ liver
partition associated to selective portal vein ligation
(ALPPS) that was proposed for the treatment of
patients with large amount of liver tumors and an
expected small liver remnant, allowing its feasibility
and avoiding postoperative liver failure.
Method: We present a case of a 58 year-old male with
an 11 cm peripheric cholangiocarcinoma on segments
4, 7 and 8 invading the right and middle hepatic veins
and very close to the left hepatic vein. An extended
right hepatectomy was indicated however, liver volume-
try showed that segments 1, 2 and 3 represented 22%
of the entire liver volume.
Results: Preoperative portal vein embolization was nec-
essary however, authors feared that during waiting time
for liver hypertrophy, the lesion could grow and
become unressectable; decision was made for an AL-
PPS. During the procedure the right branch of the por-
tal vein and segment 4 pedicle were ligated; the liver
was sectioned at the level of the falciform ligament.
After 6 days a CT volumetry showed a 49% increase.
At the 7th postoperative day, the second step of the
operation was performed (extended right hepatectomy).
Patient outcome was uneventful with hospital discharge
at the 12th postoperative day.
Conclusions: Our group has performed 7 cases of AL-
PPS: 6 for colorectal cancer liver metastasis and the
present case; All procedures were indicated for fit
young patients (<60 years) and the second step was
always performed within 8 days from the first one.
Mean liver growth was 48%. Postoperative morbidity
was 42% and all patients had a good outcome with no
mortality. Despite a subject of debate, ALPPS is a use-
ful tool for selected patients with liver tumors.
PPL24-072
MACROSCOPIC CLASSIFICATION OF
PVTT AND BACK FLOW
THROMBECTOMY FOR THE
TREATMENT OF ADVANCED HCC
WITH VP4 PVTT
Takumi Fukumoto, Masahiro Kido, Atsushi Takebe,
Motofumi Tanaka, Kuramitsu Kaori, Tetsuo Ajiki,
Ippei Matsumoto, Shinzeki Makoto, Taro Okazaki and
Yonson Ku
Kobe University, Japan
Introduction: To improve the prognosis of HCC
patients with PVTT, development of less invasive, sim-
ple and effective thrombectomy technique for deeply
sitting PVTT is imperative. To this purpose, we have
proposed new macroscopic classification of PVTT
which has a high degree of availability for thromberc-
tomy and have developed the new thromberctomy tech-
nique based on this classification. The objective of this
study was to evaluate the efficacy of the new thromb-
erctomy technique which is referred as the “ Back flow
thrombectomy (BFT) technique,” and show the treat-
ment results of liver resection for HCC with contralat-
eral deeply sitting PVTT.
Method: Until the end of 2011, 43 multiple bilobular
HCC patients with Vp4 were performed reductive hep-
atectomy with tumor thrombectomy. In 22 of 43
patients, BFT were used. Sixteen of 23 patients had
PVTT in the contralateral second portal branch. Seven-
teen of 43 patients were not performed. Percutaeous
Isolated Hepatic Perfusion (PIHP) as adjuvant chemo-
therapy because of either economical reason, extrahe-
patic metastases, tumor progression, hepatic
dysfunction or infectious complications.
Results: Patency rates of portal vein at thrombectomy
site of all (43)/BFT (22) 3 and 6 months after hepatec-
tomy were 92%/90% and 87%/86%, respectively. The
median OS of all 43 patients was 14 months and the 1
and 3-year OS rate was 55.5% and 19.1% respectively.
In 26 patients who could undergo PIHP as second
treatment, the median OS was 17 months and the 1
and 3-year OS rate was 69.2% and 23.1% respectively.
Conclusions: Tumor thrombectomy by BFT achieved
high patency rate of portal vein 6 months after hepa-
tectomy and expands therapeutic window for adjuvant
chemotherapy for patients with multiple bilobular HCC
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and Vp4 PVTT who were previously untreatable. An
impressively increased survival rate achieved by addi-
tional PIHP in this setting advocates surgical multidis-
ciplinary approach for multiple bilobular HCC with
Vp4 PVTT.
PPL24-073
LAPAROSCOPIC LIVER RESECTION
FOR COLORECTAL LIVER
METASTASES: A SINGLE CENTER
ANALYSIS OF 101 CONSECUTIVE
CASES
Yasushi Hasegawa, Hiroyuki Nitta, Takeshi
Takahara, Hidenori Itabashi, Shoji Kanno, Hirokatsu
Katagiri, Masahisa Ishibashi, Akira Sasaki and Go
Wakabayashi
Iwate Medical University School of Medicine, Japan
Introduction: Laparoscopic liver resection for colorectal
liver metastases (CRLM) remains limited to a relatively
small number of institutions. Recently, the operative
results have been reported to be comparable with open
laparotomy, however its long term outcomes have been
reported in few series. The aim of this study was to
assess the operative results and the long term outcomes
of laparoscopic hepatectomy (LH) for CRLM in a sin-
gle institution.
Method: At Iwate Medical University Hospital first
LH for CRLM was performed in 1998, and consecutive
101 patients underwent LH for CRLM. The operative
results, the oncological factor, the overall survival rate,
and the recurrence free survival rate were analyzed.
Results: The median (range) operative time was 228
(70–591) minutes, the blood loss was 116 (3–1567) mL,
the hospital stay was 9 (4–256) days, the morbidity
(Clavien-Dindo classification ≥II) was 13.9%, and the
mortality was 1%. Overall survival and the disease free
survival rate were 93.8 and 68.1% at 1 year, 66.7 and
35.4% at 3 years, 60.9 and 35.4% at 5 years, respec-
tively.
Conclusions: Laparoscopic hepatectomy for CRLM
was feasible in terms of not only the operative results
but also the oncological outcomes.
PPL24-074
CRYOABLATION IN PATIENTS WITH
UNRESECTABLE LIVER AND
PANCREATIC TUMORS
Alexey Chzhao, Dmitriy Ionkin, Olga Zhavoronkova,
Nataliya Vetsheva, Anna Shurakova, Sergey Bugaev
and Sergey Kungurtsev
Member of IHPBA, Russia
Introduction: Results of the treatment of patients with
localy advanced liver and pancreatic tumors are poor.
We analysed results of cryoablation in patients with
unresectable colorectal liver metastases (CLM) and
pancreatic head cancer.
Method: Since 2007, cryoablation was performed in 60
pts. (24 pts – for colorectal liver metastases and 36 –
for pancreatic heard cancer). Mean age was
54  3 years. Size of lesions in the liver ranged from
1.5 to 9 cm, the number of lesions – from 1 to 10
(4  3). Size of lesions in the pancreas ranged from 2.5
to 10 cm in length. Time of cryoablation ranged from
2 to 5 minutes at T° from 175 to 186°C. All of
patients had adjuvant chemotherapy. 5 pts with CLM
(20.8%) postoperatively have got transarterial chemo-
embolization.
Results: There was no postoperative mortality and
postoperative morbidity was low. Long-term results of
cryoablation were studied in 20 patients with CLM and
28 patients with cancer of pancreatic head.
Kaplan–Meier survival analysis showed in patients with
CLM: 6 months – 84%, 12 months – 66%, 24 months
– 41%, 28 months – 36%, 36 months – 22%. Mediana
– 18 months. Kaplan–Meier survival analysis showed
in patients with cancer of the head of the pancreas:
6 months – 56%, 12 months – 32%, 24 months – 17%,
28 months – 4.3%. Mediana – 8 months.
Conclusions: Cryoablation in patients with unresectable
colorectal liver metastases and pancreatic cancer in
combination with chemotherapy increases survival rate
to some extent. The perspectives of further improve-
ment in the treatment of unresectable pancreatic cancer
and metastatic liver tumors connected with the multi-
disciplinary approach including systemic and regional
chemotherapy, target and biology therapy in combina-
tion with one of the method of locoregional therapy.
PPL24-075
CLINICOPATHOLOGICAL STUDY OF
INTRADUCTAL PAPILLARY
NEOPLASMS OF THE BILE DUCT
(IPNB) – REPORT OF FOUR CASES-
Yuichi Kondo, Yuji Iimuro, Tadamichi Hirano,
Nobukazu Kuroda, Toshihiro Okada, Yasukane
Asano, Kazuhiro Suzumura, Ikuo Nakamura, Shogo
Tanaka and Jiro Fujimoto
Hyogo College of Medicine, Japan
Introduction: Intraductal papillary neoplasms of the
bile duct (IPNB) was introduced as a precancerous and
early neoplastic lesion by WHO 2010 tumor classifica-
tion of digestive system. We clinicopathologically stud-
ied four resected cases of IPNB.
Method: Among 320 patients of primary liver cancer
who underwent liver resection at Hyogo College of
Medicine between 2008 and 2012, four patients were
diagnosed as IPNB on the basis of pathological histol-
ogy. We immunohistochemically evaluated the expres-
sion of Cytolelatin (CK)7, CK19, CK20, Ki-67, P53,
PAS-Alcian blue. Mucin immunohistochemistry was
also performed for mucin core protein MUC1, MUC2,
MUC5AC and MUC6. Epithelial types such as intesti-
nal, gastric, pancreatobiliary, and oncocytic type were
determined by morphology and mucin core protein
staining.
Results: In four patients (two males and two females),
all cases were diagnosed as biliary cancer (intrahepatic
cholangiocarcinoma or bile duct cancer) before opera-
tion. All cases were negative both HCV-Ab and HBs-
Ag. Serum levels of CA19-9 elevated in two cases.
Median tumor diameter was 3 cm (range 2.2–17.0 cm).
Three patients were undertaken left hemihepatectomy
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and one of three was undertaken bile duct reconstruc-
tion, and one was undertaken right hemihepatectomy.
Hisotologically, tumor showed an intraluminal, grow-
ing papillary tumor covered by neoplastic biliary epi-
thelial cells, three of four were pancreatobiliary type
and one was intestinal type. Immunohistochemically,
all cases were positive for CK7, PAS-Alcian blue. Inva-
sive IPNB cases were based on MUC1 expression, and
MUC2 expression was detected in intestinal type
tumor. MUC5AC was expressed by all cases.
Conclusions: IPNB have been proposed as the biliary
counterpart of intraductal papillary mucinous neo-
plasms of the pancreas. More detailed morphologic and
molecular studies are necessary to clarify the clinico-
pathological features of IPNB.
PPL24-076
ASSOCIATING LIVER PARTITION AND
PORTAL VEIN LIGATION FOR STAGED
HEPATECTOMY-OUR INITIAL
EXPERIENCE
Vivekanandan Shanmugam1, Anand Bharathan2,
Rajesh Rajalingam3, Manoj Shrivastav4, Kumar
Palaniappan10, Gomathy Narasimhan5, Rajasekhar
Perumalla7, Srinivas Reddy6, Thomas Cherian9 and
Mohamed Rela8
1FRCS, India; 2DNB (GI Surgery), Postdoctoral
fellowship in Liver Transplantation, India; 3M Ch (GI
Surgery) Postdoctoral fellowship in Liver
Transplantation, India; 4DNB (General Surgery),
Postdoctoral fellowship in HPB Surgery, India; 5MS,
ASTS Fellowship (USA), India; 6MS, DNB, FRCS, Ph
D, India; 7MS, DNB, FRCS, India; 8MS, FRCS, India;
9FRCS (Gen), FRCS, India; 10DNB (GI Surgery),
Fellowship (LT and HPB), India
Introduction: Associating liver partition and portal vein
ligation for staged hepatectomy (ALPPS) has been pro-
posed recently as one of the techniques to prevent liver
failure in patients undergoing major hepatectomy with
small future liver remnant (FLR). It has been proposed
that it is more effective & quicker than portal vein em-
bolisation (PVE) to induce hypertrophy of FLR. We
review our experience with this new procedure in our
first 3 patients.
Method: Our first three consecutive patients undergo-
ing ALPPS between January 2013 and June 2013 were
reviewed. Due to insufficient FLR all the three patients
were deemed inoperable. All of them had either pri-
mary or secondary tumours of liver.
Results: Three patients (2 male and 1 Female) with age
33, 36 and 66 years respectively were operated during
this period. Indications were hepatocellular carcinoma
in two and metastasis secondary to GIST in one.
Extended hepatectomy was required in all 3 patients
but their FLR was under 20%. They all had normal
liver function tests before the surgery except one who
had high bilirubin for which he had percutaneous tran-
shepatic biliary drainage of the contralateral liver. Time
interval between the two stages was 16, 18 and 34 days
respectively. There was an increase of 74%, 64% and
60% in the FLR 2 weeks from the time of first stage of
ALPPS. One patient died due to liver failure and sep-
sis, 3 weeks after the second stage of ALPPS despite
having adequate liver volume. One patient had enceph-
alopathy and bile leak but recovered well. The patient
who waited for 34 days did not have any complications
at all.
Conclusions: ALPPS is a feasible option in patients
with small future liver remnant. But caution is required
in selecting patients for the same as it carries high com-
plication rate.
PPL24-077
APPROPRIATE TREATMENT
STRATEGIES IMPROVE SURVIVAL
FOR PATIENTS WITH
HEPATOCELLULAR CARCINOMA NO
LARGER THAN 10 CM AND PORTAL
VEIN TUMOR THROMBUS
Jiazhou Ye, Liang Ma, Bangde Xiang, Jianhong
Zhong, Tao Bai, Ningfu Peng and Lequn Li
Affiliated Tumor Hospital of Guangxi Medical
University, China
Introduction: Portal vein tumor thrombus appears to be
the terminal stage of HCC. PVTT was considered as a
contraindication to hepatic resection. However, hepatic
resection, TACE, and hepatic resection associated with
postoperative TACE have been reported to achieve
longer survival periods. Our study aims at comparing the
survival periods after different treatment strategies.
Method: Three hundred and thirty-eight patients were
divided into four groups and underwent different treat-
ments: (1) conservative treatment group (75): immuno-
therapy combined with nutritional therapy was
prescribed, (2) chemotherapy group (86); (3) hepatic
resection group (90): tumors and PVTT were resected;
and (4) hepatic resection combined with postoperative
TACE group (87). All patients were followed until
death or June 30, 2012, or until death. Survival rate
and differences among groups were analyzed.
Results: The survival rates at 1-, 2-, and 3-year in the
group IV were 49%, 37% and 19%, which were signifi-
cant higher than the other three groups. The 1-, 2-, and
3-year in the group III were 28%, 20%, 15% and 17.5%,
0%, 0% in the group II, which were significant higher
after surgical resection than TACE. The 1-, 2-, and 3-
year survival rates in the group I were all 0%. Mean
postoperative survival period in the first branch or above
was significantly longer than extend to the main trunk
(14.5  3.6 months vs 8.3  2.1 months). The survival
period of patients received postoperative TACE ≥ 3
(21.6  4.1 months) was longer than those who didnt
receive postoperative TACE (15.1  2.4 months) and
just 1–2 cycles (8.2  1.3 months) (p < 0.0001).
Conclusions: Surgical resection is the most effective
therapeutic strategy. Postoperative TACE is necessary
in preventing recurrence and prolonging survival per-
iod. TACE should be recommended for unresectable
HCC.
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PPL24-078
GROWING RATE OF PORTAL VEIN
TUMOR THROMBUS IN PATIENTS
WITH HEPATOCELLULAR
CARCINOMA AND ITS CLINICAL
IMPLICATIONS
Takumi Fukumoto, Masahiro Kido, Atsushi Takebe,
Motofumi Tanaka, Kaori Kuramitsu, Tetsuo Ajiki,
Ippei Matsumoto, Shinzeki Makoto, Taro Okazaki and
Yonson Ku
Kobe University, Japan
Introduction: Portal vein tumor thrombus (PVTT) rep-
resents the most significant factors for a dismal progno-
sis in patients with hepatocellular carcinoma (HCC).
When the portal trunk is completely obstructed with
PVTT, a life-threatening sequence of events such as
massive ascites, variceal hemorrhage, and hepatic fail-
ure ensues and frequently precludes surgical interven-
tion. This study was undertaken to elucidate the
growing rate of PVTT to determine the timing of surgi-
cal intervention for patients with PVTT.
Method: This study included 64 HCC patients with
PVTT (56 males, 8 females). Hepatitis B virus was posi-
tive in 22, hepatitis C virus positive in 37. The extent
of PVTT was serially determined in each patient by
image studies including computed tomography, mag-
netic resonance imaging, ultrasonography, and digital
subtraction angiography. Based on these data, the
growth rate of PVTT was estimated according to the
site of PVTT.
Results: When the tip was in the second order branch,
PVTT reached the first order branch of the ipsilateral
portal branch with a mean time period of 60  12 days
(mean  SE). In contrast, once PVTT reached the con-
tralateral portal vein, its growth rate from the first to sec-
ond order branch significantly increased to 20  4 days
compared with the ipsilateral side (p < 0.05). The growth
rate of PVTT from the first order branch to the portal
trunk and from the portal trunk to the opposite first
order branch were 38  8 and 11  4 days, respectively,
showing a significant increase after reaching the contra-
lateral portal vein (p < 0.05).
Conclusions: These data indicates that PVTT rapidly
obstructs the bilateral portal veins once it reaches the
portal trunk. Thus we recommend a semi-emergent sur-
gical resection for those patients with PVTT in the portal
trunk when liver function allows a planned hepatectomy.
PPL24-079
A COMPARING OF SIMULTANEOUS
VERSUS STAGED MAJOR LIVER
RESECTION FOR COLORECTAL
CANCER LIVER METASTASES
Young Ki Kim, Jai Young Cho, Yoo-Seok Yoon, Dae
Wook Hwang, Woohyung Lee and Ho-Seong Han
Seoul National University Bundang Hospital, Korea
Introduction: The optimal surgical strategy in colorectal
cancer liver metastases (CRLM) remains still controver-
sial. Several centers are recommand staged operation
because high rate of complications, longer operation
time and delayed hospitalization in simultaeneous
major liver resection (MLR) group. The aim of this
study was to compare of outcomes between simulta-
neous and staged MLR to CRLM.
Method: From June 2003 to September 2012, 80
patients underwent MLR for CRLM. 44 patients
underwent simultaeneous hepatectomy and colorectal
surgery, and 36 patients underwent staged hepatec-
tomy. Clinicopathologic, operative, and perioperative
data and complications were evaluated.
Results: All patient and tumor characteristics are simi-
lar in both group. The simultaneous group had a
longer rate of operation time (437  136 minutes vs
336  111 minutes, p = 0.001). Estimated blood loss
(836.3  836.5 mL vs 739.4  520.7 mL, p = 0.547),
transfusion rate (34% vs 27%, p = 0.631) and hospital-
ization (15.7  10.2 days vs 13.9  5.7 days,
p = 0.692) were not significant difference in both
group. Mortality (one patient in simultaneous group),
morbidity (30% vs 25%, p = 0.802), and colonic move-
ment normalization rates were similar in the two
groups. Considering both surgical procedures (colorec-
tal, p = 0.529 + liver resection, p = 0.626), there was
no significant difference between two group.
Conclusions: MLR can be feasibly and safely per-
formed in selected patients at CRLM with similar peri-
operative outcomes and morbidities.
PPL24-080
LIVER ABSCESS INFILTRATE
THORACIC CAVITY WITH THROMBUS
INFERIOR VENA CAVA
Kazutoshi Kida, Takatsugu Oida, Hisao Kano, Kenji
Mimatsu, Youichi Kuboi, Atsushi Kawasaki and
Nobutada Fukino
Social Insurance Yokohama Central Hospital, Japan
Introduction: Liver abscesses infiltrate thoracic cavity
caused by amebiasis, in 13–15% of cases. A few cases,
lung abscesses was caused by penetration of the liver
abscess. In such cases, treated by surgical or percutane-
ous transpleural dranage at the first. However, in the
present case, surgical or percutaneous drainage had high
risks because of thrombus in the Inferior vena cava.
Amoebic liver abscess merges a vascular complication of
hepatic veins and inferior vena cava thrombosis. We
administered antibiolotics and heparization for throm-
bus, not surgical or percutaneous drainage, at the first.
Method: A 59-year-old man was admitted to our hos-
pital because of bloody phlegm and cough. Chest and
abdominal computed tomography scan revealed abscess
infiltrated at the right diagram between the liver and
lung, and thrombus in the Inferior vena cava. End-
amoeba histolytica antibody was positive. These find-
ings diagnosed liver abscess infiltrate thoracic cavity
with thrombus Inferior vena cava.
Results: As a result, inflammation was improved in
laboratory examination, and liver and lung abscess
were reduced on CT images. Antibiotics were obtained
the similar percutaneous drainage.
Conclusions: This is a first report of the liver abscess
infiltrate thoracic cavity with thrombus Inferior vena
cava.
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PPL24-081
FAVORABLE OUTCOMES OF
COMPLETE SURGICAL RESECTION
FOR HEPATOCELLULAR CARCINOMA
WITH MAJOR PORTAL VEIN OR
HEPATIC VEIN TUMOR THROMBUS
Wipusit Taesombat, Boonchoo Sirichindakul,
Bunthoon Nonthasoot, Jade Suphapol and Supanit
Niwatwongs
King Chulalongkorn Memorial Hospital, Chulalongkorn
University, Thailand
Introduction: The presence of tumor thrombus in por-
tal vein or hepatic vein in patient with hepatocellular
carcinoma (HCC), is one of the most poor prognostic
factor. The role of complete liver resection is still con-
troversial for this advanced stage tumor.
Method: Medical records of 268 patients who under-
went liver resection for HCC between January 2005
and December 2012 were retrospectively reviewed.
Thirteen (4.8%) of these patients had pathological con-
firmed tumor thrombus of major portal vein or hepatic
vein. The perioperative and long-term outcomes were
evaluated.
Results: Among 13 patients, preoperative transarterial
chemoembolization (TACE) was performed in 10
patients. None of them had tumor progression. All
patients underwent major hepatectomy with tumor
thrombectomy. Ten patients had complete microscopic
surgical resection. Perioperative morbidity was 23%,
but without mortality. Median survival was 30 months
(mean follow-up 38 months). The 1- and 3-year overall
survival rate were 92% and 76%. The 1- and 3-year
disease free survival rate were 56% and 39%. Eight
patients had recurrent tumor either intrahepatic or
extrahepatic recurrence, 7 patients underwent early
treatment of the recurrence by TACE, radiofrequency
ablation or surgical resection.
Conclusions: Complete surgical resection of HCC with
tumor thrombus, in combination of careful patient
selection, closed postoperative follow up and early
treatment of the recurrent tumor are associated with
favorable survival rate.
PPL24-082
PRIMARY HEPATIC
NEUROENDOCRINE TUMOR: A CASE
SERIES
Chetan Kantharia, Sharvari Pujari, Ramkrishna
Prabhu, Avinash Supe, Ravindra Bapat and Vikram
Chaudhari
Seth GS Medical College & KEM Hopsital, Mumbai,
India
Introduction: Primary neuroendocrine tumor (NET) of
the liver is a very rare neoplasm. Hence it is difficult to
make a proper diagnosis, which requires strict exclusion
of possible extrahepatic primary sites. Meticulous work
up is necessary to rule out an occult extrahepatic malig-
nancy with hepatic metastasis to confirm the primary
nature of hepatic carcinoids. Besides it is important to
distinguish it from other liver neoplasm’s. The mainstay
of treatment is curative liver resection. We present a
case series of three patient of primary neuroendocrine
tumor of liver.
Method: Of the three paients, two were operated and
one treated conservatively.
Results: Of the two operated both are alive after
3 years, with one having recurrence. The patient who
was conserved died at the end of 2 years.
Conclusions: Though Neuroendocrine tumors involving
the liver are common, primary hepatic neuroendocrine
tumours are rare. To qualify it as a primary hepatic
tumour, it requires extensive workup. It has an inherent
malignant potential that must be recognized. Manage-
ment remains surgical resection, with several alternative
options available for non-resectable tumours and severe
symptoms.
PPL24-083
CHOLEDOCHAL CYSTS IN ADULTS
AND THEIR COMPLICATIONS
Mirza Qasim Beg, Sharvari Pujari, Ramkrishna
Prabhu, Avinash Supe, Ravindra Bapat and Chetan
Kantharia
Seth GS Medical College & KEM Hospital, Parel,
Mumbai-12, India
Introduction: Despite choledochal cysts being common
in children, an increasing number of patients present
with ongoing symptoms in adult life. The aim of this
study was to review the management of adult patients
with choledochal cysts in a tertiary referral centre.
Method: The records of 31 patients with choledochal
cysts presented to us between 2009 and November 2012
maintained as a prospective database were analyzed for
demography, clinical presentation, radiological investi-
gation, management, and outcome.
Results: There were 9 males. Based on preoperative
cholangiogram and operative findings 19 (61.2%)
patients had Type I and 8 (25.8%) Type IV A cysts. 3
patients had Type III and 1 patient had Type II cyst.
The presenting complaints was cystolithiasis in 16
(51.6%) patients followed by cholangitis 9 (29.03%),
acute pancreatitis 2 (6.45%), hepatolithiasis, malig-
nancy, portal hypertension and chronic pancreatitis 1
patient each. One patient had H/O having undergone
surgery for cyst in childhood, with recurrence again
with cystolithiasis. Acute pancreatitis and cholangitis
were managed conservatively. Endoscopic stenting was
performed in patients with cholangitis and those requir-
ing staged treatment as a result of portal hypertension.
Overall 30 patients underwent cyst excision with Roux-
en-y hepaticojejunostomy and 1 patient of malignancy
subjected to Whipple surgery. The overall morbidity
was 16.12 per cent, wound infection 12.9% (4 patients)
and bilio-enteric anastomotic leak 1 patient.
Conclusions: Choledochal cysts in adults are not
uncommon. Acute pancreatitis, cholangitis and portal
hypertension are managed conservatively and then fol-
lowed up by definitive surgery. Cyst excision with
Roux-en-Y hepaticojejunostomy is necessary to prevent
the recurrence of complications. Patients with previous
inadequate cyst excisional procedures should undergo
Poster Panel [Liver] 435
© 2014 The Authors
HPB 2014, 16 (Suppl. 2), 406–549 HPB © 2014 Americas Hepato-Pancreato-Biliary Association
revision surgery, to reduce recurrent symptoms and the
risk of developing cholangiocarcinoma.
PPL24-084
ALPPS: PROLONGATION OF “SPLIT
TO RESECTION INTERVAL” ALLOWED
FOR ADJUSTMENT OF TREATMENT
STRATEGY IN 30% OF CASES
Michael R. Sch€on, Konstantinos Kouladouros, Daniel
G€artner, Katharina Fedtke, Daria Wirch, Peter
Reimer, Klaus Tatsch, Martin Bentz, Thomas R€udiger
and Christoph Justinger
Klinikum Karlsruhe, Germany
Introduction: Right portal vein occlusion plus «in situ
split» is a new method to induce hypertrophy of the func-
tional remnant volume (FRV) for two-stage liver resec-
tion in 7–9 days. However, a simultaneous growth
induction of preexisting hepatic micrometastases has
been reported. For this reason a certain percentage of
patients might not have an oncological benefit from this
procedure. Though, the optimal interval between split
and resection remains unclear. Therefore, in the current
trial the split to resection interval was prolonged and the
effect on the therapeutic strategy analyzed.
Method: Nine patients (4 male 5 female, age 40–
76 years) underwent split liver resection for metastatic
bilateral liver tumors. The number of metastases varied
between 4 and 13. The mean interval from split and to
second step liver resection was 48 days.
Results: After the prolonged interval right or extended
right hemi-hepatectomy was carried out as planned ini-
tially during split resection in 66% of patients. In one
case a new metastases was diagnosed in segment 1 and
a right hemi-hepatectomy plus additional segment 1
resection was performed. The patient is free of meta-
static recurrence 24 months after liver resection. In two
patients diffuse metastatic liver disease occurred in the
FRV during the prolonged interval. In those the onco-
logical strategy was changed and patients transferred to
palliative chemotherapy.
Neither the split-resection-plane nor adhesions posed
a major intraoperative problem. The postoperative
morbidity after the prolonged interval was not in-
creased.
Conclusions: Prolongation of the split-to-resection
interval changed the therapeutic strategy significantly in
30% of patients. However, it was not associated with a
higher surgical morbidity. We suggest that a longer
split-to-resection interval can be used as a diagnostic
tool to identify preexisting yet undiagnosed metastasis
and adjust the oncological therapy.
PPL24-085
LAPAROSCOPIC SURGERY FOR
TREATING RECURRENT
HEPATOCELLULAR CARCINOMA
Masaru Tsuchiya, Yuichiro Otsuka, Akira Tamura,
Jun Ishii, Tetsuya Maeda, Toshio Katagiri, Yoshihisa
Kubota, Satoru Kagami and Hironori Kaneko
Toho University School of Medicine, Japan
Introduction: Repeat hepatectomy has been demon-
strated to be effective in treating recurrent hepatocellu-
lar carcinoma (HCC). However, because the indications
for repeat hepatectomy depend on the type of recur-
rence and residual hepatic functional reserve, the proce-
dure is only suitable for a limited number of patients,
and other treatments are often selected. We discuss our
clinical experience with laparoscopic surgery for recur-
rent HCC and report our analysis of its effectiveness.
Method: Seventy-four of 178 HCC patients underwent
laparoscopic surgery in 2002–2012; 25 were treated for
recurrent HCC. The characteristics and postoperative
outcomes of these 25 patients were retrospectively
investigated.
Results: The mean interval from first-line treatment to
laparoscopic surgery for recurrent HCC was
53.3 months. Fifteen patients underwent laparoscopic
hepatectomy, 1 underwent laparoscopic radiofrequency
ablation, 8 underwent resection of an extrahepatic met-
astatic tumor, and 1 patient received diagnostic assess-
ment. Fourteen of the 24 patients who underwent
laparoscopic surgery had a repeat recurrence after sur-
gery; however, none of these were stump or port-site
recurrences. The survival rates at 1 and 2 years were
75.6% and 44.0%, respectively. The average of overall
survival month was significantly higher in patients with
intrahepatic recurrence than in those with extrahepatic
recurrence (38.2 months vs 19.1 months; p = 0.046). In
addition, the average of disease-free survival month
was longer in patients with intrahepatic recurrence,
although not significantly so (19.0 months vs
10.6 months, p = 0.19).
Conclusions: Laparoscopic surgery appears to be an
effective, minimally invasive option for the diagnosis
and treatment of both intrahepatic recurrence and
extrahepatic recurrent HCC.
PPL24-086
LIVER TRANSPLANTATION IN
ALCOHOLIC LIVER DISEASE
Wontae Cho, Jin Yong Choi, Seung Hwan Lee, Hyung
Hwan Moon, Sanghoon Lee, Jong Man Kim, Jae
Berm Park, Choon Hyuck David Kwon, Jae-Won Joh
and Sung Joo Kim
Samsung Medical Center, Sungkyunkwan University,
Korea
Introduction: The primary effective strategy for patients
with alcoholic liver disease (ALD) is total alcohol absti-
nence. When total alcohol abstinence does not result in
a significant improvement of liver function, liver trans-
plantation (LT) represents the gold standard treatment
for end-stage ALD. This study evaluated the outcome
of LT in ALD.
Method: We evaluated 76 patients from Oct 2001 to
Feb 2013. Clinical records were reviewed for intake
and duration of alcoholic consumption, abstinence
duration, history of psychiatric consultation, recidivism
and survivals.
Results: Mean survival year after LT was 3.47 (SD:
2.71, range: 0–11.41) and there was no significant dif-
ference between acute and chronic alcoholic liver fail-
ure (p = 0.099). The amount of alcoholic consumption
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and duration, history of pchychiatric consultation, and
type of LT (LDLT vs DDLT) also showed no statisti-
cal significance. The role of 6 months abstinence was
not clear in patients survivals (p = 0.064).
Conclusions: Liver transplantation for acute alcoholic
hepatitis has good prognosis and should not be banned
for LTLDLT can be applied for alcoholic liver disease
with similar survival as DDLT. A flexible approach to
“6 months rule” should be applied. A multidisciplinary
support for alcoholic patients is warranted.
PPL24-087
RIGHT HEPATECTOMY AND
CAVOPLASTY USING THE GREATER
SAPHENOUS VEIN WITH
THORACOABDOMINAL AND
ANTERIOR APPROACH FOR HUGE
HEPATOCELLULAR CARCINOMA
WITH IVC TUMOR THROMBUS
Gil Chun Park, Sunggyu Lee, Hyoungwoo Park and
Donghwan Jung
Asan Medical Center, Ulsan University, Korea
Introduction: Conventional hepatic resection for large
hepatocellular carcinoma (HCC) is associated with vari-
ous complications including excessive bleeding, tumor
rupture, and spread of tumor cells, curtailing both the
short-term and long-term survival outcome. To sur-
mount these problems, many experts employed the ante-
rior approach for major hepatic resections and fashioned
the liver hanging maneuver technique, or combined it.
Results: The 49 year-old male as a known HBV carrier
was refered to our center for surgical treatment. On the
laboratory findings, child A compensated liver cirrhosis
was noted. Preoperative imaging study showed no dis-
tant metastasis, but huge infiltrative HCC in right pos-
terior segment with tumor invasion in the portal vein
and RHV extended into the IVC. TACE was done
7 weeks before surgery. He underwent the right lobec-
tomy and IVC tumor thrombectomy by excision includ-
ing the IVC partial wall with anterior approach and
thoracoabdominal incision, and then cavoplasty was
performed by using the GSV patch. Without complica-
tions during the operation and postoperative days he
made a well recovery, and discharged postoperative
2 weeks. Until now, there is no evidence of disease recur-
rence.
PPL24-088
MAJOR LIVER RESECTION FOR
LARGE, LOCALLY ADVANCED
HEPATOCELLULAR CARCINOMA IN
PATIENTS WITH CHRONIC LIVER
DISEASE
Piyush Kumar Sinha, Shridhar Satuskar, Kishore GSB,
Senthil Kumar, Shweta Singh, Shalini Thapar, Archana
Rastogi, Tushar Kanti Chattopadhyay, Shiv Kumar
Sarin and Viniyendra Pamecha
Institute of Liver and Biliary Sciences, India
Introduction: Liver resection for large (≥5 cm) hepato
cellular carcinoma (HCC) remains a clinical challenge
in patients with chronic liver disease (CLD).
Method: Prospectively collected data of patients with
large HCC and CLD who underwent major liver resec-
tion (≥3 segments) between March 2011 and August
2013.
Results: Twelve patients (10 men) with median age of
52 years (20–72) with good performance status and no
extra hepatic disease underwent surgery. Eight patients
were in Child Pugh Class A and four patients were in
Class B. Etiology-(HBV: 7, HCV: 2, Ethanol: 1,
NASH: 2). BCLC staging was stage B: 8 and stage C:
4. Median AFP was 6.9 (1.4–62561). On CT scan, three
patients had segmental portal vein involvement, one
patient had bilobar disease and one had biliary
obstruction. Seven patients had extended resection (>5
segments), four had right hepatectomy; one had modi-
fied right hepatectomy (3 segments). On histopathol-
ogy, all twelve patients had R0 resection, median
tumor diameter was 10.7 cm (5–18 cm), liver paren-
chyma showed cirrhosis in 6, fibrosis in 3 and chronic
inflammation in three. All tumors were moderately dif-
ferentiated (Edmonson Grade 2); six vascular invasion
(3 macrovascular); one biliary invasion. Four had mul-
tifocal disease. Posthepatectomy liver failure according
to ISGLS grading; Grade A: 10 and Grade C: 2. Fifth
postoperative day median serum bilirubin was 2.8 mg
% (0.9–11.1); median INR 1.3 (1.1–1.8). Morbidity
according to Clavien-Dindo classification was Grade 1–
8, Grade 2 -2, Grade 3B-1 and Grade 5 -1. Antiviral
treatment was given to all seven patients with HBV
related CLD. Overall survival was 83%, with disease
free survival of 82% (9/11) at a median follow up of
14 months (1 to 30).
Conclusions: Major liver resection for large, locally
advanced HCC in CLD has shown excellent outcome
in our series.
PPL24-089
10-YEAR EXPERIENCE OF
LAPAROSCOPIC LIVER RESECTION
FOR SEVERAL LIVER DISEASES
Ju Ik Moon, In Seok Choi, Sang Eok Lee, Yu Mi Ra,
Won Jun Choi and Dae Sung Yoon
Kunyang University Hospital, Korea
Introduction: The aim of this study is to describe a 10-
year experience of laparoscopic liver resection for sev-
eral liver diseases.
Method: Between November 2004 and August 2013,
126 cases of 122 patients underwent laparoscopic liver
resection at Department of Surgery at Konyang Uni-
versity Hospital, Daejeon, Korea. The following char-
acteristics and results were evaluated retrospectively
through the medical records.
Results: Forty-two laparoscopic hepatectomies (33.3%)
were for benign disease and 84 (66.7%) for malignant
tumors. The malignant tumor included hepatocellular
carcinoma (HCC) in 34 cases, colorectal cancer metas-
tasis in 35, gallbladder cancer in 8, intrahepatic cholan-
giocarcinoma in 4, breast cancer metastasis in 2 and
gastric cancer metastasis in 1. Benign tumor included
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intrahepatic stone in 30 cases and biliary cystadenoma
in 5. According to type of hepatectomy, left hepatec-
tomy was performed in 21 cases; bisegmentectomy was
performed in 9 and wedge resection in 26. Also, radical
cholecystectomy (including segmentectomy 4a, 5 and
lymph node dissection) was performed 8 cases. Of
thirty intrahepatic duct stone cases, 15 cases was per-
formed common bile duct exploration and stone
removal. Conversion to laparotomy was necessary in 9
patients (7.1%). And 19 cases (15.1%) required intra-
operative blood transfusion. One patient with alcoholic
liver cirrhosis who underwent left lateral sectionectomy
for HCC with conversion to open surgery died 67 days
after surgery.
Conclusions: According to our experiences, laparo-
scopic liver resection is considered feasible and safe
method to use in the cases of several liver diseases.
PPL24-090
LIVER STIFFNESS MEASUREMENT BY
FIBROSCAN: A USEFUL TOOL FOR
THE ASSESSMENT OF
COMPLICATIONS OF PORTAL
HYPERTENSION IN PATIENTS WITH
CIRRHOSIS
Abdul Matin, Praveen Sharma, Pankaj Tyagi, Vikas
Singla, Naresh Bansal and Anil Arora
Sir Ganga Ram Hospital, Afghanistan
Introduction: Transient elastography (FibroScan) is a
new, non-invasive, rapid, and reproducible method
allowing evaluation of liver fibrosis by measurement of
liver stiffness. The aim of this study was to evaluate the
sensitivity of liver stiffness measurement (LSM) for the
detection of complications of cirrhosis.
Method: All consecutive patients with cirrhosis were
studied. Cirrhosis was diagnosed either on liver biopsy
or on clinical, biochemical and radiological basis.
Patient’s Child–Pugh score (CTP), model for end stage
liver disease (MELD) and complications due to portal
hypertension were recorded. Liver stiffness measure-
ment (LSM) by Fibroscan was done at the time of
admission.
Results: Patients (n = 210) (age 51  12 years, M:F
164:46) were enrolled. Their baseline CTP score
(8.8  2.2), MELD score (17.1  7.8) and LSM was
54.9  18.9 kPa. Etiology of cirrhosis was due to alco-
hol, n = 63, cryptogenic, n = 89, HBV, n = 25, HCV,
n = 20, autoimmine, n = 10 and Wilson, n = 3. LSM
was significantly correlated with CTP score (0.415,
p = 0.001), MELD score (0.28, p = 0.001), total biliru-
bin (0.169, p = 0.01), albumin (0.213, p = 0.002) and
platelet count (0.156, p = 0.02). The cut off values for
the presence of oesophageal varices (49.3 kPa sensitiv-
ity 74%, specificity 77%), cirrhosis Child–Pugh B or C
(54.1 kPa, sensitivity 76%, specificity 66%), past his-
tory of ascites (52.6 kPa, sensitivity 84%, specificity
70%), hepatocellular carcinoma (62.9 kPa, sensitivity
75%, specificity 63%) and hepatic encephalopathy
(57 kPa, sensitivity 75%, specificity 63%).
Conclusions: Transient elastography is a promising
non-invasive method for detection of complications
portal hypertension in patients of cirrhosis. Its use for
the follow up and management of these complications
could be of great interest and should be evaluated
further.
PPL24-091
A CASE OF SIMPLE LARGE LIVER
CYST WITH HIGH LEVEL OF CA19-9 IN
THE SERUM
Satoru Kagami, Toshio Katagiri, Yuichiro Otsuka,
Yoshihisa Kubota, Jyun Ishii, Tetsuya Maeda, Masaru
Tsuchiya, Akira Tamura and Hironori Kaneko
Toho University, Japan
Introduction: Carbohydrate antigen 19-9 (CA19-9) is
used as a biomarker to differentiate benign from malig-
nant gastrointestinal disorders. In spite of various diag-
nostic modalities, biliary cystic neoplasms (biliary
cystadenoma and cystadenocarcinoma) remain to be
difficult to diagnose preoperatively.We report a case of
simple large liver cyst with high level of CA19-9 in the
serum.
Method: The patient was 63-year-old woman. The
CA19-9 showed high level in serum in the regular health
checkup. The abdominal CT scans revealed a large sim-
ple liver cyst in the right lobe of the liver which was
12.7 9 11.6 cm in diameter. The liver cyst was checked
up by outpatient, however it was increased and elevated
CA19-9 level as 340 U/mL. Abdominal ultrasonogram
showed a large cystic lesion without any nodule inside of
the cyst. MR image demonstrated a hyperintense lesion.
We believe that the high serum level of CA19-9 was due
to the large liver cyst. She was underwent Laparoscopic
deloofing procedure. There were no findings suggestive
of malignant lesion intraoperatively.
Results: There were no complications after surgery. In-
traoperative cystic fluid aspiration showed serous fluid
with extremely high levels of CA19-9 as 3640070 U/
mL. The result of pathological examination of the cyst
proved benign. The serum CA19-9 level was decreased
rapidly after operation. The postoperative course was
uneventful and there is no recurrence for 10 months
follow up.
Conclusions: The elevated level of CA19-9 in serum
may not be helpful in the preoprative diagnosis of bili-
ary cystic neoplasm in our case. This case showed quite
a rare large liver cyst with abnormally high levels of
CA19-9 in serum and cystic fluid.
PPL24-092
TREATMENT STRATEGY FOR HCC
PATIENTS WITH ADVANCED AGE 80
OR MORE YEARS-OLD
Koji Minami, Shinichi Ueno, Masahiko Sakoda,
Satoshi Iino, Kiyokazu Hiwatashi, Kousei Maemura,
Yukou Mataki, Hiroshi Kurahara, Hiroyuki Shinchi
and Syoji Natsugoe
Kagoshima University, Japan
Introduction: In this study, results following several
interventions in HCC patients with 80 or more years-
old were compared with those with 65 or less years-old.
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Method: Retrospective comparison was made between
62 patients equal to or more than 80 years-old (Elderly
group) and 851 patients equal to or <65 years-old
(Youth group). Between 1990 and 2005, total of 1797
patients with primary HCC underwent to initial treat-
ment such as hepatic resection (HR), ablation therapy,
or transarterial chemoembolization (TACE) in the
Kagoshima carcinoma-of-liver study group.
Results: Total of 225 patients (Elderly n = 10; Youth
n = 215) were treated by HR, 198 patients (Elderly
n = 8; Youth n = 190) by ablation, and 469 patients
(Elderly n = 42; Youth n = 427) by TACE. In terms of
the frequency of each therapy, no differences were seen
between the 2 groups. Although patients treated by
TACE showed poorer survival than those received HR
or ablation in Youth group, no clear difference during
the 3 treatment was seen in Elderly group. When com-
paring both groups according to the therapy, the
elderly patients showed poorer survival than the youth
in HR and ablation, however, no significant difference
was seen in TACE. Multivariate comparisons about
disease-free survival (DFS) and overall survival in each
group. In DFS, size and the number of tumor were
prognostic factors for Youth group; liver damage for
Elderly group. HR was a good prognostic factor in
both groups. On the other hand, in overall survival,
size and the number of tumor, liver damage, were prog-
nostic factors for Youth group;none for Elderly group.
HR was necessarily not a good prognostic factor in
Elderly group.
Conclusions: In HCC patients in Elderly group, Taken
together with complication and performance status, it
should be respected to employ treatment with lower
invasiveness.
PPL24-093
COX-2 EXPRESSION AND THE
PREVALENCE OF REGULATORY T
CELLS IN TUMOR AND NON-TUMOR
SITES OF HEPATOCELLULAR
CARCINOMA
Yasuyuki Nakata, Mariko Araki, Keiko Kamei,
Hajime Ishikawa, Takuya Nakai and Yoshifumi
Takeyama
Kinki University Faculty of Medicine, Japan
Introduction: The expression of cyclooxygenase-2
(COX-2) plays a role in the differentiation and guid-
ance of regulatory T cells (FOXP3+ Tregs), and this
has also been studied extensively in hepatocellular car-
cinoma (HCC). In this study, we investigated the
expression of COX-2 and the prevalence of FOXP3+
Tregs in tumor and non-tumor sites to elucidate the
relationship between the two molecules and their asso-
ciation with the clinicopathological features of HCC
and disease outcome.
Method: This study involved 44 patients with HCC
who had undergone hepatectomy without any preoper-
ative treatment. Paraffin-embedded nodules (n = 44)
were sectioned for immunostaining with COX-2 and
FOXP3 monoclonal antibodies, and the degree of
COX-2 expression and the prevalence of FOXP3+
Tregs were measured.
Results: COX-2 expression in non-tumor site showed a
positive correlation with the number of FOXP3+ Tregs
(p < 0.001). In addition, in non-tumor site, the high
FOXP3+ Tregs prevalence group was significantly
associated with TNM stages (p = 0.003) and AFP
(p = 0.027). The expression of COX-2 in non-tumor
site was also significantly associated with disease-free
survival (p = 0.005).
Conclusions: The present findings suggest the associa-
tion of COX-2 expression in non-tumor site with a dis-
ease-free survival and thus the recurrence of HCC. In
addition, COX-2 expression and the prevalence of
FOXP3+ Tregs are positively correlated in non-tumor
site, indicating that their interaction influences the out-
come of HCC. To prevent the recurrence of HCC, it
may be necessary to inhibit the expression of COX-2.
PPL24-094
SINGLE-INCISION LAPAROSCOPIC
LEFT LATERAL SEGMENTECTOMY:
“DRUM STICK” AND “BAG-IN-BAG”
TECHNIQUE
Minoru Tanabe1, Daisuke Ban1, Atsushi Kudo1,
Noriaki Nakamura1, Takumi Irie1, Takanori Ochiai1,
Satoshi Matsumura1, Shinji Tanaka1, Yuta Abe2 and
Yuko Kitagawa2
1Tokyo Medical and Dental University, Japan; 2Keio
University School of Medicine, Japan
Introduction: We recently have created a multitask nee-
dle device named “drumstick” that can be assembled
inside the abdominal cavity. We also invented the novel
concept of “nested surgery” and introduced the “bag-
in-bag” technique to minimize the destruction of the
abdominal wall. We will present our new technique of
single-incision laparoscopic left lateral segmentectomy.
Method: An intraumbilical, 2.5 cm incision was made
and multi-access port was introduced. The pneumoperi-
toneum was established at 13 mmHg. A 5 mm flexible
fiberscope was used in all operations. <“Drumstick”
device> Liver parenchymal transection was accom-
plished with the ultrasonic scalpel and CUSA. Our ori-
ginal needle device, Drumstick, was punctured through
the upper abdominal wall. This device was assembled
inside the abdominal cavity and played multiple roles
including retraction to control the transection plane,
aspiration of hemorrhage, and a water dripper for he-
mostasis with bipolar coagulation. <“Bag-in-bag” tech-
nique> The resected lobe of the liver was placed in a
large tissue retrieval bag within the abdominal cavity.
Then, only the opening of the bag was pulled through
the umbilicus. Multi-access port was re-inserted in the
opening and pneumoperitoneum was established inside
the bag. The resected liver was re-incised into pieces so
that each of them could be contained to a smaller bag,
by carefully avoiding injury to the tumor. The small
bags were removed one by one from the umbilicus and
finally the large bag came out without extending the
incision.
Results: We have performed five cases of left-lateral
segmentectomy in the patients with hepatic tumors.
There were no significant complications and all patients
discharged with a short hospital stay after operation.
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Conclusions: Our new technique significantly improved
the exposure of the surgical field, and minimized the
umbilical incision in single-incision laparoscopic hepa-
tectomy.
PPL24-095
MIDDLE HEPATIC VEIN
RECONSTRUCTION BY USING
PARIETAL PERITONEUM DURING
HEPATECTOMY FOR RECURRED HCC
Sam Youl Yoon
Korea University Ansan Hospital, Korea
Introduction: We report the case of a 32-year-old
female patient with recurred HBV related HCC. Initial
operation was done for the 8.7 cm HCC in the left lat-
eral lobe 3 years ago.
Method: Recurred 1.8 cm HCC very closed to middle
hepatic vein in S8 was removed by partial hepatectomy.
Main middle hepatic vein was removed partially, then
parietal peritoneum patch was used for reconstruction
for middle hepatic vein.
Results: The patency of middle hepatic vein was intact
and there was also no tumor recurrence after 6 months.
Conclusions: By using the parietal peritoneal patch
graft, tumor resection margin and preservation of main
hepatic vein could be achieved easily.
PPL24-096
BISEGMENTECTOMY 7–8: A SAFE AND
EFFECTIVE ALTERNATIVE TO RIGHT
HEPATECTOMY
Joo dong Kim, Dong Lak Choi and Young Seok Han
Daegu Catholic University Medical Center, Korea
Introduction: A lesion localized in segment 7–8 and
infiltrating the RHV is usually an indication for a right
hepatectomy. However, if there is the presence of a
small remnant liver, steatotic or cirrhotic liver, paren-
chymal sparing liver resection should be considered in
order to prevent postoperative liver failure.
Recent studies have been introduced usefulness of bi-
segmentectomy 7–8 to leave an adequate remnant liver
and reduced postoperative morbidity and mortality.
This report described S7, 8 bisegementectomy as an
safe alternative to right hepatectomy without postoper-
ative morbidity and to obtain the long-term tumor
recurrence.
Method: A 57-year-old woman with known hepatitis B
related liver cirrhosis was referred for surgical treat-
ment to hepatocellular carcinoma. CT scan demon-
strated large HCC infiltrating right hepatic vein at S7,
8. We planned to perform a bisegmentectomy 7–8
instead to right hepatecomy because of small remnant
left liver volime and the presence of large inferior right
hepatic vein. The operation began with mobilization of
the right liver with complete dissection of retrohepatic
vena cava. Inferior right hepatic vein was identified.
Right hepatic vein was dissected and encircled. Paren-
chymal transection was performed based on tumor ves-
sel relationship at intraoperative ultrasonography and
on anatomical findings at color-doppler ultrasonogra-
phy. After complete resection, No S5, 6 congestion was
encountered.
Results: Postoperative course was uneventful and the
patient was discharged on postoperative 10th day.
Abdominal CT scan 2 year after hepatectomy showed
neither congestion nor atrophy at S6 area and there
was no tumor recurrence.
Conclusions: Bi-segmentectomy 7–8 should be a safe
alternative to right hepatectomy in the selected pateints.
Moreover, it can provide the curative resection without
unnecessary sacrifice of functional parenchyma with
minimal morbidity.
PPL24-097
THORACOABDOMINAL APPROACH
FOR RIGHT SIDED HEPATIC
RESECTION
Gil Chun Park, Taeyong Ha, Deokbok Moon, Giwon
Song, Donghwan Jung, Chulsoo Ahn, Kihun Kim,
Shin Hwang and Sunggyu Lee
Asan Medical Center, Ulsan University, Korea
Introduction: Resection of a large malignancy in the
right liver or a small tumor located at the superior and
posterior part of the right liver requires extensive hepatic
mobilization. A thoracoabdominal approach might facil-
itate hepatic resection in such situations, but the safety
and benefits of this approach remain unclear. We have
employed the thoracoabdominal approach in selected
patients with a difficult right-sided hepatic resection.
Method: We reviewed the medical records of the
patients who underwent the hepatectomy for hepatic
malignancy under the thoracoabdominal approach
from Apr. 1998 to Jun 2012 at Asan Medical Center
retrospectively. Five patients were included. Periopera-
tive outcomes were evaluated.
Results: Sex ratio (M:F) was 4:1, median age was 67
(range 36–74). The range of the follow up was 2–
60 months. Diagnoses were 4 hepatocellular carcinoma,
1 intrahepatic cholangiocarcinoma. Median maximal
tumor size was 15.5 cm, and median operative time
was 502 minutes. The amount of the pRBC transfusion
was 2–5 pints (except one case; 45 pints). Postoperative
complications were 2 cases of the pleural effusion, 1
pneumonia, and 1 hepatic failure. Hospital stay was
23 days (range 20–37). Hospital mortality was one case
caused by the pneumonia. There were two cases of the
disease recurrence.
Conclusions: The thoracoabdominal approach is a safe
operative approach that can facilitate resection of mas-
sive tumors in the right liver or tumors involving seg-
ments 7 and 8 without increased morbidity.
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PPL24-099
USEFULNESS OF CONVERTED ICGR15
CALCULATED FROM 99MTC-GSA
SCINTIGRAPHY BEFORE RIGHT
HEPATECTOMY IN A PATIENT WITH
ICG EXCRETORY PERFECTLY DEFECT
Satoshi Iino, Shinichi Ueno, Masahiko Sakoda,
Kiyokazu Hiwatashi, Koji Minami, Hiroshi Kurahara,
Yuko Mataki, Kosei Maemura, Hiroyuki Shinchi and
Shoji Natsugoe
Kagoshima University, Japan
Introduction: In Japan, ICGR15 value is important to
decide the tolerable excision quantity of the liver. We
experienced a case of ICG excretory perfectly defect
patient and performed major hepatectomy safely refer-
ring to the value of converted ICGR15 calculated from
99mTc-GSA scintigraphy LHL15 value.
Method: A 59-year-old woman was diagnosed as RS
rectal cancer with multiple live metastasis. TNM classi-
fication of malignant tumors, 7th edition staging was
T3N1bM1a(liver) StageIVA. After six courses chemo-
therapy using FOLFOX + Panitumumab, primary
lesion was resected. At that point, liver metastasis
reduced to 66% and was judged PR with RECIST cri-
teria. Liver right lobectomy + S4 partial resection of
57% liver resction was necessary for the all liver metas-
tasis excision. Though, liver dysfunction was not admit-
ted in laboratory data, only ICGR15 showed
abnormally high level of 97.1%. The ICGR15 value
suggested that necessary liver excision be impossible.
99mTc-GSA scintigraphy was another criterion of liver
preliminary function. Conversion of data from 99mTc-
GSA scintigraphy to ICGR15 is an easy and conve-
nient method and we have reported 119-115xLHL15
converts 99mTc-GSA scintigraphy LHL15 value into
ICGR15.
Results: According to this calculating formula, con-
verted ICGR15 of this patient was 12.74%. So we
judged the operation was safe and liver right lobec-
tomy + S4 partial resection was performed. The post-
operative course was excellent, and she left to home on
the 10 days after operation.
Conclusions: In ICG excretory perfectly defect patient,
converted ICGR calculated from 99mTc-GSA scintigra-
phy is effective to know true liver preliminary function.
PPL24-100
EVALUATION OF PREOPERATIVE
PROGNOSTIC FACTORS PREDICTIVE
OF TUMOR RECURRENCE AND
SURVIVAL IN PATIENTS WITH
HEPATOCELLULAR CARCINOMA
Jae Hyun Han, Dong Goo Kim, Gun Hyung Na, Eun
Young Kim, Soo Ho Lee, Young Kyoung You and
Tae Ho Hong
Catholic University of Korea, Seoul St. Mary’s Hospital,
Korea
Introduction: Tumor recurrence after surgical resection
for hepatocellular carcinoma (HCC) is an obstacle to
long-term survival. Thus, selection of appropriate
patients is important, especially those with advanced
tumors.
Method: From January 2000 to June 2012, we retro-
spectively analyzed 298 patients who had undergone
surgical resections for HCC with curative intent and
evaluated preoperative prognostic factors.
Results: The 5 years disease free survival and overall
survival were 47.0% and 58.7% respectively. In multi-
variate analysis, an alpha-fetoprotein (AFP) level of
>100 ng/mL and a standardized uptake value (SUV) of
positron emission tomography–computed tomography
of >3.5 were predictive factors for tumor biology,
recurrence, and survival. Tumor size of >5 cm and a
relative enhancement ratio (RER) calculated from mag-
netic resonance imaging were also significantly associ-
ated with prognosis in univariate analysis. We
established a scoring system to predict prognosis using
AFP, SUV, and RER. In those with tumors of >5 cm,
it showed predicted both recurrence (p = 0.005) and
survival (p = 0.001).
Conclusions: The serum AFP, tumor size, SUV and
PER are useful for prognosis preoperatively. Base on
these data, it is possible to predict a good prognosis
after surgical resection using our scoring system even in
large size tumors.
PPL24-101
COMPARISON OF LAPAROSCOPIC
VERSUS OPEN HEPATECTOMY ON
THE BASIS OF SERUM
PROCALCITONIN LEVEL
Koshi Matsui, Shigeaki Sawada, Isaku Yoshioka,
Shinichi Sekine, Kazuto Shibuya, Isaya Hashimoto,
Tomoyuki Okumura, Toru Yoshida, Takuya Nagata
and Kazuhiro Tsukada
Univaersity of Toyama, Japan
Introduction: Procalcitonin (PCT) is produced in the
systemic organs such as lung, liver, kidney, fat and
muscle, but is not secreted from the blood components
such as leukocytes. Therefore, serum PCT level is not
affected by drugs that induce leukocyte reaction such
as anticancer agents or steroids. In addition, PCT is
useful in the differential diagnosis of infection in cir-
rhotic patients. It is considered that PCT level reflects
surgical stress even in hepatectomy patients with cirrho-
sis and received preoperative chemotherapy.
Method: To evaluate the degree of surgical stress, we
compared of (OH) Open Hepatectomy and (LH) Lapa-
roscopic Hepatectomy in patients with liver tumors by
measuring the PCT. Patients who had no significant
postoperative complications were analysed.
Results: LH was 8 cases: 5 of HCC, 3 of metastatic
liver tumor. OH was also 8 cases: 4 of HCC, 4 of meta-
static liver tumor. Operation method was, LH: Five
cases of partial resection, 3 cases of segmental resec-
tion, OH: seven cases of partial resection, one case of
segmental resection. The mean operative time was
284 minutes (LH), and 334 minutes (OH) (p = 0.48).
The average of bleeding were 290.6 mL (LH),
723.6 mL (OH) (p = 0.03). The average of PCT on the
first day after surgery was 0.369 in the LH, and 0.619
in the OH. It was lower in the LH significantly more
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than OH on the first day after surgery (p = 0.02). There
was no significant difference in the WBC, CRP. There
was no correlation between the PCT value and amount
of bleeding.
Conclusions: Based on the serum PCT level, it was sug-
gested that the laparoscopic hepatectomy is less inva-
sive compared to open surgery.
PPL24-102
INTRAHEPATIC SPLENOSIS
MIMICKING HEPATOCELLULAR
CARCINOMA IN A CHRONIC
HEPATITIS C PATIENT WITH NO
HISTORY OF SPLENIC TRAUMA
Naoya Sato1, Tusyoshi Abe2, Nobuyasu Suzuki2,
Mitusru Waragai2, Yasushi Teranishi2, Atai Sato2,
Ayaka Azami2 and Mitsukazu Gotoh1
1Fukushima Medical University, Japan; 2Southern
Tohoku Research Institute for Neuroscience, Japan
Introduction: Intrahepatic splenosis (IS) was defined as
auto-transplantation of splenic tissue. The case reports
about IS, which might develop in the patients with
splenic injury or surgery, are still rare and is difficult to
make differential diagnosis of IS from hepatic neo-
plasms. We had an opportunity to treat an extremely
rare case of IS patient without no history of splenic
injury or surgery.
Method: Case report. A 58-year-old man with chronic
hepatitis C was referred to our hospital for further
examination of liver dysfunction. Serum AFP was ele-
vated (24.9 ng/mL). Abdominal ultrasonography (US)
revealed the low echoic mass in the posterior segment
of liver. Based on the characteristic image findings by
enhanced CT and EOB-MRI exam, the tumor was
diagnosed as hepatocellular carcinoma (HCC). He
underwent right lateral segmentectomy of the liver. His-
topathological findings revealed as IS which consisted
of sinusoidal structure, lymphoid follicular aggregates
and fibrous bands from its capsule continuing into the
inner portion of the lesion, described as a trabeculae
which is specific for splenic architecture. His postopera-
tive course was uneventful and he discharged our hos-
pital on sixteenth postoperative days.
Results: It is quite difficult to differentiate IS from
HCC, when IS develop in patient with chronic hepati-
tis,because both two entities has same radiological fea-
tures: the lesion have slightly inhomogeneous
enhancement in the arterial phase and diminished
enhancement in the equilibrium phase Abdominal US
and tissue biopsy might be helpful in the differential
diagnosis of IS. On US examination of this case, it
revealed a “hyperechoic capsule” which histologically
consists of well-developed fibrous capsule with many
small vascular channels. On the other hand, HCC usu-
ally have hypoechoic capsule, so called halo, which had
no vascular component.
Conclusions: This is the first reported case of IS which
developed in a patient without history of splenic injury
or splenectomy.
PPL24-103
PORTAL HYPERTENTION WITH
SEVERE ESOPHAGEAL AND GASTRIC
VARICEAL HAEMORRHAGE TREATED
BY MODIFIED HASSAB’S PROCEDURE
Hai Ding and Xiaodong Liu
Southeast University, China
Introduction: Hassab’s operation, which involves gas-
troesophageal decongestion and splenectomy, is the pri-
mary surgical procedure used for devascularization.1
Although the devascularization of all the vessels of the
upper half of the stomach and distal esophagus are per-
formed, it can lead to a high risk of repeat bleeding
and prolonged operation time, which increasing the risk
of intraoperative.
To cope with these obstacles, the modified Hassab’s
procedure was developed to be used. This study evalu-
ated the effectiveness of modified Hassab’s procedure
in patients with esophageal and gastric variceal bleed-
ing. We detected the surgical security and reliability of
modified Hassab’s procedure by observing the postop-
erative repeat bleeding situation and long-term survival
rate of the patients to support our hypothesis.
Method: Between 2004.01 and 2008.01, sixty patients
with liver cirrhosis and portal hypertension underwent
the modified Hassab’s operation. In group 1, 27 of
them had acute esophageal and gastric variceal bleed-
ing and the other 33 patients had a history of variceal
bleeding in group 2 in this retrospective study (includ-
ing three and four patients were lost in follow up,
respectively).
Results: The overall 4-year survival rates were 79.2%
and 96.6% and median survival times were estimated
to be 1144 days in group 1 and 1427 days (p = 0.043)
in group 1 and group 2, respectively. Moreover, the
perioperative mortality rate was 20.8% versus 0%
(p = 0.010) and the postoperative repeat bleeding rates
were 29.2% versus 0% (p = 0.002) between the two
groups. Preoperative prognostic indicators for death
were emergency patients with Child–Pugh score ≥ 10.
Conclusions: Modified Hassab’s procedure is a simple,
safe and effective therapy to control gastroesophageal
variceal bleeding not only in the elective situation but
also in the emergencies in cirrhotic patients with portal
hypertension.
PPL24-104
AN APPRAISAL ON PERCUTANEOUS
APPROACHES FOR PORTAL VEIN
EMBOLIZATION
Oleksandr Korshak, Denys Fedorov, Oleksandr
Grinenko, Andriy Gusev, Oleksiy Popov, Marat
Grigorian, Vadim Kondratiuk, Oleg Kotenko and
Sergiy Soohachev
National Institute of Surgery and Transplantology,
Ukraine
Introduction: Portal vein embolization (PVE) is effec-
tive method for prevention of liver failure after major
liver resections.
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Method: Different percutaneous approaches, either well
established or newly developed, were analyzed on the
base of 192 PVE performed in our department.
Results: PVE first described by Kinoshita was pro-
duced by contralateral approach. Done from the future
liver remnant (FLR), currently mostly via Sg3 portal
branch (PB), has an advantage of easier catheterization
of PB to be embolized. This approach is infrequent (18
(9.4%) PVE) in our clinic due to theoretical possibility
of FLR damage and was used to avoid transtumoral
puncture. Most popular approach in our clinic is ipsi-
lateral approach (164 (85.4%) PVE) via Sg5PB (112
(58.3%) PVE) due to easy access and fact that possible
complications related to puncture site located within
the liver to be removed. However in case of awkwardly
located tumor that course deformation of portal vein
confluence catheterization of distally located Sg4PB can
become challenging procedure. Debates for Sg4PB
embolization are still active, background for wich are
technical difficulties for stable cathererisation of the lat-
ter and possibility of nontarged embolization. For
patients who have to underwent right hepatic trisec-
tionectomy with significant deformation of hepatic
hilum in presence of remarkable Sg4PB in our clinic
was developed ipsilateral approach via Sg4PB (7
(3.6%) PVE). Most difficult for catheterization Sg4PB
are punctured under US guidance that gives us stable
catheter position and possibility for embolization the
latter at time of access tract embolization. For emboli-
zation of right lobe PB there is no need for superselec-
tive catheterization as embolic material could be
delivered with blood flow via proximaly located cathe-
ter within right PB. In absence of safe transhepatic
approach transplenic approach (3 (1.6%) PVE) could
be feasible alternative.
Conclusions: Selection of the appropriate percutaneous
approach for PVE is a key point enabling effective liver
regeneration without complication that could preclude
major liver resection.
PPL24-105
TELANGIECTATIC FOCAL NODULAR
HYPERPLASIA OF THE LIVER
COMPLICATED WITH HEMORRHAGE
AND NECROSIS
Sae Byeol Choi1, Pyoung Jae Park1, Sam Yeol Yoon2,
Hyung Joon Han2, Wan Bae Kim1, Tae Jin Song2 and
Sang Yong Choi2
1Korea University Guro Hospital, Korea; 2Korea
University Ansan Hospital, Korea
Introduction: Telangiectatic focal nodular hyperplasia
(FNH) is the non-classical form of the FNH. Although
these may have risks of rupture or malignant degenera-
tion, this remains unclear. Here, we demonstrate a case
of telangiectatic FNH complicated with hemorrhage
and necrosis during follow up.
Results: A-33-year-old man visited to emergency room
for abrupt onset epigastric pain. From 2 years ago, he
was diagnosed to have multiple hepatic mass, compati-
ble with focal nodular hyperplasia, in the regular
medical check-up. In the CT scan, 6.2 cm sized
well-marginated mass, located in the left lateral section
of the liver, showing arterial enhancement in the arte-
rial phase, and faint enhancement of the portal and
delayed phase scan.
At this time, laboratory result shows slightly increase
AST and ALT. He shows severe tenderness on epigas-
tric area. In the follow-up CT scan, the mass located in
the left lateral segment became larger, with containing
slightly enhancing lesion on the precontrast scan sug-
gesting that intratumoral hemorrhage occurred. We
decided to perform left lateral sectionectomy of the
liver.
On section of the specimen, the cut surface showed
vaguely nodular lesion, measuring 7.6 cm in size, with
hemorrhage and necrosis. Most part of the mass con-
sisted of necrosis due to hemorrhage. However, some
portion consisted with dilated sinusoids with increased
number of thickened vessels, and also showed CD34
positivity in sinusoidal epithelium. Therefore pathologi-
cal result was telangiectatic focal nodular hyperplasia
although definite diagnosis is limited due to massive
necrosis around the hematoma.
Conclusions: Bleeding is not a common complication
of the FNH. Usually FNH was not necessary to resect
when diagnosis was made. However, as shown in our
case, a possibility that hemorrhage or necrosis may be
induced during its progress and follow-up period
should be taken into consideration.
PPL24-106
ANALYSIS OF SURVIVORS MORE
THAN 15 YEARS AFTER CURATIVE
HEPATIC RESECTION OF
HEPATOCELLULAR CARCINOMA
Min-Che Lin and Cheng-Chung Wu
Taichung Veterans General Hospital, Taiwan
Introduction: The purpose of the study is to clarify the
clinicopathologic features of patients with survival per-
iod longer than 15 years after curative resection for
hepatocellular carcinoma.
Method: Between January 1987 and June 1998, 361
patients underwent hepatic resection for HCC in our
hospital. Thirty-four (9.4%) patients survived more
than 15 years, and 327 (90.6%) patients survived
<15 years. The clinical outcome of the patients surviv-
ing longer than 15 years was followed until June 2013.
The clinicopathological features of the two groups
longer and <15 years was compared and analyzed.
Results: Among the 34 patients surviving longer than
15 years after curative resection of hepatocellular carci-
noma, 22 (64.7%) patients were attributed to TNM
stage I, 6 (17.6%) were stage II and 6 (17.6%) were
stage III. By the time of July 2013, 28 (82.4%) were
still disease free and alive. Two patients had tumor
recurrence but still alive, two patients died of tumor
recurrence. One patient died of cardiovascular accident
and one died of prostate cancer. Four patients (11.8%)
underwent re-resection of recurrent tumors. The longest
period of survival was 23 years and 2 months. In com-
parison with patients surviving <15 years, patients with
survival period longer than 15 years had a significant
higher percentage of stage I (64.7% vs 29.1%) and
small tumors (<3 cm, 41.2% vs 23.5%), and significant
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lower percentage of micro-vascular invasion (14.7% vs
37.3%).
Conclusions: The patients surviving longer than
15 years after curative hepatic resection of hepatocellu-
lar carcinoma have favorable pathological features of
early TNM staging, small tumor and low micro-vascu-
lar invasion. The life-long follow-up is still mandatory
for long-term survival.
PPL24-107
A PROPENSITY CASE-MATCHED
ANALYSIS FOR ENDOSCOPIC VERSUS
OPEN HEPATIC RESECTION FOR
PATIENTS WITH HEPATOCELLULAR
CARCINOMA MEETING THE MILAN
CRITERIA
Toshiro Masuda1, Toru Beppu2, Katsunori Imai1,
Hirohisa Okabe1, Hiromitsu Hayashi1, Hidetoshi
Nitta1, Akira Chikamoto1, Masafumi Kuramoto3,
Shinya Shimada3 and Hideo Baba1
1Graduate School of Life Sciences, Kumamoto
University, Japan; 2Kumamoto University Hospital,
Japan; 3Kumamoto Social Insurance General Hospital,
Japan
Introduction: Recent studies have demonstrated that
endoscopic hepatectomy for hepatocellular carcinoma
(HCC) is less invasive and can provide similar dis-
ease-free and overall survival compared with conven-
tional open hepatectomy. The aim of this study is to
compare endoscopic and open hepatectomy for HCC
patients meeting the Milan criteria using propensity
case-matched analysis.The aim of this propensity
case-matched analysis is to compare endoscopic
hepatectomy and open hepatic resection for hepato-
cellular carcinoma (HCC) patients meeting the Milan
criteria.
Method: Between 1999 and October 2012, a total of
269 HCC patients who met the Milan criteria per-
formed endoscopic hepatectomy (n = 89) or open hepa-
tectomy (n = 180). A one-to-one propensity case-
matched analysis was applied to equalize the back-
ground bias in the two groups.
Results: The overall morbidity was 6.7% and no mor-
tality was observed in the endoscopic hepatectomy
group. With propensity matching, 57 endoscopic hepa-
tectomy and 57 open hepatectomy patients showed
equivalent preoperative clinical characteristics. The
median operative time (p = 0.020) and median blood
loss (p < 0.001) were significantly lower in the endo-
scopic hepatectomy group than open hepatectomy, and
the median postoperative hospital stay was significantly
shorter in the endoscopic hepatectomy group
(p < 0.001). The cumulative 5- and 10-year disease-free
survival rates were 35.2% and 15.6% in the endoscopic
hepatectomy group, and 34.9% and 14.6% in the open
hepatectomy. The cumulative 5- and 10-year overall
survival rates were 74.3% and 44.4% in the endoscopic
hepatectomy group, and 67.6% and 60.8% in the open
hepatectomy.
Conclusions: For HCC patients meeting the Milan cri-
teria, this propensity study demonstrated that endo-
scopic hepatectomy is a safe and less invasive treatment
modality with equivalent disease-free and overall sur-
vival when compared with open hepatectomy.
PPL24-108
SAFE AND FEASIBLE EXTRAHEPATIC
GLISSONEAN ACCESS IN
LAPAROSCOPIC ANATOMICAL LIVER
RESECTION
Fumitaka Ishige, Akihiro Cho, Hiroshi Yamamoto,
Osamu Kainuma, Arimitu Hidehito, Hiroo
Yanagibashi, Mamoru Satou and Matuo Nagata
Chiba Cancer Center, Japan
Introduction: Recent rapid developments in technologi-
cal innovations, improved surgical techniques and the
accumulation of extensive experience by surgeons have
improved the feasibility and safety of laparoscopic liver
surgery. However, laparoscopic anatomical liver resec-
tion remains a highly specialized field, as major techni-
cal difficulties remain, such as hilar dissection and
pedicle control.
Method: During open anatomical liver resections, each
Glissonean pedicle is often ligated and divided en bloc
extrahepatically before parenchymal dissection. We
describe herein a novel technique by which each Glisso-
nean pedicle can be easily and safely encircled and
divided en bloc extrahepatically during laparoscopic
anatomical liver resection.
Results: Glissonean pedicles could be encircled en bloc
extrahepatically, as planned. No serious complications,
including major bleeding or injury of the portal triad,
were encountered during procedures.
Conclusions: Extrahepatic Glissonean access appears
feasible and safe for laparoscopic anatomical resection
of the liver.
PPL24-109
IMPACT OF PREOPERATIVE
COMPUTER ASSISTED THREE-
DIMENSIONAL RECONSTRUCTION
AND VIRTUAL RESECTION BASED ON
MRI FOR HEPATECTOMY
Zhao Gang, Song Tian-qiang and Hao Xi-shan
Tianjin Medical University Cancer Institute and
Hospital, China
Introduction: Hepatectomy is a complicated operation
because surgeons should consider the anatomical struc-
ture, vascular variability and the remnant/remainder
volumes. In the past decade, the computer assisted
three-dimensional (3D) reconstruction based on CT
became ordinary, which maked the preoperative precise
liver volume measurement easily. But nowadays, the
using of MRI is more and more popular, because that
can provide more information in diagnosis. There is
infrequent report about MRI-3D reconstruction, so the
aim of this study was to assess the feasibility and accu-
racy of a 3D reconstruction and virtual hepatectomy
based on MRI in hepatectomy.
Method: There were 125 patients (88 primary hepatocel-
lular carcinoma, 12 cholangiocarcinoma, 15 liver meta-
static carcinoma, 10 hepatic hemangioma) underwent
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preoperative 3D reconstruction/virtual hepatectomy
with MRI (using EDDA system, USA) by the same sur-
geon. To each case, the anatomical structure, especially
the artery anomaly, was marked particllarly. And the
volumes of occupied lesion, total liver, resecting/remnant
were calculated and the resected volume was compared
with the actual specimen weight.
Results: In 125 patients, each case was planned individ-
ually. The average time for one case was about 30 min-
utes. The predicted liver resection volume showed a
significant correlation with the actual value (r = 0.94,
p < 0.05). Also there were some anomaly cases: 4 cases
with right hepatic artery comes from superior mesen-
teric artery, 2 cases with left hepatic artery comes from
celiac trunk and 10 cases with “middle hepatic artery.”
To these vascular variability cases, the surgeons became
more self-confident and reduced lots of time in the
operation.
Conclusions: Preoperative 3D reconstruction and virtual
hepatectomy based on MRI is feasible and accurate.
The process can help the surgeon learn the anatomical
structure, excising scope and the remnant / remainder
volume. Three-dimensional reconstruction leads to an
increased precision of operation planning and to a sig-
nificant improvement of safety of liver surgery.
PPL24-110
PERIOPERATIVE RESULTS OF
EXTENDED LIVER RESECTIONS FOR
HEPATOBILIARY MALIGNANCY
Jean Phillipe B€achler, Juan Francisco Guerra, Felipe
Leon, Jorge Martınez and Nicolas Jarufe
Pontificia Universidad Catolica de Chile, Chile
Introduction: Extended liver resection (ER) is often
associated with high perioperative morbidity and mor-
tality. Occasionally, it represents the only surgical
option for primary or metastatic liver lesions. The aim
of this study is to compare the surgical results in
patients who underwent a hepatic resection of more
than two segments versus an ER.
Method: Retrospective study, including all cases from
September 2004 to April 2013. Non-anatomical, seg-
mental and laparoscopic resections were excluded. 2
groups were defined; Group I: ER (more than four seg-
ments); Group II: Hepatic resections from 2 to 4 seg-
ments. Demographic data, surgical indication, technical
aspects, transfusions, post-operative liver function,
morbidity and mortality were reviewed. Chi-square and
Mann–Whitney tests were used.
Results: In this period, 270 hepatectomies were per-
formed. 129 procedures met inclusion criteria. Group I
(n = 39), mean age 56.3  2.01 years old. Malignancy
(Metastases / primary lesions) dictates surgery in all
cases. Median operative time: 300 minutes (180–720),
intermittent Pringle maneuver: 46% of cases, median
time of 42.5 minutes (6–75). 51.3% received transfu-
sions. 18 patients developed perioperative complica-
tions. One patient died due to portal thrombosis and
liver failure. Median in-hospital stay was 12 days (4–
50). Group II (n = 90): mean age: 56.4  1.5 years old,
60% of the cases due to malignancy. Median operative
time: 210 minutes (90–660). Intermittent Pringle
maneuver: 46% of cases, median time of 25 minutes
(7–90). 19% of cases received transfusions. 29 cases
developed perioperative complications. One patient
died due to massive postoperative bleeding. Median in-
hospital: 7.5 days (4–70). Univariate analysis demon-
strated no differences in perioperative complications
and 30-day re-admission. Transfusions, Pringle time
and operative time were significantly higher in Group I.
Multivariate analysis demonstrated no differences.
Conclusions: Surgical results of ER are similar than for
less invasive liver resections, despite the larger amount
of liver parenchyma resected.
PPL24-111
INITIAL EXPERIENCE OF TOTALLY
LAPAROSCOPIC COLORECTAL AND
MINOR LIVER RESECTIONS IN
COLORECTAL CANCER WITH
SYNCHRONOUS LIVER METASTASIS
Marcos Diego Garcıa Ejarque1, Matıas Ezequiel
Morra1, Ezequiel Anibal Silberman1, Rafael Jose
Maurette1, Jorge Diego Bogetti1, Mariano Bregante1,
Eduardo Agustın Porto1, Juan Carlos Patron Uriburu2
and Mario Cesar Salomon2
1British Hospital of Buenos Aires, Argentina; 2???
Introduction: Combined resection of colorectal cancer
(CRC) with synchronous liver metastases (SLM) is con-
troversial due to the difficulty of the abdominal
approach for both resections, the possible increased
morbidity and the impact on oncologic results. The aim
of the present study is to establish the feasibility of lap-
aroscopic colon and liver combined resection for pri-
mary CRC with SLM.
Method: We retrospectively analyzed all patients who
underwent simultaneous colon and liver laparoscopic
resection due to CRC with SLM from August 2008 to
March 2013. We excluded major hepatectomies or
metastases located next to main vessels, doubts to
achieve an R0 resection or contraindication for laparo-
scopic surgery.
Results: Ten patients underwent totally laparoscopic
approach for CRC and SLM. The mean age was 59
(36–73). The numbers of liver lesions in the preopera-
tive images were 1 or 2, located in segment II to VIII,
with a mean size of 25 mm (10–50 mm). Surgical pro-
cedure for CRC included 2 low anterior resections, 3
right colectomy and 5 left colectomy. The livers resec-
tions were: 7 segmentectomy (segments III, V, VI and
VII), 2 right anterior sections, 2 bisegmentectomy (V-
VI and IVb-III) and 1 left lateral sectionectomy. Five
patients were converted to open surgery. The mean
operative time was 414 minutes (260–560 minutes). The
mean hospital stay was 12 days (5–49). There were no
mortality and the morbidity rate was 60% (STROC I–
IV). The overall survival up to 1–4 years was 89% and
61% respectively and the disease-free survival 54% and
13% respectively.
Conclusions: In this initial experience, totally laparo-
scopic approach seems to be a feasible and safe option
to treat primary CRC with SLM in highly selected
patients. It has an acceptable rate of morbidity and
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satisfactory oncological results. The conversion to open
surgery is recommended, every time R0 resections are
compromised.
PPL24-112
USEFULNESS OF LAPAROSCOPIC
HEPATECTOMY IN THE ELDERLY
PATIENTS
Kazuto Shibuya, Koshi Matsui, Shigeaki Sawada,
Isaku Yoshioka, Isaya Hashimoto, Shozo Hojo,
Tomoyuki Okumura, Toru Yoshida, Takuya Nagata
and Kazuhiro Tsukada
University of Toyama, Japan
Introduction: Recently, malignant disease cases in the
elderly is increased. Elderly patients often various mor-
bidities, so in the treatment, there is a tendency that is
required minimally invasiveness. In about 10 years lap-
aroscopic hepatectomy is spreading in our country. It
was introduced in our department from 2010. Laparo-
scopic hepatectomy has emerged as a viable option;
however, its usefulness for elderly patients is undefined.
We reviewed the validity of the adaptation of this sur-
gical procedure for elderly patients.
Method: Thirty patients who have performed laparo-
scopic hepatectomy were identified between 2010 and
2012 in our hospital. Three patients were over 80 years
old, compared to the group of under 80 years old
patients. We analyzed retrospectively various clinical
factors.
Results: Mean of age was 86.3 and 63.4 years old,
respectively. Diseases were two cases of hepatocellular
carcinoma (HCC) and one case of cholangiocellular
carcinoma in over 80 years group, on the other hand in
under 80 years group, there are 20 cases of HCC, four
cases of liver metastasis, and three of the others. There
was no significant difference in liver function and per-
formance status. Partial resection was performed for all
of over 80 years old patients. In the group of under
80 years, it was applicable for partial resection in 23,
subsegmentectomy in 1, segmentectomy in 3. Operation
time, intraoperative blood loss, and postoperative hos-
pital stay were similar between the two groups. In the
over 80 group, there were two cases of respiratory dys-
function, were found in all cases of renal dysfunction,
however, there were no complication.
Conclusions: It was suggested the safety and validity of
laparoscopic hepatectomy for the elderly patients, simi-
lar to the non-elderly patients.
PPL24-113
CORRELATION BETWEEN LIVER
REGENERATION AND OPERATIVE
MORBIDITY AFTER RIGHT AND RIGHT
EXTENDED HEPATECTOMIES
Valerio Lucidi, Natalia Ciobanu, Ja^d Abi-Khalil,
Georgios Katsanos, Maria Antonietta Bali, Brigitte
Ickx, Pieter Demetter and Vincent Donckier
Erasme University Hospital ULB, Belgium
Introduction: Surgical resection is usually the only
curative treatment of liver tumors. Major liver resection
is sometimes necessary but not always feasible due to
insufficient remnant liver volume. The objective of this
study is to correlate postoperative liver regeneration
with biological and clinical outcome after right (RH)
and right extended hepatectomy (REH).
Method: Fifty-two patients undergoing RH/REH for
malignant tumor between 2005 and 2012 in whom com-
plete pre-and postopertive liver imaging was available
were reviewed. Liver volumetry has been performed
preoperatively and at 1, 3 and 6 months after resection.
Postoperative morbidity and biological evolution have
been prospectively recorded. The evolution of remnant
liver volume (RLV) hypertrophy has been analized and
compared depending on post-operative Dindo-Clavien
morbidity.
Results: Operative indication was colorectal liver metas-
tases in 23 (44.2%), hepatocellular carcinoma in 14
(26.9%), biliary tumors in 13 (25%), and other tumors in
2 (3.84%) cases. Preoperative portal vein embolization
(PVE) has been performed in 30 (57.69%) patients.
Overall morbidity was 61.5%, major complications rep-
resenting 40.38%. Average preoperative RLV was
596 mL or 40.8% of total liver volume (TLV) and
0.86% of body weight. The average TLV at 1, 3 and
6 months postoperatively was of 899, 1002 and 1076 mL
representing a volumetric hypertrophy rate of 55%, 27%
and 13% between each control. At 3 months cirrhotic
livers had a 40.7% volume increase versus 79% for non-
cirrhotic. No difference in volumetric increase between
patients with or without major complications.
Conclusions: Liver regeneration is mostly obtained at
1 month after major liver resection, no significant
hypertrophy occurs after 3rd month. Liver regeneration
rate is lower in cirrhotic livers and seems not to be cor-
related with morbidity after right or right extended
hepatectomy.
PPL24-114
PREOPERATIVE AST TO PLATELET
RATIO (APRI) IS AN INDEPENDENT
PROGNOSTIC FACTOR FOR RESECTED
HEPATOCELLULAR CARCINOMA
Shunli Shen, Shunjun Fu, Bin Chen, Ming Kuang,
Lijian Liang and Baogang Peng
The First Affiliated Hospital, Sun Yat-sen University,
China
Introduction: The objective of this study was to investi-
gate the prognostic value of platelet-based indices
including platelet count, platelet-lymphocyte ratio
(PLR), and aspartate aminotransferase-platelet ratio
index (APRI), in HCC after curative resection, espe-
cially in patients with HBV infection.
Method: We retrospectively reviewed 332 patients with
HCC treated with curative hepatectomy from 2006 to
2009. Preoperativel platelet count, as well as demo-
graphics, clinical, and pathologic data were analyzed.
Low preoperative platelet count, PLR, APRI were
defined as <300/mm3, <115/mm3, and <0.62 respec-
tively. Univariate and multivariate regression was per-
formed for predictors of disease-free survival (DFS)
and overall survival (OS).
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Results: Both DFS and OS of patients with low plate-
let count, PLR, and APRI were significantly better
than the elevated groups (p < 0.05). On multivariate
analysis, APRI, tumor size ≥5 cm, tumor without cap-
sulation, multiple tumors were associated with both
poor DFS and OS. In addition, macrovascular invasion
was an independent prognostic factor for poor DFS.
The 1, 3, 5 years DFS rate were 52%, 36%, 32% for
patients with APRI <0.62 and 35%, 22%, 19% for
patients with APRI ≥0.62. Correspondingly, the 1, 3,
5 years OS rate were 77%, 51%, 42% and 63%, 35%,
29% for both groups. Both DFS and OS of APRI
<0.62 group were significantly better than the elevated
group (p = 0.009 and 0.002, respectively). Patients with
elevated APRI tended to have cirrhosis, HBV infection,
surgical margin <1 cm, and more capsulated.
Conclusions: Elevated platelets based inflammatory
indices, especially APRI was associated with adverse
characteristic features and poor prognosis in HCC,
especially for patients with HBV infection or cirrhosis.
Anti-platelet treatment might represent an promising
therapy against HCC recurrence.
PPL24-115
HEPATIC RESECTION OF
COLORECTAL LIVER METASTASES:
RISK FACTORS FOR EARLY TUMOR
RECURRENCE
Valerio Lucidi, Desislava Germanova, Ja^d Abi-Khalil,
Georgios Katsanos, Maria Antonietta Bali, Raphael
Marechal, Brigitte Ickx, Pieter Demetter and Vincent
Donckier
Erasme University Hospital ULB, Belgium
Introduction: Hepatic resection remains the mainstay
for curative treatment of colorectal liver metastases
(CRLM). Many prognostic scores have been imple-
mented to select patients to undergo surgery but none
is accurate enough to identify patients who will not
benefit from hepatectomy. The aim of our study is to
detect preoperative clinical features that may predict
early cancer recurrence (ER), which might reflect the
aggressiveness of cancer, in a consecutive series of
patients undergoing first hepatectomy for CRLM and
evaluated the impact of ER on overall survival (OS).
Method: Two hundred and fifteen patients undergoing
a first hepatectomy for CRLM between 2005 and 2012
were analyzed. Patients with ER, as defined by cancer
recurrence in the first year after hepatectomy, were
identified and compared with patients with delayed
recurrence (DR) and without recurrence (NR). OS and
disease free survival (DFS) were compared in the differ-
ent groups to determine the influence of the types of
recurrences. Different clinical risk factors were com-
pared between patients with ER and patients with DR
and NR.
Results: Overall, 5 year OS and DFS were 45.3 and
35.7%, respectively. After a mean follow-up of
33 months, ER was diagnosed in 86 patients (40%)
and DR in 40 (18.6%). In patients with ER, 5-year OS
was significantly reduced as compared with the group
DR + NR, representing respectively 40.4% versus
57.3% (p < 0.001). Predictive factors significantly
associated with ER in multivariate analyses and avail-
able before liver surgery were: N+ stage of the primary
tumor, synchronous CRLM, initially unresectable
CRLM and absence of response to neoadjuvant chemo-
therapy. Points were attributed to each factor, leading
to a score from 0 to 8. In the entire population, OS
was significantly correlated with this score.
Conclusions: The association of many preoperative
clinical negative predictive factors may permit to select
patients that will not benefit from surgery in terms of
OS.
PPL24-116
CANCER STEM CELL MARKERS
PREDICT EARLY RECURRENCE AND
PROGNOSIS IN HEPATOCELLULAR
CARCINOMA
Zhe Guo and Le-Qun Li
Guangxi Medical University, China
Introduction: Surface markers CD133, CD90, and Ep-
CAM have been recognized as putative liver cancer
stem cell (LCSCs) markers. The aim of this study was
to investigate the recrudescent and prognostic impacts
of CD133, CD90, and EpCAM in hepatocellular carci-
noma (HCC).
Method: Ninety HCC patients who underwent curative
hepatectomy between April 2007 and April 2009,
including 38 cases with early recurrence and 52 cases
with non-early recurrence, were collected. After propen-
sity score analysis to adjust for baseline differences, 25
pairs of matched patients were selected. Tissue samples
from HCC patients and ten normal adult liver tissue
samples were collected. The expression of CD133,
CD90, and EpCAM were detected by immunohisto-
chemistry. The association of CD133, CD90, and Ep-
CAM expression with early recurrence and survival of
the patients were evaluated.
Results: Significant differences between normal adult
liver tissue and cancer were observed for all surface
markers (p < 0.001). Expression of CD133 was only
associated with tumor capsule (p = 0.005). Expression of
CD90 were linked to higher histopathologic grade
(p = 0.010) and tumor size (p = 0.034). Expression of
EpCAM was correlated with elevated serum AFP levels
(p = 0.021). The expression of CD90 and EpCAM in the
early recurrence group were significantly higher than that
in non-early recurrence group (p = 0.001, p = 0.045),
but the expression of CD133 were not statistically differ-
ent (p = 0.440). In multivariate analysis, only positive
CD90 expression was significantly associated with early
recurrence. Additionally, Positive expression of CD90
and EpCAM, Edmondson grade, tumor size were signifi-
cantly associated with the prognosis of HCC patients in
log-rank test, and COX regression analysis revealed that
independent prognostic predictors were tumor size and
positive expression of EpCAM.
Conclusions: This research suggests that expression of
CD133, CD90, and EpCAM is linked to tumor pro-
gression. Additionally, positive EpCAM expression
indicates a poor prognosis, and positive CD90 expres-
sion can serve as a significant predictor for early recur-
rence in HCC.
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ELEVATED PREOPERATIVE
PERIPHERAL BLOOD MONOCYTE
COUNT PREDICTS POOR PROGNOSIS
FOR HEPATOCELLULAR CARCINOMA
AFTER CURATIVE RESECTION
Shunli Shen, Shunjun Fu, Bin Chen, Ming Kuang,
Lijian Liang and Baogang Peng
The First Affiliated Hospital, Sun Yat-sen University,
China
Introduction: The aim of this study was to determine
whether monocyte count was prognostic in hepa-
tocellular carcinoma (HCC) following curative resec-
tion, especially in hepatitis B virus (HBV) associated
HCC.
Method: Preoperative absolute number of peripheral
monocytes, as well as demographics, clinical, histopath-
ologic, and laboratory data of 351 HCC patients trea-
ted with curative surgery were retrospectively reviewed
and analyzed.
Results: On univariate and multivariate analysis, ele-
vated monocyte count (≥545/mm3), tumor size ≥5 cm,
non-capsulation, and multiple tumors (more than one
tumor) were associated with poor DFS and OS. The 1,
3 and 5-year DFS rate was 58%, 41% and 35% respec-
tively for patients with monocyte counts <545/mm3,
and 36%, 23% and 21% for patients with monocyte
counts ≥545/mm3 (p < 0.01). Correspondingly, the 1, 3
and 5-year OS rates were 79%, 53% and 46% for
monocyte counts <545/mm3, and 64%, 36% and 29%
for monocyte counts ≥545/mm3 (p < 0.01). Both DFS
and OS of HCC patients with monocyte counts <545/
mm3 were significantly better than for patients with
monocyte counts ≥545/mm3. Subgroup analysis indi-
cated that DFS after hepatic resection of HBV infected
patients was significantly better for the patients with a
peripheral blood monocyte count <545/mm3
(p < 0.001), but it didn’t differ between patients with-
out HBV infection (p = 0.858). In addition, DFS was
significantly better for the patients with a peripheral
blood monocyte count <545/mm3, whether cirrhosis
was present or not (p = 0.018 vs p = 0.002). Patients
with elevated monocyte counts tended to have a larger
tumor (p = 0.019).
Conclusions: Elevated preoperative monocyte count is
an independent predictor of worse prognosis for
patients with HCC after hepatic resection, especially
for patients with HBV infection. Postoperative adju-
vant treatment might be considered for patients with
elevated preoperative monocyte counts.
PPL24-118
OUTCOMES OF HEPATIC RESECTION
FOR LARGE HEPATOCELLULAR
CARCINOMA: SPECIAL REFERENCE
TO POSTOPERATIVE RECURRENCE
Shogo Tanaka, Yuji Iimuro, Tadamichi Hirano, Seikan
Hai, Yuichi Kondo, Nobukazu Kuroda, Toshihiro
Okada, Kazuhiro Suzumura and Jiro Fujimoto
Hyogo College of Medicine, Japan
Introduction: Safety and efficacy of hepatic resection
for large hepatocellular carcinomas (HCC ≥ 10 cm in
diameter) remain controversial.
Method: Surgical results of patients with HCC ≥ 10 cm
(n = 24) who underwent hepatic resection over an 11-
year period were compared to those of patients with
HCC < 10 cm (n = 291).
Results: There was no significant difference in mortality
between the two groups (p > 0.99). Overall 5-year sur-
vival rate was 44.6% among patients with HCC ≥ 10 cm
and 70.5% among those with HCC < 10 cm (p = 0.010);
however, there was no significant difference in disease-
free survival rate between the two groups (p = 0.16).
Incidence of synchronous intra- and extrahepatic recur-
rence was higher in patients with HCC ≥ 10 cm than in
those with HCC < 10 cm (p = 0.0012). Macrovascular
invasion alone was an independent risk factor for poor
prognosis (hazard ratio (HR): 11.1) and recurrence (HR:
6.02) after hepatic resection for HCC ≥ 10 cm, which
was correlated with synchronous intra- and extrahepatic
recurrence.
Conclusions: Hepatic resection for large HCC is safe
and efficacious. However, incidence of synchronous
intra- and extrahepatic recurrence is high, especially in
patients with macrovascular invasion.
PPL24-119
CORRELATION OF GENE EXPRESSION
OF ATP-BINDING CASSETTE PROTEIN
AND TYROSINE KINASE SIGNALING
PATHWAY IN PATIENTS WITH
HEPATOCELLULAR CARCINOMA
Katrin Hoffmann, Lin Shibo, Xiao Zhu, Markus W.
B€uchler and Peter Schemmer
Ruprecht Karls University Heidelberg, Germany
Introduction: Recent evidence suggests an involvement
of the tyrosine kinase signaling pathway in the develop-
ment of ATP-binding cassette (ABC) protein-mediated
multidrug resistance in cancer. The aim of our study
was to determine the relevance of kinase and multi-
drug-resistance protein expression in human hepatocel-
lular carcinoma (HCC).
Method: Paired tissue samples of HCC and corre-
sponding peri-neoplastic tissue from 15 patients under-
going surgical resection were analyzed. The gene
expression of ABC proteins and Mitogen-activated pro-
tein kinase (MAPK) signaling cascade kinases was eval-
uated by realtime-PCR and correlated with a series of
clinicopathological parameters. In vitro effects of MEK
inhibition were evaluated in HepG2 cells.
Results: Overexpression of ABC proteins, tyrosine kin-
ases, or both was detectable in 40%, 86% and 33% of
HCC samples, respectively. MRP1-, MRP2- and
MRP3-mRNA levels were significantly increased in
13%, 20% and 33% of the HCC samples compared to
the corresponding peri-neoplastic tissue (p ≤ 0.05).
There was an association of ABCC1 and ABCC2 over-
expression in HCC tissue (p ≤ 0.05). EGFR-, RAF-,
MEK-, ERK- and MAPK-mRNA were overexpressed
in 33%, 33%, 40%, 50% and 50%, respectively com-
pared to the peri-neoplastic tissue (p ≤ 0.05). The
448 Poster Panel [Liver]
© 2014 The Authors
HPB © 2014 Americas Hepato-Pancreato-Biliary Association HPB 2014, 16 (Suppl. 2), 406–549
expression of MRP1, MRP2 and P-Glycoprotein corre-
lated statistically with the MEK gene expression.
Patients with tyrosine kinase overexpression had signifi-
cantly higher angioinvasion (p ≤ 0.05). RAF overex-
pression correlated statistically with increased tumor
size (p = 0.052). In vitro, MEK inhibition led to a
reduced ABCC1-mRNA and protein expression.
Conclusions: ABC proteins and tyrosine kinases are
significantly overexpressed in HCC tissue. The multi-
drug-resistance phenotype is associated with the MEK
expression in HCC. Inhibition of MEK might be a new
therapeutic approach to restore chemosensitivity in
patients with highly resistant tumors.
PPL24-120
NRF2 DEFICIENCY AUGMENTS THE
ACTIVITY OF HEPATIC PROGENITOR
CELLS DURING CHOLESTASIS
Guo-ying Wang1 and Guo-li Dai2
1The Third Affiliated Hospital of Sun Yat-sen
University, China; 2Indiana University-Purdue University
Indianapolis, USA
Introduction: Transcription factor nuclear factor ery-
throid 2-related factor 2 (Nrf2) is a central regulator of
cellular defense against oxidative stress and inflamma-
tion and is also involved in regulating liver regenera-
tion. The aim of the study is to evaluate whether Nrf2
mediates hepatic repair response during cholestasis.
Method: Wild-type and Nrf2-null mice were subjected
to bile duct ligation (BDL) or sham operation. Various
assessments were performed at 5, 10, 15, 25, and
40 days following surgery.
Results: Significant genotype-dependent differences in
liver injury, cell proliferation, and collagen deposition
were not seen over the time course of the study. Nrf2-
null mice exhibited a more prominent network of sep-
tual tissue containing laminin and a fetal protein
expressing cells at 15 days after injury, suggesting a
stronger repair response, than their wild-type litter
mates. In the livers of both genotypes of mice, cytoker-
atin 19 (CK19), a marker of bipotent liver epithelial
progenitors and immature biliary epithelial cells, were
expressed in the epithelial cells of newly formed bile
ducts and a population of hepatocytic-appearing cells
in parenchyma. Notably, Nrf2-null mice showed higher
hepatic protein expression of CK19 at 5 days following
BDL, indicating earlier onset of the activation of
CK19+ progenitor cells, than wild-types. CD133, a
marker of liver progenitors, were found to be expressed
by newly generated bile duct epithelial cells and a pop-
ulation of hepatocytic-appearing parenchymal cells in
the livers of the two genotypes of mice. Hepatic CD133
protein expression was gradually elevated, paralleling
continuous increase in the number of CD133+ hepato-
cytic-appearing cells, as the cholestasis progressed.
Remarkably, lack of Nrf2 let to markedly higher mag-
nitudes of the increases in hepatic CD133 protein level
and in the number of CD133+ hepatocytic-appearing
cells.
Conclusions: Collectively, our data demonstrate that
Nrf2 deficiency evokes higher activity of liver progeni-
tor cells and thus stronger liver repair response.
PPL24-121
SURGICAL RESECTION OF HEPATIC
CYSTIC ECHINOCOCCOSIS IMPAIRED
BY PREOPERATIVE DIAGNOSIS:
REPORT OF A CASE
Hwa Young Ko, Hiroshi Yoshida, Junji Ueda,
Yasuhiro Mamada, Nobuhiko Taniai, Masato
Yoshioka, Akira Matsushita, Tomohiko Yasuda and
Eiji Uchida
Nippon Medical School, Japan
Introduction: Cystic echinococcosis (CE) is a rare affer-
ent infectious disease in Japan. Echinococcosis is one
of the most familiar zoonosis and mainly infects the
human liver.
Method: This article reports a case of a hepatic cyst
being diagnosed after surgical resection. A 40-year-old
Syrian male was admitted for evaluation of a hepatic
cyst.
Results: Enhanced CT of the abdomen revealed a large
cystic lesion, in the left lateral sector of the liver, which
had many septa like a honeycomb. We preoperatively
diagnosed this lesion as cystadenocarcinoma or CE.
We performed a left hepatectomy. Pathological exami-
nation revealed the presence of protoscolices in the
fluid of the cysts and led to a diagnosis of this lesion as
CE.
Conclusions: On seeing patients with huge hepatic cysts
who come from an epidemic area, we should consider
hepatic CE.
PPL24-122
CONSTRUCTION OF A NEW HCC
CLASSIFICATION FOR
HEPATOCELLULAR CARCINOMA AND
COMPARISON WITH PREVIOUS NINE
STAGING SYSTEMS
Yan Tao, Bi Xinyu, Zhao Hong, Zhou Jianguo, Huang
Zhen, Zhang Yefan, Zhao Jianjun, Cai Jianqiang and
Li Zhiyu
Cancer Hospital, Chinese Academy of Medical Sciences
& Peking Union Medical College, China
Introduction: It has been validated that HCC of differ-
ent etiologies may belong to different populations
which lead to different prognosis. China has the highest
mobility of HCC accounts about 55% of the world,
but there is still no consensus on which is the best sys-
tem to predict prognosis in ethnic Chinese population.
Reviewing the existing stagings, only the CUPI staging
is the only system for HBV infection suitable for ethnic
Chinese, but its priority to other stagings remains to be
validated and improved, so it is imperative to explore
other better staging systems showing significant good
predictive value for ethnic Chinese.
Method: From 1999 to 2010, 908 ethnic Chinese
patients diagnosed with HCC (mainly hepatitis B-asso-
ciated) were enrolled into this study. A multivariate
analysis on 24 patient characteristics was performed
using a Cox regression model. Independent prognostic
factors were introduced to construct the new HCC clas-
sification. Akaike information criterion (AIC) was
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calculated to have an overall assessment of a certain
staging system for the comparison across different stag-
ing systems. Survival curves were plotted with the Kap-
lan–Meier method and were compared for all HCC
staging systems.
Results: Of the previous nine HCC staging systems,
TNM staging system showed the best prognostic signif-
icance (AIC = 3719.39), but it had discriminatory for
patients with advanced disease for not considering liver
function. The new HCC classification shows a better
stratification ability for late stage candidates than that
of TNM and the best prognostic ability
(AIC = 3711.41).
Conclusions: For patients with mainly hepatitis B-asso-
ciated HCC, the new HCC classification was more dis-
criminant than all other nine staging systems. It still
showed the best ability at predicting survival. Neverthe-
less, the new HCC classification needs to be validated
by different cohorts of patients before it can be recom-
mended for general use.
PPL24-123
PRELIMINARY EXPERIENCE WITH
MULTIPLE MICROWAVE ABLATION
FACILITATED BY COMPUTER-
ASSISTED LIVER NAVIGATION IN
ADVANCED NEUROENDOCRINE LIVER
METASTASIS
Pascale Tinguely1, Mathias Worni1, Delphine Ribes2,
Matthias Peterhans3, Stefan Weber2 and Daniel
Candinas1
1Bern Inselspital, Switzerland; 2University of BERN,
Switzerland; 3CAScination AG, Switzerland
Introduction: We have previously reported on a novel
means to control multiple liver lesions by computer
assisted liver surgery (CALS) and demonstrated its ben-
efits in over 100 patients suffering from advanced colo-
rectal metastasis and primary liver tumors. Here we
report our preliminary experience with CALS in the
setting of advanced forgut neuroendocrine tumors with
a multitude of neuroendocrine liver metastasis (NLM).
Method: We report on 2 patients with synchronous
NLM. In Pat 1 the primary tumor was located in the
pancreas (T3N1M1 G2) and the liver was seeded with
37 lesions as assessed by MEVIS reconstruction. Fol-
lowing metabolic therapy with DOTATOC we used
Microwave ablation (MWA) with CALS in order to
target 16 zones within the liver.
In Pat 2 the primary was located in the jejunum
(T2N0M1 G1) and there were 63 NLM as assessed by
MEVIS reconstruction. All tumor zones were targeted
in combination with a Seg. VI resection. MWA param-
eters were set between 10 seconds and 2 minutes at 100
Watt in both procedures. Both patients received
4 weeks oral antibiotics.
Results: No perioperative complications occurred and
both patients were dismissed within 8 and 11 days,
respectively. In Pat 1, CALS was followed by SIRT for
further treatment of 10 remaining metabolically active
lesions. The patient remains asymptomatic, with low
Chromogranin A levels and stable lesions for a follow
up period of 15 mts. In Pat 2, postoperative CT scan
3/63 remaining lesions. At follow-up of 2 mts the
patient remains asysmptomatic with normalised Chro-
mogranin levels.
Conclusions: Targeting of multiple, even high-num-
bered NLM can be achieved safely according to this
preliminary experience, in particular without infectious
complications with CALS directed microwave ablation.
This might serve as adjunct to other therapies for the
control of advanced NLM.
PPL24-124
RADIOFREQUENCY ABLATION AS
EMERGENCY TREATMENT IN A
MASSIVE HEMOPERITONEUM FROM
A MULTIFOCAL HCC
Francesco D’Amico, Maurizio Romano, Domenico
Bassi, Francesco Enrico D’Amico, Riccardo Boetto,
Alessandra Bertacco, Alessandro Vitale, Giacomo
Zanus and Umberto Cillo
HPB and Liver Transplant Unit Padova University,
Italy
Introduction: The hemoperitoneum is one of the possi-
ble complications of HCC that may require emergency
surgery as an alternative to radiological locoregional
therapies.
We present a case report of a 78-year-old patient with
an alcholic related end stage liver disease and a multi-
focal HCC with massive neoplastic evolution of the cir-
rotic liver associated with refractory ascites.
Method: Abdominal CT scan, showed multiple and
bilateral foci of bleeding from broken liver cancer. He
was urgently transferred from the radiology unit in the
operating room for massive hemoperitoneum and hem-
orrhagic shock. The middle line laparotomy detected a
massive hemoperitoneum. The cirrhotic liver in an
involution phase had reabitation of umbilical vein and
collateral vessells.
Results: The liver completely subverted by tumor had
two spontaneous bleeding lacerations on Segment II
and IV uncontrollable with conventional hemostatic
techniques. It was decided, therefore, to carry out the
coagulation of the multiple vascular afferents of each
single mass by means of RF cycles performed circum-
ferentially on both nodules for a total of 40 minutes.
The final hemostasis resulted ultimately effective. The
patient was transferred to the ICU for postoperative
monitoring in terms of hemodynamic stability. In sec-
ond post-operative day the patient was discharged and
reassigned to the medical ward of belonging.
Conclusions: The multifocal bleeding HCC still has an
extremely high mortality, the angiographic control of
multiple bilateral bleeding lesions can be extremely dif-
ficult and can be contraindicated by the location of the
lesions and by the overall clinical condition of the
patient, especially from the hemodynamic point of
view.
In this case, treatment with RF has proven to be effec-
tive in the control of multiple and bilateral hepatic
lesions, only as hemostatic-intent. This particular tech-
nique allowed us to attack the lesion at the level of the
vascular pedicle in order to control the bleeding.
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PPL24-125
PRECISE ABLATION OF THE
SEGMENTAL GLISSONIAN PEDICLE
BY ULTRASOUND-GUIDED
RADIOFREQUENCY IN ANATOMIC
LIVER RESECTION
Jiye Chen, Yukun Luo, Kai Jiang, Shouwang Cai,
Wenzhi Zhang and Jiahong Dong
Chinese PLA General Hospital, China
Introduction: Anatomic liver resection has been widely
accepted as the most optimum surgical option for
HCC. However, the current techniques to delineate the
segment have certain limitations. This research is to
demonstrate the technique of ultrasound guided seg-
mental glissonian pedicle radiofrequency ablation prior
to liver resection in a porcine model.
Method: Twelve animals were divided into 2 groups.
Coagulative destruction of the segmental vessels was
induced by introduction of a ‘‘cooled-tip’’ radiofre-
quency electrode under ultrasound guidance. In group
B, the hepatic artery was clamped temporarily at the
time of radiofrequency ablation. Three segments were
resected on each pig.
Results: There was no mortality or morbidity in either
group following RFA application. Demarcation areas
were clearly observed in 92% of all targeted segments
(83% vs 100%; p = 0.000) within an average of
124.0  36.2 seconds following application of radiofre-
quency. The flow rate of the targeted segmental portal
branches was 0 cm/s after radiofrequency. There was
no difference in the flow rate of the unaffected segmen-
tal vessels following RFA. The mean ablated length of
segmental portal, arterial and biliary tract branches
was 1.67  0.43, 1.33  0.40 and 1.65  0.35 cm
respectively. There was no significant difference
between the two groups.
Conclusions: The experiment showed that the technique
of ultrasound guided RFA ablation of the segmental
glissonian pedicle is expedient, safe and effective.
Simultaneous temporary occlusion of the hepatic artery
adds further benefit. The probe needs to be at least
1.5 cm away from non targeted structures to avoid
unintended thermal injury.
PPL24-126
SUSTAINED METHYLENE BLUE
STAINING TO GUIDE ANATOMIC
HEPATECTOMY
Shouwang Cai, Shizhong Yang, Wenping Lv, Weidong
Duan, Weiyi Wang, Zhiqiang Huang and Jiahong
Dong
Chinese PLA General Hospital, China
Introduction: The boundary of the target hepatic seg-
ment within the liver parenchyma cannot be marked
using a conventional anatomic hepatectomy approach.
This study described a novel methylene blue staining
technique for guiding anatomic resection of hepatocel-
lular carcinoma (HCC).
Method: Between February 2009 and December 2010,
anatomic hepatectomy was performed in 57 HCC
patients using a novel sustained methylene blue staining
technique. Sustained staining was achieved by injecting
methylene blue into the distal aspect of the portal vein
after exposing Glisson’s sheath. The hepatic pedicle
was immediately ligated, and the hepatic parenchymal
transection was performed along the interface between
methylene blue stained tissue and unstained tissue.
Results: Anatomic hepatectomies were subsegmentecto-
my (n = 8), monosegmentectomy (n = 27), multiseg-
mentectomy (n = 16), and hemihepatectomy (n = 6).
The portal vein was successfully injected with methy-
lene blue in 100% of cases, and complete staining of
the target hepatic segment was achieved in 52/57
(91.2%) cases. Mean intraoperative bleeding was
330  70 mL, and the postoperative complication rate
was 22.8% (13/57). All complications were successfully
managed via conservative treatment. Surgical margins
were all negative on pathologic examination. Mean
duration of postoperative follow-up was 34 months
(range, 24–46 months). No local recurrence (around the
surgical margin) occurred.
Conclusions: This novel technique of achieving sus-
tained staining by injecting methylene blue then imme-
diately ligating the hepatic pedicle is simple and
feasible. It can guide the selection of the surgical mar-
gin during hepatic parenchyma transection to improve
the accuracy of anatomic hepatectomy for the treat-
ment of HCC.
PPL24-127
A SUCCESSFUL RESECTED CASE OF
HILAR CHOLANGIOCARCINOMA
WITH RIGHT-SIDED ROUND
LIGAMENT
Masato Yoshikawa, Mitsuo Shimada, Tohru
Utsunomya, Yuji Morine, Satoru Imura, Tetsuya
Ikemoto, Yusuke Arakawa, Mami Kanamoto, Shichi
Iwahashi and Yu Saito
Tokushima University, Japan
Introduction: A right-sided round ligament is a rare
congenital anomaly with a reported frequency of 0.2–
1.2%, and is defined when the gallbladder is located to
the left of the round ligament without situs inversus.
We herein report a resected case of hilar cholangiocar-
cinoma with right-sided round ligament.
Method: A 63-year-old female consulted a local physi-
cian due to icterus. After insertion of endoscopic retro-
grade biliary drainage tube, she was referred to our
hospital. Laboratory findings at admission were as fol-
lows: WBC 7100/lL, AST 56 U/L, T-BIL 1.4 U/L,
CEA 1.7 ng/mL, CA19-9 903 U/mL, HCV Ab (),
HBs Ag (), ICGR15 21.8%, LHL15 0.935. MRCP
revealed a right-sided hilar cholangiocarcinoma.
MDCT showed that the round ligament existed from
right portal vein. Branching type of portal vein in cases
with right-sided round ligament is generally classified
into trifurcation type and bifurcation type, and this
case had the trifurcation type, in which the first branch
of the portal vein ran to the posterior segment and then
the portal vein formed a trunk of the left and right
anterior portal veins.
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Results: Operative procedure: Right lobectomy with
lymphadenectomy and extrahepatic bile duct resection.
Operation time was 510 minutes, and blood loss was
324 mL. Pathological diagnosis was as follows: Brcsl,
flat invasive type, S0, hinf2, H0, ginf0, panc0, du0, pv2,
a2, n2, T4N2M0, Stage IVb. The patient had an
uneventful postoperative course.
Conclusions: We successfully performed right hepatic
lobectomy in a case of hilar cholangiocarcinoma with a
right-sided round ligament. From the surgical point of
view, a precise preoperative identification of right-sided
round ligament would be important, because it accom-
panies several types of abnormal intrahepatic vessel
ramification.
PPL24-128
FIVE-YEAR SURVIVAL OF AFP-
PRODUCING GASTRIC CANCER WITH
SYNCHRONOUS LIVER METASTASIS:
REPORT OF A CASE
Takuma Nishino, Kenji Koneri, Yasuo Hirono, Katsuji
Sawai, Mitsuhiro Morikawa, Makoto Murakami,
Takanori Goi, Atsushi Iida, Kanji Katayama and Akio
Yamaguchi
University of Fukui, Japan
Introduction: Alpha-fetoprotein-producing gastric can-
cer (AFPGC) is a rare subtype of gastric cancer. It is
associated with a poor prognosis because it readily
metastasized to the liver and lymph nodes. Despite
attempts to treat AFPGC using many types of thera-
pies, the prognosis remains poor. We show a case of
AFPGC treated using multimodal therapy who sur-
vived for 5 years. Here, we focus on the effectiveness of
hepatic intra-aterial chemotherapy combined with oral
administration of sorafenib tosylate.
Method: No method.
Results: AFPGC is associated with bleak prognosis
becauce of liver and lymph node metastasis. We present
a case of AFPGC with synchrous liver metastasis who
survived for 5 years. A 69-year-old man with upper
abdominal pain was referred to our hospital. Apper
gastrointensional endscopy showed a Borrmann II-like
tumor in the lower part of the stomach. Computed
tomography (CT) showed a hypovascular tumor in the
left lobe of the liver. Serum AFP levels were increased.
We diagnosed AFPGC with synchronous liver metasta-
sis. After administering oral tegafur/gimeracil/oteracil
potassium, we perfomed distal gastrectomy and admin-
istered hepatic intra-arterial cisplatin injection. Liver
metastasis showed partial responce on CT. Despite left
hepatic lobectomy, further metastases to the liver and
mediastinal lymph nodes became difficult to control.
After sorafenib tosylate administration, stabilization of
the disease was observed for 4 months. We conclude
that hepatic intra-arterial chemotherapy and oral
administration of sorafenib tosylate may potentially
improve the prognosis in such cases.
Conclusions: We present a case of AFPGC with syn-
chronous liver metastasis who survived for 5 year.
PPL24-130
REAPPRAISAL OF ANATOMICAL
RESECTION FOR THE PATIENT OF
HEPATOCELLULAR CARCINOMA
FROM A VIEWPOINT OF THE
RECURRENCE SITE
Go Watanabe, Hiroshi Uchinami, Masato Yoshioka
and Yuzo Yamamoto
Akita University, Japan
Introduction: Necessity of segment-oriented anatomical
resection (AR) for hepatocellular carcinoma (HCC) is
still under debate. We studied this issue from a view-
point of the site of recurrence.
Method: One hundred and forty-three surgical cases of
HCC between 2002 and 2011 at our hospital were ret-
rospectively reviewed. Primary cases of single HCC
smaller than 5 cm with R0 resection were enrolled
because larger tumor was hardly a candidate of non-
anatomical resection (non-AR). As a result, 50 patients
of 20 with AR and 30 with non-AR were extracted and
a recurrence rate, time to recurrence and intrahepatic
recurrence site were analyzed.
Results: Cumulative recurrence rate followed a distinct
two-stage locus: Steep increase within 30 months post
surgery and moderate increase thereafter. To exclude
de novo carcinogenesis, only the recurrence within
30 months was handled hereafter. De novo recurrence
was only 3 in AR and 2 in non-AR. Background liver
function was significantly poorer in non-AR. Extrahe-
patic recurrence was comparable between the groups.
There was no difference in the intrahepatic recurrence
rate between the groups: AR = 6/20 and non-AR= 13/
30 (chi square test, p = 0.39), suggesting non-benefit of
AR. Then we analyzed whether the intrahepatic recur-
rence site after non-AR was biased to the segment (or
sector) identical to that of the primary tumor or not.
Out of 13 patients, the recurrence site after non-AR
was within the identical segment (or sector) in 6
patients and beyond the identical segment (or sector) in
7 patients, suggesting non-benefit of AR again.
Conclusions: Although the number of cases is small
and factors like a distance of surgical margin etc. are
lacking in this study, the benefit of AR was not demon-
strated from the viewpoint of the recurrence site in our
daily practice. A larger study of the recurrence site
after non-AR is warranted to settle the long-lasting
debate about clinical value of AR.
PPL25-001
ROBOTIC PANCREATECTOMY AND
HEPATECTOMY: INITIAL EXPERIENCE
AT SINGAPORE GENERAL HOSPITAL
Brian Goh, Jen-San Wong, Chung-Yip Chan, Peng-
chung Cheow, Alexander Chung and London Ooi
Singapore General Hospital, Singapore
Introduction: The most significant advance in laparos-
copy in the last 10 years is the advent of robotic lapa-
roscopic surgery using specialised systems. Although
robotic surgery has been adopted routinely for various
surgical procedures such as prostatectomy, its use in
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liver and pancreatic surgery remains limited. Presently,
the application of robotic technology for pancreatec-
tomy and hepatectomy remains controversial and few
large series’ have been reported worldwide. This study
aims to examine our institution’s preliminary experi-
ence with robotic liver and pancreas resections.
Method: This is an IRB-approved prospective study of
5 consecutive patients who underwent robotic pancrea-
tectomy or hepatectomy with the da Vinci-Si Surgical
System (Intuitive Surgical Sunnyvalle, Calif. USA).over
a 6-month period at a single institution.
Results: During the study period there were 3 robotic
hepatectomies including 1 left lateral sectionectomy, 1
segment II/III resection (non-anatomical) and 1 seg-
ment V resection with cholecystectomy. The hepatecto-
mies were performed for suspected hepatocellular
carcinoma in 2 patients and for a large symptomatic
haemangioma in 1 patient. Two patients underwent
robotic spleen-saving (vessel preserving) distal pancrea-
tectomies for a solid pseudopapillary neoplasm and an
indeterminate pancreatic cystic neoplasm. The median
age of patients was 53 (range, 38–66) years and there
were 4 males. The median total operating time (includ-
ing docking time) was 350 (range, 155–540) minutes
and the median blood loss was 200 (range, 50–
300) mL. No conversions were required and there were
no mortalities or major morbidities (>Clavien-Dindo
grade 2). The median hospital stay was 5 (range,
3–14) days.
Conclusions: Our initial experience confirms the feasi-
bility and safety of the application of robotic-assisted
surgery in pancreatic and liver resections.
PPL25-002
MULTIVARIATE ANALYSIS OF 353
CONSECUTIVE PATIENTS AFTER
RESECTION OF HEPATIC
METASTASES FROM COLORECTAL
CANCER
Sung Won Jung, Dong-Sik Kim, Young Dong Yu,
Pyoung Jae Park, Sae Byeol Choi, Sam Youl Yoon,
Hyung Joon Han, Tae Jin Song and Sang Yong
Choi
Kosin University College of Medicine, Korea
Introduction: To report the 5 year overall survival and
disease free survival results in patients who have under-
gone resection of hepatic metastases from colorectal
cancer.
Method: Between May of 1990 and December of 2011,
353 patients treated with hepatic resection for colorec-
tal liver metastases were evaluated. 54 patients were
excluded because of R1 colon resection and lack of
medical record.
Results: Metastases were synchronous in 186 patients
and metachronous in 113 patients. 182 patients had sol-
itary metastases, while 94 patients had 2 or more
metastases. 199 patients had metastases confined to sin-
gle lobar and 77 patients had metastases involving
more than one lobar.
The median survival of these 299 patients were
40 months and the cumulative 5 year overall survival
rate was 47.1% and 5 year disease free survival rate
was 31.4%.
Univariate predictors which were related to overall sur-
vival were grade of primary colorectal tumor (moderate
or well differentiated 63.9%, poorly differentiated
36.5%, p = 0.019), largest size of liver metastases
(<5 cm 52%, ≥5 cm 18.2%, p = 0.002), extent of liver
resection(<3 segments 52.3%, ≥3 segments 29%,
p = 0.021), perioperative chemotherapy(CTx 52%, no
CTx 31.2%, p = 0.018) and whether R0 or R1 resec-
tion (R0 44.2%, R1 26.3%, p = 0.0001). Whereas, pre-
dictors for disease free survival was grade of primary
colorectal tumor, alone (moderate or well differentiated
38%, poorly differentiated 0%, p = 0.029).
In the multivariate analysis, grade of primary colorectal
tumor, whether R0 or R1 resection, and perioperative
chemotherapy were related to overall survival and
grade of primary colorectal tumor and whether R0 or
R1 resection were related to disease free survival.
Conclusions: Our data suggest that better overall and
disease free survival can be predicted with moderate or
well differentiated primary colorectal cancer and R0
liver resection. And patients with perioperative chemo-
therapy have benefit for overall survival but no benefit
for disease free survival.
PPL25-003
ANALYSIS OF THE RISK FACTORS
FOR EARLY CANCER RECUR OR
DEATH WITHIN ONE YEAR AFTER
LIVER RESECTION IN PATIENTS WITH
COLORECTAL CANCER LIVER
METASTASIS
Sung Won Jung, Dong-Sik Kim, Young Dong Yu,
Pyoung Jae Park, Sae Byeol Choi, Sam Youl Yoon,
Hyung Joon Han, Tae Jin Song, Sang Yong Choi and
Sung Ok Suh
Korea University College of Medicine, Korea
Introduction: Curative liver resection is currently
accepted as the most effective treatment for patients
with colorectal cancer liver metastases (CRLM). How-
ever, some patients have early recur or death within
1 year after liver resection. We analyzed the risk factors
for early cancer recur and death.
Method: Between May, 1990 and December, 2011, 279
patients who underwent hepatectomy for CRLM at our
center. They were grouped ED (early death within
1 year after hepatectomy), NED (alive over 1 year after
hepatectomy), ER (early recur within 1 year after hepa-
tectomy) and NER (no recur over 1 year after hepatec-
tomy). Risk factors for early cancer recur and death
were analyzed.
Results: The ED Group included 26 patients, The
NED group included 253 patients. The ER Group
included 72 patients, The NER Group included 207
patients. The cause of death included cancer progres-
sion (n = 20, 76.9%), hepatic failure (n = 3, 11.5%),
operation-related (n = 2, 7.7%), and other (n = 1,
3.8%). In univariate analysis, surgery alone without
perioperative chemotherapy and poor differentiation of
colorectal cancer were identified risk factors for early
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death, and metachronous metastasis, surgery alone
without perioperative chemotherapy, tumor size ≥5 cm,
multilobular metastasis, CEA>50 ng/mL, and poor dif-
ferentiation of colorectal cancer were identified risk fac-
tors for early recur. Multivariate analysis, surgery
alone without perioperative chemotherapy and poor
differentiation of colorectal cancer were identified risk
factors for early death and tumor size ≥5 cm, surgery
alone without perioperative chemotherapy and poor
differentiation of colorectal cancer were identified risk
factors for early recur.
Conclusions: More adjunctive perioperative chemother-
apy should be considered for patients with these risk
factors (tumor size ≥5 cm and poor differentiation of
colorectal cancer), because these patients tend to die or
recur within 1 year after liver resection.
PPL25-004
THE OUTCOMES OF SURGICAL
TREATMENT OF HUGE HCC
Yong-Bae Kim1, Sang Bum Kim1, Chang-Sup Lim3,
Ryoung-go Kim1, Dong Wook Choi2 and Eun-bin
Ryu1
1Korea Cancer Center Hospital, Korea; 2Sungkyunkwan
University, School of Medicine, Korea; 3Dongnam
Institute of Radiological and Medical Sciences, Busan,
Korea
Introduction: Hepatocellular carcinoma (HCC) is the
second cause of cancer-related death in Korea.
Although, the surgical resection is a gold standard in
treatment of HCC, there are some debates for the treat-
ment of huge ≥10 cm) HCC. We have evaluated the
outcomes of resection of huge HCC.
Method: We reviewed 646 patients who had undergone
surgical treatment for HCC between Jan 1987 and Jun
2013. Fifty-four of 646 patients had huge HCC. Clinic-
o-pathologic parameters affecting survival were analy-
sed using univariate and multivariate analyses.
Results: There were no postoperative mortality in huge
HCC group. Postoperative complication rate were
33.8% in small HCC group and 45.3% in Huge HCC
group, but didn’t reached statistical significance
(p = 0.098). Huge HCC group had the tendencies of
higher HBV infection, transfusion rate, venous inva-
sion, and liver cirrosis than smaller HCC group with
statistically significance. Five year overall survival rate
were 61.9% in small HCC group and 42.3% in huge
HCC group (p < 0.0001). Multivariate analysis revealed
that absence of macrovascular invasion and lymph
node metastasis are the good prognostic factors for sur-
vival in huge HCC group.
Conclusions: Despite of its aggressive nature of huge
HCC, surgical treatment tend to be more invasive. The
surgical resection for huge HCC, however, can be done
with safe and showed relatively favorable survival out-
comes. Lymph node metastasis and macrovascular
invasion were the independent prognostic factors.
PPL25-005
PRIMARY HEPATIC LEIOMYOMA
ARISING IN HEALTHY PATIENT: A
CASE REPORT
Choong Young Kim and Chol Kyoon Cho
Chonnam National University Medical School, Korea
Introduction: Leiomyomas are very rare, benign liver
tumors developed from the smooth muscles of the ves-
sels or bile ducts. It can be more observed in patients
with immunosuppression or organ transplantation.
Herein, we report a case of primary hepatic leiomyoma
arising in healthy patient.
Method: A 42-year-old woman was referred to our
hospital for further evaluation of the presence of hepa-
tic mass, detected on ultrasonogram (US) performed
for routine screening examination. The patient was
asymptomatic. She had no history of liver disease or
oral contraceptive usage. Physical examination revealed
a mass in epigastic area of abdomen. All the routine
laboratory tests including liver function tests and tests
for tumor markers yielded normal findings. Abdominal
computed tomography (CT) scan demonstrated a
7.4 9 7.1 cm sized well-defined mass in left subhepatic
space that showed heterogenous enhancement in arte-
rial phase, homogenous and delayed enhancement in
delayed phase. Liver magnetic resonance images (MRI)
scan demonstrated a 7.5 9 7 cm sized mass showed
low signal intensity on T1 and T2 weighted images.
There was displacement of portal triad, but no evidence
of hepatic artery or portal vein involvement. The find-
ing suggested hepatic adenoma or neurogenic tumor.
Results: The patient underwent laparotomy with exci-
sion of mass, caudate lobe wedge resection. At laparot-
omy, there was a 8 9 8 9 6 cm sized round, whitish
smooth mass on caudate lobe and there was no vascu-
lar invasion. Microscopically, the tumor is composed of
bland-looking spindle cells with whirling pattern and
showed negative margin for tumor. Immunohistochemi-
cal staining was positive for Actin, Desmin, Vimentin,
Caldesmon. Stains for CD34, C-kit, CK, S-100, HMB-
45, EMA were negative. Pathologically, the tumor was
identified as a primary hepatic leiomyoma.
Conclusions: Primary hepatic leiomyoma is a rare neo-
plasm and it should be considered differential diagnosis
of other liver lesions.
PPL25-006
SIMULTANEOUS LAPAROSCOPIC S8
SEGMENTECTOMY OF LIVER AND
LADG IN PATIENT WITH
SYNCHRONOUS HCC AND EGC
Ju Ik Moon, In Seok Choi, Nak Song Sung, Sang Euk
Lee, Won Jun Choi, Dae Sung Yoon, Yu Mi Na and
Jung Seok Lee
Kunyang University Hospital, Korea
Introduction: As we encounter patients diagnosed with
double primary cancer, we think over a proper way of
treatment. Nowadays, preferable treatment on both
early gastric cancer (EGC) and hepatocellular carci-
noma (HCC) is laparoscopic surgery. Various litera-
tures have reported there are no differences with
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oncologic safety and feasibility between open and lapa-
roscopic surgery for each cancer. Hereby, we report
simultaneous laparoscopic S8 segmentectomy and lapa-
roscopic-assisted distal gastrectomy (LADG) in patient
with synchronous HCC and EGC.
Method: A 58-year-old male patient was diagnosed
with EGC and HCC (S8) during cancer screening test.
He presented with a 3.9 9 4 cm sized HCC confirmed
by ultrasound (US)-guided biopsy in segment 8 of the
liver and 1 cm sized EGC (signet ring cell carcinoma)
that is located at great curvature of antrum, and local-
ized at mucosa without lymphovascular invasion con-
firmed by Endoscopic US (EUS). Laparoscopic S8
monosegmentectomy was firstly performed with 4 ports
method (umbilicus and epigastrium: 11 mm, Rt. mid-
abdomen and Lt. upper abdomen: 5 mm), and LADG
with D2 lymph node dissection was performed later
with additional 2 ports (Rt. lower abdomen: 11 mm,
Lt. lower abdomen: 5 mm).
Results: An operating time was 215 minutes, and esti-
mated blood loss was 100 cc. Diet was started at post-
operative day 3 and discharged at postoperative day 8
without another complications.
Conclusions: We suggest that simultaneous laparo-
scopic treatment for synchronous HCC and EGC
would be safe and feasible method.
PPL25-007
THE EFFECT OF VARIOUS
IMMUNOSUPPRESSANT ON EPCAM+,
CD133+ CELLS
Hae Won Lee, Kwang-Woong Lee, Kyung-Suk Suh,
Nam-Joon Yi, YoungRok Choi, Hyeyoung Kim,
Suk-Won Suh, Tae Yoo and Jeong-Moo Lee
Seoul National University College of Medicine, Korea
Introduction: Liver transplantation (LT) for HCC has
been increasing. HCC recurrence after LT is an impor-
tant risk factor affecting survival. Therefore, optimal
immunosuppressant to reduce HCC recurrence is
important in advanced cases. According to the cancer
stem cell (CSC) theory, the effect on CSC is important
to select optimal immunosuppressant. In this study, we
evaluate the effect on CSC by various immunosuppres-
sant.
Method: CSC subpopulation was defined as EpCAM+,
CD133+. Double negative subpopulation was defined
as non-CSC. Huh7 and 4 kinds of immunosppressants
(Sirolimus, Tacrolimus, Cyclosporine A, MMF) were
used. Cell proliferation was measured by MTT assay.
Apoptosis was measured Annexin V and 7-AAD kit.
Cell cycle was measured by FACS.
Results: Total cell proliferation was decreased in Siroli-
mus or MMF treated group. However, the proportion
of CSC was increased in both groups. No significant
change was identified in Tacrolius or Cyclosproine
treatment group. Apoptosis was decreased in CSC sub-
population, however, increased in non-CSC sub-popu-
lation after Sirolimus treatment. Cell cycle arrest was
measured in both CSC and non-CSC sub-populations
by Sirolimus (G1 arrest) or MMF (S arrest) treatment.
No cell cycle change was identified in Tacrolimus or
Cyclosporine A treatment group.
Conclusions: Cell proliferation of total cells was inhib-
ited by Sirolimus. However, CSC was more resistant to
Sirolimus in Huh7. Additional policy to reduce the
number of CSC is needed in Huh7.
PPL25-008
A COMPOSITE PARAGANGLIOMA AND
ANAPLASTIC NEUROBLASTOMA OF
RETROPERITONEUM DEVELOPED IN
ADULT MIMICKING HEPATIC TUMOR
Hee Joon Kim, Choong Young Kim, Young Hoe Hur,
Yang Seok Koh, Chol Kyoon Cho and Hyun Jong
Kim
Chonnam National University Medical School, Korea
Introduction: Paragangliomas are more common in the
head and neck region. Composite paraganglioma-neu-
roblastoma of retroperitoneum is extremely rare. We
report a case of retroperitoneal composite paragangli-
oma with anaplastic neuroblastoma developed in the
adult mimicking hepatic tumor.
Method: A 62-year-old man visited outpatient depart-
ment with a complaint of right upper quadrant pain.
Abdomen CT and MRI demonstrated an
11 9 11 9 16 cm sized mutiseptated cystic mass in
right hepatic lobe. He underwent right hepatectomy
under the diagnosis mucinous cystic tumor. In opera-
tion finding, there was about 20 9 15 cm sized large
cystic mass in right hepatic lobe extended to retroperi-
toneum.
Results: On sectioning, the tumor had both cystic and
solid component and the border between the tumor
and liver was well marginated. Pathological result of
cystic lesion was paraganlglioma with CD56(+), synapt-
ophysin (+) and Ki-67 (+, 2–3%) on immunohistochem-
ical stain. On the other hand, the result of solid
component was anaplastic neuroblastoma – CD56 (+),
synaptophysin (), Ki-67 (+, 10–15%). The patient dis-
charged on postoperative 15th day without any compli-
cation.
Conclusions: Composite paragaglioma with neuroblas-
toma are rare tumors of the retropeitoneum in the
adult. Regardless of age, such tumors should be consid-
ered in the differential diagnosis of retroperitoneal
masses even if it looks hepatic tumor.
PPL25-009
MIR-101 IS DOWN-REGULATED BY
THE HEPATITIS B VIRUS X PROTEIN
AND INDUCES ABERRANT DNA
METHYLATION BY TARGETING DNA
METHYLTRANSFERASE 3A
Xufu Wei1, Tingxiu Xiang1, Guosheng Ren1, Cui Tan1,
Rui Liu1, Xiao Xu2 and Zhongjun Wu1
1The First Affiliated Hospital of Chongqing Medical
University, China; 2The First Affiliated Hospital,
Zhejiang University School of Medicine, China
Introduction: The hepatitis B virus x (HBx) protein has
been implicated in HBV-related hepatocellular carci-
noma (HCC) pathogenesis. However, whether HBx reg-
ulates miRNA expression that plays important roles in
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gene regulation during hepatocarcinogenesis remains
unknown.
Method: The expression of microRNA-101 (miR-101)
in HBV-related HCC tissues and HCC cells was evalu-
ated by real-time PCR. The direct target of miR-101,
DNA methyltransferase 3A (DNMT3A), was identified
in silico and validated using a 3′-UTR reporter assay.
miR-101 was functionally characterized in cells with
transiently altered miR-101 expression.
Results: HBx expression was found to have a signifi-
cant inverse correlation with miR-101 expression in
HBx-expressing HepG2 compared to control HepG2
cells. miR-101 expression was frequently down-regu-
lated in HBV-related HCC tissues compared to adja-
cent noncancerous hepatic tissues and had a significant
inverse correlation with DNMT3A expression in HBV-
related HCCs. Further characterization of miR-101
revealed that it negatively regulated DNA methylation
partly through targeting DNMT3A. HBx-mediated
miR-101 down-regulation and DNMT3A up-regulation
supported the enhanced DNA methylation of several
tumor-suppressor genes in HBx-expressing cells.
Conclusions: Our studies demonstrating the deregula-
tion of miR-101 expression by HBx may provide novel
mechanistic insights into HBV-mediated hepatocarcino-
genesis and identify a potential miRNA-based targeted
approach for treating HBV-related HCC.
PPL25-010
HEPATICOJEJUNOSTOMY: A
REAPPRAISAL OF ITS INDICATIONS,
RESULTS, AND LONG TERM
OUTCOME
Adithya Naragund, Sharvari Pujari, Ramkrishna
Prabhu, Avinash Supe, Ravindra Bapat and Chetan
Kantharia
Seth GS Medical College & KEM Hospital, Parel,
Mumbai-12, India
Introduction: HJ though commonly performed, if not
properly performed has both immediate and long term
complications. The present study evaluates our out-
come of HJ performed in a mixed cohort of patients of
iatrogenic bile duct injuries, biliary tract, pancreatic
malignancies and other benign biliary pathology.
Method: Between 2008 and May 2013, the records and
operative notes of all patients of HJ were reviewed with
regards to surgical technique, operative mortality, post-
operative complications and postoperative liver func-
tion tests with respect to biliary function. End-to-side
HJ done in majorit, with Hepp-Couinaud approach in
high strictures and recurrences. Anastomosis done with
4/0 PDS taking interrupted sutures. The mean follow-
up was 19.4 months (range 1.0–44.7 months).
Results: Eight-eight (48 females) hepaticojejunostomies,
including three redo anastomoses, were performed. The
indications included 28 following Whipples surgery, 17
following choledochal cyst excision, 40 secondary to
iatrogenic BDI and 3 for benign primary biliary pathol-
ogy. End-to-side hepaticojejunostomy was performed in
72 patients and 16 performed by Hepp-Couinaud tech-
nique. This was for patients of BDI (E3-11, E4-4, E5-1)
including 3 re-do HJ. There was one perioperative
death secondary to sepsis following bile leak. Bile leak
was in 3. The long-term results of 65 patients were: 56
symptom-free; 7 had brief episodes of cholangitis, 5 of
whom treated conservatively, and 2 with PTBD for
stricture. 1 reoperation for stricture and one on whom
redo anastomosis was done subjected to Left hepatic
resection.
Conclusions: Hepaticojejunostomy is a safe and reliable
method for biliary reconstruction. Interrupted sutures
using PDS 4.0 provides good results. It should be per-
formed in centers capable of dealing with complica-
tions.
PPL25-011
A CASE OF PRIMARY HEPATIC
NEUROENDOCRINE TUMOR
UNDERGOING A REPEAT
HEPATECTOMY
Kamei Natsuko, Koizumi Satoshi, Shimada Jin,
Katayama Masafumi, Kishi Shinya, Kobayashi
Shinjiro, Nakano Hiroshi, Fujino Takashi and Otsubo
Takehito
St. Marianna Univercity School of Medicine, Japan
Introduction: The most common site of primary gastro-
enterological neuroendocrine tumor (NET) is the ileum,
followed by the rectum, appendix, and pancreas. The
liver is the most common site for NET metastases, but
primary hepatic NET is extremely rare, with only about
100 cases having been reported in the English-language
literatures. We report a case with the primary hepatic
NET undergoing a repeat hepatectomy.
Method: A 65-year-old man without clinical symptoms
had presented with a hepatic cystic tumor since 2 years,
and was referred to our hospital because the tumor
showed the gradual enlargement in size.
Results: Abdominal enhanced computed tomography
and magnetic resonance image showed a hypervascular
tumor with cystic component of the segment 8 of the
liver. The preoperative diagnosis was cystadenocarcino-
ma of the liver. We performed a partial hepatectomy of
the Segment 8, and the tumor was curatively resected
with negative margin. Histopathological diagnosis of
the tumor was NET-G2 according to WHO classifica-
tion. Postoperative examinations did not show the pos-
sible primary site of gastrointestinal, pancreatic, or
other organic NET. The final diagnosis was the pri-
mary hepatic NET with stage III (T3N0M0) as the
clinical stage of the liver.
Four deposits of the liver were detected 11 months
after the surgery, and these tumors due to intrahepatic
recurrence were resected by partial hepatectomies
26 months after the first surgery. The patient is still
alive without recurrence 31 months after the first sur-
gery.
Conclusions: Reported 5-year survival of the primary
hepatic NET was only 10–20%. Therefore, hepatec-
tomy should be always considered for the primary
hepatic NET to improve prognosis, and the repeat hep-
atectomy also seems to be considered for intrahepatic
recurrence of this tumor.
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PPL25-012
PRIMARY HEPATIC
CARCINOSARCOMA WITH PORTAL
VEIN TUMOR THROMBI IN A
HEPATITIS B VIRUS CIRRHOSIS
PATIENT: A CASE REPORT
Kunmoo Choi, Gabjin Cheon, Daewoon Eom and
Jaehong Ahn
Gangneung Asan Hospital, Korea
Introduction: Hepatic carcinosarcoma is defined as a
malignant tumor containing an intimate mixture of
either hepatocellular carcinoma (HCC) or cholangiocel-
lular carcinoma (CCC) and sarcomatous elements. The
pathogenesis of the sarcomatous element has not been
fully clarified and the prognosis of this neoplasm is
extremely poor. We report a case of primary hepatic
carcinosarcoma with portal vein tumor thrombi in a
50-year-old Korean man with hepatitis B virus
cirrhosis.
Method: Patient was admitted with vague upper
abdominal pain for 1 month. His blood tests were sig-
nificant for elevated aspartate aminotransferase 48 IU/
L, alanine aminotransferase 60 IU/L (normal < 40 IU/
L), alkaline phosphatase 606 IU/L (normal < 343 IU/
L), total bilirubin 1.4 mg/dL (normal < 1.2 mg/dL)
and carbohydrate antigen 19-9 level 69.4 U/ml (nor-
mal <37 U/mL). CT scan and MRI of the abdomen
showed about 6 9 4 cm mass in left lobe of liver and
left portal vein thrombosis extended to main trunk and
right extrahepatic portal vein. Subsequently underwent
needle biopsy revealed an undetermined type of
malignant mesenchymal tumor, which was positive for
vimentin and smooth muscle actin in immunohisto-
chemical stain. There was no evidence of distant metas-
tasis in positron emission tomography CT scan. Left
hepatectomy and portal vein tumor thrombectomy
were performed.
Results: Pathology report was hepatic carcinosarcoma
containing an intimate mixture of cholangiocellular and
spindle cells in the liver as well as portal vein tumor
thrombi. The cholangiocellular components of the
tumor were positive for CK7 and negative for glypican
and hepatocyte. Spindle cell components were positive
for vimentin and CD34 with vascular proliferation.
Two months later, the patient had intrahepatic recur-
rence with invasion of anterior branch of right portal
vein, which was followed by death 4 months later due
to disseminated malignancy.
Conclusions: Because of highly invasive and metastatic
characteristics, carcinosarcoma should be included in
the differential diagnosis of a large hepatic mass.
PPL25-013
TRIPLE POSITIVE TUMOR MARKERS
PREDICT EARLY RECURRENCE AND
POOR SURVIVAL IN
HEPATOCELLULAR CARCINOMA
MEETING MILAN CRITERIA
Shinichi Sugiyama, Toru Beppu, Shigeki Nakagawa,
Hirohisa Okabe, Hidetoshi Nitta, Katsunori Imai,
Hiromitsu Hayashi, Akira Chikamoto, Hiroshi
Takamori and Hideo Baba
Kumamoto University, Japan
Introduction: Several studies have indicated that tumor
markers of hepatocellular carcinoma (HCC), including
alpha-fetoprotein (AFP), Lens culinaris agglutinin-reac-
tive fraction of AFP and des-c -carboxy prothrombin
were good predictors of malignant potential. However,
the prognostic factors for early-stage HCC meeting the
Milan criteria are not clarified in the past and it is
important to discover the highly malignant group of
HCC.
Method: This retrospective study analyzed 199 patients
who underwent hepatectomy for HCC within Milan
criteria between January 2001 and May 2009. The
cumulative recurrence -free and overall survival and
prognostic factors were analyzed according to the num-
ber of positive tumor markers. Cox proportional haz-
ards regression analyses were performed to estimate
risk factors for recurrence and survival. Furthermore,
the relationships were examined between clinicopatho-
logical parameters and the expression patterns of the 3
tumor markers.
Results: Expression patterns of 3 tumor markers were
related to the presence of multiple tumors and maxi-
mum tumor size. In patients with triple positive tumor
markers, 5-year recurrence-free and overall and survival
was poor; 17.1% and 61.4%, respectively. Multivariate
analysis revealed that ICGR15 > 12.6% [relative risk
(RR) 2.46, p = 0.0146], maximum tumor diameter lar-
ger than 3 cm (RR 2.71, p = 0.0035) and triple positive
markers (RR 2.57, p = 0.0198) were independent risk
factors for overall survival and HCV-Ab positive (RR
1.65, p = 0.0154), non-initial treatment for HCC (RR
1.87, p = 0.0047) and triple positive tumor markers for
HCC (RR 1.68, p = 0.0376) were independent risk fac-
tors for recurrence. From pathological findings, inva-
sive growth, microvascular invasion and moderate or
poor differentiation were related to the expression pat-
terns of the 3 tumor markers.
Conclusions: Triple positive tumor markers for early-
stage HCC within Milan criteria showed poor progno-
sis and malignant characteristics in pathological find-
ings. Examination of these markers would be useful for
predicting the degree of malignant potential in early-
stage HCC.
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PPL25-014
THE ESTABLISHMENT AND
OBSERVATION OF CIRRHOSIS MODEL
IN NEW ZEALAND RABBITS BY
CARBON TETRACHLORIDE
Yi-Zhen Gong1, Tao Peng1, Guang-Zhi Zhu1 and Le-
Qun Li2
1The First Affiliated Hospital, Guangxi Medical
University, Nanning, Guangxi, China; 2The Affiliated
Tumor Hospital, Guangxi Medical University, Nanning,
Guangxi, China
Introduction: The purpose of this study is to establish a
relatively simple yet stable cirrhotic model in New Zea-
land rabbits with Carbon Tetrachloride (CCl4) treat-
ment.
Method: Stage-1: Twenty-four male New Zealand
white rabbits were randomized into A, B, C and D
groups, given placebo, low, medium and high dosages
of CCl4, respectively. The levels of BW (body weight),
TP (total protein), Alb (albumin), Glo (globulin), ALT
(alanine aminotransferase), AST (aspartate transamin-
as), G-GT (c-glutamyltransferase), WBC (white blood
cell), RBC (red blood cell), HGB (hemoglobin) and
PLT (platelet) in each group were recorded. Liver
biopsy were conducted every 2 weeks in a randomly
manner. At stage-2, CCl4 treatment was stopped when
liver biopsy revealed pathological cirrhosis. And the
above indices were continually recorded for 8 weeks.
Meanwhile, biopsy was conducted to monitor the sta-
bility of the liver cirrhosis.
Results: Three New Zealand rabbits in Group C died
in the 2nd – 3rd week, five rabbits in Group D died in
the 10th week. The liver pathology for cirrhosis
revealed that all animals in group-A were staged S0,
three in group-B were S4 and the other two were S3.
At the second stage, biopsy showed that liver fibrosis
of 5 New Zealand rabbits in the Group B improved
significantly in the third week (p < 0.05).
Conclusions: Pathological cirrhosis appeared in male
New Zealand white rabbits receiving subcutaneous
injection of 0.3 mL/kg CCl4 dissolved in olive oil (1:1
ratio) once every 3 days for 10 weeks. The fibrosis
improved in <3 weeks after the withdrawal of CCl4,
and both liver function and hemogram indices recov-
ered to normal levels, suggesting that a sustained treat-
ment of CCl4 is necessary to maintain the cirrhotic
model.
PPL25-016
ISOLATED COMPLETE CAUDATE
LOBECTOMY FOR HEPATIC TUMOR
OF THE ANTERIOR TRANSHEPATIC
APPROACH: SURGICAL APPROACHES
AND PERIOPERATIVE OUTCOMES
Yingbin Liu
Xinhua Hospital, School of Medicine, Shanghai Jiaotong
University, China
Introduction: How to resect the caudate lobe safely is a
major challenge to current liver surgery which requires
further study.
Method: Nine cases (6 hepatic cell carcinoma, 2 cav-
ernous hemangioma and 1 intrahepatic cholangiocaci-
noma) were performed using the anterior transhepatic
approach in the isolated complete caudate lobe resec-
tion. During the operation, we used the following tech-
niques: the intraoperative routine use of Peng’s
multifunction operative dissector (PMOD), inflow and
outflow of hepatic blood control, low central venous
pressure and selective use of liver hanging maneuver.
Results: There were no perioperative deaths observed
after the operation. The median operating time was
230  43.6 minutes, the median intraoperative blood
loss was 606.6  266.3 mL and the median length of
postoperative hospital stay was 12.6  2.9 days. The
incidence of complications was 22.22% (2/9).
Conclusions: PMOD and “curettage and aspiration”
technique can be of great help of in the dissection of
vessels and parenchyma, clearly making caudate lobe
resection safer, easier and faster.
PPL25-017
RAPIDLY ENLARGED INFLAMMATORY
HEPATOCELLULAR ADENOMA:
REPORT OF A CASE
Kenji Koneri, Hidetaka Kurebayashi, Mitsuhiro
Morikawa, Makoto Murakami, Yasuo Hirono,
Takanori Goi, Atsushi Iida, Kanji Katayama and Akio
Yamaguchi
University of Fukui, Japan
Introduction: A new classification for hepatocellular
adenoma (HCA) was described in 2006 in WHO classi-
fication of tumors of the digestive system. According to
this classification, HCA is grouped into three subtypes
based on genotype and phenotype as follows: hepato-
cyte nuclear factor (HNF) 1a-inactivated HCA, b-cate-
nin-activated HCA and inflammatory HCA (IHCA).
Among these subtypes, IHCA results from a molecular
gain-of-function mutation of the interleukin (IL)-6
pathway, and shows characteristic pathological features
such as inflammatory cell infiltration, sinusoidal dilata-
tion and increased expression of inflammatory proteins
such as serum amyloid A (SAA) and C-reactive protein
(CRP). A non-negligible number of IHCA patients
have recently been reported in Western countries, but
very few in Asian countries. We now report a case of
an IHCA asian male patient, who showed rapid
enlargement of tumor and underwent surgical resection
after preoperative perflubutane microbubble (Sonazoid)
contrast-enhanced ultrasonography and gadolinium
ethoxybenzyl diethylenetriaminepentaacetic acid
(Primovist) contrast-enhanced magnetic resonance
imaging.
Method: No method.
Results: Screening abdominal CT scan for the fatty liver
patient (Japasense, middle-aged male) revealed a 1.7-cm
liver mass in the anterior segment of the liver. After
19 months, the lesion had rapidly enlarged to 6 cm in
diameter and the patient was referred to our hospital.
On Sonazoid-US, the tumor showed a characteristic
centripetal filling pattern in the vascular phase. We per-
formed hepatic anterior segment resection because we
could not rule out malignant tumor. Histopathological
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examination showed hyperplasia of mildly atypical he-
patocytes and sinusoidal dilatation with marked inflam-
matory cell infiltration. Immunohistological staining
revealed positive staining for serum amyloid A and C-
reactive protein. As the result, we diagnosed this tumor
as IHCA. The patient remains alive 51 months after
operation without evidence of recurrence.
Conclusions: We present a rare case of rapidly enlarged
IHCA in an asian patient.
PPL25-018
VIRTUAL HEPATECTOMY IS USEFUL
FOR SIMULATION OF ANATOMICAL
HEPATECTOMY IN PATIENTS WITH
HEPATOCELLULAR CARCINOMA AND
INTRAHEPATIC PORTAL VEIN
ANOMALY
Shingo Yamashita, Shunichi Ariizumi, Kotera
Yoshihito, Yutaka Takahashi, Satoshi Ogata, Akiko
Oomori, Shin Yamamoto, Satoshi Katagiri, Yosihito
Egawa and Masakazu Yamamoto
Tokyo Women’s Medical University, Japan
Introduction: Intrahepatic portal vein anomaly is rare,
but it is the most dangerous anomaly in liver surgery.
Method: We present two cases of hepatocellular carci-
noma (HCC) and intrahepatic portal vein anomaly.
Results: A 65-year-old man had alcoholic cirrhosis and
HCC, 5.3 cm in diameter. 3D-CT showed HCC in the
posterior section, left-sided gallbladder, right-sided liga-
mentum teres, and an intrahepatic portal anomaly with
a ramification of the anterior portal branch from the
left portal vein Anatomical segmentectomy of segment
6 was performed safely on the basis of virtual hepatec-
tomy simulation.
A 76-year-old man had hepatitis C virus-related cirrho-
sis and HCC, 4 cm in diameter. 3D-CT showed HCC
in the anterior section and an intrahepatic portal
anomaly with a ramification of the anterior portal
branch from the left portal vein. Anatomical anterior
sectionectomy was performed safely on the basis of vir-
tual hepatectomy simulation.
Conclusions: Anatomical hepatectomy was successfully
performed on the basis of virtual hepatectomy simula-
tion in 2 patients with HCC and intrahepatic portal
vein anomaly.
PPL25-019
SHORT AND MIDDLE TERM
OUTCOMES AFTER LAPAROSCOPIC
VERSUS OPEN LIVER RESECTION FOR
HEPATOCELLULAR CARCINOMA: A
SINGLE INSTITUTION EXPERIENCE
Yutaka Takeda1, Shin Nakahira1, Yoshiteru Katsura1,
Hideki Sakisaka2, Hirokazu Taniguchi2, Chiyomi
Egawa2, Takeshi Kato2 and Shigeyuki Tamura2
1Division of Hepato-Biliary-Pancreatic Surgery, Japan;
2Division of Surgery, Japan
Introduction: Laparoscopic liver resection (LLR) has
been reported as a safe, minimally invasive, and effec-
tive approach to the management of hepatocellular
carcinoma (HCC). However, outcomes regarding tumor
recurrence and patient survival in comparison with the
conventional open approach are limited. The aim of
this study was to analyze the perioperative results and
survival outcomes of LLR versus open liver resection
(OLR).
Method: Between June 2010 and May 2013, 104
patients underwent pure laparoscopic liver resection
(PLLR) for HCC at Kansai Rosai Hospital. Historical
control patients (n = 82) who received OLR for HCC
between January 2004 and March 2010 were included
for comparison.
Results: The patient age was elder in the PLLR group
than the OLR group (71.6 vs 68.6; p = 0.0081). No sig-
nificant differences were noted between the PLLR and
OLR groups with respect to patient gender or liver
damage. The intraoperative blood loss was lower in the
PLLR group than the OLR group (143.9 mL vs
1226.6 mL; p < 0.0001). With the PLLR compared
with the OLR group, operation time was 295.4 minutes
versus 203.0 minutes (p < 0.0001) and hospital stay
was 14.4 days versus 15.5 days (p = 0.5992). AST on
the POD1 was 467.0 IU/L versus 396.9 IU/L
(p = 0.2558), ALT was 336.9 IU/L versus 304.4 IU/L
(p = 0.5223), total bilirubin was 0.89 mg/dL versus
1.18 mg/dL (p = 0.0002), WBC was 9151/lL versus
11585/lL (p < 0.0001), and CRP was 0.97 mg/dL ver-
sus 2.80 (p < 0.0001). The surgical margins were similar
in the two groups. The 1 year disease-free survival at
1 year of stage I, II, III HCC were 83.1% versus
78.9% (p = 0.6899), 73.7% versus 79.2% (p = 0.6114),
and 67.9% versus 43.5% (p = 0.2181) for PLLR and
OLR, respectively.
Conclusions: Compared with open liver resection, lapa-
roscopic liver resection for HCC is associated with less
blood loss and lower systemic influence with no com-
promise in survival.
PPL25-020
CLINICAL TREATMENT OF MULTIPLE
HEPATOCELLULAR CARCINOMA: A
RETROSPECTIVE ANALYSIS ON 113
CASES
Lu Chen and Qiang Li
Tianjin Medical University Cancer Hospital, China
Introduction: Multiple hepatocellular carcinoma (multi-
ple HCC) refers to that the number of tumor is more
than or equal to two Hepatocellular carcinoma, previ-
ous studies showed that the 5-year survival rate of mul-
tiple hepatocellular carcinoma cases is <30%, far lower
than that of patients who just have only one single
lesion. This study researched and analysed 113 cases of
multiple hepatocellular carcinoma, clinicopathological
features, the choice of treatment and prognosis.
Regarded giving the patients a better and suitable treat-
ment choose as a starting point.
Method: Data for 113 multiple hepatocellular carci-
noma patients were collected between January and
December 2009 in Tianjin Medical University cancer
Hospital. All these patients were assigned to three dif-
ferent groups according to different treatments included
underwent radical hepatic resection, transarterial
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chemoembolization and supportive treatment. Depend-
ing on the BCLC classification, 83 (73.5%) were BCLC
B, and 30 (26.5%) BCLC C. Statistical analysis was
used to analyse overall survival and independent risk
factors related to prognostic survival.
Results: The 1-, 2-, and 3-year overall survival rates of
these patients were 36%, 19%, and 11%, respectively,
and the median survival was 11.6 months. The 1-, 2-,
and 3-year survival rates of radical hepatic resection
group were 64%, 45%, and 27%, significantly higher
than that of TACE group (33%, 13%, and 7%) and
supportive treatment group (0%, 0%, and 0%). Uni-
variate analysis showed that age, tumor location, hepa-
titis background, tumor size, total tumor number,
treatment and ALT were poor prognostic factors for
multiple HCC. Multivariate analysis revealed that age,
hepatitis, tumor size, tumor number, treatment were
independent risk factors related to prognostic survival.
Conclusions: The patients with multiple hepatocellular
carcinoma who are in class B or class C for BCLC clas-
sification can also benefit from hepatic resection, if
their liver function can tolerance and operation can
achieve R0 resection.
PPL25-021
HEME OXYGENAGE-1 EXPRESSION AS
PROGNOSTIC FACTOR IN PATIENTS
WITH HEPATOCELLUAR CARCINOMA
Cheon Soo Park1, Hyuk Jae Jang1, Dae Woon Um1,
Ki Sung Kang2 and Gun Moo Choi1
1Gangneung Asan Hospital, Korea; 2Korea Institute of
Science and Tecnology (KIST), Korea
Introduction: Heme oxygenase-1 (HO-1) is an impor-
tant enzyme as Heme degradation. HO-1 degrades
heme to carbon monoxide (CO), biliverdin, and ferrous
iron. HO-1 is increased in stressful condition and major
role of enzyme as antioxydative and antiapoptotic
effect. HO-1 potently influences tumor growth and
metastasis. Some study suggested that HO-1 may play
a role in tumor induction and can potently improve the
growth and spread of tumor, and that HO-1 is related
to tumor differentiation, apoptosis, progression, angio-
genesis, and metastasis. This study represented that
HO-1 expression as prognostic factor in patients with
hepatocellular carcinoma (HCC).
Method: In this study, the expression of HO-1 in
human HCC tissues (n = 96) was investigated by
immunohistochemistry. The correlation of HO-1 with
the clinicopathological characteristics was analyzed.
That resected tumor tissues was confirmed HCC by
pathologic division and stored by Paraffin block. Via-
ble HCC tissues were achieved and immunohistochemi-
cal stain for HO-1 was done. We analyzed survival by
Kaplan–Meier method and crosstabs by chi-square test.
Results: Results showed that HO-1 was expressed in 40
HCC tissues from 96 cases (41.6%). Overall survival
(OS) was not statistical difference in HO-1 positive
HCC versus negative HCC, mean value was
53.1 months versus 59.5 months (p = 0.102). But dis-
ease free survival (DFS) was statistical difference in
HO-1 positive HCC versus negative HCC, mean value
was 32.3 (months) versus 45.1 (months) (p = 0.044). A
high HO-1 expression rate showed a close association
with histological differentiation (Edmondson-Steiner
grade 3, 4), positive microvascular invasion and capsule
invasion (p < 0.05). These results demonstrate that
HO-1 is associated with malignant progression in
HCC.
Conclusions: Actually HO-1 stained HCC patients was
highly recurrence rate, histologically poor grade (E/S
grade 3–4), microvascular invasion, and capsular inva-
sion. Thus HO-1 in HCC can be one of prognostic fac-
tor and marker of recurrence.
PPL25-022
TRANSARTERIAL
CHEMOEMBOLIZATION IN
UNRESECTABLE HEPATOCELLULAR
CARCINOMA: A STUDY OF
PROGNOSIS AND SIDE EFFECTS
Ishara Maduka, Shelat Vishal, Winston Woon, Low
Jee Keem and Sameer Junnarkar
Tan Tock Seng Hospital, Singapore
Introduction: Transarterial chemoembolization (TACE)
alone or in combination with radiofrequency ablation
(RFA) is used as a non curative treatment in hepatocel-
lular carcinoma (HCC) for non resectable tumours or
as bridging treatment for patients awaiting surgery.
The study retrospectively evaluated a consecutive series
of patients who underwent TACE to identify incidence
of procedure specific complications and prognosis.
Method: A retrospective descriptive cross sectional
study was carried out and 175 TACE sessions were
included in the study, Data were gathered by way of
referring to the relevant medical records of the patients.
Results: Out of the 175 cases studied 144 (82.28%)
were males and 31 (17.71%) were females. Mean age of
the participants were 67.8  9.78 years. 46 (26.28%)
patients who underwent TACE reported as having
immediate (within 24 hours) complications while 8
(4.5%) reported as having early (within 30 days) com-
plications. Out of the complications reported post
TACE fever was the commonest complication noted
with 48 (27.42%) patients reported as having docu-
mented fever post procedure. Other common complica-
tions noted were groin haematoma 13 (7.42%), arterial
bleed 3 (1.71%), arterial dissection 2 (1.14%), Pleural
effusion 3 (1.71%), Liver abscess 2 (1.14%) and hepatic
infarction 2 (1.14%). TACE related mortality was 4
(2.28%). Overall response assessment using mRECIST
criteria found that 10 (5.7%) had complete response
(CR) in follow up imaging studies done up to 1 year.
While 62 (35.42%) had progressive disease (PD), 25
(14.28%) had partial response (PR) and 61 (34.85%)
had stable disease (SD). The average survival from the
date of diagnosis was 25.72  6.72 months.
Conclusions: TACE carries a significant morbidity and
post TACE fever which in most instances occurred
without a septic focus was the most common complica-
tion noted. Tumour response rate for TACE is still
minimal suggesting that it should always be used con-
comitantly with surgery and RFA when possible to
achieve curative outcome.
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PPL25-023
REAL-TIME ULTRASOUND
NAVIGATION SYSTEM FOR SYSTEMIC
LIVER RESECTION
Masaki Matsuda1, Yasuji Seyama1, Junichi Shindoh2,
Keigo Tani1 and Nobutaka Umekita1
1Tokyo Metropolitan Bokutoh Hospital, Japan;
2University of Tokyo, Japan
Introduction: Systemic liver resection of tumor-bearing
portal region is a basic procedure in the treatment of
hepatocellular carcinoma (HCC). However precise
parenchymal transection along intersegmental planes is
not always easy and technically demanding, so optimal
navigation method is required. We devised a simple
new navigation approach to guide hepatic parenchymal
transection by continuous ultrasound monitoring with
the probe positioned behind the liver (Shindoh J., Sey-
ama Y. et al. Hepato-Gastroenterology 60; 590–594,
2013).
Method: Real-time ultrasound monitoring with a probe
applied from behind the liver was tried as means of
locating the site where resection was proceeding in the
liver and confirming the direction of hepatic parenchy-
mal transection to facilitate systemic resection of the
liver.
Results: The real-time ultrasound navigation technique
was performed during 11 hepatectomies. Continuous
scanning of the liver was clearly helpful in i) confirming
the site in the liver where the resection was being pro-
ceeded and the direction of the parenchymal transec-
tion; ii) predicting blood vessels to be encountered in
deeper transection planes; iii) ensuring a safe surgical
margin around tumor. The mean speed of parenchymal
transection was faster (2.4 cm2/miniutes vs 1.2 cm2/
minutes, p = 0.009) and the amount of blood loss per
transected area was smaller (4.4 mL/cm2 vs 7.2 mL/
cm2, p = 0.05) in patients treated with the current tech-
nique.
Conclusions: Continuous ultrasound monitoring of the
liver is useful to make the parenchymal transection
easy.
PPL25-024
SIGNIFICANCE OF THERAPEUTIC
OPTIONS FOR RECURRENT HCC
AFTER LIVER RESECTION
Nobuyuki Takemura, Kiyoshi Hasegawa, Junichi
Shindoh, Takeaki Ishizawa, Junichi Kaneko, Taku
Aoki, Yoshihiro Sakamoto, Yasuhiko Sugawara and
Norihiro Kokudo
Graduate School of Medicine, University of Tokyo,
Japan
Introduction: High incidence of the recurrence after
resection of hepatocellular carcinoma (HCC) needs
appropriate management of recurrent HCC. The aim
of this study is to evaluate the clinical significance of
each therapeutic option for recurrent HCC.
Method: From 1994 to 2010, 1091 patients underwent
1015 first time hepatectomies for HCC at this institu-
tion. Among them, recurrence occurred in 727 patients
(70.5%). They underwent surgery (SUR; n = 265),
radiofrequency ablation or percutaneous ethanol injec-
tion therapy (RFA/PEI; n = 155), transarterial chemo-
embolization (TACE; n = 429), systemic chemo or
local radio therapy (CorRT; n = 133), and liver trans-
plantation (LT; n = 5) including duplication. Survivals
of each main treatment for recurrence were investi-
gated.
Results: The 1-, 3-, 5-year overall survival rates of the
all patients after first time hepatectomy were 94, 75,
60%. The 1-, 3-, 5-year disease free survivals were 65,
35, 25%. Among 727 patients who had the recurrent
HCC, a total of 660 patients underwent some of the
treatments. The other 64 patients only underwent best
supportive therapy. The 1-, 3-, 5-year overall survival
rate and median survival time after recurrence accord-
ing to the main treatment for recurrence were 96, 76,
61% and 6.7 years in SUR group (n = 249), 93, 70,
46% and 4.6 years in RFA/PEI group (n = 118), 100,
80, 80% and Not ascertained in LT group (n = 5), 77,
36, 15% and 2.1 years in TACE group (n = 251), and
69, 21, 10% and 1.6 years in CorRT group (n = 37)
respectively.
Conclusions: Aggressive treatments for recurrent HCC
including repeat hepatectomy may improve patient sur-
vival.
PPL25-025
CLINICOPATHOLOGIC EVALUATION
OF 35 CASES OF HEPATOCELLULAR
CARCINOMA WITH BILE DUCT
TUMOR THROMBI
Yebin Pang, Ningfu Peng, Bangde Xiang, Chao Ou,
Zhe Guo and Lequn Li
Tumor Hospital of Guangxi Medical University, China
Introduction: Hepatocellular carcinoma (HCC) with
bile duct tumor thrombi (BDTT) is a rare type of pri-
mary liver cancer, and the aim of this study was to
evaluate the clinicopathologic characteristics of patients
with this kind of disease.
Method: Thirty-five patients with HCC and BDTT
among 594 patients with HCC who underwent hepatic
resection were selected in this study. The clinical and
pathological characteristics of these 35 patients were
analyzed and the Kaplan–Meier method was adopted
for evaluating survival. The expression of liver stem cell
markers was investigated by immunohistochemistry.
Results: In 17 of 35 patients with BDTT, the diameter
of the primary tumor was <5 cm (range: 0–17 cm,
mean 6.87  0.65 cm). Most of the primary tumors
were poorly differentiated (23/35, 66%), laced an intact
tumor capsule (21/35, 60%), and had microvessel inva-
sion (29/35, 83%). None of the patients had evidence
of direct tumor invasion into the bile duct wall macro-
scopically or microscopically. The positive rate of the
liver stem cell markers CD90, EpCAM, CK19, VEGF
and CD133 was 82.9%, 77.1%, 71.4%, 85.7% and
80%, respectively. Postoperative overall survival rates
at 1, 2, and 3 years were 80%, 57.1%, and 25.7%,
respectively. The log-rank test showed that the survival
rates of HCC patients with BDTT were significantly
worse than HCC patients without BDTT (p = 0.000).
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Conclusions: HCC with BDTT has aggressive charac-
teristics and the long-term prognosis is extremely
dismal.
PPL25-026
ASSESSMENT OF ROLE OF SURGERY
IN PORTAL HYPERTENSION
Chetan Kantharia, Sharvari Pujari, Ramkrishna
Prabhu, Avinash Supe and Ravindra Bapat
Seth GS medical College & KEM Hopsital, Mumbai,
India
Introduction: Surgery for portal hypertension is associ-
ated with high mortality, rebleed rates and portosys-
temic encephalopathy. Though other effective
therapeutic options are available for bleeding from por-
tal hypertension, surgery has a definite role. The pres-
ent study evaluates the mortality and morbidity, and
factors affecting outcome of patients undergoing sur-
gery.
Method: Records of 29 patients operated between 2007
and 2010 who underwent surgery were analyzed with
particular attention to operative mortality, rebleeding,
and encephalopathy and factors affecting their out-
come. Survival was calculated according to the Kap-
lan–Meier method. Devascularization surgery included
devascularisation of the greater curvature with splenec-
tomy and stapled esophageal transection. Follow up
period ranged from 12 to 36 months.
Results: Of 29 patients subjected to surgery, 5 were
Cirrhotic, 5 NCPF, 16 EHPVO and 3 BCS. 19 patients
were of Child A (3-Cirrhotic, 4 NCPF and 12
EHPVO). 10 patients were Child B (2 Cirrhotic, 1
NCPF, 4 EHPVO and 3 BCS). DSRS was performed
for 3 patients (Child A Cirrhotic). PSRS was performed
for 12 patients (5 NCPF, 7 EHPVO). Mesocaval Shunt
was performed for 3 patients (All patients of BCS). 11
patients underwent Devascularization (2 Cirrhotic, 9
EHPVO), of which 1 was an emergency surgery (cir-
rhotic). 2 patients had rebleed (cirrhotic). 2 had ascites
(1 each of Cirrhotic and BCS). No patient had post
operative encepahalopathy. Mortality was in three
patients (2 Cirrhotic and 1 BCS). 26 patients are sur-
viving.
Conclusions: Surgery is a one-time procedure with a
low mortality rate and good long-term results. The two
most important factors in predicting the results of sur-
gery are the Childs score and the timing of the opera-
tion, with good results obtained in patients with good
liver function and who had an elective operation.
PPL25-027
PURE LAPAROSCOPIC ANATOMICAL
LIVER RESECTION FOR HCC AND
OTHER LIVER TUMORS
Zenichi Morise, Norihiko Kawabe, Jin Kawase,
Masashi Isetani, Rie Yoshida, Satoshi Arakaw,
Hidetoshi Nagata and Hirokazu Tomishige
Fujita Health University School of Medicine Banbuntane
Houtokukai Hospital, Japan
Introduction: It is thought that anatomical liver resec-
tion is the better surgical option for HCC to secure the
complete resection of the cancer bearing portal area.
Anatomical liver resection is also useful for the resec-
tion of deep small tumors with difficult localization.
We evaluate our experience for pure laparoscopic ana-
tomical liver resection.
Method: Out of 69 (41 HCC, 28 others; 1–6 tumors/8–
107 mm) pure laparoscopic hepatectomies, 26 under-
went anatomical liver resection (3 of hemihepatectomy
or extended, 14 of sectorectomy or extended, 9 of small
anatomical resection). In the resection of 1 or more sec-
tor, Glissonian pedicle of the sector is encircled and
clamped extrahepatically and divided afterward during
the transection. We employed caudal approach, one
direction transaction without the mobilization of the
liver, for the oncological equality to open anterior
approach. For many of the patients with poor liver
function, we employed small anatomical resection
under the control of intrahepatic small Glissonian pedi-
cles during the transaction.
Results: The operating time of more than 1 sector
(excl. LLS) is 336–848 minutes and intraoperative
blood loss is 100–3569 mL (<500 mL in recent 5 cases).
Those of LLS are 217–403 minutes, 0–181 mL. Those
of small anatomical resection are 278–498 minutes, 0–
181 mL. There is no operative mortality and the com-
plications were observed in 5 patients. In the resection,
the exposure of the main hepatic veins on the border of
the sectors is feasible and excellent laparoscopic view
around IVC area made it possible to encircle the roots
of major hepatic vein from caudal/dorsal direction
behind the liver. For patients with poor liver function
undergone small resection, 3D simulation from preop-
erative CT is useful to locate the root of Glissonian
pedicle and tumor.
Conclusions: Pure laparoscopic anatomical liver resec-
tion is feasible with accumulation of experience, using
laproscopic specific views/techniques, and preoperative
3D-CT simulation.
PPL25-028
LOCO-REGIONAL MANAGEMENT OF
COLORECTAL LIVER METASTASIS
Sharvari Pujari, Ramkrishna Prabhu, Avinash Supe,
Ravindra Bapat and Chetan Kantharia
Seth GS Medicollege & KEM Hospital, Parel, Mumbai-
12, India
Introduction: Liver metastases develop in approxi-
mately 60 percent of patients with CRC at some point
during the course of their disease. Left untreated,
patients with metastatic liver disease have a poor prog-
nosis. Though Liver Resection is a gold standard for
these patients, many times, they are poor candidates
for liver resection because of the distribution of tumors
within the liver at presentation. They are best treated
with Locoregional treatment such as Radiofrequency
ablation, and Trans Arterial Chemo-embolization. The
present study assesses the outcome of patients of Colo-
rectal Liver Metastasis treated with locoregional man-
agement.
Method: Of a total of 178 patients operated for colo-
rectal malignancy from 2007 to 2012, a total of 31
patients (20 M: 11 F, age range: 45–78 years) presented
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with colorectal liver metastasis. Of these 14 patients
were subjected to Liver Resection. 17 patients were
subjected to Locoregional treatment due to either
inability to operate or due to not wanting of second
surgery (3 patients). All the 17 patients were subjected
to a combination of TACE followed by RFA. The
average follow up was for 72 months and their survival
was observed. The Quality of Life was observed for all
the patients using modified SF-36 score (Graded as
Poor, Fair, Good and excellent).
Results: In the resected group survival was seen in 9
of 14 patients with good quality of life in all. In
comparison survival in patients with TACE and RFA
was 8 of 17 patients with quality of life good to
excellent.
Conclusions: Loco-regional management of manage-
ment of Liver tumor has a definite role in the manage-
ment, with the patient leading a fairly good quality of
life.
PPL25-029
PATHOLOGICAL COMPLETE
REMISSION WITH LONG TERM
SURVIVAL AFTER HEPATIC ARTERIAL
CHEMOTHERAPY IN ADVANCED
HEPATOCELLUAR CARCINOMA WITH
MAIN PORTAL VEIN THROMBOSIS
Man Ki Kim, Sung Su Yun, Hwa Kyung Jung, Dong
Shick Lee and Hong Jin Kim
Yeungnam University Medical Center, Korea
Introduction: The prognosis of advanced hepatocellular
carcinoma (HCC) patients with portal vein thrombosis
is very poor even after surgery.
Aim: We report a case of pathologically confirmed
complete remission of HCC induced by hepatic arterial
infusion chemotherapy (HAIC).
Method: A 45-year-old male patient had a massive
HCC in the right and main portal veins. He achieved a
partial response after two cycles of HAIC with 5-fluo-
rouracil (750 mg/m2) and cisplatin (25 mg/m2).
Results: After completion of six cycles he received a
curative partial hepatectomy, and histopathology
revealed complete necrosis without any viable tumor
cell. He has been in good health without recurrence at
40-month follow-up.
Conclusions: This result suggests that this regimen is a
promising therapeutic modality for the treatment of
advanced HCC with portal vein tumor thrombosis.
PPL25-030
RESECTION FOR LARGE ADVANCED
HEPATOCELLULAR CARCINOMA
FOLLOWING TUMOR DOWNSTAGING
BY TRANSCATHETER ARTERIAL
CHEMOEMBOLIZATION AND
HEPATIC INFUSION CHEMOTHERAPY
Koji Okuda, Toshirou Ogata, Yuuichirou Maruyama,
Ryuuichi Kawahara, Hisamune Sakai, Masafumi
Yasunaga, Hikoyuki Horiuchi and Hisafumi Kinosita
Kurume University, Japan
Introduction: Outcome of patients having a large
(>5 cm) hepatocellular carcinoma (HCC) with macro-
scopic vascular tumor thrombus or multiple intrahepat-
ic metastases is dismal generally. The aim of this study
is to evaluate the feasibility of sequential liver resection
following downstaging of initially unresectable large
advanced HCC by transcatheter arterial chemoemboli-
zation (TACE) and hepatic arterial arterial infusion
chemotherapy (HAI).
Method: A retrospective study was conducted. 17
patients with initially unresectable HCC (diame-
ter > 5 cm) with major portal vein/IVC/RA tumor
thrombus or multiple intrahepatic metastases who
underwent resection following successful TACE and
HAI were enrolled in this study.
Results: An average tumor diameter was 80 mm. 12
cases had the major (1st branch/main) portal vein or
IVC/RA tumor thrombus, and 11 had multiple intrahe-
patic metastases. For downstaging modality, 4 patients
underwent TACE, 11 underwent HAI and 2 underwent
TACE + HAI. An average interval between downstag-
ing treatment and resection was 6.4 months. The values
of AFP and PIVKA-II were 42,614 and 18,874 before
downstaging therapy, 3525 and 1590 after downstaging,
and 97 and 23 after resection, respectively. 1-, 3- and 5-
year OS were 94.1, 76.0 and 57.0%, respectively. Five-
year disease-free rate was 39.4%. Multivariate analysis
of preoperative characteristics showed that IVC/RA
tumor thrombus was a significant poor prognostic fac-
tor, because of a high incidence of postoperative pul-
monary metastasis.
Conclusions: Resection following tumor downstaging
by TACE and HAI gives good long term results and
possibility of a cure for patients having a large HCC
with major vascular tumor thrombus or multiple intra-
hepatic metastases. This strategy should be investigated
further by prospective randomized controlled trials.
PPL25-031
A NOVEL LAPAROSCOPIC
HEPATECTOMY WITH GLISSONIAN
PRECOAGULATION AND
MONITORING ISCHEMIC AREA
Toru Beppu1, Hidetoshi Nitta2, Hiromitsu Hayashi2,
Katsunori Imai2, Shinichi Sugiyama2, Hirohisa Okabe2,
Daisuke Hashimoto2, Akira Chikamoto2, Takatoshi
Ishiko2 and Hideo Baba2
1Kumamoto University Hospital, Japan; 2Kumamoto
University, Japan
Introduction: Laparoscopic hepatectomy has spread
rapidly as a curative and less invasive therapeutic
modality for primary and secondly liver tumors. Pure
laparoscopic hepatectomy for small tumor locating at
deeper-site of the liver is relatively difficult instead of
superficial tumor. Therefore we developed a new “lapa-
roscopic hepatectomy following Glissonian precoagula-
tion.”
Method: (1) Ultrasound-guided Glissonian blood flow
occlusion of a planned resected liver using radio-fre-
quency ablation (RFA). Percutaneous RFA was per-
formed using a cooled-tip electrode with a 2 cm
metallic tip and the power application was increased to
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100 W in the impedance control mode and the elec-
trode was left in the liver for 6–10 minutes. (2) Under-
standing of the extent of ischemic area using
laparoscopic contrast-enhanced intraoperative ultra-
sound (CE-IOUS) with SonazoidTM and laparoscopic
Photo Dynamic Eye (PDE) camera with indocyanine
green (ICG) administration. (3) Completion of laparo-
scopic hepatectomy with surgical aspirator and energy
devices. We applied this method for three patients (2
hepatocellular carcinoma and one colorectal liver
metastasis) treated with laparoscopic hepatectomy.
Results: (1) A sufficient ischemic area can be obtained
by 1–3 RFA procedures. (2) An ischemic area was well
visible both on liver surface by PDE camera and in
deeper-site of the liver by CE-IOUS during whole time
of the operation in all patients. (3) A total amount of
intraoperative blood loss was minimal because of ische-
mia of cutting line of the liver. (4) The tumor was com-
pleted removed with adequate surgical margin, and no
complication was observed.
Conclusions: A new laparoscopic hepatectomy was fea-
sible and quite beneficial. It is because of secure stop-
page of regional blood flow with RFA and monitoring
visualized ischemic area by PDE camera and laparo-
scopic CE-IOUS.
PPL25-032
TECHNICAL ADVANCEMENT AND
CURRENT ROLE OF LAPAROSCOPIC
LIVER RESECTION IN THE
TREATMENT OF HEPATOCELLULAR
CARCINOMA
Yuichiro Otsuka, Yoshihisa Kubota, Masaru Tsuchiya,
Toshio Katagiri, Jun Ishii, Tetsuya Maeda, Akira
Tamura, Satoru Kagami and Hironori Kaneko
Toho University Faculty of Medicine, Japan
Introduction: Liver resection has been demonstrated as
the preferable initial treatment for patients with resect-
able Hepatocellular carcinoma (HCC). Laparoscopic
liver resection (LLR) has been technically progressing
as a new ideal surgical option offers minimal invasive-
ness, as well as effectiveness in patients suffering pri-
mary and metastatic liver diseases. The aim of this
study is to discuss the ability and current role of LLR
for HCC.
Method: We retrospectively reviewed 97 consecutive
patients who underwent LLR for HCC in our institu-
tion.
Results: Among the 97 cases, 84 (86.5%) had histologi-
cally confirmed chronic liver disease including liver cir-
rhosis. Tumor location in the liver was infero-lateral
segments in 74 cases (76.3%), and the postero-superior
segments in 23 cases (23.7%). Anatomical resection of
the liver other than left lateral sectionectomy was 25
(25.8%), and major liver resection (resection more than
3 Couinaud’s segments) was 9 (9.3%). Eleven cases
(11.3%) had 2 or more liver resection, or resection with
tumor ablation therapy for multiple HCCs. Repeat
resection for recurrent HCC was performed in 8
patients (8.6%). Postoperative complications were seen
in 16 cases (16.5%), otherwise, no severe complication
above Clavien-Dindo classification grade IIIb was
encountered, except a case of accidental cerebral infarc-
tion. No postoperative liver failure, gas embolism or
operative death was observed. As a consequence of
accumulation of our experience with expansion of sur-
gical indication for LLR, the candidacy of LLR in
HCC patients had remained 20% of all liver resections
including open liver resection in the early period, how-
ever, it has been increasing up to 60% lately in our ser-
ies.
Conclusions: LLR is effective surgical treatment for
HCC. Technical refinement of LLR with accumulation
of experience enables to perform difficult surgery with
safety. Therefore, LLR could be applied more fre-
quently, and is expected further development as impor-
tant option for treatment of HCC.
PPL25-033
MINIMALLY INVASIVE LIVER
RESECTION FOR COLORECTAL LIVER
METASTASIS
Yoshihisa Kubota, Yuichiro Otsuka, Masaru Tsuchiya,
Toshio Katagiri, Jun Ishii, Tetsuya Maeda, Akira
Tamura and Hironori Kaneko
Toho University School of Medicine, Japan
Introduction: Since 1993, we have performed minimally
invasive laparoscopic liver resection (LLR) to treat
malignant liver cancer, including colorectal liver metas-
tases (CLM). However, further studies are needed to
accumulate sufficient evidence on the oncological out-
come of LLR for CLM.
Method: To elucidate the efficacy of LLR for CLM,
this study comparatively analyzed the invasiveness and
short-term prognosis of LLR (n = 41 cases) and open
liver resection (OR) (n = 54 cases) performed for CLM
after 2006 and also investigated the safety of LLR fol-
lowing chemotherapy.
Results: Compared with the OR group, the LLR group
had significantly less blood loss (p < 0.001) and a
shorter hospital stay (p < 0.001). The E-PASS scoring
system was used to compare surgical invasiveness, and
although the preoperative risk score did not differ
between the groups, the surgical stress score and com-
prehensive risk score were significantly lower in the
LLR group (p < 0.001). Concerning the survival rate
and disease-free survival rate, there were no significant
differences between procedures. However, more clinical
cases and longer follow-up periods are needed to reach
a definitive conclusion.Preoperative hemanalysis, intra-
operative bleeding, complications, and postoperative
length of stay did not differ significantly between LLR
patients with preoperative chemotherapy and those
with surgery alone, indicating no adverse effects of che-
motherapy.
Conclusions: LLR can be an effective minimally inva-
sive surgery in CLM patients receiving both periopera-
tive chemotherapy and surgery. Because LLR is
comparable with OR with regard to short-term onco-
logical outcome, LLR may be a valuable option for
CLM.
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PPL25-034
STUDY OF THE
CLINICORADIOLOGICAL
CORRELATION IN THE PATIENTS OF
PORTAL HYPERTENSIVE BILIOPATHY
Sharvari Pujari, Ramkrishna Prabhu, Avinash Supe,
Ravindra Bapat and Chetan Kantharia
Seth GS Medical College & KEM Hospital, Parel,
Mumbai-12, India
Introduction: Patients with portal biliopathy (PB) usu-
ally are asymptomatic, rarely experiencing jaundice,
cholangitis and choledocholithiasis. This study analyses
clinical and radiological co-relation and outcome of
intervention in PB patients.
Method: This is prospective analysis of 2 years, March
2010–2012. Patients of EHPVO were assessed for, etiol-
ogy of PVT, Symptoms, serum alkaline phosphatase
and total bilirubin. Doppler USG of abdomen and
MRCP were done in all. Patients were grouped into
Clinically Symptomatic and Asymptomatic group.
ERCP and CT-Angiography to assess for shuntable
vessels done in symptomatic patients. F/U of serum
alkaline phosphatase and total bilirubin done at end of
30, 90 and 180 days and thereafter 6 monthly. MRCP
done at end of 1 year in whom intervention was done.
Statistical analysis done using SPSS v11.5.
Results: Thirty-nine patients (20 females, age range 13–
69 years) were studied. 34 had radiological evidence of
PB (87.17%). 9 (23.07%) were clinically symptomatic,
5 had Jaundice with cholangitis and 4 only jaundice.
The radiological abnormality in 34 was: Varicoid: 23,
Fibrotic: 7 Mixed: 4. Their distribution in symptomatic
patients was: Varicoid: 6 and 3 Fibrotic. Five of nine
symptomatic patients were subjected to ERCP stenting.
PSRS shunt done in two, Choledocho Jejunostomy in
1, and cholecystectomy with T-Tube insertion in 1.
Conclusions:
1. There is a definite Clinico-Radiological-Biochem-
ical co-relation in patients with Symptomatic
Portal Biliopathy.
2. Biochemical parameters are more realistic as
compared to radiological parameters alone to
investigate clinical condition of Portal Biliopathy.
3. Of Radiological parameters; Epicholedochal
venous plexus, Stricture with dilatation, Delayed
enhancement were found to be statistically signif-
icant.
4. Biochemical and Radiological parameters were
statistically significant with the p < 0.0001 in the
clinically symptomatic group.
PPL25-035
EN BLOC RESECTION RIGHT
HEMILIVER, CAUDATE LOBE OF
LIVER AND IVC FOR LOCALLY
ADVANCED MALIGNANT ADRENAL
TUMOR
Kwangsik Chun, Juhong Park and Insang Song
Chungnam National University School of Medicine,
Korea
Introduction: Locally advanced tumor such as adrenal
and renal malignant tumors invaded to IVC and liver
was regarded as unresectable state or recommended
palliative treatment till now. But advance of surgical
technique and intensive treatment make the surgeon
perform more radical surgery.
Method: We report a case of en bloc resection of right
hemiliver, caudate lobe and intrahepatic IVC and pros-
thetic graft reconstruction in adrenal tumor with liver,
diaphragm crux and IVC invasion.
Results: A 46-year-old man visit for right frank pain
began 2 months ago. Vital signs were within normal
range, too. Screening abdomen CT scan reveal 8.5 cm
sized adrenal mass with IVC and liver invasion. In
24 hours urine test, metanephrine was 1.8 mg/day, epi-
nephrine, VMA, cortisol, norepinephrine were within
normal range. There was no metastatic foci and lymph
node involvement in preoperative MRI and PET CT
scan. In preoperative CT scan left side liver volume
was about 30% of total liver volume but ICG R15 was
37.6%, so preoperative right portal vein embolization
was done. Three weeks later, right hepatectomy and
caudate lobectomy and IVC resection was performed
by en bloc resection. During IVC resection and graft
reconstruction, extracorporeal circulation was per-
formed. Dacrone prosthetic graft was used for IVC
graft. 3 pint PRC were transfused during surgery.
Adrenal gland tumor was revealed malignant pheochro-
mocytoma with direct invasion to IVC and liver by
pathologic examination.
Conclusions: Combined liver and IVC resection is diffi-
cult but feasible in selected patients and can be adopted
to locally advanced adrenal gland tumor.
PPL25-036
SURGICAL TREATMENT FOR
HEPATOCELLULAR CARCINOMA
WITH BILE DUCT THROMBOSIS:
EVALUATION OF BILE DUCT
THROMBECTOMY
Takahisa Shirahama, Koji Okuda, Kazuhiro Mikagi,
Yuichiro Maruyama, Hisamune Sakai, Ryuichi
Kawahara, Toshiro Ogata, Masahumi Yasunaga and
Hisahumi Kinoshita
Kurume University School of Medicine, Japan
Introduction: HCC with bile duct tumor thrombosis
(BDT) is a rare event and the standard surgical proce-
dure is unclear. We are on the basis of hepatic resec-
tion with removal of the BDT without bile duct
resection. The aim of this study was to evaluate the fea-
sibility of bile duct thrombectomy without bile duct
resection.
Method: Fifteen patients who underwent liver resection
for HCC with BDT in our department from 1980 to
2011 were reviewed retrospectively.
Results: Thirteen patients underwent hepatic resection
with thrombectomy without bile duct resection. 2
patients underwent a bile duct resection combined with
hepatic resection. The postoperative recurrence was 12
cases (thrombectomy: 11/13, bile duct resection: 1/2).
In the thrombectomy group (TG), recurrence were
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single intrahepatic recurrence: 2 cases, multiple intrahe-
patic recurrence: 4, multiple lung metastasis: 3, and bile
duct metastasis: 1, which located in the remnant intra-
pancreatic bile duct. In the bile duct resection group
(RG), recurrence form was multiple liver metastasis: 1
case. Recurrence-free survival was 399 days in TG and
189 days in RG. Recurrence treatments in TG were
TACE: 2 cases, RFA: 2, TAI: 2, reoperation: 1 and
non treatment: 2. Recurrence treatment in RG was
TAI + molecular target drug: 1 case. The 5-year OS
was 38%, and 3 patients survived over 10 years in TG.
Conclusions: Three patients survived over 10 years in
the thrombectomy group. The majority of recurrence
form was intrahepatic recurrence, and needed interven-
tional therapy. Recurrence in the remnant bile duct was
observed only 1 of 13 cases, which occurred in the in-
trapancreatic bile duct. Prophylactic bile duct resection
should be done with pancreatoduodenectomy, however,
this is not realistic in cases with chronic liver disease.
Further, hepaticojejunostomy increases the risk of cho-
langitis and liver abscess during interventional therapy
for intrahepatic recurrence. Our conclusion is that
thrombectomy without bile duct resection is feasible for
HCC with BDT.
PPL25-037
SMALL REMNANT LIVER VOLUME
CASE EXPERIENCE AFTER MAJOR
LIVER RESECTION
Jung Woo Lee, Young Joo Lee, Kwang Min Park, Jae
Hoon Lee, Ki Byoung Song, Song Chul Kim, Jong
Hee Yoon, Dong Joo Lee and Jung Soo Nam
Asan Medical Center,Ulsan University, Korea
Introduction: Generally, Major hepatectomy can be
performed safely at RLV (remnant liver volume)/TLV
(total liver volume) ≥30% or RLV/BWR (body weight
ratio) ≥0.6.
Recent reports have shown that this limit can be
decreased to 20–25% without a high death rate.
In this retrospective study, we investigate 42 patients
under RLV/TLV <30% or RLV/BWR <0.6 about post
operative hepatic dysfunction, morbidity, hopital days
and so on after major hepatectomy.
Method: Records were reviewed of 42 consecutive
patients who falls under RLV/BWR <0.6 or RLV/TLV
<30% in which underwent major hepatectomy between
2008 and 2012.
RLV (cubic centimeter) was measured preoperatively
with three-dimensional helical computed tomography;
TLV (total liver volume; cubic centimeter) was calcu-
lated from the patients BSA.
The relation between RLV/TLV and RVL/BWR was
examined using linear regression analysis.
Post hepatectomy liver failure (PHLF) was defined as
both a prothrombin time<50% and total serum biliru-
bin level >50 mol/L after postoperative day 5.
Continuous variables were expressed as median and
compared using the Mann–Whitney U-test. Hepatic
dysfunction and morbidity were compared using Fish-
er’s exact test.
Results: PHLF patience along 50/50 criteria was 7
(16.67%) during 42 patients, and 1 patient expired due
to PHLF. Five patients out of 7 patients were recov-
ered until normal laboratory value. There is a jaundice
patience for 2 months during progress observation. At
cirrhosis, preoperative chemotherapy, fatty change, and
DM; there was no affect of occurrence as PHLF. Cho-
lestasis and caudate lobectomy revealed risk factor of
PHLF (p = 0.002). In morbidity, only caudate lobec-
tomy was significant risk factor.
Conclusions: As follows from our research, acceptable
rate of PHLF has been reported for small remnant liver
operation with no cholestasis and even with PHLF,
every patient was recovered their liver function except
two cases.
Though, a comparative study with non-small remnant
liver group will be necessary, major hepatectomy can
perform under RLV/BWR <0.6 or RLV/TLV <30% in
non-cholestatic patients.
And major hepatectomy can be done with enough pre-
operative decompression for cholestatic patient.
PPL25-038
A LONG TERM SURVIVAL CASE OF
INTRAHEPATIC SARCOMATOID
CHOLANGIOCARCINOMA
Junho Sohn and Jong Hoon Park
Daegu Fatima Hospital, Korea
Introduction: Intrahepatic sarcomatoid cholangiocarci-
noma is a rare disease which is sarcomatous changes in
cholangiocarcinomas. Many of characteristics of this
tumor are still unknown but prognosis is worse than
for a ordinary intrahepatic cholangiocarcinoma. We
experienced a patient with intrahepatic sarcomatoid
cholangiocarcinoma who survived for 10 years from
initial diagnosis and we present our case.
Method: Case report.
Results: A 71-year-old man was admitted to our hospi-
tal suffering from persistent fever and right pleuritic
pain for 2 months. Imaging studies showed a huge
hepatic mass which was revealed to be a sarcoma-like
mass of the right hemiliver. Hepatectomy was per-
formed and gross finding was 18 9 16 9 15 cm in size
with a yellowish-fanning, diffusely soft, friable and
clearly demarcated mass on cross section. Microscopi-
cally the tumor cells were contained in the sarcomatous
component (63%), tumor necrosis (36%) and adenocar-
cinoma component (0.6%) on histological mapping.
Histologically, the tumor was composed of malignant
osteoid tumor cells. Immunohistochemical staining for
cytokeratin was positive in the sarcomatous compo-
nents. After curative surgery, early peritoneal and int-
rahepatic recurrence occurred in 2 months. He received
transcatheter arterial chemoembolization (TACE) using
cisplatin and adriamycin regimens and systemic chemo-
therapy with epirubicin and ifosfamide 6 times over
8 months. He took annual CT scans for 5 years and
there was no evidence of tumor recurrence. He is still
alive without tumor recurrence for 10 years from initial
diagnosis of this tumor.
Conclusions: Intrahepatic sarcomatoid cholangiocarci-
noma is a rare disease and there are just a little knowl-
edges about its characteristics. Many papers reported
short term survival even after aggressive treatment. We
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experienced early recurrence after surgery for sarcoma-
toid cholangiocarcinoma but TACE and systemic che-
motherapy worked effectively and complete cancer
remission was achieved. Further studies should be nec-
essary to find out what factors contribute good progno-
sis of this aggressive disease.
PPL25-039
SIMULTANEOUS LAPAROSCOPIC
RESECTION OF PRIMARY
COLORECTAL CANCER AND LIVER
METASTASIS
Chi-Young Jeong and Soon-Chan Hong
Gyeongsang National University School of Medicine,
Korea
Introduction: Liver metasasis of colorectal cancer
(CRC) is common. Resection of solitary tumors of pri-
mary and metastasis CRC can have a favorable out-
come. Open resection of primary CRC and liver
metasis in one operation or in separate operations is
currently common practice. Synchronus resection of
primary CRC and liver metastasis by laparoscopy have
recently been reported. The efficacy and safety of syn-
chronous laparoscopic resection are in debate. The
aims of the present study was to report our initial expe-
rience with simultaneous laparoscopic resection and
evaluate oncologic results.
Method: From Jan 2009 to Aug 2013, 12 cases of lapa-
roscopic hepatectomy on liver metastasis of CRC were
performed. In simultaneous resection, additional tro-
cars were inserted at upper abdomen by surgeon’s pref-
erence after colorectal procedures were completed.
Liver parenchymal resection was performed using the
ultrasonic shears, Ligasure, ultrasonic dissector, clip,
endoscopic linea stapler. For major hepatectomy, hilar
approach was firstly performed. Pringle’s maneuver
was not routinely performed during wedge resection
due to the harmful effect on colorectal anastomosis.
The margin from the lesion is ideally 1 cm and is
marked by intraoperative ultrasound.
Results: Type of precedure were 2 right hepatectomy, 1
left hepatectomy, 3 left lateral sectionectomy, 1 caudate
lobectomy, and 9 wedge resection. All procedures were
completed via a totally laparoscopic approach with no
conversion. Simultaneous resections were performed on
six cases. In 4 cases, over two lesions were resection.
Conclusions: In conclusion, within the limits of a retro-
spective, noncomparative study analyzing a small sam-
ple, this study shows that simultaneous laparoscopic
resection of primary CRC and metastatic liver tumors
can be performed safely and is technically feasible in
selective patients. Large scale randomized controlled
trials are needed to demonstrate the effectiveness of this
minimally invasive approach.
PPL25-040
RATIONALE AND SURGICAL
TECHNIQUE OF LAPAROSCOPIC LEFT
LATERAL SECTIONECTOMY WITH
ENDOSCOPIC STAPLE
Man Ki Kim, Sung Su Yun, Hwa Kyung Jung, Dong
Shick Lee and Hong Jin Kim
Yeungnam University Medical Center, Korea
Introduction: Laparoscopic left lateral sectionectomy
(LLLS) has been accepted with popularity in its bene-
fits related to minimally invasive surgery. Some sur-
geons like to isolate glissonian pedicles to segment 2
and 3 and control individual pedicles with surgical
clips. But others like to control glissoinan pedicles to
segment 2 and 3 at once with endoscopic stapling
device without isolating each pedicles. The aim of this
study is to find rationale (safety, outcomes, learning
curve) of LLLS with endoscopic staples.
Method: We retrospectively analyzed and compared
the clinical outcomes(operation time, blood loss, hospi-
tal stay, learning curve, complication rate, etc.) in 33
patients who underwent LLLS between April 2004 and
December, 2011 depending on surgical technique
whether isolate each glissonian pedicles (individual
group, n = 20) or not (batch group, n = 13). To see the
learning curve, we arbitrarily divided first and second
half period (before and after December, 2009) depend-
ing on case number 17.
Results: There was one open conversion in individual
group. Mean operative time was 265.3  21.3 minutes
(mean  SE) in the individual group and
170.0  22.9 minutes in batch group. Operation time
in batch group was significantly shorter than individual
group (p = 0.007). There was no blood transfusion in
batch group, but 4 out of 20 patients in individual
group needed blood transfusion during surgery. Mean
post-operative hospital stay were 10.7  1.1 and
9.4  0.8 days in individual and batch group
(p = 0.46). Mean operative time in the first and second
half of individual and batch group were 271.9  28.9/
254.3  32.2 minutes and 209.0  29.1/
142.1  30.7 minutes (first half/second half). In batch
group, we could save operation time significantly
(p = 0.027) in second half period without morbidity
and mortality.
Conclusions: The LLLS with endoscopic staple (batch
group) was easy and safe technique with short learning
curve and better outcomes without mortalty and mor-
bidity. We will show schematic pictures and video to
support rationale for LLLS with endoscopic staples.
PPL25-041
MISTAKING PRIMARY LIVER
TUBERCULOSIS FOR A MALIGNANCY.
COULD SURGERY BEEN AVOIDED?
Azlanudin Azman1, Iman Ghoneim1, Zamri Zuhdi1,
Affirul Ariffin2, Hairol Othman1 and Razman Jarmin1
1Universiti Kebangsaan Malaysia, Malaysia; 2Univiersiti
Sains Islam Malaysia, Malaysia
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Introduction: Primary liver tuberculoma is a rare entity
within healthy immuno-competent individuals.
Conversely, most of cases are secondary and are associ-
ated with miliary tuberculosis (TB). We report a case
of primary hepatic TB which was misdiagnosed and
treated initially as a primary liver tumour.
Method: Case report.
Results: A 56-year-old lady presented with epigastric
pain, loss of weight and appetite of 3 weeks duration.
Clinical examination revealed jaundiced patient with
upper quadrant tenderness. Initial blood work-up
revealed anaemia, a deranged liver profile and an ele-
vated CA-19-9 (562 U/mL). Computed tomography
(CT) demonstrated an ill-defined 3.5 9 4.0 cm hetero-
geneously enhancing mass at the liver hilum with peri-
portal lymphadenopathy. She was diagnosed with cho-
langiocarcinoma. Biliary decompression via ERCP was
performed and she was then subjected for a central
hepatectomy. Intra-operatively, we noted yellowish
nodules over the entire liver with mesenteric and omen-
tal lymphadenopathy dissimilar to the CT findings. A
frozen section biopsy revealed predominantly lympho-
plasmacytic inflammatory infiltrates, multiple granu-
loma with central necrosis and multinucleated
Langhan’s-type giant cells suggestive for tuberculosis.
In subsequent testing the patient was nonreactive for
HIV, HBV, HCV and sputum AFB. Chest X-ray also
showed no suspicion of pulmonary TB. She was started
on anti-tuberculous therapy and her condition has
improved since.
Conclusions: Although hepatic involvement can be seen
in up to 80% of the disseminated cases of TB, isolated
primary liver TB is rare because of the low oxygen ten-
sion within the liver, making it unfavourable for myco-
bacterium growth. A preoperative diagnosis of hepatic
TB was not immediately made in this case as the his-
tory, the elevated tumour marker and imaging results
inclined towards a diagnosis of malignancy. It was only
via frozen section biopsy was diagnosis confirmed.
Despite the rarity of this condition, liver tuberculosis
should be considered a differential diagnosis for liver
lesions to avoid unnecessary surgery.
PPL25-042
COMPARISON OF HEPATIC
RESECTION AND RADIOFREQUENCY
ABLATION FOR SOLITARY
HEPATOCELLULAR CARCINOMA
SMALLER THAN 4 CM
Weiguang Xu, Bong-Wan Kim, Yong Keun Park,
Jae Youn Cheong, Sung Won Cho and Hee Jung
Wang
Ajou University School of Medicine, Korea
Introduction: Hepatic resection (HR) is considered the
modality of choice for the patients with early hepato-
cellular carcinoma (HCC). Radiofrequency ablation
(RFA) is generally recognized as an alternative treat-
ment to HR for early HCC, especially for patients with
impaired liver function. However, there is controversy
to choose first line treatment modality for the early
HCC between HR and RFA. The aim of this study is
to compare the oncological outcomes of two therapeu-
tic modalities for early HCC including HR and RFA.
Method: Between January 2002 and February 2009,
118 patients with a single HCC smaller than 4 cm who
underwent HR (n = 75), or who completely ablated by
RFA (n = 43) were enrolled in this study. The out-
comes after treatments of the two groups were analyzed
and compared each other to evaluate efficacy of the
treatment modalities.
Results: In HR group, tumor size was larger than in
RFA group (2.54  0.90 cm vs 2.20  0.74 cm, respec-
tively, p = 0.035). Platelet count in HR group was
higher than in RFA group (1.43 9 105 vs 1.19 9 105,
p = 0.031). All patients in HR group (n = 75) was
Child–Pugh class A, but RFA group showed 37 Child–
Pugh class A and 6 Child–Pugh class B (p = 0.003).
Median recurrence free survival times were 79 months
in HR group, 45 months in RFA group. And overall
5 years survival rate in HR group and RFA group
were 80.8% and 87.9%, respectively. There was no sig-
nificant difference in recurrence free or overall survival
between the HR group and RFA group (p = 0.076 and
p = 0.475, respectively). A multivariate analysis
revealed that lower serum albumin level and decreased
platelet count were independent risk factors for recur-
rence.
Conclusions: RFA exhibited similar therapeutic effects
with HR in terms of patients survival for early HCC, if
RFA could exhibit complete ablation.
PPL25-043
LAPAROSCOPIC VERSUS OPEN
ABLATION THERAPY FOR
TREATMENT TO PRIMARY
UNRESECTABLE AND SMALL
HEPATOCELLULAR CARCINOMA
Kiyokazu Hiwatashi, Masahiko Sakoda, Shinichi
Ueno, Satoshi Iino, Hiroshi Kurahara, Yuko Mataki,
Kosei Maemura and Hiroyuki Shinchi
Kagoshima University Graduate School of Medicine,
Japan
Introduction: This study aimed to retrospectively evalu-
ate the relative perioperative safety and postoperative
outcome of the laparoscopic/thoracoscopic approach
versus the open approach to RFA for primary unresec-
table and small HCC.
Method: We retrospectively analyzed 55 patients who
underwent open (n = 32) or laparoscopic/thoracoscopic
RFA (n = 23) for primary unresectable and small HCC
between January 2005 and December 2010.
Results: There was a trend showing that laparoscopic/
thoracoscopic RFA was performed for tumors located
in the anterior segment (e.g., segments III, V, VIII).
The laparoscopic/thoracoscopic RFA group had a sig-
nificantly lower intraoperative blood loss, shorter oper-
ative time, and shorter postoperative hospital stay,
compared with the open RFA group. No major post-
operative complications occurred in patients who
underwent laparoscopic/thoracoscopic RFA. No signifi-
cant differences in overall survival, recurrence-free
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survival and local recurrence rates were observed
between the two groups.
Conclusions: In consideration of operative invasiveness
and postoperative recovery, laparoscopic/thoracoscopic
RFA is superior to the open approach in patients with
unresectable and small HCC. The surgical outcome did
not differ between the two approaches. Laparoscopic/
thorascopic RFA can be considered to be a useful pro-
cedure for ablation therapy.
PPL25-044
LINE-1 HYPOMETHYLATION AS A
POOR PROGNOSTIC INDICATOR
AFTER CURATIVE HEPATECTOMY
FOR PATIENTS WITH
HEPATOCELLULAR CARCINOMA
Chengzhan Zhu, Tohru Utsunomiya, Satoru Imura,
Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa,
Atsusi Tajima, Issei Imoto and Mitsuo Shimada
Tokushima University, Japan
Introduction: Global DNA hypomethylation is associ-
ated with increased chromosomal instability, leading to
carcinogenesis. Long interspersed nuclear element-1
(LINE-1) sequences are highly repeated human retro-
transposon sequences and constitute a substantial por-
tion (approximately 17%) of human genome. DNA
methylation in LINE-1 repetitive element is a surrogate
marker of global DNA methylation level. We herein
examined the clinicopathological significance of LINE-
1 methylation status in surgical patients with hepatocel-
lular carcinoma (HCC).
Method: Fifty-two patients with HCC, who underwent
a curative hepatectomy were enrolled in this study.
Bisulfite-specific PCR and DNA pyrosequencing were
performed to quantify the methylation levels of three
CpG sites of LINE-1 using the PyroMark Q24
Advanced system. The average of the relative amounts
of C in the 3 CpG sites was used as the overall LINE-1
methylation level. The patients were divided into two
groups; hypermethylation group (n = 28) and hypome-
thylation group (n = 24) according to the average value
of LINE-1 methylation level in the tumor tissues.
LINE-1 methylation level was compared with clinico-
pathological variables.
Results: Pyrosequencing analysis showed the significant
hypomethylation of LINE-1 in tumor tissues compared
with non-tumor tissues (48.0  12.3 vs 68.6  2.4,
p < 0.001). LINE-1 hypomethylation significantly con-
tributed to greater tumor size, more tumor numbers,
and higher incidence of intrahepatic metastasis
(p < 0.05). Tumor stage in the hypomethylation group
was significantly more advanced than that in the hyper-
methylation group (p < 0.05). The patients in the hy-
pomethylation group had a significantly poorer disease-
free survival (DFS) and overall survival (OS) compared
with those in the hypermethylation group. Multivariate
analysis showed that LINE-1 hypomethylation in the
tumor tissues was independently associated with both
DFS and OS after hepatectomy for the HCC patients.
Conclusions: LINE-1 hypomethylation in the patients
with HCC was associated with more advanced tumor
and poorer prognosis after hepatectomy, suggesting
that it has potential for use as a prognostic biomarker.
PPL25-045
LIVER RESECTION WITH
HYPOTHERMIC IN SITU LIVER
PERFUSION FOR MALIGNANT AND
BENIGN LESIONS
Aliaksei Shcherba, Elena Avdey, Denis Efimov,
Andrew Minou, Alexander Dzyadzko and Aleh Rumo
Minsk Center for Organ and Tissue transplantation,
Belarus
Introduction: The aim of the study is to demonstrate
the benefit of in situ hypothermic perfusion during
liver resection (LR) with total vascular exclusion
(TVE) for malignant and benign lesions locolized
near or invading the hepatocaval confluence and/or
inferior vena cava.
Method: Vascular occlusion techniques were used in
108 out of 215 LR performed in a period from 2008 to
July 2013 years. They included Pringle maneuver (34
cases), selective vascular isolation (62 cases), TVE – 6
cases and TVE with hypothermic liver perfusion (6
cases). Major LR was defined as a resection of 4 and
more Couinaud segments. Biliary complications, post-
hepatectomy liver failure were defined according to IS-
GLS criteria.
Results: The average time of surgical procedure was
longer in cases of LR with TVE and hypothermic liver
perfusion, 712  155 minutes, than in standard major
LR, 280  154 minutes (Mann–Whitney, p = 0.00001).
The average blood loss in LR with TVE and hypother-
mic perfusion was 2880  1948 and 588  478 mL in
standard major LR (Mann–Whitney, p = 0.00003).
Grade B-C posthepatectomy liver failure developed in
2 of 6 LR with TVE and TVE with hypothermic liver
perfusion each (33.3%) and in 8 of 48 standard major
LR (16.6%; p = 0.6). Grade B-C biliary complications
developed in 3 of 12 cases (25%) of LR with TVE and
hypothermic liver perfusion and in 9 of 48 cases
(18.7%) of standard major LR, but the difference was
not statistically significant. There was one hospital
mortality after all 12 LR with TVE and hypothermic
perfusion (16.6%). Mortality after standard major LR
comprised 8.3% (4 of 48; Fisher test, p = 0.6).
Conclusions: TVE with hypothermic liver perfusion
expands the resectability not only of malignant but also
benign liver lesions and permits to avoid the liver trans-
plantation in hardly accessible benign liver tumors with
the acceptable rate of complications.
PPL25-046
HEPATIC RESECTION FOR LARGE
HEPATOCELLULAR CARCINOMA
Saravanan Janakiraman, P Anbalagan, R
Kamalakannan, PS Senthilkumar, R Ravi, Jeswanth
Sathyaneesan, Ravichandran Palaniyappan and
Manoharan Govindhan
The Tamil Nadu Dr. MGR Medical University, India
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Introduction: Hepatocellular carcinoma is the fifth most
common cancer worldwide with 1 million new cases a
year. The role of hepatic resection for HCC larger than
10 cm is less clear. Several studies presented a gloomy
picture of high morbidity and mortality following resec-
tion of large HCC. Nevertheless we have followed an
aggressive policy of surgical resection as it provides sig-
nificant local control with good quality of life. The aim
of this study is to evaluate the perioperative and short
term outcomes along with the clinicopathologic factors
influencing overall survival after resection of large
HCC.
Method: Between August 2009 and December 2011, 42
consecutive patients underwent hepatic resection for he-
patocellualar carcinoma. Thirty patients had HCC with
maximum diameter greater than 10 cm. These 30
patients were included in study prospectively.
Results: Patients were analyzed with respect to the 18
prognostic factors affecting their overall survival. Uni-
variate analysis revealed blood loss more than
1000 mL, the need for blood transfusion, unencapsu-
lated tumours, high grade tumours and microscopic
vascular invasion were associated with worse overall
survival. Other variables were not significant for overall
survival on univariate analysis. None of the above fac-
tors were found to be significant by multivariate analy-
sis.
Conclusions: Even in the presence of associated cirroh-
osis, resection of large HCC which offers the only pros-
pect for cure is justified, provided that patients are
carefully selected in terms of liver function reserve and
liver remnant volume.
PPL25-047
THE FEASIBILITY OF THIRD OR MORE
REPEAT HEPATECTOMY FOR
RECURRENT HEPATOCELLULAR
CARCINOMA
Yoshihiro Mise1, Kiyoshi Hasegawa1, Junichi
Shindoh1, Takeaki Ishizawa1, Junichi Kaneko1, Taku
Aoki1, Yasuhiko Sugawara1, Masatoshi Makuuchi2
and Norihiro Kokudo1
1Tokyo University Hospital, Japan; 2Japanese Red Cross
Medical Center, Japan
Introduction: The 2nd hepatectomy has been accepted
as an effective treatment for recurrent hepatocellular
carcinoma (HCC), providing comparable long-term
survivals with those of initial hepatectomy. However,
the feasibility and prognostic benefits of multiple repeat
resection (more than 3 times) have not been adequately
assessed. The aim of this study is to investigate the fea-
sibility of multiple repeat hepatectomy for recurrent
HCC.
Method: From 1994 to 2011, a total of 1341 patients
underwent curative hepatectomy for HCC. Among
them, 941 underwent the 1st hepatectomy for the pri-
mary HCC and 289 underwent the 2nd hepatectomy
for the 1st recurrence of HCC. The remaining 110
patients underwent multiple repeat hepatectomy (3rd:
74, 4th: 28, and 5th: 8). Patient demographics, tumor
characteristics, and surgical outcomes were compared
among those who underwent initial hepatectomy
(1stHx), 2nd hepatectomy (2ndHx), and 3 or more hep-
atectomies (multiHx).
Results: No significant differences were found in
patient demographics among the 3 groups. Surgical
duration was significantly longer in multi Hx (median:
6.4 hours, range: 0.7–13.3 hours) than in 2nd Hx (med-
ian: 5.9 hours, range: 1.7–13.9 hours). Postoperative
bile leakage and would infection were more frequently
observed in multi Hx (12.5%, 2.9%) than in 2nd Hx
(6.2% [p = 0.04], 0.4% [p = 0.03]). The 3/5-year disease
free survival rates were 36.6%/27.1% in 1st Hx,
24.4%/17.9% in 2nd Hx (p < 0.001 [1st vs 2nd]), and
21.0%/12.8% in multi Hx (p < 0.01 [1st vs multi],
p = 0.95 [2nd vs multi]). The3/5-year overall survival
rates were not significantly different among the 3
groups (1st Hx: 79.4%/65.3%, 2nd Hx: 76.7%/60.5%,
multi Hx: 81.5%/68.2%).
Conclusions: Multiple repeat hepatectomy offers com-
parable disease-free and overall survivals to the 2nd
hepatectomy. However, the technical complexity of
multiple repeat hepatectomy is associated with the
increased risks of postoperative bile leakage and wound
infection.
PPL25-048
SURGICAL SITE INFECTION AFTER
SIMULTANEOUS COLORECTAL AND
LIVER RESECTION FOR COLORECTAL
CANCER AND LIVER METASTASIS
Masahiko Kinoshita1, Hiromu Tanaka3, Shigekazu
Takemura1, Takatsugu Yamamoto2, Chikaharu
Sakata1, Yorihisa Urata1, Takayoshi Nishioka1,
Akinori Nozawa1, Genya Hamano1 and Shoji Kubo1
1Osaka City Univercity Graduate School of Medicine,
Japan; 2Ishikiriseiki Hospital, Japan; 3Higashisumiyoshi
Morimoto Hospital, Japan
Introduction: Although simultaneous colorectal resec-
tion and liver resection is a radical treatment for
patients with synchronous colorectal cancer and liver
metastasis, postoperative complications, including sur-
gical site infection (SSI), are unresolved issues after the
operation. In this retrospective study, we investigated
risk factors for SSI after simultaneous colorectal and
liver resections.
Method: The subjects were 17 patients who underwent
simultaneous colorectal and liver resection for synchro-
nous colorectal cancer and liver metastasis between
April 2006 and March 2013. The T factor of main
lesions in most patients were classified into T3 and T4.
Thirteen patients had lymph node metastases. The
numbers of metastatic liver tumors ranged 1–6, and the
maximum diameter of the liver tumor ranged 10–
45 mm. The resected liver weight ranged 20–350 g. SSI
included intraabdominal infection and wound infection.
Risk factors, including operative procedures, for SSI
were evaluated.
Results: The SSI developed in 7 of 17 patients after the
operation. The abscess formation along the liver cut
surface developed in 4 patients, intraabdominal infec-
tion with leakage of the intestinal anastomosis devel-
oped in 2 patients. Wound infection developed in 2
patients. The resected liver weight in the group of SSI
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was larger in patients with SSI than in those without
SSI (p < 0.05). The incidence of SSI tended to be
higher in patients who underwent Pringle maneuver
during liver resection than in patients who did not the
maneuver (p = 0.0503).
Conclusions: The increased weight of the resected liver
and Pringle maneuver may affect the development of
SSI after simultaneous colorectal and liver resection.
PPL25-049
SINGLE HCC ≤3 CM IN LEFT LATERAL
SEGMENT: LIVER RESECTION OR
RADIOFREQUENCY ABLATION?
Jong Man Kim, Tae Wook Kang, Jin Yong Choi,
Wontae Cho, Seunghwan Lee, Hyunghwan Moon,
Choon Hyuck David Kwon, Hyunchul Rhim and
Jae-Won Joh
Samsung Medical Center, Sungkyunkwan University,
Korea
Introduction: Liver resection and radiofrequency abla-
tion (RFA) are accepted as effective treatments for small
hepatocellular carcinoma (HCC). The purpose of this
study was to evaluate the long-term results of RFA com-
pared to left lateral sectionectomy (LLS) in patients with
Child–Pugh class A disease for the treatment of single
and small HCC in the left lateral segment.
Method: We reviewed the data of 133 patients with sin-
gle HCC (≤3 cm) in left lateral segments who under-
went curative LLS (n = 66) or RFA (n = 67) between
2006 and 2010.
Results: The median follow-up period was 33.5 months
in the LLS group and 29 months in the RFA group
(p = 0.060). Most patients had hepatitis B virus-related
HCC. The hospital stay was longer in the LLS group
than in the RFA group (8 days vs 2 days; p < 0.001).
The 3-year disease-free survival rate and overall sur-
vival rate in the LLS group were 60.0% and 93.3%,
compared to 39.6% and 74.4% in the RFA group
(p = 0.050 and p = 0.018, respectively). Increased PIV-
KA-II levels and small tumor size were associated with
HCC recurrence in multivariate analysis.
Conclusions: There is no doubt that liver resection is
the gold standard for single HCC ≤3 cm in the left lat-
eral segment. However, RFA can be considered as a
primary treatment for HCC with preoperative low PIV-
KA-II levels.
PPL25-050
CAN THE MODEL FOR END-STAGE
LIVER DISEASE SCORE REPLACE THE
INDOCYANINE GREEN CLEARANCE
TEST IN THE SELECTION OF RIGHT
HEMIHEPATECTOMY IN CHILD–PUGH
CLASS A?
Jong Man Kim, Jin Yong Choi, Wontae Cho,
Seunghwan Lee, Shin-Seok Yang, Hyunghwan Moon,
Milljae Shin, Choon Hyuck David Kwon and Jae-Won
Joh
Samsung Medical Center, Sungkyunkwan University,
Korea
Introduction: The Model for End-stage Liver Disease
(MELD) score was developed to reflect hepatic reserve
in patients. The aim of the present study was to iden-
tify the correlation of MELD scores with the assess-
ment of the risk of hepatic function after hepatectomy
in patients with hepatocellular carcinoma (HCC)
related to hepatitis B virus (HBV).
Method: A case-control study was performed based on
data for 141 consecutive patients who underwent cura-
tive right hepatic resection between January 2006 and
June 2010.
Results: All patients were Child–Pugh class A. The
mean age of the patients was 50 years (range, 29–
73 years). The group included 114 men (80.9%) and 27
women (19.1%). The distribution of MELD scores
(median 7, range 6–14) and indocyanine green retention
rate at 15 minutes (ICG-R15) (median 9.2%, range
1.1–19.5%) showed no significant correlation
(p = 0.615). Only one perioperative death (0.7%)
occurred within 30 days, which was the result of liver
failure by hepatic artery dissection during the Pringle
maneuver. Hepatic dysfunction occurred in 25 patients
(17.7%) after liver resection. In multivariate analysis,
male gender, increased HBV DNA level, and elevated
serum aspartate transaminase (AST) level were signifi-
cantly related with hepatic dysfunction. Tumor size and
satellite nodule were closely associated with tumor
recurrence in HBV-related HCC after right hepatec-
tomy and satellite nodule was a predisposing factor for
mortality in those patients.
Conclusions: MELD score does not accurately predict
hepatic function after right hepatectomy in patients
with resectable HBV-related HCC. MELD scores were
not correlated with the ICG-R15 values in patients
with Child–Pugh class A.
PPL25-051
INTRAHEPATIC METASTASIS IS MORE
RISKY THAN MULTIPLE
OCCURRENCE IN HEPATOCELLULAR
CARCINOMA PATIENTS AFTER
CURATIVE LIVER RESECTION
Jong Man Kim, Jin Yong Choi, Wontae Cho,
Seunghwan Lee, Shin-Seok Yang, Hyunghwan Moon,
Milljae Shin, Choon Hyuck David Kwon and Jae-Won
Joh
Samsung Medical Center, Sungkyunkwan University,
Korea
Introduction: The characteristics of multiple nudules in
hepatocellular carcinomas (HCCs) after curative liver
resection remain obscure. We compare the clinicopath-
ologic characteristics and prognoses between patients
with hepatic lesions with multicentric occurrence (MO)
and intrahepatic metastasis (IM) at the time of surgical
resection.
Method: The histopathologic features of multiple
tumors from 198 patients of HCC were analyzed and
divided into MO group (n = 51, 25.8%) for multicen-
tric HCCs and an IM group (n = 147, 74.2%) in cases
with intrahepatic metastases. Overall survival rate, dis-
ease-free survival and clinicopathologic differences were
compared between the two groups.
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Results: Microvascular invasion and increased tumor
size were the most important factors discriminating the
IM group from the MO group (p < 0.001 and p = 0.027,
respectively). Kaplan–Meier and log rank tests revealed
that disease-free survival and overall survival rates in the
MO group were significantly higher than those for the
IM group (p < 0.001 and p < 0.001, respectively). A
multivariate analysis of Cox’s proportional hazards
model showed that increased alpha-fetoprotein (AFP)
and protein induced by vitamin K antagonist-II (PIV-
KA-II) levels, portal vein invasion and intrahepatic
metastases were the most important prognostic factors.
Conclusions: Among HCCs, the prognosis of patients
with MO is significantly better than that of patients
with IM.
PPL25-052
DIFFERENCES BETWEEN
HEPATOCELLULAR CARCINOMA AND
HEPATITIS B VIRUS INFECTION IN
PATIENTS WITH AND WITHOUT
CIRRHOSIS
Jong Man Kim, Jin Yong Choi, Wontae Cho, Shin-
Seok Yang, Seunghwan Lee, Hyunghwan Moon,
Choon Hyuck David Kwon and Jae-Won Joh
Samsung Medical Center, Sungkyunkwan University,
Korea
Introduction: In patients with hepatitis B virus (HBV)
infections, differences in hepatocellular carcinoma
(HCC) between those with liver cirrhosis and those
without cirrhosis have not been elucidated. The aim of
this study was to compare clinicopathological charac-
teristics and survival between non-cirrhotic and cir-
rhotic patients with HBV. Furthermore, we aimed to
determine prognostic factors for tumor recurrence after
hepatectomy in patients with HBV and HCC.
Method: Between 2005 and 2010, 441 curative hepatec-
tomies for HCC in patients with cirrhosis and 454 for
HCC in patients without cirrhosis were performed. The
clinicopathologic characteristics and survival between
the two groups were compared and prognostic factors
for tumor recurrence were identified by univariate and
multivariate analysis.
Results: Cirrhotic patients had lower platelet counts,
PIVKA levels, and tumor size than non-cirrhotic
patients. Serum ALP, HBV DNA, and ICG levels, as
well as the incidence of positive HBeAg in cirrhotic
patients, were higher than in non-cirrhotic patients.
HCC differentiation in non-cirrhotic patients was
poorer than in cirrhotic patients. The 1-year, 3-year
and 5-year disease-free survival rates were 72.0%,
61.0% and 55.7% in non-cirrhotic patients, and 68.6%,
51.5% and 45.9% in cirrhotic patients, respectively
(p = 0.013). However, The 1-year, 3-year and 5-year
overall survival rates were 92.4%, 81.7% and 74.8% in
non-cirrhotic patients, and 91.9%, 82.4% and 78.7% in
cirrhotic patients, respectively (p = 0.683). Risk factors
for tumor recurrence in each group varied in multivari-
ate analyses. Increased age, high platelet counts, micro-
vascular invasion, serosal invasion, and intrahepatic
metastasis predisposed to tumor recurrence in non-cir-
rhotic patients, but elevated PIVKA-II and ALP levels,
low serum albumin levels, portal vein invasion, intrahe-
patic metastasis, and tumor size were predisposing fac-
tors for recurrence in cirrhotic patients.
Conclusions: The clinicopathologic characteristics and
risk factors for tumor recurrence in cirrhotic and non-
cirrhotic HCC patients with HBV infection differ.
PPL25-053
LONG-TERM OUTCOME OF
LAPAROSCOPIC VERSUS OPEN LIVER
RESECTION FOR HEPATOCELLULAR
CARCINOMA: A CASE-CONTROLLED
STUDY WITH PROPENSITY SCORE
MATCHING
Hyeyoung Kim, Kyung-Suk Suh, Kwang-Woong Lee,
Nam-Joon Yi, Hae Won Lee, Young Rok Choi, Suk-
Won Suh, Tae Yoo and Jeong-Moo Lee
Seoul National University College of Medicine, Korea
Introduction: Laparoscopic liver resection (LR) for
hepatocellular carcinoma (HCC) is usually applied to
superficial and left side small lesions. Therefore, well
designed comparative studies about the results of LR
versus open liver resection (OR) for HCC are difficult
and still uncommon. The aim of this study was to com-
pare the perioperative and long-term oncologic out-
comes of LR versus OR for HCC between well-
matched patient groups.
Method: Between January 2000 and March 2012, 205
patients (43 with intent to treat with LR, 162 OR)
underwent primary liver resection of less than three
segments for HCC in our center. To select a compari-
son group, propensity score matching (PSM) was used
at 1:1 ratio with covariates of baseline characteristics
including tumor characteristics. Outcomes were com-
pared between the matched groups.
Results: The two groups were well balanced by PSM
and 29 patients were matched respectively. In LR, there
were more non-anatomical resection (65.5 vs 34.5%,
p = 0.012), less postoperative ascites (0.0 vs 17.2%,
p = 0.025), shorter hospital stay (7.69  2.94 vs
13.38  7.37 days, p < 0.001). Except these, there were
no significant differences in perioperative and long-term
outcomes. The 1-, 3- and 5- year survivals were 100%,
100% and 92.2% in LR, and 96.5%, 92.2% and 87.7%
in OR (p = 0.267). The 1-, 3- and 5-year disease-free
survivals were 81.7%, 61.7% and 54.0% in LR, and
78.6%, 60.9% and 40.1% in OR, respectively
(p = 0.929).
Conclusions: The outcome of LR for HCC was techni-
cally feasible and safe in selected patients, and LR
showed similar perioperative and long-term oncologic
outcomes when compared with OR matched with PSM.
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PPL25-054
TUMOR LYSIS SYNDROME
FOLLOWING 7-DAY SORAFENIB
TREATMENT FOR HEPATOCELLULAR
CARCINOMA: A CASE REPORT
Hee Yeon Kim, Chang Wook Kim and Chang Don
Lee
Catholic University of Korea, Uijeongbu St. Mary’s
Hospital, Korea
Introduction: Sorafenib, an oral multi-targeted tyrosine
kinase inhibitor, is indicated for the treatment of
advanced hepatocellular carcinoma. Although rare,
tumor lysis syndrome can be a fatal adverse event in
hepatocellular carcinoma (HCC) patients with large
tumor burden.
Method: A 55-year-old hepatitis B carrier visited our
clinic with progressive dyspnea for 3 weeks. Chest and
abdominal computed tomography revealed a huge
HCC in the left lobe of liver with invasion of inferior
vena cava, right atrium, and pulmonary arteries as well
as multiple lung metastasis.
Results: After 8 days sorafenib administration, tumor
lysis syndrome was diagnosed based on the characteris-
tic finding of hyperuricemia, hyperkalemia, acute kid-
ney injury with a massive tumor necrosis on the follow-
up imaging. Despite discontinuation of sorafenib and
supportive care, the patient’s clinical course rapidly
deteriorated.
Conclusions: This is a rare, but fatal complication in
an early period following sorafenib treatment for HCC.
Careful follow-up after sorafenib commencement is
required for early diagnosis and management of tumor
lysis syndrome especially in HCC patients with preex-
isting risk factors.
PPL25-055
ASSOCIATION BETWEEN
POLYMORPHISMS OF PPM1E GENE
AND TUMOR SIZE OF
HEPATOCELLULAR CARCINOMA
PATIENTS IN KOREAN POPULATION
Min-Su Park and Sang-Mok Lee
Kyung Hee University Medical Hospital, Korea
Introduction: Hepatocellular carcinoma (HCC) is the
most common type of primary liver cancer in Korea.
The protein phosphatase, Mg2 + /Mn2 + dependent,
1E (PPM1E) inactivates multiple substrates including
5’-AMP activate protein kinases (AMPK) which inhib-
its the growth and survival of cancer cells. However,
no study on the possible genetic association of PPM1E
single nucleotide polymorphism (SNP) with HCC has
been conducted yet.
Method: HCC patients (153 males and 30 females) and
healthy individuals (167 males and 224 females) were
enrolled in this study. We selected three exonic SNPs
(rs16943333, rs3809724 and rs3809723) in the 3′- UTR
of the PPM1E gene.
Results: rs16943333, rs3809724 and rs3809723 of
PPM1E were not significant differences between the
HCC group and the control group. In the further
analysis, we divided HCC patients into two groups
according to tumor size, serum AFP level, UICC stage,
radiologic morphology and portal vein thrombosis. We
found that rs16943333 and rs3809724 in PPM1E were
significantly associated with the tumor size. The geno-
type frequency of rs16943333 was associated with
tumor size in the codominant 2 (G/G vs A/A,
p = 0.038, Fisher’s exact p = 0.06, OR = 6.27, 95%
CI = 1.11–35.41), dominant (G/G/G/A vs A/A,
p = 0.014, OR = 2.27, 95% CI = 1.17-4.41) and log-
additive models (p = 0.0058, OR-2.16, 95% CI = 1.23–
3.79). In the allele frequency analysis, rs16943333 was
associated with tumor size (p = 0.010, OR = 2.07, 95%
CI = 1.19–3.59). The genotype frequency of rs3809724
was associated with tumor size in the codominant 2 (C/
C vs T/T, p = 0.030, Fisher’s exact p = 0.09,
OR = 5.31, 95% CI = 1.17–24.05), dominant (C/C/C/T
vs T/T, p = 0.030, OR = 2.04, 95% CI = 1.07–3.89)
and log-additive models (p = 0.011, OR-1.97, 95%
CI = 1.16–3.37). In the allele frequency analysis,
rs3809724 was associated with tumor size (p = 0.023,
OR = 1.84, 95% CI = 1.09–3.12).
Conclusions: In conclusion, we found that PPM1E
polymorphisms were significantly associated with tumor
size of HCC patients.
PPL25-056
HISTOPATHOLOGIC FACTORS
AFFECTING TUMOR RECURRENCE
AFTER HEPATIC RESECTION IN
COLORECTAL LIVER METASTASES
Min-Su Park1, Nam-Joon Yi1, Sang-Yong Son2,
Kyoung Bun Lee1, Kwang-Woong Lee1, Seung-Yong
Jeong1, Kyu Joo Park1, Kyung-Suk Suh1 and Jae-Gahb
Park1
1Seoul National University Hospital, Korea; 2Seoul
National University Bundang Hospital, Korea
Introduction: Hepatic resection is a standard method of
treatment for colorectal liver metastases (CRLM).
However, the pathologic factors of metastatic liver
lesions that affect tumor recurrence are less well defined
in CRLM. The aim of this study was to evaluate the
risk factors for recurrence of CRLM, focusing on histo-
pathologic factors of metastatic lesions of the liver.
Method: From January 2003 to December 2008, 117
patients underwent curative hepatic resection for colo-
rectal liver metastases were reviewed. Tumor size and
number, differentiation, tumor budding, angio-inva-
sion, dedifferentiation and tumor infiltrating inflamma-
tion of metastatic lesions were investigated.
Results: The mean number of hepatic tumors was 2
(range 1–8). The mean size of the largest tumor was 2.9
(range 0.3–18.5) cm in diameter. The moderate differ-
entiation of the hepatic tumor was the most common
in 86.3% of the patients. Tumor budding, angio-inva-
sion, and dedifferentiation were observed in 81%, 34%,
and 12.8% of patients. Inflammation infiltrating tumor
was detected in 6.8% of patients. Recurrence after
hepatic resection appeared in 69 out of 117 cases
(58.9%). Recurrence-free survival at 1-, 2- and 5-year
were 62.4%, 43.6% and 34.3%. The multivariate analy-
sis showed the number of metastases ≥3 (p = 0.007),
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the tumor infiltrating inflammation (p = 0.047), and
presence of dedifferentiation (p = 0.020) to be indepen-
dent risk factors for tumor recurrence.
Conclusions: Histopathological factors, i.e., dedifferen-
tiation and tumor infiltrating inflammation of the meta-
static lesion, could be one of the risk factors of
aggressive behavior as well as the number of metastases
even after curative resection for CRLM.
PPL25-057
INTRACTABLE BILE LEAKAGE AFTER
LIVER RESECTION
Akinori Nozawa, Shoji Kubo, Shigekazu Takemura,
Chikaharu Sakata, Takahiro Uenishi, Yorihisa Urata,
Takayoshi Nishioka, Masahiko Kinoshita and Genya
Hamano
Osaka City University, Japan
Introduction: The bile leakage is a major complication
after liver resection and sometimes falls in intractable.
We investigated risk factors for intractable bile leakage
after liver resection.
Method: The subjects in this study were 336 patients
who underwent liver resection between January 2008
and December 2012. We investigate the characteristics
in clinicopathological findings in patients with bile leak-
age to investigate risk factors for bile leakage. In addi-
tion, we also investigate risk factors for intractable bile
leakage. We defined “intractable bile leakage” when
patients with bile leakage required a period of 1 month
or longer in order to cure the bile leakage.
Results: The bile leakage developed in 15 of the 336
patients after liver resection. By univariate analysis,
large tumor, tumor at the hilar area, a high-risk opera-
tion (right anterior sectionectomy, left medial sectionec-
tomy, and right anterior and left medial
sectionectomy), a long operation time, and large
amount of intraoperative blood loss were risk factors
for the bile leakage. By multivariate analysis, hilar area
type tumor was an independent risk factor for bile
leakage. Of the 15 patients with bile leakage, 7 patients
had intractable bile leakage. Three of the 7 patients
had the stenosis or the obstruction of proximal bile
duct (duodenal side of the leakage point), whereas no
patients with bile leakage but not intractable had such
stenosis or obstruction. Intrabdominal infection
occurred in all 7 patients with intractable bile leakage
whereas no patients with bile leakage but not intracta-
ble had the infection.
Conclusions: The hilar area type tumor was an inde-
pendent risk factor for bile leakage after liver resection.
The stenosis or obstruction of the bile duct (duodenal
side of the leakage point) and intraabdominal infection
were risk factors for intractable bile leakage.
PPL25-058
METAANALYSIS OF INTERMITTENT
PRINGLE MANOEUVRE VERSUS NO
PRINGLE MANOEUVRE IN ELECTIVE
LIVER SURGERY
Sanjay Pandanaboyana and Stephen Wigmore
Royal Infirmary Edinburgh, UK
Introduction: Intermittent pringle manoeuvre (IPM) is
frequently used during liver surgery. This metaanalysis
aimed to review the impact on blood loss, operating
time and morbidity and mortality with and without use
of IPM.
Method: An electronic search was performed of the
MEDLINE, EMBASE, PubMed databases using both
subject headings (MeSH) and truncated word searches
to identify all articles published that related to this
topic. Pooled risk ratios were calculated for categorical
outcomes, and mean differences for secondary continu-
ous outcomes, using the fixed-effects and random-
effects models for meta-analysis.
Results: Four randomised controlled trials encompass-
ing 392 patients were analysed to achieve a summated
outcome. Pooled data analysis showed the use of IPM
resulted in reduced transection time/cm2 (mean differ-
ence (MD) 0.53 [0.88, 0.18] minutes/cm2
(p = 0.003) but with comparable blood loss (mL/cm2)
(MD 1.67 [4.41, 1.08] mL/cm2, p = 0.23), overall
blood loss (MD 20.42 [89.42, 48.58] mL), blood
transfusion requirements (RR 0.78 [0.40, 1.52, p = 0.47]
and morbidity and mortality compared to NPM (No
Pringle manoeuvre). In addition there was no signifi-
cant difference in the postoperative hospital stay (MD
0.37 [0.60, 1.34] days.
Conclusions: There is no evidence that the routine use
of IPM improves perioperative and postoperative out-
comes compared to NPM and its routine may not be
recommended.
PPL25-059
CHANGE OF GROWTH PATTERNS IN
GLYCOGEN STORAGE DISEASE TYPE I
Young Rok Choi, Nam-Joon Yi, Jae Sung Ko, Jin
Soo, Tae Yoo, Suk-Won Suh, Jeong-Moo Lee, Kwnag-
Woong Lee and Kyung-Suk Suh
Seoul National University College of Medicine, Korea
Introduction: Glucose storage diseases (GSD) show
growth retardation. This study aims to analyze the
change of physical growth after portocaval shunt (PCS)
or/and liver transplantation (LT) in GSD type I.
Method: We reviewed retrospectively 56 patients (M:
F = 38:18) with GSD type I between 1975 and 2013.
Among them, 13 underwent LT (at median 14 year-
old, range 9–21, LT group) and 17 with PCS (10, 4–12,
PCS group). Their data were compared with the nor-
mal data of CDC & WHO and the height standard
deviation scores (Z-scores) and its annual differences
(delta Z-score) were calculated and presented. And a
modified delta Z-score (m-delta Z-score) was defined an
annual difference between Z-score of operation group
and the cross-sectional median Z-score of non-opera-
tion group.
Results: Regardless of height at birth, Z score for their
height was sharply decreased to less than zero within
4 years in all patients. After operations, there was a
spurt of height in the postoperative period. The median
Z-score was 3.1 in LT group and 2.7 in PCS group
at the time of operations. They caught up growth up to
Z = 0.25 at postoperative 4 years in LT group and to
Z = 0.6 at postoperative 6 years in PCS group. Delta
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Z-score were +0.4 and +0.6 respectively in the postoper-
ative 1st year after LT or PCS. Then delta Z-score
decreased annually. The m-delta Z-scores changed to
positive values 2 years later after PCS or LT, relatively
to the median Z-score of non-op group.
Conclusions: Patients with GSD type I showed a
growth spurt after LT or PCS and caught up growth
2 years later.
PPL25-060
GLISSONEAN PEDICLE TRANSECTION
FOR ANATOMIC LIVER RESECTION
Nguyen Thuan, Tran Cong Duy Long, Nguyen Hoang
Bac, Le Tien Dat and Dang Quoc Viet
Non, Vietnam
Introduction: Hepatocellular carcinoma (HCC) is one
of the most common malignant tumors globally. It is
an aggressive tumor that usually develops in a cirrhotic
liver with limited functional reserve. With advanced
surgical techniques and perioperative care, outcome
after hepatic resection for HCC has greatly improved
with low operative morbidity and mortality. However,
the high incidence of postoperative recurrence remains
a serious problem. As long as liver function is ade-
quate, anatomic resection is strongly recommended as
the best surgical procedure for HCC.
Despite its first description by Takasaki 1986, there has
been wide acceptance of the procedure to date. Our
aim was to study the clinical effect of anatomic liver
resection using Glissonean pedicle transection for
HCC.
Method: This study included 142 patients who under-
went anatomic liver resection using Glissonean pedicle
transection between 1/1/2011 and 7/31/2013.
Results: Almost types of hepatectomy were performed
(except caudate lobectomy). Mean operation time was
163.72  55.61 minutes (90–360). Median blood loss
was 200 mL (50–2500, 25th and 75th percentage were
100, 300 respectively). Right portal vein and posterior
bile duct injury rate were 2.1% and 2.1% respectively.
Posterior biliary leakage rate was 2.8%. There was no
reoperation. Mortality rate was 0%. 1-year and 2-year
recurrent rate were 18.6% and 44.5% respectively. 1-
year and 2-year survival rate were 93.2% and 42.3%
respectively.
Conclusions: The results of current study suggest that
Glissonean pedicle Transection for anatomic liver resec-
tion is a simple, feasible, safe, effective procedure and
should be widely applied for HCC treatment.
PPL25-061
EFFICACY OF MELOXICAM, COX-2
INHIBITOR, FOR RECURRENT
HEPATOCELLULAR CARCINOMA
AFTER CURATIVE SURGERY
Tomoki Ryu, Yuko Takami, Masaki Tateishi,
Yoshiyuki Wada and Hideki Saitsu
Kyushu Medical Center, Japan
Introduction: As hepatocellular carcinoma (HCC) has a
high rate of recurrence even after curative treatments,
chemopreventive agents for recurrent HCC will likely
prove beneficial in improving the prognosis of HCC.
Recently, cyclooxygenase-2 (COX-2) has been found to
be overexpressed in HCC. This study investigated the
effects of meloxicam, a clinically used COX-2 inhibitor,
for recurrent HCC after curative treatment.
Method: We have treated 114 patients with meloxicam
(15 mg/day) for recurrent HCC after curative surgery,
hepatic resection or surgical microwave ablation
(microwave coagulo-necrotic therapy; MCN), in our
institute from January 2004 to December 2009. The
median size of recurrent tumor was 10.8 mm (range, 5–
23 mm), the median number of recurrent tumor was
1.9 (range, 1–25). Effects of meloxicam were evaluated
by MRI according to RECIST version 1.1 criteria
6 months after initiating meloxicam administration and
overall survival was retrospectively evaluated and sta-
tistically analyzed.
Results: Of these 114 cases, 3 cases (2.6%) achieved
complete response (CR), 6 cases (5.2%) achieved par-
tial response (PR), 37 cases (32.4%) showed stable dis-
ease (SD) and 68 cases (59.6%) showed progressive
disease (PD). Between the CR + PR + SD group (46
cases) and the PD group (68 cases), no significant dif-
ferences in liver function, tumor size, tumor number,
tumor markers, operative procedure at first curative
surgery or operative times were found. Mean duration
from starting meloxicam to retreatment for recurrent
HCC was 582 days in the CR + PR + SD group and
322 days in the PD group (p < 0.0001). The 1-, 3-, 5-
year overall survivals for the CR + PR + SD group
and the PD group were 100%, 95.6%, 83.6% and
100%, 83.1% and 57.4%, respectively. The overall sur-
vival was better in the CR + PR + SD group than in
the PD group (p = 0.0481).
Conclusions: Administration of meloxicam, the COX-2
inhibitor, for recurrent HCC may prolong the time to
progression of recurrent HCC and provide a better
prognosis.
PPL25-062
CURATIVE TREATMENT OF
OLIGOMETASTATIC LIVER AND LUNG
DISEASE FROM ANAL SQUAMOUS
CELL CARCINOMA: A CASE SERIES
Koroush Haghighi, Stephen Thompson, David
Goldstein, Philip Truskett and Gina Hesselberg
Prince of Wales Hospital, New South Wales, Australia
Introduction: At present there is limited evidence to
guide the management of patients with oligometastatic
disease in the setting of anal squamous cell carcinoma
(SCC). At The Prince of Wales (POW) Hospital in Syd-
ney, by analogy with oligometastatic rectal cancer, we
have selectively treated such patients with curative
resection. This study aims to assess outcomes in poten-
tially curative oligometastatic anal SCC patients, hy-
pothesising that cure may be achieved with aggressive
treatment.
Method: A retrospective review of the POW Department
of Radiation Oncology anal SCC databases was per-
formed. Eligible patients included those with primary
diagnosis of anal SCC and synchronous or subsequent
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oligometastatic disease surgically treated with curative
intent. Patient, tumour and treatment characteristics
were extracted and disease outcomes assessed.
Results: Four eligible patients were identified, with me-
tastecomy performed 2011–2013. Three had single met-
astatic lesions to liver and one had a single metastasis
to lung. Two patients were immunosuppressed (one
with HIV, the other with SLE on prednisolone). Man-
agement of the primary anal lesion was with definitive
chemoradiotherapy in three cases and abdominoperi-
neal resection in the patient with SLE. Two patients
had synchronous oligometastatic liver disease and one
patient presented 30 months post-primary treatment.
Surgical management involved central liver resection
(n = 1), bisegmental resection (n = 1) and hemi-hepa-
tectomy (n = 1). The fourth patient with oligometastic
lung disease, diagnosed 14 months post-initial treat-
ment, was managed with wedge resection. Post-metas-
tecomy, two patients were treated with adjuvant
chemotherapy and one with adjuvant chemo-radiother-
apy. Average follow up post-metastectomy was
12.3 months (range 2–24). Two of four patients remain
disease-free at 2 and 15 months post resection. The two
patients who developed recurrent metastases had a dis-
ease free survival of 24 and 25 months. The average
overall survival was 23 months.
Conclusions: This case series demonstrates that curative
treatment of oligometastatic anal SCC is possible in
selected cases.
PPL25-063
EPIDEMIOLOGY OF METASTATIC
COLON CANCER AMONG SAUDIS
Faisal Al-Alem1, Eve Simoneau2, Thamer Traiki1,
Nour Al-Malk1, Khayal Alkhayal1, Ahmad Zubaidi1,
Omar Obaid1, Hisham Mansi1, Khalid Alsaleh1 and
Mazen Hassanain2
1KKUH, Saudi Arabia; 2McGill university, Canada
Introduction: The incidence of colorectal cancer in
Saudi Arabia is rising, being the most common cancer
in the male population. However, little is known about
the epidemiology of metastatic colon cancer. The coun-
try has a population of over 26 M people with a med-
ian age and life expectancy of 25 and 75 years old
respectively. Our study aim is to present the incidence
and management patterns of metastatic colorectal can-
cer in Saudi Arabia.
Method: The incidence of colorectal cancer in Saudi
Arabia is rising, being the most common cancer in the
male population. However, little is known about the
epidemiology of metastatic colon cancer. The country
has a population of over 26 M people with a median
age and life expectancy of 25 and 75 years old respec-
tively. Our study aim is to present the incidence and
management patterns of metastatic colorectal cancer in
Saudi Arabia.
Results: In 2008, SCR reported 904 cases with male
predominance. The median age was 59, 29.2% of
patients had synchronous disease. At our tertiary cen-
ter, there were 191 new colon cancer cases with male
predominance (57%) and a mean age at diagnosis of
58. Median follow up was 3 years. Rectal cancer was
the primary site in 33% of cases. 64 (33%) patients
had synchronous disease 39(20%) were hepatic and 23
(12%) were lung metastasis. Total 15 follow up patients
had metachronous disease 7% hepatic and 4% was
lung. Out of the total liver metastasis 20% were
resected.
Conclusions: Metastatic colon cancer is a considerable
problem occurring in a relatively young population.
More effective screening, possibly at an earlier age with
population-specific guidelines, and better treatment
strategies are needed to improve this important public
health burden.
PPL25-064
DEVELOPMENT OF A LAPAROSCOPIC
LIVER RESECTION PROGRAM AND
STRATEGIES TAKEN TO INCREASE
COMPATIBILITY – A LARGE VOLUME
CENTER’S 10 YEARS’ EXPERIENCE
Wontae Cho, Jin Yong Choi, Seung Hwan Lee, Hyung
Hwan Moon, Choon Hyuck David Kwon, Jae-Won
Joh, Jae Berm Park, Sung Joo Kim, Suk-Koo Lee and
Jong Man Kim
Samsung Medical Center, Sungkyunkwan University,
Korea
Introduction: The application of laparoscopic liver
resection has had little progress since the first laparo-
scopic liver resection was performed two decades ago.
The slow acceptance of laparoscopic approach in liver
resection is primarily due to the technical difficulty of
the operation, fear of gas embolism, potential massive
bleeding, and possible inferior outcome in malignant
diseases. In the last 5 years, it has gained much popu-
larity among surgeons and many centers are currently
performing laparoscopic liver resection or are planning
to start one.
Method: A total of 355 patients who underwent lapa-
roscopic hepatectomy of Samsung medical center
between January 2003 and April 2013. Clinical chart
and operation record was reviewed for preoperative
and postoperative patients’ clinical status.
Results: As in most centers from 2008 to 2011, laparo-
scopic liver resection was mainly done for lesions for
small tumors at the so called ‘antero-lateral segments’
(segments 2–6) requiring limited resection and most
anatomic liver resections were primarily left lateral sec-
tinectomies.
Since 2011, major resections such as left or right hepa-
tectomies and liver resections for lesions in difficult
locations (segment 1, 7, 8) have been performed
increasingly, up to the half of total cases.
Conclusions: The main innovations taken between 2011
and 2012 were the application of bipolar electro-cau-
tery, the use of increased intra-abdominal pressure dur-
ing bleeding and the mid-term positive results on the
survival on patients receiving laparoscopic liver resec-
tion for malignant tumor. We are now in an era where
laparoscopic approach for liver resection is being
accepted more widely and it has become important for
institutions to have a good laparoscopic program.
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PPL25-066
EXPERIENCES OF LAPAROSCOPIC
LIVER RESECTION IN VARIOUS LIVER
DISEASE
Kwangsik Chun, Insang Song, Seokhwan Kim and
Seheon Kim
Chungnam National University School of Medicine,
Korea
Introduction: To review and investigate the experiences
of laparoscopic liver resection in various liver disease
Method: From April 2008 to December 2010 in
Chungnam national university, 49 cases of laparoscopic
liver resection were performed among 157 liver resec-
tions. During formal 1 year, mainly laparoscopy
assisted liver resections were performed and during
later 2 years totally laparoscopic liver resections were
main operative type. Surgery type is decided preopera-
tively by intension to treatment. Clinical data were col-
lected retrospectively and comparatively analyzed by
surgery type.
Results: Mean age was 60.0 (35–85), sex ratio (M:F)
was 1:1.3. Preoperatively 28 patients were diagnosed
intrahepatic duct stone with recurrent pyogenic cholan-
gitis, 9 patients were hepatocellular carcinoma, 5
patients were colorectal cancer with liver metastasis
and 7 patients were benign hepatic tumors. Laparos-
copy assisted liver resection was 16 cases (32.7%) and
totally laparoscopic liver resection was 33 cases
(67.3%). Anatomical major liver resection was 40 cases
(81.6%) and 9 cases (18.4%) were nonanatomical resec-
tion. Mean operaion time was 264.3 minutes (75–
570 minutes) and intraoperative transfusion was done
in 7 patients (14.3%). Mean postoperative hospital stay
was 10.2 days (4–32 days). Except preoperative planned
laparosocopy assisted liver resection, open conversion
was happened in two cases. Complications were hap-
pened in 4 cases, two cases were bile leakage. Pulmo-
nary atelectasis and indigestion were happened in one
case each. All of them were solved by conservative
managements. Mean malignant tumor size was 2.4 cm
(1.8–5.0 cm) and mean tumor free margin was 1.9 cm
(0.7–5.0 cm). But tumor recurrence was happened in 5
cases (35.7%). Two cases (22.2%) were hepatocellular
carcinoma and three cases (60%) were colorectal cancer
liver metastasis.
Conclusions: In this study, we conclude laparoscopic
liver resection is feasible operation but it needs to be
carefully conducted when it comes to malignant
tumors.
PPL25-067
MESENTERICO-LEFT PORTAL BYPASS
(REX SHUNT) IN CONGENITAL
CAVERNOMATOUS
TRANSFORMATION OF PORTAL VEIN:
TWO CASES REPORT
Chia-Yu Lai and Shao-Bin Cheng
Taichung Veterans General hospital, Taiwan
Introduction: Extrahepatic portal vein thrombosis or
cavernomatous transformation is the frequent cause of
extrahepatic portal hypertension in children. Life-
threatening variceal bleeding reoccurs in these patients
whose liver parenchyma is functionally normal. Surgi-
cal shunt procedures are indicated including portosys-
temic shunt and mesenterico-left portal shunt (REX
shunt). REX shunt, which restores the physiologic hep-
atopetal portal flow, is preferable according to the lim-
ited articles published. The cases we reported
highlighted the effectiveness of REX shunt in treating
patients with variceal bleeding secondary to extrahe-
patic portal hypertension.
Method: Two cases were illustrated. Both presented to
clinical attention at age of 7 due to recurrent variceal
bleeding despite of repeated endoscopic sclerotherapy
or banding. REX shunt procedure was performed with
autologus internal jugular vein and expanded polytetra-
fluoroethylene prosthetic graft as interposition conduit,
respectively.
Results: Esophageal variceal bleeding ceased after the
REX shunt procedure and the follow-up endoscopy
revealed no evidence of varices 3 months postopera-
tively.
Conclusions: Mesenterico-portal bypass (REX shunt)
procedure is effective and curative in treating extrahe-
patic portal hypertension for restoration of normal
hepatopetal portal flow.
PPL25-068
A CASE OF SYMPTOMATIC
SPONTANEOUS INTRAHEPATIC
PORTOSYSTEMIC SHUNT MANAGED
BY LAPAROSCOPIC HEPATIC VEIN
CLOSURE
Keon-Young Lee, Yong Sun Jeon and Kee Chun Hong
Inha University School of Medicine, Korea
Introduction: Intrahepatic portosystemic shunt (IPSS)
is uncommon and usually follows trauma or iatrogenic
injury, but spontaneous shunts may also occur. The
shunts should be treated when they cause symptoms,
which may mimic hepatic encephalopathy. Early and
accurate diagnosis is crucial to prevent misdiagnosis as
a psychiatric or neurologic disorder. Although interven-
tional endovascular management of the shunts is the
treatment of choice, a surgical approach can be used
when the percutaneous approach fails.
Method: We report here a case of symptomatic sponta-
neous IPSS between the posteroinferior branch of right
portal vein and the accessory right inferior hepatic vein,
which was successfully managed with laparoscopic clo-
sure of the hepatic vein.
Results: The encephalopathic symptoms resolved
promptly after the closure.
Conclusions: We conclude that IPSS can be treated by
laparoscopic hepatic venous occlusion in selected cases
of patients.
Poster Panel [Liver] 477
© 2014 The Authors
HPB 2014, 16 (Suppl. 2), 406–549 HPB © 2014 Americas Hepato-Pancreato-Biliary Association
PPL25-069
SIMULTANEOUS LIVER AND
PANCREATIC RESECTIONS: A SINGLE
CENTER EXPIRIENCE
Pietro Addeo, Elie Oussoultzoglou, Pascal Fuchshuber,
Serena Langella, VitoDe Blasi, Gael Simone and
Philippe Bachellier
Hepato-Pancreato-Biliary Surgery and Liver
Transplantation, France
Introduction: In western countries, Simultaneous Liver
and Pancreatic Resections (SLPR) are rarely performed
operations because of high postoperative mortality and
morbidity. Mortality rates up to 30% were reported for
major liver resection associated with pancreaticoduo-
denectomy. This study evaluates the safety and out-
comes of SLPR at a tertiary European center for
Hepato-Pancreato-Biliary Surgery.
Method: Between January 1994 and January 2012, 50
consecutive patients with a mean age of
57.3  1.9 years (range, 20–81) underwent SLPR. Indi-
cations for surgery were neuroendocrine carcinoma
(16), biliary cancer (15), colon cancer (5), duodenal
cancer (1) and others (13). Twelve patients (24%) had
preoperative biliary drainage, five patients (10%)
underwent pre-operative portal vein embolization
(PVE) and 9 patients (18%) received preoperative che-
motherapy.
Results: The type of pancreatic resections included
pancreaticoduodenectomy (30), distal pancreatectomy
(17), spleen preserving distal pancreatectomy (2), and
total pancreatectomy (1). Twenty-three patients (46%)
had associated major hepatectomies, 27 (54%) under-
went minor liver resections and 11 (22%) had associ-
ated vascular resections. The transfusion rate was 32%
and overall mortality and morbidity rates were 4% and
46%. Univariate and Multivariate analysis showed no
differences in postoperative morbidity for extent of
liver resections (major vs minor) or the type of pancre-
atic resections and preoperative chemotherapy was the
only independent risk factors associated with postoper-
ative morbidity(p = 0.02).
Conclusions: SLPR can be performed with acceptable
morbidity and mortality rates. Postoperative outcomes
do not vary with the extent of liver resection or the
type of pancreatic resection. Major hepatectomy should
not be considered a contraindication to SLPR in
selected patients. Patients receiving preoperative chemo-
therapy should be carefully evaluated and selected very
cautiously.
PPL25-070
ANESTHESIA WITH REMIFENTANIL IS
RECOMMENDED FOR HEPATECTOMY
ON HEPATOCELLULAR CARCINOMA
Kyunghwa Park, Jyunji Kita, Masato Kato, Mitugi
SHimoda and Keichi Kubota
Second Department of Surgery, Japan
Introduction: The advantage of remifentanil, a synthetic
narcotic drug, is an immediate effect. In current
researches, remifentanil has been shown to be able to
control intraoperative blood pressure and, therefore, it
has been frequently used for general anesthesia.
Method: In 40 cases who underwent hepatectomy in
2006, fentanyl was used (fentanyl group: FG), while in
52 cases undergoing hepatectomy in 2009, remifentanil
was employed (remifentanil group: RG). Intraoperative
and posetoperative volumes of urine, mean blood sugar
level, and insulin consumption were compared between
the two groups. In order to evaluate intraoperative
vital conditions, the 92 patients were divided into sta-
ble-condition group (SG: n = 33) and non-stable-condi-
tion group (NSG: n = 59). To obtain clinical data,
anesthesia charts were reviewed.
Results: There were no significant differences in age,
intraoperative bleeding amount, serum albumin level,
serum creatinine level and HbA1c level between FG
and RG.
However, there were statistically significant differences
in operation time (332 vs 254 minutes: p < 0.01), anes-
thesia time (420 vs 330 minutes: p < 0.01), balance of
intraoperative: hydration (volume of infusion – amount
of bleeding – urine volume)/weight/anesthesia time (7.6
vs 9.9 mL/kg/hours: p < 0.01), intraoperative urine vol-
ume/operation time (58 mL vs 72 mL: p < 0.03) and
blood sugar level (208 vs 178 g/dL: p < 0.01) between
FG and RG. Within 24 hours after surgery, blood
sugar level and insulin consumption showed no signifi-
cant differences.
Comparison between SG and NSG showed significant
difference in blood sugar level (158 vs 145 g/dL:
p < 0.05), within 24 hours after surgery, blood sugar
level (197 vs 186 g/dL: p < 0.03) and insulin consump-
tion (6 U vs 2 U: p < 0.01).
Conclusions: The anesthesia that can maintain stable
vital condition during surgery has a strong effect of
controlling blood sugar level during a perioperative
period in hepatectomy patients with hepatocellular car-
cinoma. Anesthesia with remifentanil is recommended
for hepatectomy patients with hepatocellular carci-
noma.
PPL25-071
VENOUS THROMBOEMBOLIC
PROPHYLAXIS FOLLOWING HEPATIC
RESECTION: PATTERNS OF CARE
AMONG LIVER SURGEONS
Gaya Spolverato, Matt Weiss, Aslam Ejaz, Kenzo
Hirose, Christopher Wolfgang and Timothy Pawlik
Johns Hopkins, USA
Introduction: Broad consensus does not exist around
the utilization of venous thromboembolic (VTE) pro-
phylaxis for patients undergoing hepatic resection. We
sought to define what clinical factors impact choice of
VTE prophylaxis among hepato-pancreato- biliary
(HPB) surgeons.
Method: Surgeons who perform liver resections were
invited to complete a web-based survey regarding their
opinions on VTE prophylaxis. The impact of physician
and clinical factors on VTE prophylaxis was analyzed.
Results: Two hundred and four responses were
received (response rate-67%). Most respondents were
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male (91%), from the United States (80%), and prac-
ticed at an academic center (87%). Surgical training
varied: HPB (24%), transplantation (25%), surgical
oncology (33%), combined HPB/transplantation
(13%), or no specialty training (29%). Respondents
estimated the risk of a VTE event was higher following
a majr (8%) versus minor (5%) resection. Although
98% of respondents routinely used VTE prophylaxis,
there was considerable variability: sequential compres-
sion devices (89%), unfractionated heparin Q12 hours
(31%), unfractionated heparin Q8 hours (30%), and
low-molecular weight heparin (37%). While 88% of
respondents noted their use of VTE prophylaxis was
not impacted by operative indication (benign vs malig-
nant), 16% of surgeons stated that a major resection
reduced their likelihood of administering prophylaxis.
Other factors associated with a decreased likelihood of
administering pharmacologic prophylaxis included: ele-
vated INR (75%), thrombocytopenia (63%), liver
insufficiency (58%), large operative blood loss (45%)
and early complication (7%). Of note, 47% of respon-
dents routinely waited until ≥POD1 before initiating
pharmacologic prophylaxis and 35% hold VTE pro-
phylaxis until there are no signs of coagulopathy. A
minority of respondents (14%) said they routinely send
patients home on pharmacologic prophylaxis. While
81% of surgeons state that their hospital has institu-
tional guidelines for VTE, a comparable number (80%)
believe that consensus guidelines would be helpful.
Conclusions: There is considerable practice variation
regarding VTE prophylaxis among liver surgeons.
While the vast majority of surgeons routinely employ
VTE prophylaxis, the methods, timing and purported
contraindications to VTE prophylaxis differ signifi-
cantly among liver surgeons.
PPL25-072
EXPRESSION OF FATTY ACID
BINDING PROTEINS IN A MOUSE
MODEL OF OBESITY-ASSOCIATED
HCC
Kyle Thompson, David Iannitti, Iain McKillop and
David Sindram
Carolinas Medical Center, USA
Introduction: Hepatocellular carcinoma (HCC) is the
3rd leading cause of cancer-related mortality. Risk fac-
tors for HCC include viral hepatitis infection, aflatoxin
exposure and chronic alcohol consumption, with obes-
ity emerging as an increasingly important risk factor.
The aim of this study was to investigate expression of
fatty acid binding proteins (FABPs) as potential bio-
markers and/or mechanistic modulators of obesity-
associated HCC.
Method: Male C57BL/6 mice were injected with vehicle
(Veh) or diethylnitrosamine (DEN; 5 mg/kg) at 21–
24 days. At 5 weeks, mice were placed on control diet
(CD; 10% kcal%/fat) or high fat diet (HFD; 60% kcal
%/fat) and maintained. At 42 weeks mice were sacri-
ficed and livers examined for gross tumor incidence.
Liver sections were formalin-fixed for histological
analysis or snap-frozen. To assess FABP expression,
RT-qPCR and immunoblots were performed.
Results: Animals on HFD-Veh formed large tumors in
30% of animals, an effect exacerbated by DEN admin-
istration (90%), compared to small tumors in 60% in
CD-DEN. Expression of FABP1 was upregulated in
CD-DEN and HFD-DEN compared to Veh-injected
animals. FABP2 was unchanged between CD-Veh and
– DEN and HFD-Veh animals. However; there was a
2-fold down regulation of FABP2 in livers of HFD-
DEN non-tumor tissue (NT) compared to HFD-DEN
tumor (T) tissue. No significant FABP3 was detected;
however, there was ~1000-fold upregulation of FABP4
in HFD animals compared to CD animals, an effect
exacerbated in DEN-injected animals. FABP5
expression was downregulated in HFD-Veh and HFD-
DEN-NT tissue; however, HFD-DEN-T tissue
expressed 3-fold higher levels.
Conclusions: FABPs are dysregulated in obesity-associ-
ated HCC. Interestingly, there is a reciprocal relation-
ship between expression of FABPs 1, 2 and 5 in tumor
tissue from HFD-DEN mouse livers compared to dis-
tant NT liver tissue. These findings suggest FABPs may
be biomarkers for obesity-associated HCCs. Further
studies should be conducted to determine the mechanis-
tic impact, if any, on FABP dysregulation on the initia-
tion and progression of obesity-associated HCC.
PPL25-073
REDUCUCTION OF COMPLICATIONS:
THE PROGRESSION OF
LAPAROSCOPIC LIVER RESECTION
Adam Hauch, Seeyuen Lee, Adam Golden, Erica
Kane, Emad Kandil and Joseph Buell
Tulane University School of Medicine, USA
Introduction: Laparoscopic hepatic resection has been
described as safe and efficacious. This study examines
the drift in incidence and severity of post-operative
complications arising from laparoscopic compared to
open liver resection.
Method: Retrospective review of 615 patients managed
by a single surgeon from 2000 to 2013. Analysis con-
trasts the demographics and post-operative outcomes
between both groups. Complications were examined
and compared using the Clavien-Dindo Classification
for severity.
Results: Seven hundred and fifty-three hepatic resec-
tions in 615 patients were examined. Open surgery was
reserved for smaller lesions (4.5 cm vs 5.1 cm:
p = 0.064) and predominately in malignant lesions
(44.8% vs 78.2%: p < 0.001). Complications were more
frequent in open procedures (40.2% vs 20.2%:
p < 0.001) although the severity of complications was
not significantly different (p = 0.846). Concordantly an
open approach resulted in a higher percentage of
patients requiring critical care (89.7% vs 12.9%:
p < 0.001) resulting in a longer hospitalization
(8.5 days vs 3.4 days: p < 0.001).
Conclusions: This study confirms laparoscopic hepatic
resection carries a lower incidence of complication.
Notably the severity of the complications is equivalent
between the laparoscopic and open groups. The higher
utilization of critical care services and prolonged hospi-
talization may also be attributed to an increased
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complexity of open resections not performed laparo-
scopically.
PPL25-074
SECOND HEPATIC RESECTION FOR
RECURRENT PANCREAS LIVER
METASTASES
Mauricio Ribeiro, Nathalie Reigada, Andre Gallo,
Paulo Corsi, Fabio Ferreira and Luiz Szutan
Faculdade de Cie^ncias Medicas da Santa Casa de S~ao
Paulo, Brazil
Introduction: Multiple liver resections have successful
outcome in colorectal metastases. However still remains
controversial in the literature the treatment of liver
metastases of pancreatic adenocarcinoma. The second
hepatectomy for metastatic pancreas has been rarely
performed in these patients.
Method: Case report based on our files and literature
review.
Results: Female patient underwent pancreaticoduoden-
ectomy (PD) for adenocarcinoma pancreas uneventful.
Remained asymptomatic util 13th month postoperative
when a CT showed hepatic metastases. She underwent
non anatomic segment IV and partial resection of
transverse colon single metastasis in the liver confirmed
by CT PET preoperative and US intra-operative.
Pathology confirmed metastasis and showed negative
margins. She had so far no complications. Evolves
asymptomatic until new CT showed a new metastasis
in the 8th month postoperative hepatectomy and 21th
month postoperative PD when she underwent segmen-
tectomy IV and V and right colectomy due to recur-
rence of metastasis, uneventful and with good
postoperative outcome. Pathology confirmed metastasis
and showed negative margins. Remained asymptomatic
for 31 months. Died at 32 months post-operatively.
Conclusions: The improvement in the treatment of pan-
creatic adenocarcinoma and intensive monitoring of
these patients may allow the second hepatectomy in
selected cases.
PPL25-075
THE EFFECT OF ALCOHOL ON SIRT1
EXPRESSION AND FUNCTION IN
ANIMAL AND HUMAN MODELS OF
HEPATOCELLULAR CARCINOMA
Kyle Thompson1, John Humphries2, David Niemeyer1,
David Iannitti1, David Sindram1 and Iain McKillop1
1Carolinas Medical Center, USA; 2University of North
Carolina at Charlotte, USA
Introduction: Risk factors for hepatocellular carcinoma
(HCC) include chronic ethanol (EtOH) consumption
and viral hepatitis. Sirt1 is a NAD+-dependent deacety-
lase implicated in alcohol-induced liver injury and over-
expressed in human HCC. The aims of this study were
to investigate Sirt1 expression in mouse models of
EtOH feeding and HCC, and in human HCC cells with
differing alcohol metabolism profiles.
Method: Juvenile (23–25 days) C57BL/6 and B6C3
mice were injected with DEN and randomized to
receive drinking water (DW) or EtOH-DW for 8 weeks
when 36 weeks old. Livers were analyzed for HCC inci-
dence and size, and Sirt1 expression. In parallel human
HepG2 HCC cells or HepG2 cells transfected to
express ADH and CYP2E1 (VL-17a cells; Dr. Clemens,
Omaha, NE) were treated with alcohol (0–50 mM)
and/or CAY10591 (Sirt1 activator; 10 lM, 24 hours).
Results: B6C3 mice exhibited significantly elevated
Sirt-1 expression versus C57BL/6 mice and Sirt-1
expression was elevated in HCC versus non-tumor
liver. However, EtOH-feeding did not further alter
Sirt1 expression in mice of either background despite
EtOH increasing size and incidence of HCC in B6C3
mice. In vitro, VL-17a-cells exhibited significantly
greater alcohol metabolizing capacity versus HepG2-
cells and EtOH treatment significantly decreased Sirt1
expression in VL-17a-cells, an effect not observed in
HepG2. Concomitantly, EtOH-treatment stimulated
VL-17a-cell growth but not that of HepG2 cells and
these EtOH-dependent changes in VL-17A-cell growth
were abrogated by CAY10591 pretreatment.
Conclusions: Sirt1 expression correlates with suscepti-
bility to HCC formation in different mouse strains, but
is not further affected by chronic alcohol feeding. Con-
versely Sirt1 expression and function is directly influ-
enced by capacity to metabolize alcohol in human
HCC cells in culture. These apparent discrepancies in
Sirt1 expression-function may reflect differences in
enzyme expression compared to activity or more com-
plex changes in genes that are targeted for deacetyla-
tion during tumor progression in the setting of chronic
alcohol feeding-treatment.
PPL25-076
MULTIPLE SURGERIES IN THE
TREATMENT OF HEPATIC
METASTASES
Aranzazu Prada, Gerardo Blanco, Jose Angel Flores,
Isabel Gallarin and Ernesto Barzola
Hospital Infanta Cristina Badajoz, Spain
Introduction: Exposing the postoperative results and
survival in the medium-long term repeat surgery of
liver metastases in the Hepato-Biliary-Pancreatic and
Liver Transplant Surgery (Hospital Infanta Cristina,
Badajoz), from February2006 to May2013.
Method: We reviewed the medical history of 259
patients who underwent liver metastases during this
period. 54 parameters were collected, including demo-
graphic and hospitalization data, characteristics of the
primary tumor and metastases, parameters in relation
to surgery, postoperative morbidity and survival in the
medium/long term.
From these data was performed retrospective statistical
analysis used SPSS18.0 for Windows.
Results: Of the 259 cases, 181 (69.9%) was a single
intervention for hepatic metastases and in 78 cases were
patients who required more than one surgery. 31
(11.9%) was the first of consecutive interventions, 38
(14.6%) was the second intervention, 8 (3.08%) the
third and the fourth one (0.38%). Of the 78 cases of
multiple surgeries 56 were males (71.8%). The mean
age was 3.92  11.7. The origin of the primary tumor
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was colorectum in 82.1%, neuroendocrine in 9% and
no colorrectal no neuroendocrine in 9%. In 39 cases
the metastasis was single (50%). Major hepatectomy
was performed in six patients (7.7%) RF was per-
formed in 35 patients (44.9%), as the only procedure in
18 (23.1%). They pointed transfusion 20 patients
(25.6%). Overall morbidity was 16.7%. Surgical mor-
bidity 11.5%, the postoperative length of hospital stay
was 9.4  9.99 days. The comparison of variables
between single/multiple surgeries found no statistically
significant differences. The comparison of survival after
a single/multiple intervention was 84/92% at 1 year,
57/65% at 3 years and 36/43% at 5 years (no statisti-
cally significant differences).
Conclusions: The repeated resection of liver metastases
is frequently performed -Repeated surgery of metasta-
ses in our unit is a safe technique with acceptable mor-
bidity and mortality -In comparison with the first
intervention, repeated resections show acceptable
results.
PPL25-077
USE OF TRANSARTERIAL
CHEMOEMBOLIZATION (TACE) FOR
HEPATOCELLULAR CARCINOMA
(HCC) TUMOR DOWNSTAGING
William Chapman, Neeta Vachharajani, Katherine
Fowler, Majella Doyle and Nael Saad
Washington University in St Louis, USA
Introduction: Current strategies for HCC management
utilize liver-directed therapy as first-line therapy for
patients with hepatic confined tumors and Child’s class
A or B cirrhosis. We recently performed a 3.5-year pro-
spective assessment of successful downstaging for
patients with HCC in the setting of cirrhosis.
Method: Between 7/1/2009 and 12/31/2012, 781 TACE
procedures were performed on 431 newly diagnosed
HCC patients. TACE was performed using a combina-
tion of epirubicin, Ethiodol, and Gelfoam particles with
selective tumor targeting as the standard approach.
Patient demographics, recurrence, and survival results
were reviewed.
Results: One hundred and seventy-six patients were
outside of Milan criteria at time of initial TACE (Stage
III-91, Stage IVA1-49, Stage IVA2-36). 23/176 outside
Milan cases have been gone on to liver transplantation
thus far, with the remainder of downstaged patients
either currently listed, unfit for OLT for other reasons,
or not interested in OLT. Overall, 101/431 patients
undergoing TACE therapy have gone on to OLT.
Overall survival after TACE therapy is 91.2%, 85.1%,
and 76.4% at 1-, 2-, and 3-year in the 101 undergoing
OLT.
Conclusions: TACE therapy provides an effective initial
strategy for first-line treatment of patients with HCC in
the setting of cirrhosis. In patients presenting with hep-
atically confined non-metastatic disease, this therapy
may allow for tumor downstaging and subsequent liver
transplantation.
PPL25-078
LIVER RESECTION FOR COLORECTAL
LIVER METASTASES (CRLM) IS SAFE
IN THE ELDERLY PATIENTS.
Samuele Vaccari, Mariateresa Mirarchi, EmilioDe
Raffele, Silvia Palumbo, Ferdinando Lecce, Barbara
Dalla Via, Dajana Cuicchi, Roberto Bellusci, Antonino
Cavallari and Bruno Cola
U.O. Chirurgia Generale e d’Urgenza – Prof. Cola, Italy
Introduction: Liver resection (LR) is an accepted treat-
ment for patients with CRLM and has been recently
proposed also for selected elderly patients. The aim of
this study was to clarify the perioperative outcome of
LR in patients older than 75 years.
Method: From January 2000 to June 2013, 246 LR
have been performed for CRLM with curative intent;
in 26 a explorative laparotomy or a RFTA were per-
formed and were excluded. 220 patients were enrolled:
99 younger than 65 years (YG), 92 between 65 and
75 years (OG) and 29 older than 75 years (VOG).
Patients’ demographics, clinical and histopathological
parameters, intra and perioperative results were ana-
lyzed. ANOVA and Student’s t tests were used for sta-
tistics; significance was defined as p < 0.05.
Results: YG included 61 males and 38 females, aged
54.62  8.42 years [25–65]; OG included 68 males and
24 females, aged 68.91  2.86 years [65–75] and VOG
included 15 males and 14 females, aged
78.59  2.70 years [75–85]. Unique CRLM were
35.4%, 46.7% and 44.8% in YG, OG and VOG,
respectively (p = NS). Mean diameter of the largest
tumour was 34.64  23.85 mm [6–130] in YG,
40.89  28.69 mm [8–200] in OG and
33.68  13.79 mm [8–60] in VOG (p = NS). Duration
of surgical procedure was 349  141 minutes [150–
820], 375  161 minutes [90–800] and 315  153 min-
utes [115–745] in YG, OG and VOG, respectively
(p = NS). Intraoperative blood transfusions were
245  510 mL [0–3300], 262  506 mL [0–2500] and
168  327 mL [0–1200] in YG, OG and VOG, respec-
tively (p = NS). Postoperative hospital stay was
10.38  4.17 days [6–33], 11.21  7.79 days [6–68] and
10.24  6.29 days [4–32] respectively (p = NS). Postop-
erative complications were 13.13%, 19.56% and
17.24% in YG, OG and VOG respectively (p = NS).
Two patients died, one in OG and one in VOG, respec-
tively (p = NS).
Conclusions: Advanced age should not be considered a
deterrent for liver resection in patients with CRLM.
PPL25-079
TRANSLATIONAL SCIENCE IN A
SURGICAL RCT: GETTING THE MOST
OUT OF YOUR INVESTMENT
Aasmund Avdem Fretland1, Airazat M. Kazaryan2,
Bard I. Røsok1, Bjørn A. Bjørnbeth1, Kjersti
Flatmark1, Marit H. Andersen1, Andrey Sokolov1,
Ronny Kristiansen1, Karl Øyri1 and Bjørn Edwin1
1Oslo University Hospital, Norway; 2Telemark Hospital
Trust, Norway
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Introduction: Laparoscopic liver resection is standard
procedure in many specialized centres. However, there
is to date no RCT validating the surgical and oncologi-
cal equivalence of laparoscopic and open liver resec-
tion. The Oslo Comet-study is a RCT on laparoscopic
and open liver resection for colorectal liver metastases.
Primary end point is 30 days morbidity. However, a
large RCT is costly and demands great effort from par-
ticipating patients and medical professionals. This war-
rants maximum utilization of the data collected.
Method: We have initiated several translational studies
in addition to evaluating the primary and secondary
targets:
1:. A comparison of the inflammatory response.
2:. Establishment of a bio bank for genome analysis
of tumour tissue. Linking of genome data to
clinical information will facilitate identification
of prognostic factors.
3:. A health economy evaluation of a) in-hospital
costs, b) 1-year cost/quality of life and c) lifetime
cost of the two procedures.
4:. Development of software for multidisciplinary
team meetings. It includes functionality for tar-
geting modern anti cancer treatment based on
genome information.
5:. Evaluation of novel imaging methods for liver
tumours: Liver specific FDG-PET and CT perfu-
sion.
6:. Development of software for segmentation and
3d-reconstruction of liver anatomy. This is used
interactively during surgery and further pros-
pects include tracing of laparoscopic instru-
ments, and updates as the liver changes position
during surgery.
Results: The patients give written consent to participa-
tion in all translational studies upon entering the ran-
domized trial.
Conclusions: A RCT is considered the most valid study
design to determine the effect of interventions. How-
ever, they are so demanding to perform that research
institutions often consider other study designs. In order
to maximize output of our RCT we have expanded the
trial with several translational studies. This organiza-
tion importantly provides clinical data for scientists to
whom such data is often difficult to obtain, and facili-
tates hypothesis generation and new discoveries.
PPL25-080
RIGHT PORTAL VEIN LIGATION AND
IN-SITU SPLITTING BY LAPAROSCOPY
FOR TWO-STAGE HEPATECTOMY
Martine Goergen, Juan Santiago Azagra, Olivier Facy,
VitoDe Blasi and Luca Arru
Centre Hospitalier de Luxembourg, Luxembourg
Introduction: Objective: To evaluate the interest and
describe the technical aspects of laparoscopic right por-
tal vein ligation and in-situ splitting in two stage hepa-
tectomy.
Background: Two-stage hepatectomy with portal vein
ligation or embolization can be used to treat bilobar
liver metastases and to decrease the risk of liver
insufficiency. Recently, right portal vein ligation com-
bined with in-situ splitting has been proposed to
increase left lobe hypertrophy before an early second
stage. The interest of laparoscopy has never been evalu-
ated in this setting.
Method: A 63-year-old patient presented with meta-
chronous bilobar liver metastases from colorectal can-
cer. The laparoscopic first stage included segment-III
wedge-resection, segment II and IV radiofrequency
ablation, right portal vein ligation and in-situ splitting.
The completion of the right hepatectomy was per-
formed 10 days later, with an uneventful outcome.
Results: The first step was feasible and safe. Left lobe
hypertrophy was measured at 40%. The second step
was performed by laparotomy because of major adher-
ences and the need for subcostal extraction. The overall
procedure was perfectly tolerated, with no signs of liver
failure.
Conclusions: Two-stage hepatectomy with right portal
vein ligation and in-situ splitting is feasible and safe by
laparoscopy. The interest is to improve the post-opera-
tive outcome of each step in order to improve tolerance
to the overall procedure.
PPL25-081
FALLING BARRIERS TO
LAPAROSCOPIC LIVER RESECTION
Adam Hauch, Seeyuen Lee, Adam Golden, Erica
Kane, Emad Kandil and Joseph Buell
Tulane University School of Medicine, USA
Introduction: Laparoscopic liver resection is an accepted
modality for the management of a variety of benign and
malignant tumors. Initial efforts were focused on periph-
eral lesions. We now examine selected patient demo-
graphics and extent of operative interventions that might
have previously precluded a laparoscopic approach.
Method: Retrospective review of 615 patients managed
by a single surgeon from 2000 to 2013. Analysis was
performed to compare and contrast demographics and
operative characteristics between both open and laparo-
scopic hepatic resections.
Results: Seven hundred and fifty three hepatic resec-
tions in 615 patients were reviewed. Demographics
(age, BMI, incidence of cancer and cirrhosis) were com-
pared between open and laparoscopic approaches and
found to be equivalent. In contrast ASA was higher in
the open group (3.0 vs 3.1: p < 0.05) as was the extent
of resection as indicated by number of segments
resected (3.0 vs 2.4: p < 0.001) and percentage of major
resections (formal lobe) (23.3 vs 47.0: p < 0.001).
Conclusions: This analysis identified few patient demo-
graphics as continued barriers to a laparoscopic
approach. Initial analysis does confirm open surgical
techniques are reserved for patients deemed more criti-
cally ill, using ASA as a surrogate marker. The inci-
dence of formal lobar resection was aslo significantly
different indicating large atypical resections are most
often reserved for an open approach. This study dem-
onstrates that some barriers to a laparoscopic approach
for liver resection are diminishing. Future studies are
necessary to delineate the persistent barriers for contin-
ued adaptation of the laparoscopic approach.
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PPL25-082
HEPATIC TUBERCULOMA:
DIAGNOSTIC DIFFICULTY
Badr Serji, Mohammed Ouazni, Abdelilah Belhachmi,
Amine Benkabbou, Hadj omar El malki, Raouf
Moshine, Lahcen Ifrine and Abdelkader Belkouchi
University Mohammed Vth Souissi Rabat Morocco,
Morocco
Introduction: Hepatic tuberculosis is seen in about
14% of abdominal localisation. It’s usually seen as a
secondary localisation of pulmonary or peritoneal
tuberculosis (80%). Levine described 6 entities of
liver involvement from wish tuberculoma poses the
problem of differential diagnosis with tumours. We
report 2 cases.
Method: Case 1: woman 55 years old, in diabetic diet,
treated on 1987 for pulmonary tuberculosis. The
patient underwent a thoraco abdominal CT for chronic
cough wish found a hepatic incidentaloma of 4 cm in
segment V. the patient had cytolysis without cholesta-
sis. Hepatic viral serology and tumour markers were
negatives. Percutaneous biopsy found epithlo€ıd granu-
loma without necrosis.
Case 2: man 66 years old, presenting 6 month before
it’s admission abdominal pain without vomiting, jaun-
dice or gastrointestinal bleeding. Abdominal ultraso-
nography showed hypo echogenic mass involving
segment VI and VII. Abdominal CT confirmed localisa-
tion and hypo density character. Percutaneous biopsy
wasn’t contributive. Tumour markers and hepatic viral
serology were negative. Gastroduodenoscopy and col-
poscopy showed no lesion.
Results: Case 1: after multidisciplinary staff with infec-
tious disease doctors, the decision to not start antibacil-
lary treatment was taken. We performed right
laparoscopic hepatectomy. Immediate outcomes were
uneventful. Histopathology exam showed epithlo€ıd
granuloma with caseous necrosis. Case 2: under right
subcostal incision, exploration found no gastro intesti-
nal tumour, there was a hepatic mass in segment VI
and VII. We performed bi segmentectomy VI and VII.
Ouctomes were simple. Histopathology showed epit-
hlo€ıd granuloma with caseous necrosis. The two
patients underwent antibacillary treatment.
Conclusions: Hepatic tuberculoma is very rare. Diag-
nostic is difficult mimicking hepatic tumour. Non-inva-
sive treatment is desirable when it’s possible.
PPL25-083
INITIAL EXPERIENCE WITH
LAPAROSCOPIC LIVER RESECTION IN
A DEVELOPING COUNTRY
Amine Benkabbou, Amine Souadka, Badr Serji, Hajar
Hachim, Hadj Omar El Malki, Raouf Mohsine, Lahsen
Ifrine and Abdelkader Belkouchi
Ibn Sina Hopital, Morocco
Introduction: Over past decades laparoscopic liver
resection (LLR) has gained wide acceptance among he-
patobiliary surgeons community. To date, few data are
available concerning LLR programs in developing
countries. This study aimed to assess feasibility and
safety of LLR in a Moroccan surgical unit.
Method: From June 2010 to February 2013, patients
that received LLR were identified from a prospective
“liver resection” database and included in this study.
Parenchymal transection was performed using Har-
monic scalpel and bipolar clamp with no Intraoperative
ultrasound use or systematic pedicle clamping. LLR
difficulty was categorized into 3categories according to
Louisville-statement (I–III). Demographic informations,
liver lesion informations, operative details, pathological
tumor-margin and 1-month postoperative morbidity
according to Clavien-Dindo(C-D) classification were
analyzed.
Results: Among 104 patients who underwent liver
resection 13 (12.5%) had LLR. There were 7 females
with mean age of 57.5  17 years. LLR was performed
for malignant lesions in 10 (77%) patients: hepatocarci-
noma in 7 patients and synchronous rectal-liver metas-
tasis in 3 patients. Lesions were solitary in 12 (92%)
patients with median size of 50 mm (15–150 mm).
Patients with liver metastasis received combined laparo-
scopic rectal and liver resection. We used pure laparo-
scopic approach in 12 (92%) patients and hybrid one
in 1 patient. LLR difficulty was category I, II and II in
respectively 3 (23%), 6 (46%) and 4 (31%) patients.
Conversion rate to open liver resection was 15%. Mean
blood loss was 395  270 minutes with no hepatic ped-
icle clamping or peroperative blood transfusion. All
resections were tumor-free margin. Mortality rate was
nil and morbidity occurred in 4 (30%) patients: ascites
(C-D 2) and pelvic sepsis in combined resections (C-D
3b). Median hospital stay was 6 days.
Conclusions: Laparoscopic liver resection in Morocco
is safe in selected patients, since no operative mortality,
blood transfusion requirement or palliative resection
was recorded and liver related morbidity rate was low.
Intraoperative ultrasound liver examination capacities
are mandatory to improve laparoscopic liver resection
program’s quality and extend indications.
PPL25-084
TACE COMBINED WITH SORAFENIB
ON POSTOPERATIVE INTRAHEPATIC
RECURRENCE OF HEPATOCELLULAR
CARCINOMA
Zhiwei Sun, Xin Wang, Kung Dong and Tin Wang
The First People’s Hospital of Yunnan Province, China
Introduction: To study the clinical effect of transcathe-
ter arterial chemoembolization (TACE) combined with
sorafenib on postoperative intrahepatic recurrence of
hepatocellular carcinoma.
Method: Since July 2009, 3 postoperative intrahepatic
recurrence of hepatocellular carcinoma patients were
treated with TACE and orally sorafenib at a dose of
400 mg twice daily more than 6 months, ECOG score
0–2, Child–Pugh A–B. All patients by imaging evalua-
tion and liver function evaluation had no TACE treat-
ment contraindications. Adjust the dosage according to
the occurrence of adverse reactions in the treatment
process. The tumor response was evaluated the efficacy
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and adverse reactions according to the modified solid
tumor evaluation criteria (mRECIST) every 2 months,
and then the clinical efficacy and quality of life would
be evaluated.
Results: Three patients were alive since July 2009,
mRECIST evaluation in 1 PR, 2 SD. The main treat-
ment-related adverse events were hand-foot syndrome,
diarrhea and hypertension, symptomatic treatment and
reduction of medication can be alleviated.
Conclusions: Hepatocellular carcinoma in patients with
intrahepatic recurrence after TACE combined with so-
rafenib treatment does not increase the incidence of
complications, can significantly improve survival qual-
ity of life and longer survival time.
PPL25-085
INFLAMMATORY PSEUDOTUMOR OF
THE LIVER DIAGNOSED AS
METASTATIC LIVER TUMOR IN
PATIENT WITH A GASTROINTESTINAL
STROMAL TUMOR OF RECTUM: A
CASE REPORT
Yoichi Matsuo, Takahiro Shibata, Mamoru Morimoto,
Takafumi Sato, Tomoya Shamoto, Ken Tsuboi, Nobuo
Ochi, Hiroki Takahashi and Hiromitsu Takeyama
Nagoya City University Graduate School of Medical
Sciences, Japan
Introduction: Inflammatory pseudotumors (IPT) of the
liver are rare benign lesions characterized by proliferat-
ing fibrovascular tissue mixed with inflammatory cells.
A case of IPT of the liver found in association with a
malignant GIST of rectum was reported.
Method: A 74-year-old man was admitted to our hos-
pital for examination and surgical treatment of liver
tumor. His medical history revealed that he undergone
a sacroabdominal rectal amputation for malignant
GIST of rectum at the age of 65 years. CT scan
revealed a 14 mm low density area in segment 8 of the
liver. Contrast CT showed contrasting effect from the
peripheral portion. Dynamic contrast-enhanced MRI
(EOB-MRI) showed that tumor appears isointensity in
the arterial phase and was completely washed out in
the delayed phase and hepatobiliary phase. FDG-PET
showed strong uptake in the liver. Considering the
patient’s history, combined with the radiological find-
ings of the tumors, a diagnosis of liver metastasis from
malignant rectal GIST was made and partial hepatec-
tomy was performed.
Results: Microscopic examination of the paraffin sec-
tion of the liver tumor showed that it was composed of
fascicles of spindle fibroblasts and myofibroblasts
admixed with chronic inflammatory cells. The overall
pathological features were those of an IPT of the liver.
Conclusions: IPT was rarely found in the liver. More-
over, only four cases of the liver IPT in associated with
GIST were reported. Stomach, duodenum, small intes-
tine, and rectum (our case) are one case each, and metas-
tasis from GIST was pre-diagnosed in all cases.
Differential diagnosis between IPT and malignant neo-
plasms by imaging methods is difficult, because heteroge-
neity of CT findings is also often observed in malignant
tumors. Furthermore, in our case, FDG-PET revealed
the strong uptake of the tumor. So all four cases were
underwent hepatectomy. Herein, our patient is discussed
along with references from the literature.
PPL25-086
SORAFENIB IN ADVANCED
HEPATOCELLULAR CARCINOMA
WITH HBV INFECTION
Zhen Huang, Hong Zhao, Xinyu Bi, Jianjun Zhao,
Cong Li and Jianqiang Cai
Surgeon, China
Introduction: To evaluate the effect and safety of
molecularly targeted agent sorafenib in advanced hepa-
tocellular carcinoma with HBV infection.
Method: From April 2007 to February 2010, 81
advanced hepatocelluar carcinoma patients with HBV
infection were treat with sorafenib at a dose of 400 mg
twice daily.
Results: The overall incidence of treatment-related
adverse events was 84.8%. The most common adverse
events were hand-foot skin reaction, diarrhea and
hypertension. There was no grade IV adverse events
and no discontinuation of the drug due to sever
adverse events. The median overall survival time is
72 weeks and the median time to progression is
66 weeks.
Conclusions: Sorafenib prolongs the overall survival
and the time to progression of patients with advanced
hepatocelluar carcinoma, with no sever adverse events.
Prevention of adverse events and immunotherapy can
improve the effect.
PPL25-087
DIAGNOSIS AND TREATMENT OF
HEPATIC CYSTIC ECHINOCOCCOSIS
COMPANIED WITH DIGESTIVE TRACT
FISTULA
Haitao Li, Yingmei Shao, Ayifuhan Ahan, Tuergan
Aili, Bo Ran and Hao Wen
First Teaching Hospital of Xinjiang Medical University,
China
Introduction: Hepatic cystic echinococcosis (HCE) was
common zoonosis in pastoral areas, HCE could invade
hepatic surrounding organs and bring about relative
complications. When lesion of HCE were close to hol-
low organs, digestive tract fistula would take place. In
clinic, diagnosis and treatment for HCE companied
with digestive tract fistula were all very difficult, so, we
summed this kind of cases to analyze, hoped can draw
some helpful clinical lessons from these cases.
Method: Seventeen cases with hepatic cystic echinococ-
cosis accompanying digestive tract fistula were retro-
spectively analyzed in our hospital from 2008 to 2012.
All cases were examined with abdominal B ultrasound
check and CT scan for diagnosis before surgery, and
were done operation to confirm diagnosis. Different
treatment such as anti-infection therapy, nutrition sur-
port therapy and the local drainage for fistula in differ-
ent organs after surgery.
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Results: In total of 17 cases, 9 cases were complicated
with fistula of colon, 5 cases were complicated with
gastric fistula, 3 cases complicated with fistula of duo-
denum. 15 cases were cured after surgery, but 2 cases
with colonic fistula dead after surgery for severe infec-
tion. The surgery for hepatic echinococcosis compli-
cated with fistula of hollow organs was very difficult,
especially for colonic fistula. It was very important for
keeping drainage unobstructed beside fistula. But, local
colectomy should be considered if preoperative prepa-
ration of a fully. It was relatively easy for treating gas-
tric and duodenal fistula. Patients usually could be
cured after repair for fistula based on gastrointestional
decompression and postoperative enteral and parenteral
nutrition support.
Conclusions: Surgery was ideal that radical incision for
fistula was done when cystic echinococcosis was trea-
ted. Otherwise, continuous flow fistula mouth drainage
after surgery should be keep, with nutrition support,
fistula should close as possible as quickly. Only when
such comprehensive therapy could be done, the life of
patients should be saved.
PPL25-088
THE STUDY OF THE
IMMUNOLOGICAL CHANGES OF
SPLEEN DURING THE DEVELOPMENT
OF SEPSIS
Haiyan Chen2, Na Huang2, Fanpu Ji2, Rui Zhou1,
Baohua Li2, An Jiang1, Ke Li2 and Zongfang LI1
1The Second Affiliated Hospital, School of Medicine,
Xi’an Jiaotong University, China; 2The Second Affiliated
Hospital, School of Medicine, China
Introduction: To observe the pathological and immune
status change of spleen in septic rats, exploring the role
of spleen in the development and progression of sepsis
for the pathophysiology research of sepsis.
Method: We used 200  10 g SD male rats to establish
normal group, sham operation group, CLP group,
meanwhile set 6, 12, 24 hours three time points to
observe. Sepsis model was prepared by cecal ligation
and puncture (CLP). HE staining was used to observe
the histological changes of spleen; TUNEL was used to
detect the apoptosis in rat spleen; using flow cytometry
to detect percentage changes of T lymphocytes different
type in peripheral blood and spleen (CD4+ T cells,
CD8+ T cells and Treg cells).
Results: CLP group compared with the normal group,
increased spleen weight, spleen index increased; white
pulp and hyperplasia of lymphoid nodules, especially
arterial peripheral lymphoid sheath was significant
thickened in 24 hours group, there was ill-defined
between white pulp and red pulp. Normal group and
sham group had no significant difference, and occasion-
ally were few apoptotic cells; CLP group had increasing
number of apoptotic cells, and 12 hours group began
with a very significant difference (p < 0.01). Comparing
with normal group, the CD4+ T cell proportion of
CLP group at all time points in peripheral blood were
highly significant reduction (p < 0.01); and the propor-
tion of Treg cells was increased significantly in
24 hours group (p < 0.05). In the spleen, the ratio of
different T lymphocytes types in CLP group were ris-
ing, including the difference of CD4+ T cells in
24 hours group was significant (p < 0.01) and Treg cells
in 12 hours group also has a significant difference in
the increase (p < 0.05).
Conclusions: The changes of the immune status in early
sepsis may be associated with the increasing ratio of T
lymphocytes and increased apoptosis in the spleen.
PPL25-089
CLINICAL OBSERVATION OF
SORAFENIB TOGETHER WITH TACE
IN ADVANCED HEPATOCELLULAR
CARCINOMA WITH NO EXTRAHEPA
TIC METASTASI
Xinyu Bi, Jianjun Zhao, Hong Zhao and Jianqiang Cai
Surgeon, China
Introduction: To evaluate the efficacy and safety of
molecular targeted agent sorafenib together with TACE
in advanced hepatocellular carcinoma without extrahe-
patic metastasis.
Method: From April 2007 to September 2009, 45
advanced hepatocelluar carcinoma patients without
extrahepatic metastasis were orally treated with sorafe-
nib at a dose of 400 mg twice daily. Among them, 18
patients were treated with TACE (125 times).
Results: The most common adverse events in both group
s were hand foot skin reaction, diarrhea and hyperten-
sion. There were no grade 4 adverse events and no dis-
continuation of the drug due to severe adverse events in
both groups. The median overall survival time was
1610 months in sorafenib 2TACE group and
513 months in sofafenib group (p < 0101). The median
time to p rogression was 1010 months in sorafenib
2TACE group and 413 in sofafenib group (p < 0101).
Conclusions: TACE does not p romote the adverse
events in advanced hepatocelluar carcinoma without
extrahepatic metastasis treated with sorafenib. Sorafe-
nib combind with TACE prolongs the median overall
survival time and the time to progression in these
patients.
PPL25-090
IMPACT OF VIRAL HEPATITIS ON
OUTCOMES AFTER LIVER RESECTION
FOR HEPATOCELLULAR CARCINOMA:
RESULTS FROM A NORTH AMERICAN
CENTER
Rory Smoot, Jonghun Lee, Peter Kim, Scott Fung,
Steven Gallinger, Ian McGilvray, Carol-anne Moulton,
Alice Wei, Paul Greig and Sean Cleary
University of Toronto, Canada
Introduction: Hepatitis B (HBV) and hepatitis C
(HCV) are well-recognized risk factors for hepatocellu-
lar carcinoma (HCC). The characteristics and clinical
outcomes of HCC arising from these conditions may
differ. This study was conducted to compare the out-
comes of HCC associated with HBV and HCV after
liver resection.
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Method: Of 386 liver resections for HCC performed
between July 1992 and April 2011, 181 patients had
HBV and 74 patients had HCV. Patients with HBV/
HCV co-infections (n = 20), non-HBV/HCV etiology
(n = 94) and post-operative death within 3 months
(n = 17) were excluded. Patient, tumor characteristics,
peri-operative and oncologic outcomes were compared
between patients with HBV and HCV.
Results: The patients with HBV had better overall sur-
vival than patients with HCV (68 months vs
59 months, p = 0.03); however, there was no difference
in recurrence-free survival between the groups
(44 months vs 45 months, p = 0.1). The factors predic-
tive of overall survival based on multivariate analyses
included: vascular invasion (p < 0.01, HR = 3.4),
Child–Pugh score (p < 0.01, HR = 4.8), and underlying
liver disease (HCV vs HBV) (p = 0.01, HR = 1.9). Vas-
cular invasion and tumor number (p < 0.01, HR = 2.3
and p < 0.01, HR = 2.1) were independent predictors
of recurrence-free survival.
Conclusions: Overall survival but not recurrence-free
survival after liver resection for HCC is better in
patients with HBV than HCV. This survival advantage
for HBV patients may be due to differences in tumor
biology and outcomes after disease recurrence.
PPL25-091
ENHANCED EXPRESSION OF TISSUE
FACTOR IN PORTAL VEIN OF LIVER
CIRRHOTIC PATIENTS WITH PORTAL
VEIN THROMBOSIS
Yansong Pu1, An Jiang1, Hong Ji1, Song Ren1, Kunlun
Chen1, Jiangwei Li1, Jun Yang2 and Zongfang Li1
1The Second Affiliated Hospital, School of Medicine,
Xi’an Jiaotong University, China; 2the Second Affiliated
Hospital, School of Medicine, China
Introduction: Despite coagulation is defective in cir-
rhotic patients, the occurrence of portal vein thrombo-
sis (PVT) is still high. The mechanism leading to PVT
is unclear so far. Thrombosis that occur in the veins
commonly result from vascular injury. Recent studies
suggest that pathologic expression of tissue factor (TF)
within the injured vessel wall may trigger thrombosis.
We aimed to determine the expression and mechanism
of TF in portal vein of cirrhotic patients with PVT.
Method: We examined the expression of TF in portal
vein in cirrhotic patients (n = 34) and splenic rupture
patients (control group, n = 12) by immunohistochemi-
cal staining and real-time PCR. The cirrhotic patients
were classified into PVT group (n = 10) and non-PVT
group (n = 24). The expression and activity of NF-jB
p65 and c-Rel were examined by immunohistochemical
staining.
Results: The result of real-time PCR and immunohisto-
chemical staining showed that expression of TF in por-
tal vein of cirrhosis group were significantly higher
than control group (all p < 0.05). In cirrhosis group,
the protein level of TF in PVT group was also signifi-
cantly higher than non-PVT group (p < 0.05). Immu-
nohistochemistry revealed the expression of p65 and
c-Rel in portal vein of cirrhosis group were stronger
than control group (all p < 0.01). The positive signal
for p65 and c-Rel were observed in nucleus of endothe-
lial cells in portal vein of cirrhotic patients, while in
cytoplasm of endothelial cells of control group.
Conclusions: The results indicated that up-expression
of TF in local portal vein endothelial tissue may
increase the risk of PVT in cirrhosis. The translocation
of NF-jB p65 and c-Rel from the cytoplasm to the
nucleus may activate the expression of TF in portal
vein.
PPL25-092
ELIMINATING THE LEARNING CURVE
FOR LAPAROSCOPIC HEPATECTOMY
David Worhunsky, Monica Dua, Bernard Siu, George
Poultsides, Jeffrey Norton and Brendan Visser
Stanford University Medical Center, USA
Introduction: Laparoscopic liver resection (LLR)
merges experience and understanding in open liver sur-
gery with minimally invasive technical skills. This study
reflects the experience of a single hepatobiliary surgeon
with no formal training in laparoscopic liver surgery
and examines the possible learning curve associated
with LLR.
Method: Patients undergoing LLR by a single surgeon
between 2007 and 2013 were reviewed. Laparoscopic
procedure volume was compared to concurrent open
procedures. Consecutive cases were analyzed by aca-
demic year, terciles and quartiles to identify patterns in
patient selection, intraoperative characteristics and
postoperative complications.
Results: A total of 120 LLR were performed for both
benign (14%) and malignant tumors (86%). Resections
included sub-segmentectomies or segmentectomies (72),
bisegmentectomies (30), caudate resections (1), as well
as left (8), right (8) and extended hepatectomies (2).
The mean ASA of the cohort was 2.8 (SD: 0.5); 36
patients (30%) had a history of cirrhosis and 49 (41%)
had a tumor size > 30 mm. Total liver procedures per-
formed increased throughout the study period; however
the annual ratio of LLR to open procedures remained
relatively constant around 35%. Only two patients
required conversion to open surgery. There was a grad-
ual increase in case complexity; however, operative
times still progressively decreased (mean 285 vs 218 vs
209 minutes, by tercile). Even after division of the
cohort into annual, tercile and quartile groups, intra-
operative blood loss, transfusion requirements, hepatic-
related complications, overall morbidity and length of
stay were not significantly different.
Conclusions: The introduction and maintenance of
LLR into a hepatobiliary practice can be safely accom-
plished with limited morbidity and low conversion
rates. There were no significant outcome differences
throughout the study period, even at the onset of the
surgeon’s experience. The assumed learning curve asso-
ciated with the adoption of minimally invasive liver
surgery can be overcome with appropriate patient selec-
tion and gradual progression of case complexity.
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PPL25-093
CTLA-4IG INCREASES EXPRESSION OF
CD4+ CD25+ FOXP3+ TREG CELLS IN
THE SPLEEN AND PERIPHERAL
BLOOD DURING PREGNANCY IN
ABORTED MODEL OF MICE
Qing Gao, Mu Li, Shu Zhang, Haiyan Chen,
Baohua Li, Na Huang, Chen Huang and Zongfang
Li
The Second Affiliated Hospital, School of Medicine,
Xi’an Jiaotong University, China
Introduction: To investigate the effects after the admin-
istration of cytotoxic T lymphocyte-associated antigen-
4 immunoglobulin (CTLA-4Ig) for the abortion-prone
mice and the change of the Treg cells in them.
Method: Using CBA/J9DBA/2 matings as an abor-
tion-prone model, FACS was used to detect Treg cell
in the normal mice and aborted model mice duration
early-middle pregnancy, and also detected Treg cell
after CTLA-4Ig or PBS administration in each of them,
western blot and RT-PCR was use to detect the expres-
sion of Foxp3 in all the group, pregnancy outcomes
were analyzed after the mice are sacrificed at the day
14 of pregnancy.
Results: Treg cells continually increased duration of
early-middle pregnancy in the normal mice and aborted
model mice, the number of Treg cell, the level of Foxp3
was higher in the normal mice than in the aborted
model mice in spleen and peripheral blood, the preg-
nancy outcome is also better in the normal group than
the aborted group, after CTLA-4Ig administration
(10 mg/kg), the number of Treg cell, the level of Foxp3
increased in the treatment group than in the control
group, the similar changes were also found in spleens
of these groups.
Conclusions: CTLA-4Ig administration could increase
the Treg cell expression in the aborted model mice and
improve the pregnancy outcome, it could be a novel
therapy for human RSA.
PPL25-094
EVALUATION OF EIGHT DIFFERENT
CLINICAL STAGING SYSTEMS
ASSOCIATED WITH OVERALL
SURVIVAL OF CHINESE PATIENTS
WITH HEPATOCELLULAR
CARCINOMA
Yan Tao, Bi Xinyu, Zhao Hong, Zhou Jianguo, Huang
Zhen, Zhang Yefan, Zhao Jianjun, Li Zhiyu and Cai
Jianqiang
Cancer Hospital, Chinese Academy of Medical Science
& Peking Union Medical College, China
Introduction: Hepatocellular carcinoma (HCC) is a
common cancer in China, an area of high hepatitis B
virus (HBV) infection. Although several staging systems
are available, there is no consensus on the best classifi-
cation to use because multiple factors, such as etiology,
clinical treatment and populations could affect the sur-
vival of HCC patients.
Method: This study analyzed 743 HBV-related Chinese
HCC patients who received surgery first and evaluated
the predictive values of eight different commonly used
staging systems in clinic.
Results: The overall 1-, 3-, 5-year survival rates and a
median survival were 91.5%, 70.3%, 55.3% and
72 months respectively. BCLC staging systems had the
best stratification ability and showed the lowest AIC
values (2896.577), followed by TNM7th
(AIC = 2899.980), TNM6th (AIC = 2902.17), JIS
(AIC = 2918.085), Tokyo (AIC = 2938.822), CLIP
(AIC = 2941.950), CUPI (AIC = 2962.027), and Okuda
(AIC = 2979.389).
Conclusions: BCLC staging system is a better staging
model for HBV infection patients with HCC in Chinese
population among the eight currently used staging sys-
tems. These identifications afford a large group of Chi-
nese HCC patients with HBV infection and could be
helpful to design a new staging system for a certain
population.
PPL25-095
HEPATIC PERIVASCULAR
EPITHELOID TUMOR (PECOMA): CASE
REPORT
Abdaal Khan, Arsalan Khan, Shah Mohammad, Syed
Raza, Mohammad Ishaq, Mohammad Mubarak and
Javed Kazi
Sindh Institute of Urology and Transplantation, Pakistan
Introduction: Primary perivascular epithelioid cell
tumor (PEComa) of the liver has recently been
described mainly in children and young adults. It
belongs to the family of tumours which comprises an-
giomyolipoma and clear cell “sugar” tumor of lung.
Immunohistochemistry of this tumor is positive for
melanoma markers (Mart-1, HMB-45) and those of
smooth muscle (actin). We report a case of an unusu-
ally large (19 9 11 cm) hepatic PEComa in a 43 year
woman.
Method: Case Report: 43-year-old mother, with no
known co-morbids, underwent investigation for general
weakness. She was found to have a multilobulated heter-
ogeneous lesion almost replacing the right lobe and
extending to segment 4. There was enhancement in arte-
rial phase and early washout in venous phase of CT-
scan. IVC and Rt. hepatic vein appeared compressed.
Left lobe vascular structures were pushed by the expan-
sive growth. Segment 2 and 3 appeared grossly hypertro-
phied pushing the spleen inferiorly. Hb 9.3 G/dL, T Bil
1.13 mg/dL (direct 0.18), alkaline phosphatase 1324,
GGT 89, ALT 15, INR 1.0. Hepatitis serology was nega-
tive and normal AFP and CA 19-9. Chest CT and bone
scan were negative for metastasis.
Results: She underwent extended right hepatectomy via
a right thoracoabdominal approach. Post-operative
course was uneventful. Histopathology revealed a well
circumscribed, unencapsulated dark brown mass
(19 9 11 cm) with extensive areas of hemorrhages. It
was composed of nests and sheets of epitheloid cells
surrounding the sinusoidal like vascular channels.
Occasional mitosis was seen. IHC showed typical phe-
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notype of PEComa (positivity of HMB-45, Mart-1,
actin, caldesmon and myosin) and negative for
CKAE1/AE3, EMA, synaptophysin, chromogranin,
CD31, CD34, Hepar 1, AFP, S100, LCA, S100, CD56,
CD1A, CD30 and vimentin.
Conclusions: PEComa should also be considered in the
differential diagnosis of large vascular liver lesions.
PPL25-096
REAPPRAISAL OF SEQUENTIAL
PREOPERATIVE IPSILATERAL
HEPATIC VEIN EMBOLIZATION AFTER
PORTAL VEIN EMBOLIZATION TO
INDUCE FURTHER LIVER
REGENERATION IN PATIENTS WITH
HEPATOBILIARY MALIGNANCY
Bo Hyun Jung, Shin Hwang, Deok Bog Moon, Chul
Soo Ahn, Ki Hun Kim, Tae Yong Ha, Gi Won Song,
Dong Hwan Jung and Sung Gyu Lee
Asan Medical Center,Ulsan University, Korea
Introduction: Portal vein embolization (PVE) induces
shrinkage of the embolized lobe and compensatory
enlargement of the non-embolized lobe, but it does not
always induce sufficient liver regeneration. There was
no effective method to accelerate liver regeneration in
addition to PVE yet. The preliminary experience of first
12 cases on the effect of ipsilateral hepatic vein emboli-
zation (HVE) performed after PVE was presented
before, but no large-volume study was presented yet.
We herein present our 29 cases of experience regarding
on PVE-HVE.
Method: During a 5-year study period, preoperative
HVE were performed on 29 patients who had shown
limited liver regeneration after PVE awaiting major
hepatectomy (right hepatectomy, n = 28; left hepatecto-
mym n = 1). The right or left hepatic vein was embol-
ized with multiple coils after insertion of vascular
plugs.
Results: The primary diseases were hilar bile duct can-
cer in 22, hepatocellular carcinoma in 4, intrahepatic
cholangiocarcinoma in 2, and gallbladder cancer in 1.
No HVE procedure-related complications occurred, but
embolization of the wrong hepatic vein trunk occurred
in 2 patients, in whom intended operation was can-
celled in 1 and additional right HVE was performed in
1. The increase in blood liver enzymes after HVE was
comparable to that after PVE alone. In 24 patients
who underwent right hepatectomy, the proportions of
future liver remnant volume to total liver volume
increased further after HVE. Cirrotic livers showed
lower regeneration rates following HVE after PVE.
Preplanned surgery intending curative resection was
successfully performed in 25, but 4 patients underwent
palliative surgery (n = 1) and no operation (n = 3).
Conclusions: This study confirmed that preoperative
sequential application of PVE and HVE is safe and
effective in facilitating contralateral liver regeneration
by inducing more severe liver damage than PVE alone.
PPL25-097
PARENCHYMA-PRESERVING
HEPATECTOMY FOR PERIHILAR
CHOLANGIOCARCINOMA
Hyung Woo Park, Shin Hwang and SungGyu Lee
Asan Medical Center, Ulsan University, Korea
Introduction: Both curative resection and acceptably
low perioperative mortality offer the chance of long-
term survival in patients with hilar cholangiocarcinoma.
The resectability rate for hilar cholangiocarcinoma has
increased through concurrent major hepatectomies, but
these procedures are technically demanding and often
associated with serious complications. Parenchyma-pre-
serving limited hepatectomy (PPLH) has a definite
merit on patient safety, but surgical procedure becomes
more complex.
Method: PPLH was performed in 13 patients with
advanced perihilar cholangiocarcinoma by a single sur-
geon. Their medical records were analyzed retrospec-
tively.
Results: The types of PPLH included resection of
S4 + 1 (n = 8), S5 + 4a+1 (n = 2), S5 + 4+1 (n = 2)
and isolated S1 (n = 1). R0 resection was achieved in
10 patients. Pylorus-preserving pancreatectomy and
extended bile duct resection with excavation of the in-
trapancreatic bile duct was performed in 3 and 4 cases,
respectively. There was neither mortality nor major
morbidity, but prolongation of minor bile leak up to
1 month was observed in 3 patients. Their 5-year sur-
vival rate was around 40%, which is quite similar to
47% in our R0 major hepatectomy group (n = 214).
Two significant risk factors affecting survival after
resection were lymph node metastasis and curability of
surgery.
Conclusions: Major hepatectomy offers an improved
survival with a higher possibility of curative resection
than PPLH, but it still carries a risk of non-negligible
major morbidity and mortality. Less extensive proce-
dures can be conducted safely and beneficially for old-
aged patients with poor general condition and less
advanced tumor stage if tumor-free resection margins
are obtainable.
PPL25-098
EPSTEIN-BARR VIRUS ASSOCIATED
FULMINANT HEPATITIS REQUIRING
LIVER TRANSPLANTATION (CASE
REPORT)
Hyungwoo Park, Shin Hwang and Sunggyu Lee
Asan Medical Center, Ulsan University, Korea
Introduction: Epstein-Barr virus (EBV) is one of the
most common viruses, infecting more than 90% of
humans. Whereas most EBV primary infections of
infants and children are asymptomatic or have nonspe-
cific symptoms, infections of adolescents and young
adults frequently result in symptomatic infectious
mononucleosis.
Method: We report a case of fulminant hepatitis
related to a primary EBV infection in an immunocom-
petent 19-year-old male.
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Results: A previously healthy 19-year-old male devel-
oped a flu-like syndrome. A week after, the patient
present myalgia, chilling, and jaundice. He was admit-
ted to medical icu. On admission, he was febrile, icteric.
The serum ALT level was 3083 IU/L and AST level
was 1796 IU/L suggesting an acute hepatitis. Abdomi-
nal CT revealed hepatosplenomegaly without biliary
obstruction. The following day, the patient showed loss
of consciousness with acute renal failure. Mechanical
ventilation and extra-renal support were urgently
applied. Results of blood tests for hepatitis A, B, C,
and E viruses were not indicative of prior or current
infection. The serum EBV-VCA antibody were positive,
the EBV nuclear antigen antibody IgG was also posi-
tive which suggested recent primary EBV infection.
He was put on liver transplant waiting list. Two days
after, he underwent orthotropic liver transplantation.
The study of extracted liver specimen showed positive
for EBV PCR. After liver transplantation, he recovered
after an uneventful course of 26 days.
Conclusions: Sporadic cases of acute liver failure
caused by primary EBV infection have been reported in
the literature, with an overall mortality of 87%. We
report the case of a young patient who developed ful-
minant hepatitis immediately following EBV primary
infection. In addition to common blood tests, the detec-
tion of EBV antibody must be considered in any young
boy developing an acute onset of hepatitis after a flu-
like syndrome, without obvious toxic or auto-immune
cause. Our patient underwent emergent liver transplan-
tation and he recovered well.
PPL25-099
PATTERNS OF CLINICAL
PRESENTATION AND OUTCOME OF
BUDD CHIARI SYNDROME:
EXPERIENCE FROM A TERTIARY
CARE HOSPITAL IN PAKISTAN
Dr Abbas Tasleem, Ghous Bux Soomro and Zaigham
Abbas
College of Physion and Surgeon, Pakistan
Introduction: Budd Chiari Syndrome (BCS) is charac-
terized by hepatic venous outflow obstruction at level
of hepatic veins (HV), intrahepatic or suprahepatic
inferior vena cava (IVC). The aim of this study was to
determine etiology, clinical presentation and outcome
of BCS.
Method: In this observational study, patients diagnosed
as BCS were evaluated for the cause, clinical presenta-
tion and outcome. Log rank test and Cox regression
analysis was performed to identify independent predic-
tors of survival.
Results: Twenty two patients presented with BCS;
males 14, age range: 2–50 years (mean 14.9). Fourteen
(63.6%) belonged to pediatric age group. Presentation
was chronic in 59.1%, acute in 36.3% and acute on
chronic in 4.5% patients. Commonest morphological
abnormality involved HV in 50% followed by HV and
IVC in 31.8% patients. Probable etiologies were hyper-
coagulable states in 18, infections in 2 and malignancy
in 1 patient. Among hypercoagulable states, protein C
deficiency was commonest (44.4%). Seven (35%)
patients died; acute 4 and chronic 3. Causes of death
included sepsis 4, fulminant hepatic failure 1, GI bleed-
ing 1, and bleeding from site of liver biopsy 1. Poor
survival was associated with serum albumin <2.8 g/dL
(p = 0.022), bilirubin >5 mg/dL (p = 0.025), and
absence of varices (p = 0.015). Cox regression analysis
showed that low albumin and absence of varices were
independent predictors of poor survival.
Conclusions: BCS affected young patients more fre-
quently and was associated with high mortality. The
commonest etiology was hypercoagulable state. Sur-
vival was poor in patients with acute course suggested
by high bilirubin, absent varices and low albumin level.
PPL25-100
CLINICAL FEATURES AND
PROGNOSIS OF LIVER METASTASIS
FOR COLORECTAL CANCER:
CENTRALLY VERSUS PERIPHERALLY
LOCATED LESION
I-Ming Kuo, Tsung-Han Wu, Jy-Ming Chiang, Kun-
Ming Chan, Jinn-Shiun Chen and Ming-Chin Yu
Chang Gung Memorial Hospital, linkou Branch, Taiwan
Introduction: Liver resection provides long-term sur-
vival for patients with colorectal metastases. However,
controversies exist regarding the prognostic factors.
Herein, the impact of centrally located liver metastasis
on the clinical features and prognosis were evaluated.
Method: One hundred and fifty-nine patients who
underwent liver resection with curative intent for colo-
rectal liver metastasis between October 1991 and
December 2006 were enrolled. Patients were divided
into two groups: centrally located and peripherally
located colorectal liver metastasis. Patient demograph-
ics, the characteristics of the primary and metastatic
tumors, surgical outcomes, and long-term survival were
analyzed.
Results: Compared to the peripherally located group,
patients in the centrally located group showed domi-
nant in multiple metastases (p = 0.016), multiple
involved segments (p = 0.006), large metastatic lesion
(p = 0.000), and bilobar distributed metastases
(p = 0.000). The estimated 5-year recurrence-free and
overall survival rates were 22.4% and 34.2%, respec-
tively. Univariate analysis indicated that centrally
located metastasis, primary tumor of transverse colon,
positive regional lymph node metastasis, primary extra-
hepatic metastasis, synchronous liver metastasis, multi-
ple and poorly differentiation of metastatic lesions, and
hepatectomy with section margin <10 mm were prog-
nostic factors for worse recurrence-free survival and
overall survival. In addition, the advanced stage of the
primary tumor, primary tumor with obstruction or per-
foration, multiple involved segments, lesion over 5 cm
in diameter, and recurrence at extrahepatic or extrapul-
monary regions were significant prognostic factors for
overall survival alone. Multivariate analysis revealed
that inadequate section margin of liver resection and
centrally located liver metastasis were indicators for a
worse overall survival.
Conclusions: Colorectal cancer with centrally located
liver metastasis represents a prognostic factor after hep-
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atectomy is a significantly independent factor correlated
to poor long-term survival and results in early recur-
rence. Neoadjuvant chemotherapy for downstage of the
centrally located liver metastases to improve the resect-
ability is a considerable management.
PPL25-101
EXTENDED HEPATECTOMIES CAN BE
PERFORMED WITH MINIMAL
MORBIDITY AND MORTALITY
Eugenia Ip, Paul Bergamin, Jasmine Wong, Tim
Stavarkis and Koroush Haghighi
The Prince of Wales Hospital, Australia
Introduction: Extended hepatectomies are defined as
resection of four or more segments, and are reported to
be associated with increased morbidity and mortality.
Our study aims to compare morbidity and mortality of
extended and non-extended hepatectomies.
Method: All hepatectomies performed by a single sur-
geon (KS Haghighi) at 2 centres between January 2007
and July 2013 were identified. Prospectively collected
data on patient demographics, and postoperative com-
plications (Dindo-Clavien classification) were retrospec-
tively analysed between patients who underwent
extended (G1) and non-extended resections (G2).
Results: Three hundred and sixty-four hepatectomies
were performed between January 2007 and July 2013,
with 188 and 176 patients in G1 and G2. G1 had a
median age of 64 years (range 16–88) and G2 had a
median age of 60 years (range 18–93), with G1 consid-
erably older with 20.2% (n = 38) aged >75 years com-
pared to 12.5% (n = 22) in G2. Within G1, extended
right-sided resections were most common (n = 128).
Within G1, 64, 20 and 10 patients underwent neoadju-
vant chemotherapy, downstaging chemotherapy and
redo resections for recurrent disease respectively. Intra-
operative blood loss was higher in G1 (median 350 mL
vs 150 mL), and 22% (n = 43) of patients were trans-
fused a median of 2 units compared to 7.9% (n = 14)
of patients in G2 transfused a median of 2 units.
Length of HDU/ICU and hospital stay was longer in
G1 (n = 1 and 9 respectively) compared with G2 (n = 1
and 7 respectively). Major complications were experi-
enced in 3.7% and 5.1% patients in Groups 1 and 2
respectively, including radiological guided drainage of
biliary collections (n = ), IVC filter for pulmonary em-
boli (n = 1) and return to surgery (n = ). Mortality at
90 days was 1.6% (n = 3) and 2.2% (n = 4) in G1 and
G2 respectively.
Conclusions: This audit demonstrates that extended
liver resections can be performed with acceptable mor-
bidity and mortality in comparison to non-extended
liver resections.
PPL25-102
LIVER RESECTIONS CAN BE SAFELY
PERFORMED IN THE ELDERLY
Jasmine Wong, Paul Bergamin, Eugenia Ip and
Koroush Haghighi
Prince of Wales Hospital, Australia
Introduction: There is an increased number of elderly
patients considered for hepatic resections due to an
increase in life expectancy. However, liver resection is
perceived to have a high morbidity (45–50%) and mor-
tality (4–8%) rate among the elderly. This study com-
pared the outcomes of liver resections in patients
younger than age 75 years with those 75 years and
older.
Method: This study retrospectively analysed a prospec-
tive database performed by a single surgeon (KSH) in
the Prince of Wales and St. Vincents Hospitals, Sydney,
Australia. 364 patients underwent liver resections from
Jan 2007 to July 2013. Outcomes of patients younger
than age 75 years were compared with those 75 years
and older.
Results: There are 305 patients who are <75 years old
(median 58.5, range 16–74) compared to 59 patients
≥75 years old (median 79, range 75–93). The mortality
rates for the younger and older groups are 1.3%
(n = 4) and 3.4% (n = 2) respectively. The major mor-
bidity rates are 5.6% (n = 17) for the <75 and 6.8%
(n = 4) for ≥75 group (Clavien-Dindo Class 3 and 4).
49% of patients in the younger group underwent
extended resections (≥4 segments) compared to 61% in
the older group. In the younger group, 15.4% patients
received intra-operative blood transfusions compared
to 13.6% in the older group. The median intraoperative
blood loss is 250 mL (range 10–5000) in the young and
250 mL (range 20–2000) in the elderly. The median
ICU stay was 1 day (range 0–7) for <75 and 1 day
(range 0–5) for ≥75 group. The median hospital stay
was 8 days (range 1–43) for <75 and 9 days (range 2–
36) for ≥75 group.
Conclusions: Our study demonstrates that liver resec-
tions can be safely performed in the elderly with
acceptable morbidity and mortality and age should not
be a contraindication to liver resections.
PPL25-103
EXTENDED HEPATECTOMIES CAN BE
PERFORMED WITH MINIMAL
MORBIDITY AND MORTALITY
Eugenia Ip, Paul Bergamin, Jasmine Wong, Tim
Stavarkis and Koroush Haghighi
The Prince of Wales Hospital, Sydney, Australia
Introduction: Extended hepatectomies are defined as
resection of four or more segments, and reported to be
associated with increased morbidity and mortality. Our
study aims to compare morbidity and mortality of
extended and non-extended hepatectomies.
Method: All hepatectomies performed by a single sur-
geon (KS Haghighi) at 2 centres between January 2007
and July 2013 were identified. Prospectively collected
data on patient demographics, intraoperative findings
and postoperative complications (Dindo-Clavien classi-
fication) were retrospectively analysed between patients
who underwent extended (G1) and non-extended resec-
tions (G2).
Results: Three hundred and sixty-four hepatectomies
were performed, with 188 and 176 patients in G1 and
2. G1 had a median age of 64 years (range 16–88), G2
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had a median age of 60 years (range 18–93), and G1
was considerably older with 20.2% (n = 38) aged
75 years and over compared to 12.5% (n = 22) in G2.
Within G1, right-sided resections were most common
(n = 128), with 68% involving more than the minimum
4 segments (n = 45). Within G1, 64, 20 and 10 patients
underwent neoadjuvant chemotherapy, downstaging
chemotherapy and redo resections for recurrent disease
respectively. Intraoperative blood loss was higher in G1
(median 350 mL vs 150 mL), and 22% (n = 43) of
patients transfused a median of 2 units compared to
7.9% (n = 14) of patients transfused a median of 2
units. Length of HDU/ICU and hospital stay was
longer in G1 (n = 1 and 9 respectively) compared with
G2 (n = 1 and 7 respectively). Major complications
were experienced in 3.7% and 5.1% patients in Groups
1 and 2 respectively, including radiological guided
drainage of biliary collections, IVC filter for pulmonary
emboli and return to surgery. Mortality at 90 days was
1.6% (n = 3) and 2.2% (n = 4) in G1 and 2 respec-
tively.
Conclusions: Our study demonstrates that extended
liver resections can be performed with acceptable mor-
bidity and mortality in comparison to non-extended
liver resections.
PPL25-104
LAPAROSCOPIC REPEATED LIVER
SURGERY: A FEASIBLE AND SAFE
PROCEDURE
Hadrien Tranchart, Cecilia Ceribelli, Dimitrios Tzanis,
Stefano Ferretti, Guillaume Pourcher, Niaz Devaquet
and Ibrahim Dagher
Antoine Beclere Hospital, France
Introduction: In recent years laparoscopic liver surgery
(LLS) has become a real alternative to open approach.
Only a few authors reported repeated hepatic resections
performed by laparoscopic approach. The aim of this
study is to report our experience of laparoscopic
repeated liver surgery (LRLS) and to evaluate the feasi-
bility and safety of this approach.
Method: Between January 1999 and December 2012,
140 patients underwent laparoscopic liver resection
(LLR). All patients who were treated by LRLS after
previous open or laparoscopic procedure were included
in this study. Demographic data, preoperative risk fac-
tors, operative variables, histological analysis and post-
operative course were recorded.
Results: Nine repeated procedures were performed.
The mean age was 54.8  16.6 (36–77) years. Two
patients had two redo LLR. The first hepatectomy was
performed by open approach in 2 patients (28%).
Mean time between first and secondary hepatic resec-
tion was 53.3 months and between secondary and third
hepatactomy was 24 months. One major hepatectomy
was performed (a right hepatectomy combined with a
right colectomy). Mean operative time was
101.2  43.6 (60–200) minutes and mean estimated
blood loss was 62.8  53 (0–150) mL. No patients
required transfusion. The only postoperative complica-
tion was an incisional abcess. Mortality was null. The
mean hospital stay was 4 days. Two patients underwent
a second LRLS. One had an early recurrence of HCC
on segment V at 6 months and was treated by LLR.
The second patient had a recurrence of biliary cyst at
4 months which was treated by cysts fenestration. The
postoperative course was uneventful.
Conclusions: Laparoscopic redo liver surgery is a safe
and feasible procedure for both benign and malignant
pathologies with good short term results. Further stud-
ies are needed to better evaluate the long term out-
come.
PPL25-105
USE OF PHARMACOLOGIC AGENTS
FOR MODULATION OF ISCHAEMIA-
REPERFUSION INJURY DURING
HEPATECTOMY: A QUESTIONNAIRE
OF THE LIVERMETSURVEY
INTERNATIONAL REGISTRY OF
HEPATIC SURGERY UNITS.
Santhalingam Jegatheeswaran, Paul Shuttleworth,
Saurabh Jamdar, Thomas Satyadas, Aali Sheen and
Ajith Siriwardena
Manchester Royal Infirmary, UK
Introduction: Ischaemia-reperfusion (IR) injury is an
important determinant of post-operative outcome after
liver resection. N-acetylcysteine (NAC) is used in par-
acetamol overdose and its role has been extended to
include hepatic protection after liver surgery. There is
little or no evidence to support such a role. This study
undertakes a questionnaire survey of liver surgery units
undertaking resection for colorectal hepatic metastases
to obtain an overview of current practice.
Method: A questionnaire was emailed to all 446 centres
of the Livermetsurvey, an international registry of units
treating colorectal liver metastasis. Permission was
obtained from the registry organization and an email
link to a short 10-question form was sent using survey
monkey. Questions addressed liver resection practice,
use of IR modifiers, preferential choice, mode of use
and views on the need for a randomized trial.
Results: The questionnaire was live for 8 weeks from
the 18th June 2013 and 85 (19%) replies were received.
Strategies used to avoid IR included avoidance of Prin-
gle 53 (74%), ischaemic pre-conditioning 20 (28%) and
pharmacologic agents 6 (8%). 52 (77%) further said
they never used pharmacologic agents to modify IR. Of
those who used pharmacologic agents NAC was used
by 8 (44%), with the majority using a fixed dose (inde-
pendent of body weight) and starting intervention post-
operatively and continuing until normalization of trans-
aminases. 56 (81%) felt that there should be a random-
ized trial of the use of NAC.
Conclusions: The results are not an official position
statement of livermetsurvey and the small response
sample could be influenced by participant bias. None-
theless, this is the first and largest questionnaire
overview of the use of NAC in liver surgery. The
results show that it is used by a minority of liver sur-
geons but that there is strong support for a randomized
evaluation.
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PPL25-106
DAY-CASE LAPAROSCOPIC LIVER
SURGERY
Hadrien Tranchart, Panagiotis Lainas, Dimitrios
Tzanis, Stefano Ferretti, Dominique Franco and
Ibrahim Dagher
Antoine Beclere Hospital, France
Introduction: Over the last decade, laparoscopic liver
surgery (LLS) has been increasingly performed
throughout the world. At the same time day-case sur-
gery has been developed in many countries to increase
patient satisfaction and reduce hospital costs. The aim
of this study is to report a first experience of day-case
minimally invasive liver surgery.
Method: Between 1999 and 2012, 141 patients under-
went LLS including 120 laparoscopic liver resections
(LLR) and 21 unroofing of simple hepatic cysts. All
consecutive patients that underwent day-case LLS were
included in this study.
Results: Twelve patients underwent outpatient LLS.
Indications were: hepatic cysts (n = 10, 83.3%), angi-
oma (n = 1, 8.3%) and focal nodular hyperplasia
(n = 1, 8.3%). Median operating time was 92 minutes
(range 50–240). There were no conversions to open sur-
gery. Median blood loss was 35 mL (range 20–
150 mL). There were no postoperative complications.
All patients were hospitalized in our day-surgery unit
and were discharged 5–7 hours after the end of surgery.
Median postoperative pain score (standard 10-point
visual analog scale) at hospital discharge was 2.5 (range
0–8). Median quality of life at initial postoperative visit
was 8 (range 6–10) and median cosmetic satisfaction at
initial postoperative visit was 8 (range 7–10).
Conclusions: This series supports that day-case LLS is
possible and safe in selected patients.
PPL25-107
MULTIVARIATE ANALYSIS OF RISK
FACTORS FOR POSTOPERATIVE
COMPLICATIONS AFTER
LAPAROSCOPIC LIVER RESECTION
Hadrien Tranchart, Martin Gaillard, Dimitrios Tzanis,
Stefano Ferretti, Guillaume Pourcher, Niaz Devaquet,
Dominique Franco and Ibrahim Dagher
Antoine Beclere Hospital, France
Introduction: The identification of modifiable perioper-
ative risk factors in patients undergoing laparoscopic
liver resection (LLR) should lead to a better selection
and to further improvement in outcomes. The aim of
this study was to determine the risk factors of morbid-
ity after laparoscopic liver surgery using multivariate
analysis on a prospective database.
Method: All patients who underwent elective LLR
between January 1999 and December 2012 were consid-
ered eligible for this study. Data were prospectively
recorded and retrospectively analyzed. Demographic
data, preoperative risk factors, operative variables, his-
tological analysis and postoperative course were
recorded. Multivariate analysis was carried out using
an unconditional logistic regression model expressed as
an odds ratio (OR).
Results: During this period, 140 patients underwent
LLR. There were 56 male (40%) and 84 women (60%)
with a mean age of 57.8  17 years. Major hepatec-
tomy was performed in 20 patients (18.2%). Mean
operative time was 209  119 minutes. Conversion was
necessary in 7 patients (5%). Mean length of stay was
6.7  8.3 days. The morbidity rate was 20.7%
(n = 29). The mortality rate was 3.5% (n = 5). Thirteen
factors were found to be risk factors for postoperative
complications: male sex, age, advanced age (>70 year
old), obesity, ASA score = 3, major hepatectomy,
malignant tumour, operative time, blood loss, blood
loss ≥ 300 mL, transfusion, length of stay and conver-
sion. Two independent risk factors for postoperative
complications were identified: malignant tumor
[OR = 9.8 (2.5–37.6); p = 0.001] and operative time
[OR = 1.008 (1.003–1.01); p = 0.001].
Conclusions: The only modifiable risk factor which was
independently associated to postoperative complication
after LLR was the operative time. Surgeons should try
to reduce the surgical duration even if conversion is
required especially when operating patients with malig-
nant tumor.
PPL25-108
ALTERNATIVE TREATMENT OPTIONS
IN COMPLICATED ECHINOCOCCOSIS.
Gregory Christodoulidis, Michael Spyridakis and
Konstantinos Tepetes
University Hospital of Larisa, Greece
Introduction: Echinococcal disease is a major health
problem for grazing countries. The profile of compli-
cated cases may be helpful in identifying the proper
type and time of treatment.
Method: The medical records of 13 patients who
underwent surgery for complicated liver hydatid disease
were retrospectively reviewed. Data collected included;
age, gender, co-morbidities, laboratory findings,
abdominal imaging modalities, performance of ERCP,
duration of hospitalization, type of surgery performed
and complications.
Results: The mean age was 56.3 years old and 10 were
males. Six patients had rupture of the cyst in the biliary
tree (RBT), 4 had simple communication (CBT) of the
cyst with the biliar tree, 2 had a broncho-biliary fistula
(BBF) while 1 had rupture of the cyst in the abdomen.
Bilirubin was increased in 1/6 RBT cases while cholo-
static enzymes were abnormal in 5/6 RBT cases and in
all CBT and BBF cases. U/S was diagnostic in 2/6
RBT cases and in 2/4 CBT cases. CT was diagnostic in
2/6 RBT cases, in 1/4 of CBT, in both BBF cases.
MRI/MRCP was diagnostic in 2/6 RBT cases and in 1/
2 BBF cases. ERCP pre-operatively was performed in
1/6 of RBT cases, in 1/4 of CBT cases and in all BBF
cases. Postoperative ERCP due to bile leakage was per-
formed in 2/6 RBT cases and in 2/4 CBT cases. Sur-
gery mainly performed was partial cystectomy,
common bile duct exploration, suture of the biliary tree
communication and omentoplasty (6/10). For BBF
partial cystectomy and suturing of the fistula was
performed.
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Conclusions: Complicated cases mainly include the rup-
ture in the biliary tree who may not present as acute
cholangiitis. Laboratory and imaging examinations
may be inconclusive and therefore diagnosis is estab-
lished either after multimodality imaging or intraopera-
tively. ERCP preoperatively may be of value in
decreasing the possibility for bile leakage postopera-
tively.
PPL25-109
ACUTE BUDD CHIARI DUE TO A
SIMPLE LIVER CYST – GOOD CYST
GONE BAD?
Jennifer Long, Hannah Vaughan-Williams, Joshua
Moorhouse, Harsheet Sethi and Nagappan Kumar
Cardiff Liver Unit, University Hospital Wales, Cardiff,
Wales, UK
Introduction: Simple liver cysts are common, rarely
causing significant morbidity or mortality. Budd Chiari
syndrome (BCS), caused by obstruction of hepatic
venous outflow, is the leading cause of post-sinusoidal
liver failure. We present a rare case of BCS caused by
a simple hepatic cyst.
Method: A 16 9 16 cm liver cyst was found on com-
puted tomography of a 66-year-old woman presenting
with abdominal pain and nausea. Cyst exerted mass
effect on portal vein bifurcation and almost complete
compression of the IVC. Shortly after admission
patient developed acute liver failure, with deranged
clotting and hepatic encephalopathy. She developed
multiorgan dysfunction requiring inotropic, ventilatory
and renal support on the intensive care unit (ICU).
Cardiac output studies showed a cardiac index of 1.4
(normal 2.5–4.0 L/min/m2).
Results: An emergency laparotomy with fenestration of
cyst and drainage of two litres of purulent material lead
to a full recovery. Cystic fluid aspirates taken intra-
operatively later confirmed no evidence of echinococus
on parasitology studies and cultured mixed coliforms.
The fibrous cyst wall contained inflammatory cells and
foci of hepatocytes with no evidence of malignancy,
confirming a simple liver cyst. Liver biopsies showed
severe, confluent, bridging necrosis in a predominantly
centrilobular distribution, with no evidence of paren-
chymal liver disease.
Conclusions: Acute BCS due to rapid compression of
all major hepatic veins leading to fulminant hepatic
failure is rare. Our case highlights a rare but clinically
significant complication of a simple liver cyst that clini-
cians should be aware of when managing these “inno-
cent” lesions.
PPL25-110
SYNCHRONOUS COLORECTAL AND
LIVER RESECTION IS SAFE: A SINGLE
SURGEON’S EXPERIENCES
Paul Bergamin, Eugenia Ip, Wong Jasmine and
Koroush Haghighi
The Prince of Wales Hospital, Sydney, Australia,
Australia
Introduction: The liver is the most common distant site
of metastasis from colorectal cancer (CRC), and is
commonly managed surgically. The timing of surgical
resection of primary colorectal disease and metastases
is controversial. This study will compare the morbidity
and mortality of synchronous and sequential resections
from a single surgeon at two Australian metropolitan
centres.
Method: We retrospectively reviewed our prospectively
collected database of liver resections performed by a
single surgeon (Haghighi KS) between January-2007
and July-2013. We calculated overall survival for CRC
patients who had synchronous resection or not at 1, 3
and 5 years. Patient demographics were compared.
Outcome measures where then compared for all liver
resections including hospital length of stay (LOS),
ICU/HDU LOS, blood loss, blood transfusion, surgical
mortality and complication rates (using clavien-dindo
classification).
Results: Three hundred and sixty-four liver resections
were performed, 144 for metastatic CRC. Twenty had
synchronous bowel and liver resection (group 1), these
were compared to 347 who had liver resection only
(group 2). Demographics between the groups were
comparable. Post-operative complications for all liver
resections was 20% for group 1 and 14% for group 2.
Hospital LOS (9 vs 9 days) and ICU/HDU LOS (1 vs
1 day) were the same. Blood loss was less in group 1
(150 mL vs 350 mL). Intra-operative transfusion rates
were 3/20 (15%) for group 1 and 57/347 (16%) for
group 2 and post-operative transfusion rates were 0/20
(0%) and 17/347 (5%). Of group 1 the proportion of
extended (>4 segments) resections was 6/20 (30%) and
for group 2 182/347 (52%). Within the 144 metastatic
CRC group, the one, three and 5-year survival figures
for the were 85%, 42%, 42% for the synchronous
resection group and 94%, 71% and 44% for the non-
synchronous group.
Conclusions: Synchronous colorectal and liver resection
is safe, efficient and has comparable mortality and mor-
bidity when compared to staged liver and colorectal
resections when less than four segments are resected.
PPL25-111
LIVER RESECTION FOR METASTASIS
OTHER THAN COLORECTAL,
HEPATOCELLULAR,
CHOLANGIOCARCINOMA/
GALLBLADDER AND
NEUROENDOCRINE TUMOURS ARE
CONTROVERSIAL: A STUDY OF
SURVIVAL AND BENEFITS
Paul Bergamin, Eugenia Ip, Wong Jasmine and
Haghighi Koroush
The Prince of Wales Hospital, Sydney, Australia
Introduction: Liver resections have become safer, indi-
cations for the pool of potential hepatic metastasis that
would benefit from liver resection continues to expand.
We compare resection of hepatic metastasis other than
colorectal carcinoma (CRC), hepatocellular carcinoma
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(HCC), cholangiocarcinoma/gallbladder carcinoma
(CC/GBC) and neuroendocrine tumours (NETs) with
non-routine metastasis. The purpose of this study is to
compare the morbidity, mortality and survival of liver
resections by pathology type from a single surgeon at
two metropolitan centres in Australia.
Method: We retrospectively reviewed our prospectively
database of liver resections performed by a single sur-
geon (KSH) between January 2007 and July 2013.
Patients were divided into six pathological classifica-
tions: CRC, HCC, CC, NETs, other malignancy and
benign. Patients for the other malignancy group were
carefully selected using multi-disciplinary team tumour
meetings. We calculated overall survival at one, three
and 5 years. Patient demographics were compared.
Outcome measures included hospital length of stay
(LOS), ICU LOS, blood loss, blood transfusion, surgi-
cal mortality and complication rates (using clavien-din-
do classification).
Results: Three hundred and sixty-four liver resections
were performed for the six different pathology classifi-
cations: CRC (146), HCC (63), cholangiocarcinoma/
Gallbladder (44), NETs (13), other malignancy (39)
and benign (79). Other malignancies included: ovarian
(6), melanoma (5), sarcoma (4), breast (3), SCC (3),
gastric (3), endometrial (2), RCC (2). Demographics
between the groups were comparable. There was no dif-
ference in rates of post operative complications between
the groups. Hospital and intensive care LOS and blood
loss were comparable. For malignant conditions the 1,
3 and 5 year survival figures were CRC (93%, 70%,
46%), HCC (87%, 66%, 45%), Cholangiocarcinoma/
gallbladder (84%, 61%, 43%), NETs (75%, 37%,
37%) and other malignant (90%, 74%, 69%), revealing
no significant difference between groups.
Conclusions: For other hepatic metastasis, if carefully
selected in MDT tumour group, similar survival benefit
can be achieved when compared to CRC, HCC, CG
and NETs.
PPL25-113
TREATMENT OF HEPATOBILIARY
NEOPLASM A SINGLE CENTRE
EXPERIENCE
Byju Kundil
Pariyaram Medical College, India
Introduction: Liver resection is considered the thera-
peutic gold standard for primary and metastatic liver
neoplasm. RFA was performed mostly in patients with
unresectable liver tumors. The objective of this study is
to evaluate morbidity and mortality as a result of liver
resection and RFA for hepatobiliary neoplasm.
Method: A retrospective analysis of prospectively col-
lected data. Patients with primary and metastatic hepa-
tic malignancy resected with curative intent between
2011 April and 2012 June 30. Analyzed: tumor specifi-
cations, extent of resection, transfusions, vascular
clamping, operative time, associated procedures, and
length of hospital stay, postoperative complications
and mortality.
Results: Eighteen for Hepatocellular carcinoma, 4 hilar
cholangiocarcinoma, 16 colorectal liver metastasis, 1
adrenocortical liver metastasis, 1 intrahepatic cholan-
giocarcinoma, 1 oncvocytoma, and 2 mucinous cystade-
noma, 6 for neuroendocrine tumors. Intermittent
clamping used in 36 cases. Associated procedures in 16.
Two colectomy, 6 resection of diaphragm, one pancre-
atoduodenectomy, 2 small bowel resctyion, 4 distal
pancreatectomy, one gastrectomy One IVC resection,
two portal vein resection. Mean operative time
220 mts. Blood loss 530 mL, blood transfusion in 20
patients. 12 Right hepatectomy one extended right hep-
atectomy, 4 extended left hepatectomy. 7 left lobec-
tomy, 3 posterior sectionectomy, 21 non anatomic
resection. 20 patients developed major complications. 2
died in the postoperative period. 62 RFA procedures in
38 patients, 24 males and 14 females. l 72 tumors
ablated. 22 for Hepatocellular carcinoma, 16 metastatic
liver tumors, 12 colorectal, 2 neuro endocrine tumors.
Two laparoscopic, 8 along with other procedures, 6 co-
lectomies, 2 distal pancreatectomies. 3 along with liver
resections. All procedures done under ultrasound guid-
ance. There were no mortality, 2 patients developed
worsening of liver function. Mean hospital stay
25 days.
Conclusions: Liver resection can be performed with low
mortality and morbidity, RFA is a relatively safe, treat-
ment option for liver tumors which are unresectable.
PPL25-114
TECHINICAL ASPECTS OF SAFE
LAPAROSCOPIC RESECTION OF
HEPATOCELLULAR CARCINOMA
Daniel Kilburn1, David Cavalluci2, Leslie Nathanson2,
Richard Bryant2 and Nicholas O’Rourke2
1Bond University, Australia; 2The Royal Brisbane &
Women’s Hospital, Australia
Introduction: This series was designed to report the
technical aspects and outcomes of laparoscopic liver
resection for hepatocellular carcinoma (HCC).
Method: This is a retrospective and prospective review
of consecutive patients who underwent laparoscopic
liver resection for HCC from 1999 to 2013. We analy-
sed the surgical techniques based on the site of tumour,
looking at pre/operative details, pathology, and 1, 3
and 5-year survival/disease free survival.
Results: Forty-three HCCs were resected over 32 lapa-
roscopic operations in 29 patients (19 male; 58 years
old; range = 44–78 years old). Types of resection
included minor anatomic (n = 19; 8 left lateral section-
ectomies), minor non-anatomic (n = 8), and major
(n = 5). 65% of patients had cirrhosis.
Mean operating time was 150 minutes (range = 90–
294 minutes) and mean blood loss was 350 mL
(range = 50–1600 mL). 2 conversions occurred. The
mean postoperative length of stay was 5 days
(range = 1–12 days). There was 1 postoperative death
(decompensated cirrhosis). Margins were positive on 2
occasions. Rates of overall survival at 1, 3 and 5 years
were 95.2%, 80% and 76.9% respectively. 5-year dis-
ease free survival was 61.5%. There were 2 intra-
abdominal, extrahepatic recurrences.
Conclusions: Laparoscopic liver resection is feasible in
selected patients. Good survival rates can be achieved
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with the use of various surgical techniques. We suggest
a thoracoabdominal approach for lesions in segment 7
and 8.
PPL25-116
LONG-TERM OUTCOME OF
RUPTURED HEPATOCELLULAR
CARCINOMA: EXPERIENCE FROM A
SINGLE INSTITUTE
Hsu-Huan Chou, Wen-Hui Chan, Chien-Fu Hung,
Chao-Wei Lee, Ming-Chin Yu and Miin-Fu Chen
Chang Gung Memorial Hospital, Linkou Branch,
Taiwan
Introduction: The purpose of this study was long-term
outcome of ruptured hepatocellular carcinoma (HCC).
Method: One hundred and fifteen patients presented
with ruptured HCC from 2004 to 2009. The clinical,
laboratory and imaging findings of these patients were
collected. Survival analysis was conducted for patients
with transarterial embolization (TAE) and patients
without TAE. Multivariate analysis was to determine
prognostic factors in patients receiving TAE.
Results: The presenting symptoms are: abdominal pain
(87%), abdominal fullness (27%) and hemorrhagic
shock (24%). Patients who underwent TAE had higher
likelihood to present with shock, but the clinical tumor
characters were: smaller tumor size, less tumor vascular
invasion, lower alanine transaminase, bilirubin and
alkaline phosphatase level. Patients who underwent
TAE showed significantly better overall survival than
those in the non-TAE group in 1 year (45% vs 14%,
p < 0.001), 3 years (35% vs 14%, p < 0.001) and
5 years (29% vs 14%, p < 0.001). Multivariate logistic
regression analysis identified older age (hazard ratio
5.66, p < 0.01), tumor with vascular invasion (hazard
ratio 3.09, p < 0.01), presence of shock (hazard ratio
4.65, p < 0.01) as poor prognostic factors for the TAE
groups.
Conclusions: Transarterial embolization provides effec-
tive initial hemostasis in patients with ruptured HCC.
Patients who underwent TAE have better short-term
and long-term survival. However, older age, tumor vas-
cular invasion and presence of shock predict poor out-
come.
PPL25-117
PARENCHYMAL SPARRING IN
RESPECT TO VENOUS OUTFLOW IN
PATIENTS UNDERGOING EXTENDED
LEFT HEPATECTOMY- A MEVIS
STUDY
Jun Li, Lutz Fischer, Eike Achilles and Bjoern Nashan
University Medical Center Hamburg-Eppendorf,
Germany
Introduction: In patients with small remnant liver,
modified extended left hepatectomy (ELH) with pre-
serving partial segment 8 and total segment 5 might
avoid post-hepatectomy liver failure (PHLF) if a suffi-
cient outflow could be ensured. The aim of the study is
to find out whether preserving of segment 5 could
avoid PHLF according to the clinical course as well as
volumetric analysis by MeVis.
Method: Modified ELH was defined as resection of
segment 2, 3, 4 and most of the segment 8, with or
without segment 1. The segment 5 was kept in the rem-
nant liver with at least 1 cm margin to the tumor. A
liver volume analysis using 3D reconstruction by MeVis
was carried out. Data, including transfusion, ICU stay,
R0 status, postoperative complications, especially
PHLF or bile leak, were analyzed.
Results: Modified ELH with preserving segment 5 can
be carried out in five of seven patients who were other-
wise indicated for a left trisectionectomy for patients
with intrahepatic malignancy from April 2012. In the
other two patients tumor involvement of segment 5 and
8 made left trisectionectomy mandatory. MeVis analy-
sis showed that preserving segment 5 led to increasing
remnant liver volume 26–67%. Remnant liver was
drained by the right hepatic vein (RHV) alone in four
patients, by the RHV and the middle hepatic vein
(MHV) in two patients. R0 status was confirmed in all
five patients. No posthepatectomy liver failure devel-
oped. One patient had Grad IIIb bile leak which was
successfully managed by reoperation. No complication
was developed in others.
Conclusions: Parenchyma-sparring in ELH is feasible
and worthwhile. With respect to the venous outflow,
segment 5 can be preserved in most of the case when
no tumor involvement was found.
PPL25-118
VALUE OF TOTAL VASCULAR
EXCLUSION IN PATIENTS
UNDERGOING MAJOR HEPATECTOMY
WITHOUT CAVAL VEIN RESECTION
Jun Li, Sebastian Luense and Bjoern Nashan
University Medical Center Hamburg-Eppendorf,
Germany
Introduction: Total vascular exclusion (TVE) has been
mainly applied in resection of liver tumor involving the
hepatocaval conference or caval vein. The value of
TVE in patients undergoing major hepatectomy (>three
segments resected) but not caval vein resection was rare
reported.
Method: Patients underwent TVE since April 2012 was
studied. The duration of TVE, extension of liver resec-
tion, intraoperative hemodynamic changes, transfusion,
R0 status, ICU stay, postoperative complications were
compared between patients with TVE for caval vein
resection and TVE without caval vein resection.
Results: Among eleven patients requiring TVE, six
patients (Group 1) had a caval resection and recon-
struction. In other five patients (Group 2), TVE with
occlusion of the middle hepatic vein (MHV) – the left
hepatic vein (LHV) conference and the portal triad was
carried out. Tumor infiltration to the MHV (n = 4) or/
and LHV (n = 3) led to partial resection and recon-
struction of the hepatic vein in four patients. Preserva-
tion of MHV or/and LHV was the indication for TVE
in this group. Compared to the patients with caval vein
resection, the patients in Group 2 tolerated the TVE
well with little clinical relevant hemodynamic change
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caused by clamping. The transfusion was significant
less. The time of TVE was comparable in both groups.
R0 status was achieved in five out of six patients in
Group 1 and six out of seven venous resections in
Group 2. One patient died within the hospital stay in
Group 1 due to cardiac complication. Longer ICU stay
and more postoperative complications in Group 1 was
found to be associated with more extensive liver resec-
tion.
Conclusions: Compared to TVE for caval vein resec-
tion, TVE for major hepatic vein resection has less
impact on the hemodynamics and thus to be well toler-
ated. The application of TVE in this population could
increase the tumor resectability.
PPL25-119
SUGERY FOR RECURRENT
INTRAHEPATIC
CHOLANGIOCARCINOMA. WHAT
CRITERIA?
Alfonso Recordare1, Naim Loxha2, Fazli Shala2,
Hanumsha Kingji2 and Besim Kastrati2
1Treviso General Hospital, Treviso, Italy; 2Peja Regional
Hospital, Kosovo, Albania
Introduction: Management of patients with recurrent
intrahepatic cholangiocarcinoma (ICC) is not jet stan-
dardized. Criteria for repeated surgery are lacking. Sur-
gical resection of recurrence is rarely reported, but
better results have been obtained in comparison with
other available therapies in selected cases.
Method: A 52-year-old woman was admitted in hospi-
tal complaining epigastric pain, nausea and weight loss.
CT scan and NMR revealed a central mass of the liver
involving also the left lobe and compressing the hepatic
hylum and the caval vein. The patient underwent
enlarged left hepatectomy with ligation of the anterior
right portal pedicle (without margin exposure on ves-
sels), and regional lymphadenectomy.
One year after surgery a recurrence on the remnant
liver was evident on CT scan and confirmed at NMR.
Five nodules were located relatively close to the resec-
tion margin, and only 1 nodule was located far from
the resection margin, on segment 6.
Results: In spite of the relapse with multiple nodules,
repeated resection was considered because of the tech-
nical feasibility, the age, the good performance status
of the patient, good differentiation and the node nega-
tive status at hystology. Three atypical resection were
performed on the remnant liver. The first involved 4
nodules, and the other wedge resection separately
removed 2 nodules. Postoperative course was uneventu-
ful. The patient followed 6 cicles of adjuvant therapy.
Eleven months after surgery the patient is alive and
well without biochemical and radiological signs of
recurrence.
Conclusions: An aggressive surgical approach is war-
ranted in patients with ICC because resection offer the
only hope for prolongation of patient survival. Good
differentiation and lymphnodes negative status, that are
good prognostic factors for survival after primary
resection, would be evaluated also for the surgical
treatment of recurrence. Further experiences are
required to know if re-resection can be offered also for
multiple nodules when expected morbidity is low.
PPL25-120
TREATMENT OF COMPLICATED
HEPATIC CYSTIC HYDATIDOSIS WITH
INTRA-BILIARY RUPTURE BY
PERICYSTECTOMY IN COMBINATION
WITH ROUX-EN-Y
HEPATICOJEJUNOSTOMY
Hongqiang Yang1, Jingxia Tang2, Xinyu Peng1, Shijie
Zhang1, Hong Sun1 and Xiangwei Wu1
1The First Affiliated Hospital of the Medical College,
Shihezi University, China; 2The Medical College of
Shihezi University, China
Introduction: Intra-biliary rupture is a serious compli-
cation of hepatic cystic hydatidosis. In some cases, the
bile ducts are damaged severely and their continuity
cannot be recovered by suture, and the reconstruction
of biliary tract is difficult. Many surgeons employed
ectocystic-enteric anastomosis to reconstruct biliary
tract. With the ectocyst been conserved, the incidence
of complication residual cavity, biliary obstruction and
biliary stones were high post-operatively.
Method: This study retrospective reviewed the patients
of complicated hepatic cystic hydatidosis with intra-bili-
ary rupture who were surgically treated with pericystec-
tomy in combination with Roux-en-Y
hepaticojejunostomy in our hospital from 2005 to 2011.
The clinical features, laboratory tests, B-mode ultraso-
nography and CT, post-operative recovery, hospital
stay and complications were statistically analyzed and
the patients were followed up.
Results: Nine cases suffered from hepatic cystic hydati-
dosis with intra-biliary rupture, they suffered from pain
of the right upper quadrant and jaundice, 4 cases were
accompanied with fever and chills. Preoperative B-
mode ultrosonography and CT showed that 9 patients
had single hydatid cyst, with their average diameter
being 9.33  1.58 cm. The lesions involved segments V,
VI in 6 cases, and segment IV in 3 cases. By WHO
classification, 7 cases were classified as CE3 and 2 cases
as CE4. They all had choledochectasia. The pericystec-
tomy in combination with Roux-en-Y hepaticojejunos-
tomy were performed successfully. Intraoperatively, 2–4
biliary fistula orifices were found in each case, with the
average of the orifice being (0.79  0.20) cm. One
patient suffered from incision infection, 1 patient suf-
fered from pulmonary infection and 1 patient suffered
from reflux cholangitis. No anastomotic leaks and com-
plication residual cavity took place and follow-up
revealed no recurrence and biliary obstruction and
deposition of biliary stones.
Conclusions: The pericystectomy in combination with
Roux-en-Y hepaticojejunostomy can achieve satisfac-
tory results for treatment of complicated hepatic cystic
hydatidosis with intra-biliary rupture. The ectocyst
removed is the key procedure.
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PPL25-121
THE ASSOCIATION OF
HYPOPHOSPHATEMIA WITH POST-
HEPATETCTOMY LIVER FAILURE AND
RECOVERY
Julie Hallet1, Francis Zih1, Julia Wong2, Sherif
Hanna2, Paul Karanicolas2, Natalie Coburn2 and
Calvin Law2
1University of Toronto, Canada; 2Sunnybrook Health
Sciences Centre, Canada
Introduction: Hypophosphatemia is frequent following
liver resection, and thought to represent use of phos-
phate during liver regeneration. Its association with
postoperative liver function remains controversial, with
opposite results from small cohorts. We sought to eval-
uate the association of post-hepatectomy hypophos-
phatemia with liver failure and recovery.
Method: Consecutive liver resections were retrospec-
tively reviewed from 2003 to 2013 at a single institu-
tion. Primary outcome was occurrence of liver failure
(“50/50” criteria). Secondary outcomes were persistence
of liver failure at discharge, 30-day morbidity according
to Clavien-Dindo classification, and 30-day mortality.
Outcomes of clinically significant post-hepatectomy
hypophosphatemia cases (HP [≤0.65 mmol/L]) were
compared to non-hypophosphatemia controls (NHP).
Results: Among 400 patients retrieved, 320 (80.0%)
experienced HP. Mean postoperative nadir phosphate
was 0.49 mmol/L (SE: 0.10 mmol/L) in HP. Overall,
liver failure occurred significantly more often with HP
than NHP (19.7% vs 11.2%, p = 0.02). However, we
observed a trend towards less liver failure at discharge
in HP (1.7% vs 4.3%, p = 0.20). Length of stay, Cla-
vien-Dindo complications, and mortality did not differ.
Forty-one cases (82.0%) of liver failure recovered
before discharge. More patients who recovered experi-
enced HP compared to those who did not (70.7% vs
11.1%, p < 0.01). Among recovering patients, 20%
experienced a drop in phosphate within 24 hours of
surgery, compared to none non-recovering ones. Demo-
graphics, diagnosis and extent of surgery did not differ
between hypophosphatemia or recovery groups.
Conclusions: Based on this large sample analysis, post-
hepatectomy HP is associated with increased incidence
of liver failure, but not with increased morbidity or
mortality. HP occurred more often in patients who
recovered, highlighting efficient liver regeneration. Fur-
ther studies should explore the usefulness of the trend
of phosphate drop for early identification of patients
likely to recover fast from liver failure, and the need
and benefit of aggressive phosphate repletion.
PPL25-122
BILE DUCT INVASION OF
COLORECTAL LIVER METASTASIS
LEADS TO INCREASED RECURRENCE
AND POORER SURVIVAL AFTER LIVER
RESECTION
Llinos Dafydd, Anna Powell Chandler, Gareth
Rowlands and Nagappan Kumar
University Hospital of Wales, United Kingdom
Introduction: Liver resection for colorectal liver metas-
tases (CRLM) is now standard treatment. Risk scores
like the MSKCC score and Basingstoke index have
been used to predict prognosis. Bile duct invasion has
not been previously defined as a poor prognostic fac-
tor. After noticing poorer long term outcomes in
patients with bile duct invasion we studied further.
Method: Liver resection for CRLM patients between
Jan 2003 and Dec 2012 were included. The unit main-
tains a prospective database recording key data on
CRLM resection cases. Resection slides were indepen-
dently reviewed utilising Royal College of Pathologists
guidelines by a pathologist to identify bile duct inva-
sion. Follow-up data was obtained from the database
and through General Practitioners. A minimum
6 months follow up was included. Survival was calcu-
lated using Kaplan–Meier method and comparisons
made using the log rank test. A p < 0.05 was consid-
ered significant. Chi square test was used to compare
recurrence rates.
Results: We are reporting initial data on 109 of 215
patients. There was a M:F ratio of 73:36 with age
range 34–85, mean 65. The majority were open proce-
dures (94.5%). All types of liver resection for CRLM
were included. The perioperative mortality was 2.7%.
Bile duct invasion occurred in 20 patients (18%). The 3
and 5 year actual survival in patients with bile duct
invasion versus no bile duct invasion was 54% and
18% versus 70% and 45% (p = 0.07). The recurrence
rates with bile duct invasion was higher (22%) than if
there was no invasion (14%) (p = 0.24). Multivariate
analysis and completion of data on the 215 patients is
ongoing.Conclusions: We have shown that bile duct
invasion in liver resection for CRLM leads to higher
recurrence and poorer survival. The survival data is not
statistically different, likely due to Type II error. It is
probable that with complete data collection we may
find a significant difference.
PPL25-123
IMPAT OF ANTIVIRAL THERAPY ON
LIVER REGENERATION IN HEPATITIS
B CARRIER AFTER HEPATECTOMY
Yue Sun Cheung, Grace LH Wong, Anthony WH
Chan, Charing CN Chong, Philip CT Ip, Vincent WS
Wong, John Wong, Kit Fai Lee, Henry LY Chan and
Paul BS Lai
The Chinese University of Hong Kong, Hong Kong,
China
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Introduction: Liver regeneration occurs after partial
hepatectomy to replenish the lost functional paren-
chyma. This process is affected by chronic liver disease.
Antiviral treatment, e.g. nucleos(t)ide analog, has
shown to reduce liver-related complications and
improve survival in chronic hepatitis B patients after
curative resection of hepatocellular carcinoma (HCC).
This study aimed to evaluate the impact of nucleos(t)
ide analog on liver regeneration in hepatitis B carrier
after hepatectomy for HCC.
Method: We performed a retrospective study on hepa-
titis B carrier receiving hepatectomy in a teaching hos-
pital from June 2009 to October 2012. Patients
undergoing left lateral sectionectomy, left hepatectomy
and right hepatectomy were included. Liver regenera-
tion was measured by comparing the volume of liver
remnant on post-operative 6-month computer tomogra-
phy (CT) to the estimated future liver remnant on pre-
operative scan. Liver volume was measured by sum-
mating the cross sectional area of CT images in 5-mm
cuts and multiply by their slice thickness using com-
puter software. Association between liver regeneration,
antiviral treatment and type of operation were analysed
by linear regression.
Results: Forty-two patients were included in the study,
of whom 30 patients received antiviral drugs, whereas
12 patients had no treatment for chronic hepatitis B.
There was no significant difference in the baseline
characteristics between two groups. The mean and
standard deviation of liver volume increase was
(490.8  606.2 mL). Type of liver resections
(p < 0.001) and use of nucleos(t)ide analog (p = 0.035)
had significant association between liver regeneration in
univariate analysis. However, antiviral use became clo-
sely non-significant (p = 0.077) in multiple linear
regression, leaving type of liver resections (p < 0.005)
the only independent predictive factor.
Conclusions: Liver regeneration is associated with type
of procedure which in-turn reflecting the volume being
resected. Use of antiviral treatment might play in role
in improving liver regeneration.
PPL25-124
R1-RESECTIONS OF COLORECTAL
LIVER METASTASES ARE NOT
ASSOCIATED WITH HIGHER
RECURRENCE RATES
Hans Christian Rolff1, Peter Nørgaard1, Lars Bo
Svendsen1, Nicolai Schultz1, Martin Illemann2 and Jens
Hillingsø1
1Surgical Gastroenterology and Transplantation,
Rigshospitalet, Denmark; 2The Finsen Laboratory,
Rigshospitalet, Denmark
Introduction: The oncologic impact of R1-resection, is
a much discussed topic. We wanted to investigate if
R1-resection for colorectal liver metastases (CRLM), in
a modern setup with a liver sparing approach, repeated
resections, use of liver degrading transections devices
and with adjuvant and neoadjuvant chemotherapy, is
associated with higher rates of recurrences.
Method: Retrospective evaluation of 97 liver resections
due to CRLM in the period from January 1st 2010 to
December 31st 2011. All resections were considered
macroradical peroperatively. The study-cohort was
divided according to histologic resection status into
either R1- or R0-group. Resections with ≤1 mm tumor-
free margin were deemed R1 and resections with
>1 mm tumor-free margin were deemed R0. Patients
had follow-up CT at 6, 12, 18 and 24 months after
resection, which were evaluated for recurrence both
intra- and extrahepatically.
Results: Twenty-seven of the resections were R1 and
70 were deemed R0. The two groups were comparable
regarding hepatic involvement: mean number of metas-
tases (R0: 1.9 vs R1: 2.3 p = 0.13), mean size of largest
metastasis (R0: 3.9 cm vs. R1: 3.1 cm p = 0.74) and
rate of synchronous hepatic involvement (R0: 52.9% vs
R1: 57.7% p = 0.7). The median follow-up period was
respectively 25 months for the R0 and 22 months for
the R1-group. No difference was noted regarding the
recurrence rate between the two groups neither locally
(R0: 10% vs R1: 15% p = 0.46), any-site hepatically
(R0: 52.9% vs R1: 40.1% p = 0.3) nor extra-hepatically
(R0: 54.2% vs R1: 48.1% p = 0.6).
Conclusions: In a modern setting, with effective chemo-
therapy and liver degrading transection devices, a R1-
resection is not associated with a higher recurrence
rate.
PPL25-125
A NOVEL, VALIDATED METHOD OF
COUNTING MICRO-VESSEL DENSITY
IN COLORECTAL LIVER METASTASES
Pulathis Siriwardana1, Tu Vinh Luong2, Jenifer
Watkins2, Helen Turley4, Kevin Gatter5, Adrian
Harris4, Daniel Hochhauser3 and Brian Davidson1
1Royal Free Hospital and UCL Medical School, UK;
2Royal Free Hospital, UK; 3University College London,
UK; 4University of Oxford, UK; 5Oxford University
Hospital, UK
Introduction: Intra-tumoural microvessel density (IMD)
is a potentially useful biological marker of prognosis in
patients with solid tumours. The average number of
positively stained microvessels of the five most vascular
high power fields (HPF) at 9200 magnification is taken
as the IMD for a tumour. Areas of necrosis and des-
moplasia preclude the use of this method of quantifica-
tion of IMD in vascular hot spots in Colorectal liver
metastases (CRLM). In this study, using a smaller area
within the 9200 field to quantify IMD in CRLM was
validated.
Method: Micro-sections cut at 5 lM from the largest
CRLM of 10 patients were immunostained for CD31.
Five 9200 (0.75 mm2) fields from each slide, with no
areas of necrosis and/or desmoplasia were selected. In
the same HPF (0.75 mm2) at 9200 magnification, the
total number of microvessels visualised in the whole
field, and the microvessels within a 0.25 mm2 graticule
were counted separately. Microvessel counts were
expressed as IMD per 0.25 mm2. The intra class corre-
lation coefficient was used to compare the consistency
of the microvessels counted by the two methods.
Results: Total number of fields assessed was n = 50.
The range of counted microvessels per 0.25 mm2, with
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and without the graticule was 7–54 and 7–41 respec-
tively. The Intra class correlation coefficient was 0.96
(95% CI: 0.91–0.98).
Conclusions: When areas of necrosis and desmoplasia
interferes with quantification of IMD when using the
hotspot microvessel counting method in CRLM an
area under a 0.25 mm2 graticule can be used with
‘excellent’ consistency as an alternative to the standard
method.
PPL25-126
RESECTION OF SOLITARY LYMPH
NODE METASTASIS FOR
HEPATOCELLULAR CARCINOMA
AFTER HEPATECTOMY.
Tiffany C L Wong, TT Cheung, KS Chok, AC Chan,
W Sharr, SH Tsang, WC Dai, SC Chan, RT Poon and
CM Lo
The University of Hong Kong, Hong Kong, China
Introduction: Metachronous lymph node metastasis
after hepatectomy for hepatocellular carcinoma (HCC)
is rare and is usually associated with other extrahepatic
metastases. There is no standardized treatment in these
patients and the role of surgical resection in isolated
lymph node metastasis after curative hepatectomy
remains unclear.
Method: This is a retrospective study conducted in a
university centre in Hong Kong. Surgical resection for
lymph node metastasis would only be offered to
patients who otherwise had no other intrahepatic or
extrahepatic recurrence after hepatectomy. Data was
retrieved from a prospectively collected database.
Results: From 1989 to 2011, 11 patients had resection
of solitary lymph node metastasis after hepatectomy
for HCC. Nine out of 11 were male and majority of
them (9/11, 81.8%) were hepatitis B carrier. Median
tumor size was 5 cm, 6 tumors (54.5%) were of well or
moderately differentiation, 7 tumors (63.6%) had
microvascular invasion and the mean macroscopic
resection margin was 1 cm. All of these patients had
intra-abdominal lymph node recurrence (4 were located
in liver hilum, 4 in retroduodenal/peripancreatic region
and 3 at paraaortic region). There was no perioperative
complication or hospital mortality.
The median time from hepatectomy to the development
of lymph node metastasis was 18.2 months (6.77–
80.6 months) and none of these patients received adju-
vant treatment after hepatectomy for HCC.
The median time from lymph node to other extrahe-
patic metastasis was 6.0 months (2.2–45.6 months).
The median overall survival was 18.6 months (2.8–
108.7 months) and 1-, 3- and 5-year survival was
66.7%, 25.0% and 16.7% respectively among these
patients.
Conclusions: As effective systemic treatment for HCC
is lacking and the risk for surgical resection for lymph
node metastasis is low. Surgical resection should be
offered to HCC patients who developed solitary lymph
node metastasis.
PPL25-127
KLEBSIELLA LIVER ABSCESS
SYNDROME: A WELSH PERSPECTIVE
Anna Powell-Chandler, Bernard Maybury, Harsheet
Sethi and Nagappan Kumar
University Hospital Wales, UK
Introduction: Klebsiella pneumoniae is a well-recogni-
sed cause of liver abscess in Asia, often associated with
bacteraemia and metastatic abscesses. Reports of Kle-
bsiella liver abscess syndrome (KLAS) from Western
countries are rare.
Method: PubMed search for English language publica-
tions on KLAS revealed 32 papers, the majority of
which were single case reports. We found only one case
report of KLAS in a diabetic patient from the United
Kingdom. We present two cases of KLAS from the
Cardiff Liver Unit.
Results: A 78-year-old non-diabetic Caucasian woman
presented with fever and wound infection following
surgery for hallux valgus. Blood cultures grew klebsiella
pneumoniae. Ultrasound and CT scan revealed a mul-
tiloculated liver abscess. Antibiotics and percutaneous
drainage failed to achieve source control. Laparotomy
was performed to attempt open drainage of liver
abscess. We found a multiloculated abscess, necrotic
left liver parenchyma and thrombosed left portal and
hepatic veins. A left hemihepatectomy was performed
and led to prompt resolution of sepsis.
A 51-year-old Welshman was admitted with sepsis and
parotitis. He was taking azathioprine and tacrolimus
following renal transplant sixteen year earlier. He was
not a known diabetic but hyperglycaemic at admission.
Antibiotics were initiated but he remained septic. An
abdominal CT was performed after blood cultures grew
klebsiella pneumoniae. This showed multiple segment
II liver abscesses. He underwent a segment II liver
resection and began to make a good recovery. Antibi-
otics were continued for 6 weeks.
Conclusions: Klebsiella is a rare cause of liver abscess
in the UK. Multiloculated abscesses are not amenable
to percutaneous drainage and surgical drainage should
not be delayed. Metastatic abscesses may be the pre-
senting complaint or may cause persistent sepsis follow-
ing drainage of the primary abscess.
PPL25-128
OUTCOMES OF TRANSCATHETER
ARTERIAL CHEMOEMBOLISATION
FOR HEPATOCELLULAR CARCINOMA
Anna Powell-Chandler, Andrew Gordon and
Nagappan Kumar
University Hospital Wales, UK
Introduction: Hepatocellular carcinoma (HCC)
accounts for 1% cancers in UK. 85–90% are non-oper-
able at presentation. Liver transplantation is limited by
selection criteria and availability. Transcatheter arterial
chemoembolisation (TACE) aims to control growth,
preserve liver function and prolong life. Our current
service started in 2003. The number we are treating is
increasing.
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Method: All cases between 2003 and 2013 were
reviewed. Demographics, baseline liver function, stage
of disease, number of procedures and length of treat-
ment were recorded and all patients followed-up.
Results: Fifty referrals were made between July 2003
and January 2013. There were 2 referrals in 2003 which
increased to 12 in 2012. Of the 50, 86% were male with
a mean age of 70.8 years (range 48–84). 64% had
cirrhosis, 90% were Childs A. Tumour size ranged 1–
20 cm. 4 had multifocal disease (1–5 tumours).
Forty-four patients were suitable after angiography.
They had an average of 3.1 procedures (range 1–10)
over a mean 12.9 months (range 1–73). They were fol-
lowed-up with CT scans. One patient had severe symp-
toms of post-TACE syndrome so did not proceed with
further treatment.
Twenty-six patients died at a mean of 15.2 months
(range 1–58). Eighteen patients are alive at a mean
21.1 months (range 5–82). Cumulative survival is 57%
at 1 year, 30% at 2 years and 11% at 3 years. We
noted a significantly improved survival in those classed
Childs A (p = 0.05).
Conclusions: TACE remains a valuable tool in the
management of HCC. We noted a median survival of
12.5 months (range 1–82).
Increasing incidence of HCC and referral will put sig-
nificant demand on services. Patient factors should be
considered as may influence treatment outcomes.
PPL25-129
ALPPS PROCEDURE FOR
COLORECTAL CANCER LIVER
METASTASIS: INITIAL EXPERIENCE
Deniz Balci, Can Konca, Caglar Uzun, Ali T€uz€un,
Cihangir Akyol and Selcuk Hazinedaroglu
Ankara University, Turkey
Introduction: A prolonged survival of patients with
Colorectal cancer liver metastasis (CRCLM) is possible
with surgical treatment however limited by the inade-
quate volume of residual hepatic parenchyma (FLR –
Future Liver Remnant) and the resulting high risk of
postoperative liver failure. Recently, a two stage tech-
nique has been developed with the acronym ALPPS
(Associating Liver Partitioning and Portal Vein Liga-
tion for Staged Hepatectomy) to obtain a more rapid
increase in FLR.
Method: Between December 2012 and August 2013, 4
patients were candidates to ALPPS at the Hepatobilia-
ry Surgery Unit of Ankara University Department of
Surgery. All patients had significant medical comorbidi-
ties and all have undergone preoperative chemo-radio-
theraphy. One patient had left trisectionectomy, 2
patients had right trisectionectomy and 1 patient had
extended right hepatectomy.
Results: The mean age of patients was 57  7.9. All
patients underwent R0 liver resection without signifi-
cant postoperative liver dysfunction. The mean increase
in FLR volume was 260.3 mL (p = 0.04). All but one
patient underwent second stage operation on the 10th
postoperative day. One patient did not show sufficient
liver volume increase so surgery was delayed for an
additional 2 weeks. The mean hospital stay was
33.2  17.2 days. Two (50%) patients had bile leak
that resolved with ERCP. One patient (25%) was lost
due to pneumonia and sepsis on postoperative day 42.
Conclusions: ALPPS should be considered as a further
option to offer potentially curative surgery to patients
with CRCLM who are not candidates for a single stage
hepatectomy however with a considerable risk of mor-
tality and morbidity.
PPL25-130
PARENCHYMAL-PRESERVING LIVER
RESECTIONS DO NOT INCREASE THE
RISK OF R1 RESECTION OR LEAD TO
POORER LONG TERM OUTCOMES IN
PATIENTS UNDERGOING LIVER
RESECTION FOR COLORECTAL LIVER
METASTASES
Anna Powell-Chandler, Zsolt Kaposztas and Nagappan
Kumar
University Hospital Wales, UK
Introduction: Traditionally, anatomical resections have
been performed for colorectal liver metastases
(CRLM). Early trials found non-anatomical resections
to have a poorer outcome. We compare recent results
from our institution.
Method: We analysed patients undergoing resections
for CRLM from January 2003 to December 2012 at
Cardiff Liver Unit. Prospective database recorded
demographics, type of resection, blood loss, transfu-
sion, hospital stay, mortality and morbidity. R1 resec-
tion was defined as histological margin less than 1 mm.
Peri-operative chemotherapy was not routine. Data on
neoadjuvant chemotherapy (a small proportion of
patients) is being collected. Follow-up data was from
our records and General Practioners. We followed
patients up to 30 June 2013. We used SPSS ver 20 for
statistical analysis. Means were compared using Chi
Square test. We used Kaplan Meier method to measure
survival and Log rank test to compare various factors.
p-value <0.05 was considered significant.
Results: Two hundred and fifteen resections for CRLM
over 10 years; 146 males, 69 females, median age
67 years (range 34–86). Overall mortality 2.7% (6/215).
Ninety-nine anatomical resections performed; right hep-
atectomy(56), left hepatectomy(15), left lateral section-
ectomy(13), central hepatectomy(6), segment 6/7
resection(8), caudate lobectomy(1). Twenty-two under-
went combined hepatectomy and metastatectomy.
Ninety-four parenchymal-preserving metastatectomies
performed. The number of anatomical, combined and
parenchymal-preserving resections performed was 38,
11 and 31 respectively during 2003–2007 and 61, 11
and 63 during 2008–2012. 41 patients had R1 resection
(19%). The distribution among the groups were ana-
tomical 30/99 (30%), combined 9/94 (10%) and paren-
chymal-preserving 2/22 (10%) (p = 0.001). The 5 year
survival and median survival in the groups were 34%,
49%, 58% and 3.3, 4.9 and 6.5 years respectively.
Conclusions: Parenchymal-preserving resections are
performed increasingly. In the modern era, with
improved surgical techniques, R0 resection can be
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achieved in non-anatomical resections. This allows
preservation of liver for any future resection. We con-
clude that parenchymal-preserving liver resection has
good long term outcomes.
PPL25-131
PLATELET COUNT: A PREDICTOR FOR
THE SAFETY OF THE HEPATECTOMY
FOR HUGE (≥10 CM)
HEPATOCELLULAR CARCINOMA
Wanguang Zhang, Xinxing Wang and Xiaoping Chen
Tongji Hospital, China
Introduction: A large number of studies have made
their efforts to identify the influencing factors of the
safety of hepatectomy for HCC, but it is rarely
reported for huge HCC (≥10 cm). For all the common
factors influencing the safety of hepatic resection
referred, ALT, AST, TB, peak total bilirubin(Tbmax),
TC, PT, PTA, blood loss, blood transfusion, future
liver remnant(FLR), Chid–Pugh, ICG, PLT, tumor
size, HBV are included. This study aimed to determine
whether hepatic resection carried out for huge HCC is
safe and effective, and to identify a simple and effective
method to predict the safety for huge HCC.
Method: From January 2010 to December 2012, 58
patients with huge HCC who underwent surgical resec-
tion were enrolled in this study. Complications, survival
and recurrence data and clinicopathological factors
were examined.
Results: An overall 60-day mortality for these patients
was 5.17%. In multivariate analysis, only preoperitive
PLT and FLR were associated significantly with the
60-day mortality. 3 of 58 patients died with a platelet
count less than 150 9 109/L. Patients with a low
(<150 9 109/L) preoperitive platelet count (LPPC) had
worse postoperative liver function, higher serum mark-
ers of liver injury, and increased 60-day mortality com-
pared with patients with higher platelet counts
(≥150 9 109/L). A subgroup analysis of patients with a
preoperative platelet count of <100 9 109/L compared
with those with a count of 100 9 109/L to 149 9 109/L
showed no difference in the rate of 60-day mortalityand
major complications. 36.2% of the patients suffered
early recurrence in 1 year after resection.
Conclusions: Preoperitive platelet counts is indepen-
dently associated with the safety of the surgical resec-
tion for huge HCC. LPPC is identified as an
independent predictor of increased risk of 60-day mor-
tality. Vascular invasion and satellite nodules persisted
to be independently associated with increased rate of
postoperative early recurrence.
PPL26-001
OUTCOME OF LIVING LIVER DONORS
IN LDLT: A FIRST REPORT FROM
PAKISTAN
Faisal Dar1, Haseeb haider Zia1, Abdul wahab Dogar1,
Amna Liaqat1, Minhal Pervaiz1, Hasnain Ali Ilyas1,
Farah Imtiaz1, Nasir Ayub Khan1, Najam ul hassan
Shah1 and Mohmed Rela2
1Shifa International Hospital, Islamabad, Pakistan;
2Global Hospital Chennai, India
Introduction: Liver transplant is the treatment of choice
for end stage liver disease (ESLD). Living donor liver
transplant (LDLT) has emerged as a viable option in
countries like ours. We aimed to evaluate donor out-
comes.
Method: From May 2012 to June 2013, 39 LDLT’s
were performed. Demographic, clinical, radiological,
pathological, operative details and postoperative events
were recorded and analyzed in SPSS 19.
Results: In donors, 59% (23) were males and 41% (16)
were females. Mean donor age, BMI and LAI was
28.1 years (17–45), 25.9 and 11.7 respectively. Biopsy
was done in 28.2% (11) donors, showing fat content
(range 2–12%). Right lobe grafts without MHV were
48.7% (19), partial MHV 30.8% (8) and complete
MHV were 12.8% (5). Two (5.1%) grafts were left
lobe. One was a whole liver as domino graft. Biliary
anatomy was variant in 20.5% (8); most common was
RPHD draining into LHD 10.3% (4). Arterial variants
were 43.6% (17). Most common was replaced RHA
from SMA 12.8% (5). Mean blood loss was 554 mL
(range 200–2000). Mean graft weight for right lobe was
772 g. Mean Post transection portal pressure was 10
(range 7–16). Postoperatively, mean peak billirubin and
INR were 3.1 mg/dL (1.5–7.1) and 1.49 (1.1–2.2)
respectively. Mean hospital stay was 9 days (range 6–
18). There was no donor mortality. One patient had a
bile leak requiring ERCP. Six (15.7%) suffered minor
complications.
Conclusions: The safety of a live donor is of para-
mount importance and is dependent on strict selection
criteria, sound planning and safe surgical technique.
This is reflected in our results.
PPL26-002
COMPARISON OF SIMULTANEOUS OR
DELAYED LIVER SURGERY FOR
SYNCHRONOUS COLORECTAL
METASTASES: OUR EXPERIENCE.
Samuele Vaccari, Mariateresa Mirarchi, EmilioDe
Raffele, Silvia Palumbo, Ferdinando Lecce, Barbara
Dalla Via, Dajana Cuicchi, Francesco Varrese, Basilio
Pirrera and Bruno Cola
U.O. Chirurgia Generale e d’Urgenza – Prof. Cola,
Italy
Introduction: The optimal surgical strategy for patients
with synchronous colorectal liver metastases (CRLM)
is still unclear. The aim of this study was to compare
the outcome of simultaneous colorectal and hepatic
resection with a delayed strategy.
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Method: Data from 108 liver resections for synchro-
nous-metachronous CRLM from July 2005 to June
2013 were reviewed retrospectively. Thirty-eight
patients had a simultaneous liver resection and colorec-
tal resection (SG), 17 patients had a hepatectomy for
synchronous-CRLM after a colorectal resection (SMG)
and 53 patients had a hepatectomy for metachronous-
CRLM (MG). Patients’ demographics, clinical and his-
topathological parameters, intra and perioperative
results were analyzed. ANOVA and Student’s t tests
were used for statistics; significance was defined as
p < 0.05.
Results: The demographic data were similar among the
three groups. Intraoperative blood transfusions were
161.1  317.6 mL [0–1000], 229.4  566.8 mL [0–2250]
and 242.5  535.6 mL [0–2500] in SG, SMG and MG,
respectively (p = 0.7144). Minor LR were performed in
76.3%, 64.7% and 77.4% in SG, SMG and MG,
respectively (p = 0.4974). Duration of surgical proce-
dure was 473  172 minutes [157–820], 475  180 min-
utes [225–800] and 398  165 minutes [160–655] in SG,
SMG and MG, respectively (p = 0.9375). Postoperative
complications were 18.4%, 11.8% and 18.9% in SG,
SMG and MG, respectively (p = 0.7403). Thirty-day
mortality was 2.6%, 5.9% and 0% in SG, SMG and
MG, respectively (p = 0.2663). Postoperative hospital-
stay was 12.03  6.80 days [7–50], 13.44  14.68 days
[7–68] and 9.98  4.28 days [4–29] in SG, SMG and
MG, respectively (p = 0.2002).
Conclusions: The results of this study suggest that
simultaneous colorectal-liver resection can be safely
performed at the same time in selected patients with
synchronous CRLM with similar short- and long-term
results that delayed strategy.
PPL26-003
THE ROLE OF LIVER RESECTION IN
THE TREATMENT OF NON-
COLORECTAL AND NON-
NEUROENDOCRINE LIVER
METASTASES (NCNNLM): OUR
EXPERIENCE.
Samuele Vaccari, Mariateresa Mirarchi, EmilioDe
Raffele, Silvia Palumbo, Ferdinando Lecce, Barbara
Dalla Via, Dajana Cuicchi, Roberto Bellusci, Antonino
Cavallari and Bruno Cola
U.O. Chirurgia Generale e d’Urgenza – Prof. Cola, Italy
Introduction: Hepatic resection (HR) is an accepted
treatment for patients with colorectal liver metastases
(CRLM) and neuroendocrine liver metastases (NELM);
however, the role of surgery remains ill defined and
controversial for patients with NCNNLM. The present
study was performed to analyze the outcome of our
series of HR for NCNNLM.
Method: From January 2000 to June 2013, 300 HR
have been performed with curative intent by one of the
authors and were included in a prospective database.
Two hundred fifty-three (84.3%) HR were done for
CRLM, whereas 47 (15.7%) resections were performed
for non-CRLM. Among these, 11 were performed for
NELM and 36 for NCNNLM. Patients’ demographics,
clinical and histopathological parameters, intra and
perioperative results were analyzed. The chi-square and
the Student’s t tests were used for statistics; significance
was defined as p ≤ 0.05.
Results: NELM included 7 males and 4 females aged
63.54  10.62 years [44–79]; NCNNLM included 17
males and 19 females aged 64.28  10.06 years [47–80]
(p = ns). Intraoperative blood transfusions were
268.18  492.07 mL [0–1500] and 169.44  289.20 mL
[0–1000] in NELM and NCNNLM (p = ns). Duration
of surgical procedure was 393  133 minutes [235–680]
and 282  96 minutes [117–585] in NELM and
NCNNLM, respectively (p = 0.004). Minor LR were
45.4% in NELM and 77.8% in NCNNLM, respec-
tively (p = ns). Postoperative complications were 36.4%
and 16.8% in NELM and NCNNLM, respectively
(p = ns). There was no postoperative death. Postopera-
tive hospital-stay was 13.09  8.23 days [7–36] e di
10.83  5.71 days [5–36] in NELM and NCNNLM,
respectively (p = ns). The median overall survival, cal-
culated from the time of LR, was 25.0  37.9 months
[1–129] in the NELM and 25.9  32.8 months [0–118]
in the NCNNLM, respectively (p = ns).
Conclusions: In our experience LR for NCNNRM had
similar perioperative results than hepatectomy for
NELM and can offer acceptable long-term survival.
Besides, immediate and long term results are similar to
those of hepatic resection for CRLM.
PPL26-004
HEPATIC RESECTION AFTER
SEQUENTIAL TRANSCATHETER
ARTERIAL CHEMOEMBOLIZATION
(TACE) AND PORTAL VEIN
EMBOLIZATION (PVE) FOR
ADVANCED HEPATOCELLULAR-
CARCINOMA: AN OPTIMAL STRATEGY
Tullio Piardi1, Daniele Sommacale1, Martin Lhuaire1,
Brigitte Bernard-Chabert1, Audrey Cagniet1, Thomas F
Baumert2, Gerard Thiefin1, Jacques Marescaux2, Reza
Kianmanesch1 and Patrick Pessaux2
1DUNE POLE, France; 2Pole Hepato-Digestive-
Hopitaux Universitaires of Strasbourg-University of
Strasbourg-France, France
Introduction: Sequential transcatheter arterial chemo-
embilization (TACE) and portal vein embolization
(PVE) was proposed for reduced liver failure after
resection and controlled tumour progression. The aim
of this study was to evaluate the early post-operative
course of HCC resection after TACE and PVE.
Method: From January 2012 to June 2013, 49 patients
with HCC on cirrhosis liver were included from two-
institutional database. Thirty-three underwent surgical
resection immediately and 3 had PVE alone. Due to a
small future remnant liver (>50%), in 13 patients
(26.5%) a sequential TACE + PVE was programmed.
Clinicopathological data were analysed.
Results: The total strategy (TACE + PVE + surgery)
was performed in 12 patients. In one case (7.7%) it was
not possible due to tumor progression. TACE-PVE was
well tolerated in all patients. The mean increase of the
future liver remnant (FLR) volume was 10%. All
patients underwent a subsequent hepatic resection: 9
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right hepatectomy, 2 posterior sectoriectomy and 1
extended right hepatectomy. Anterior approach with
hanging manoeuvre was carried out in 88%. Intermit-
tent pedicle clamping was required in 66.6% (median
44 minutes; range 17–63) and in 1 was associated a
total vascular exclusion. Resection of diaphragm
(n = 3) and lymphadenectomy of hepatic pedicule
(n = 1) were associated. The post-operative mortality
and morbidity were 8% and 58%, respectively. Major
complications (Dindo ≥ III) were present in 25% and
minor complications (Dindo ≤ II) were present in
41.5%. The incidence of hepatic failure was 8.3%. The
mean hospitalisation stay in ICU was 3.25 days
(1–16 days). The mean hospital stay was 13.6 days (7–
35 days). Pathological examination revealed 100%
tumour necrosis in 16.6%, 60–80% necrosis in 58.3%,
<50% necrosis in 16.6% and 8.3% without necrosis.
Conclusions: Despite a relatively high morbidity rate,
the sequential TACE and PVE allows to propose liver
resection in patients primary not eligible for surgery.
PPL26-005
OUTCOMES OF TRANSCATHETER
ARTERIAL CHEMOEMBOLIZATION
FOR GIANT IRRESECTABLE
HEPATOCELLULAR CARCINOMA:
CASE SERIES OF 24 PATIENTS FROM A
TERTIARY HOSPITAL
Leonard Ho, Winston Woon, Sameer Junarkar, Pua
Uei, Sundeep Punamiya and Low Jee Keem
Tan Tock Seng Hospital, Singapore
Introduction: Hepatocellular carcinoma (HCC) is a
common malignancy with a global increasing incidence.
Only 30–40% of patients are surgical candidates. Sur-
gery is often contraindicated due to advanced disease
or poor hepatic function. Advances in management of
irresectable HCC using TACE has improved survival.
Presently, there is limited data on clinical outcomes in
patients with giant HCC (defined as ≥10 cm in this
study) who are treated with TACE. This study evalu-
ates the survival data of patients with giant irresectable
HCC who have undergone TACE.
Method: This retrospective study was performed on
patients in our institution with radiologically or histo-
logically proven giant irresectable HCC. These patients
underwent TACE and had their survival data reviewed.
Results: Between 2002 and 2012, 24 patients were diag-
nosed with giant irresectable HCC. 20 (83%) were
males and 4 (17%) were females. Mean age was
69 years old (50–82 years old). Main contraindications
to surgery were multiple co morbidities and poor liver
function. Median Childs’ score was 6 points (5–8). No
distant metastasis was present at diagnosis. 16 patients
(66%) underwent conventional TACE while 8 (33%)
underwent TACE with beads. Average tumor diameter
was 14.0 cm (10.1–19.0). The median number of
courses of TACE was 2. 17 (71%) patients achieved
same or reduction in tumor size post treatment while 7
(29%) patients had increase in tumor size. No patient
was admitted for tumor rupture. 3 (12.5%) patients
developed immediate post procedural complications; 1
patient died from acute liver failure while 2 patients
developed liver abscesses. 12 patients (50%) achieved
1 year survival. 3 patients (12.5%) achieved 2 year sur-
vival.
Conclusions: TACE is a safe and feasible treatment
option for patients with giant irresectable HCC.
PPL26-006
INTERDISCIPLINARY STRATEGY TO
TREAT PRIMARY UNRESECTABLE
LIVER METASTASIS OF COLORECTAL
CANCER: 5 YEAR FOLLOW-UP
Michael Vozdizhenskiy and Vyacheslav Solovov
Samara Oncology Center, Russia
Introduction: The aim of the study is to show the effec-
tiveness of the interdisciplinary approach in the treat-
ment of primary unresectable liver metastasis of
colorectal cancer (mCRC).
Method: Treatment results of 122 patients with mCRC
were included in the retrospective analysis. Strategy of
treatment were developed due to the interdisciplinary
approach of oncosurgery, medical oncologist and inter-
vention radiologist. All patients in this group had a 3–4
course of neoadjuvant chemotherapy (FOLFOX,
FOLFIRI) and 9 patients additionally intra-arterial
chemoembolization (an average 2 courses). In 62
(50.9%) patients liver resection combined with RFA.
Two-stage hepatectomy was performed in 7 (5.7%)
patients. Median follow-up was 48.7 months (12–68).
Results: Tumor response after a first-line chemotherapy
gave possibility to perform a resection in 81% of
patients, 19% had held the second line chemotherapy,
which was combined with embolization in 7.4%
patients. 3- and 5-year survival rates were 51% and
36.2%, respectively. The median survival was
41 months.
Conclusions: The multimodal approach in treatment of
primary unresectable hepatic colorectal cancer metasta-
ses increased the 5-year survival rate till 36.2%. 5-year
disease-free survival rate was 26.2%.
PPL26-007
VARICO-CAVAL SHUNT PROCEDURE
Koroush Haghighi1, Tamara Preda2 and Mark Danta2
1UNSW, Australia; 2St. Vincent’s Hospital Sydney,
Australia
Introduction: Management algorithms for patients with
cirrhotic portal hypertension have evolved into
accepted protocols. That of upper gastrointestinal (GI)
bleeding due to non cirrhotic causes remains confound-
ing. We present an approach to the management of a
patient with extensive gastro-esophageal and duodenal
varices secondary to portal, splenic and superior mesen-
teric vein thrombosis further complicated by recurrent
GI bleeding. In such a patient, TIPSS procedure is not
an option; other surgical shunts being inappropriate
due to venous anatomy. We describe a primary varico-
caval shunt technique.
Method: A 68-year-old man with GI bleeding refrac-
tory to medical and endoscopic management and
ongoing transfusion requirement was reviewed by a
hepatobiliary surgeon (KSH). Multiple imaging modali-
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ties demonstrated complete portal vein occlusion with
extension into the splenic and superior mesenteric
veins. No cause was found. Liver disease was not pres-
ent.
Multidisciplinary team review concluded that TIPSS
and standard shunt procedures were not feasible.
Prominent duodenal varices adjacent to the IVC were
considered options for shunting.
After informed consent under general anaesthesia, the
abdomen was opened. The lesser sac was entered and
portal triad defined. Prominent omental, gastric, duode-
nal and head of pancreas varices were evident. Inflow
and outflow control of the IVC was established and a
side to side varico-caval anastomosis performed to a
6 9 10 mm duodenal varix. Following removal of vas-
cular clamps, immediate variceal decompression was
noted. The patient underwent an uneventful post-oper-
ative course.
Results: Progress gastroscopy confirmed marked reduc-
tion in variceal calibre; no further GI bleeding
reported.
Conclusions: We present a primary varico-caval shunt
technique for consideration in patients with non cir-
rhotic portal hypertension with large varices and
appropriate surgical expertise to perform this opera-
tion.
PPL26-008
EARLY OUTCOME AFTER HEPATIC
RESECTION – EXPERIENCE FROM A
DEVELOPING COUNTRY WITH
LIMITED RESOURCES
Saleema Khan, Muhammad Rizwan Khan and M
Shahrukh Effendi
Aga Khan University & Hospital, Pakistan
Introduction: Recent enhancements in understanding of
surgical anatomy of liver and technological innovations
have made hepatic resection a common procedure in
the developed world. But due to lack of resources and
infrastructure, the patients from the developing world
are still not offered such procedures as a routine. We
are a tertiary care hospital located in a developing
country with limited resources and lack of modern
sophisticated equipments. The objective of our study
was to review the initial experience and early outcome
of hepatic resections performed at our hospital.
Method: Formal hepatic resection at our hospital was
started in 2008. All the patients who underwent hepatic
resection for various malignant and benign lesions of
liver between Jan 2008 and June 2013 were included in
the study. The variables studied included indications of
surgery, type of hepatic resection, blood loss, early
morbidity and mortality. The frequencies were calcu-
lated using SPSS v 19.
Results: A total of 42 patients underwent hepatic resec-
tion during the study period. Indications for surgery
included primary hepatic malignancy (23), metastatic
malignancy (9), and benign hepatic tumors (9). One
third of the patients underwent major hepatectomy.
Mean duration of surgery was 297 minutes with mean
estimated blood loss of 809 mL. Overall morbidity rate
was 38%, hospital mortality rate was 2.3%, while mor-
tality rate at 1 year was 14.2%. In a sub-group analy-
sis, 1-year mortality rate in cirrhotic patients with HCC
was 9.5%, as compared to 4.7% in non-cirrhotics; and
27.7% of the patients developed recurrence during the
follow up period.
Conclusions: Despite limitation of resources, hepatic
resection can be performed in our setup with reason-
able early postoperative outcome. Mean blood loss is
on the higher side and can be improved by modifica-
tion of technique and introduction of new technology.
The outcome of cirrhotic patients is comparatively
modest.
PPL26-009
A NOVEL AND REPRODUCIBLE
METHOD FOR MONITORING INTRA-
ABDOMINAL PRESSURE DURING CO2
PNEUMOPERITONEUM
Joel Lewin and Nicholas O’Rourke
Royal Brisbane Hospital, Australia
Introduction: Carbon dioxide pneumoperitoneum is
routine for laparoscopic surgery. Insufflator pressure
is normally set between 12 and 16 mmHg. For man-
agement of intra-abdominal bleeding during laparo-
scopic surgery, pressure can be elevated to 20 mmHg
or even greater, however the consequences of this
raised intra-abdominal pressure are uncertain and
unpredictable.
Method: This paper describes a novel technique to
measure intra-abdominal pressure (IAP). The technique
involves use of a standard anaesthetic arterial line pres-
sure transducer connected to an intra-abdominal port,
with data recorded by the anaesthetic monitoring
device. This allows constant recording of IAP on the
anaesthetic monitor, which can be immediately or sub-
sequently compared to simultaneous recordings of arte-
rial pressure, central venous pressure and other
anaesthetic parameters.
Results: This technique has been validated in standard
laparoscopy and laparascopic liver resection, and
appears to be extremely accurate. It is currently being
evaluated in laparoscopic liver surgery where pressures
of 20 mmHg are often used to reduce intraoperative
haemorrhage.
Conclusions: This previously unreported technique
allows constant, real-time monitoring of IAP and corre-
lates it with any changes in arterial or central venous
pressure, providing a fertile ground for further investi-
gative studies into the effects of carbon dioxide pneu-
moperitoneum.
PPL26-010
STAGING CIRRHOSIS TO IMPROVE
THE LONG-TERM OUTCOMES OF
LIVER RESECTION FOR
HEPATOCELLULAR CARCINOMA
Zhi-yong Huang, Bin-yong Liang and Xiao-ping
Chen
Huazhong University of Science and Technology, China
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Introduction: For patients with Hepatocellular carci-
noma (HCC) fulfilling the Milan criteria, especially for
those with compensated liver function, both liver trans-
plantation and resection could be indicated. Studies
have suggested that cirrhosis is a significant adverse
prognostic for liver resection, and liver transplantation
is superior to resection. Due to organ shortage, liver
transplantation cannot be effectively applied to every
patient on the waiting list. Severity of cirrhosis has
never been staged for evaluation on long-term out-
comes of liver resection, and whether long-term out-
comes of resection could be further improved through
patient selection by staging cirrhosis remains unknown.
Method: Two hundred and seventy-six patients with
HCC fulfilling the Milan criteria undergoing either liver
resection or liver transplantation were retrospectively
reviewed. The patients with Child–Pugh A in the resec-
tion group were stratified by different stages of cirrho-
sis that were determined by the Laennec fibrosis
scoring system, and the survivals of the subgroups with
different stages of cirrhosis were compared with those
of the transplantation group.
Results: The 5-year recurrence-free and overall survival
rates were 49.3% and 71.8%, respectively, in the resec-
tion group, and 83.6% and 89.2%, respectively, in the
transplantation group. The 5-year recurrence-free and
overall survival rates were 68.5% and 92.5%, respec-
tively, in the subgroup of no cirrhosis; 63.4% and
85.9%, respectively, in the subgroup of mild cirrhosis;
and 28.6% and 50.4%, respectively, in the subgroup of
moderate/severe cirrhosis. There was no significant dif-
ference between the subgroups of either no cirrhosis or
mild cirrhosis and the transplantation group in recur-
rence-free survival or overall survival, whereas patients
in the subgroup of moderate/severe cirrhosis had signif-
icantly worse recurrence-free and overall survival than
those of the transplantation group.
Conclusions: Liver resection achieves similar outcomes
as liver transplantation in the HCC patients with no
cirrhosis or mild cirrhosis. Liver resection could be the
first-line treatment for these patients.
PPL26-011
LASER SPECKLE CONTRAST IMAGING
FOR INTRA-OPERATIVE ASSESSMENT
OF LIVER MICROCIRCULATION: A
CLINICAL PILOT STUDY
Sam Eriksson, Jan Nilsson, Gert Lindell and Christian
Sturesson
Clinical Sciences, Lund University, Sweden
Introduction: Liver microcirculation can be affected by
a wide variety of causes relevant in liver transplanta-
tion and resectional surgery. Intra-operative assessment
of the microcirculation can possibly predict postopera-
tive outcome. The present pilot study introduces laser
speckle contrast imaging (LSCI) as a new clinical
method for assessing liver microcirculation.
Method: LSCI measurements of liver microcirculation
were performed on 10 patients undergoing liver resec-
tion. Measurements were made during apnea with and
without liver blood inflow occlusion. Hepatic blood
flow (HBF) was assessed by subtracting zero inflow
signal (ZIS) from the total signal. ZIS was obtained
after hepatic artery and portal vein occlusion and
included movement artifacts due to heart beatings. Per-
fusion was expressed in laser speckle perfusion units
(LSPU) and intra- and inter-individual variability in
liver perfusion was investigated using the coefficient of
variability (CV).
Results: Hepatic microcirculation measurements were
successfully made in all patients resulting in analyzable
speckle contrast images. Mean HBF was 410  36
LSPU. ZIS amounted to 40  4% of the total signal.
Intra-and inter-individual CV in liver perfusion were
25% and 28%, respectively.
Conclusions: LSCI allows a fast non-contact way to
assess hepatic microcirculation, permitting simultaneous
and continuous measurement of a large surface area.
By Averaging perfusion over a larger area, absolute
perfusion values can be compared between subjects
without the need for relative measurements. Technical
and software development is needed to reduce move-
ment artifacts due to heart beatings, which were found
to be considerable.
PPL26-012
MIR-526B IS INVOLVED IN DOWN-
REGULATION OF KU80 EXPRESSION
AND TUMOR PROGRESSION OF
HEPATOCELLULAR CARCINOMA
Zunyi Zhang and Zhi-yong Huang
Tongji hospital, Huazhong University of Science and
Technology, China
Introduction: Ku80 is a component of the protein com-
plex called DNA-dependent kinase. Previous study has
revealed that Ku80 is frequently downregulated in
HCC compared with the adjacent liver tissue. But the
mechanism for Ku80 down-regulation is still unknown.
MicroRNA (miRNA) is a new class of small, noncod-
ing RNAs that can down-regulate protein expression.
However, what microRNAs are involved in regulation
of Ku80‘s expression is still unknown.
Method: Based on 5 released databases named miR-
anda, miRDB, miRWalk, RNA22, Targetscan that can
be used to predict the relationship between microRNA
and target protein, miR-31, miR-340, miR-188, miR-
297, miR-520, miR-524, miR-526b and miR-623 were
implicated to be involved in the regulation of ku80
expression with the highest possibility. All these mi-
croRNAs were trasfected into HepG2 and PLC cell
lines, respectively, and Ku80 expression was detected
by Western blot. After the stable cell lines were chosen,
and the antagomir corresponding to the most effective
microRNA was tansfected into the cell lines with the
higher expression of this microRNA. The cell growth
and apoptosis were studied in vivo. Furthermore, the
microRNA expression was further investigated in
human HCC and its adjacent liver tissue. The relation-
ship between the micro RNA expression and biological
features of the tumors were analyzed in 60 different
patients with HCC.
Results: miR-526b was able to down-regulate the
expression of Ku80 in HepG2 and PLC cell lines. After
blocking miR-526b by the anatgomir, the expression of
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Ku80 was up-regulated in PLC cells. The down-regula-
tion of miR-526b resulted in growth inhibition and
apoptosis in PLC cells. miR-526b was found up-regu-
lated in HCC comparing with its adjacent liver tissue in
41% patients. And the up-regulated miR-526b was sig-
nificantly correlated with poor differentiation of the
tumor.
Conclusions: miR-526b is involved in down-regulation
of Ku80, and increased miR-526b expression is associ-
ated with tumor progression of HCC.
PPL26-013
LIVER REGENERATION AFTER
PORTAL VEIN LIGATION FOLLOWED
BY PET/MRI IN RATS
Attila Szijarto, Andras Fulop, Andras Budai, Diana
Korsos, Damjan Pekli, Gabor Lotz, Andras Kiss,
Ildiko Horvath and Krisztian Szigeti
Semmelweis University, Hungary
Introduction: Portal vein ligation (PVL) produces atro-
phy of the ligated and hypertrophy of the non-ligated
liver lobes. The aim of present study was to selectively
evaluate the glucose utilization of ligated and non-
ligated lobes in parallel with morphological alterations
after PVL using FDG PET/MRI scanner for small ani-
mals.
Method: Male Wistar rats (n = 24) underwent PVL.
The portal branches feeding approximately 80% of
liver mass were ligated. The animals were sacrificed
before (0 h), and 24, 48, 72 hours after PVL and mor-
phological examinations (regeneration rate, necrosis,
apoptosis, mitosis, glycogen content) were performed.
In a separate study additional 6 animals underwent
PET/MRI imaging by injection of 6.5  1.1 MBq of
[18F]-2-Fluoro-2-deoxyglucose in the tail vein 12 hours
before and 24, 48, 72 hours after PVL.
Results: PVL induces atrophy in ligated lobes caused
by extensive necrosis and apoptosis accompanied by
significant macrophage activity. Glycogen content
almost completely disappeared in these lobes after PVL
and remained significantly lower than the base line level
throughout the entire experiment. In contrast, the non-
ligated liver lobes underwent compensatory hypertro-
phy with increased mitotic activity of hepatocytes. The
glycogen content of these lobes did not show any sig-
nificant differences compared to the base line. In the
ligated lobes the irreversible uptake of FDG was
unchanged, while the reversible tracer kinetics
decreased as a result, there was an increased accumula-
tion of FDG. In contrast in the non-ligated lobes both
the irreversible and the reversible uptake of FDG
showed a moderate decrease.
Conclusions: In the ligated lobes accumulation of FDG
was observed caused by the increased metabolic
demand of apoptosis and inflammation and the
enhanced glygenolytic activity of cells. On the other
hand, in the non-ligated liver lobes, both the reversible
and irreversible kinetics of FDG decreased moderately
despite the high energy requirement of regeneration.
PPL26-014
PRIMARY MALIGNANT PERIPHERAL
NERVE SHEATH TUMOR OF THE
LIVER
Sangho Bae, Changho Kim and Haeil Jung
Soonchunhyang University Hospital Cheonan, Korea
Introduction: Primary malignant peripheral nerve
sheath tumor (MPNST) in a young female patient, not
associated with von Recklinghausen‘s disease is an
extremely rare in the liver. We report a case diagnosis
based on detailed immnohistochemical and electromi-
croscopic examination and its follow up.
Method: A 33-year-old female, with a history of sur-
gery for left ovary cystectomy, 8-year ago was admitted
in suncheonhyang University Hospital in cheoan, her
chief complaint was a right flank pain for a weak, on
physical examination, there was no lesion on skin (ex
cafe au lait) with neurofibromatosis type I, and labora-
tory date was not specific findings. The CT scan
showed with 12.5 9 11 cm sized mass located at right
lobe, and operative findings were a 20 9 16 cm sized
mass on right lobe with invasion on right diaphragm,
so right hepatecomy and shaving of diaphragm was
done. Histologically, on FNCLCC system, the tumor
differentiation sore was 3, mitotic count was 8 on 10
HPFs, necrosis was 30%. On immunohistochemistry,
the tumor cells were strong positive for s-100 protein,
bcl-2, vimentin,
The patinents discharged at POD#13 without complica-
tion and received 30-cycles, 6000 cGy radation therapy,
and doing well 2-month after surgery. Eight cases of
malignant shwanoma have been reported in the liver,
its prognosis are generally poor and its associated with
a highly aggressive courses of recurrence, metastases,
and death but only two cases are not associated with
von Recklinghausen‘s disease, but we first report its fol-
low up including radiation therapy.
PPL26-015
SIMULTANEOUS AND STAGED
RESECTIONS OF COLORECTAL
CANCER WITH SYNCHRONOUS LIVER
METASTASES
I-Chen Tsai, Hao-Jan Lei, Cheng-Yuan Hsia, Gar-
Yang Chau, Kuang-Liang King and Jen-Kou Lin
Taipei Veterans General Hospital, Taiwan
Introduction: The surgical strategy for colorectal cancer
with synchronous liver metastasis remained controver-
sial. The aim of the study was to review the outcome,
and cost-benefit of simultaneous and staged resection
of hepatectomy with colorectal surgery at our center.
Method: Between December 2007 and December 2012,
131 patients received liver resection for synchronous
colorectal liver metastases; 93 patients received syn-
chronous hepatectomy and colorectal surgery, and 38
received staged colorectal surgery and liver resection.
The operative and peri-operative data, complications,
hospital stay and cost were reviewed.
Results: The simultaneous resection group had more
minor hepatectomy (< 3 Couinaud segments)
(p = 0.016) and were younger than staged resection
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group (59 vs 67 years old, p = 0.001). There was no
mortality in both groups. There were no significant dif-
ferences in total or severe (grade ≧ 3, Clavien-Dindo
classification) complication in both groups (53.8% vs
41.2%, p = 0.252; 28.0% vs 15.8%, p = 0.181). Patient
required fewer hospital stay and cost in simultaneous
group (18.8 days vs 25.7 days, p < 0.001; 234,579 NTD
vs 282,834 NTD, p = 0.001). Oncological outcome were
similar in both group (3 year overall survival 68.6% vs
61.5%, p = 0.61).
Conclusions: Simultaneous colorectal and liver resec-
tion is as safe as staged surgery with no difference in
morbidity and mortality rate, comparable oncological
outcome, and fewer hospital stay and less cost.
PPL26-016
COMPARISON OF THE OUTCOME OF
PRIMARY AND REPEAT SURGICAL
TREATMENT FOR RECURRENT
COLORECTAL LIVER METASTASES
Huisong Lee1, Seong Ho Choi1, Yong Beom Cho1,
Seong Hyeon Yun1, Hee Cheol Kim1, Woo Yong Lee1,
Jin Seok Heo1, Dong Wook Choi1, Kyung Uk Jung2
and Ho-Kyung Chun2
1Samsung Medical Center, Sungkyunkwan University,
Korea; 2Gangbuk Samsung Medical Center, Korea
Introduction: The aim of this study is to investigate the
outcomes of repeat surgical treatment for recurrent
colorectal liver metastases (CLM) compared with pri-
mary surgical treatment.
Method: From October 1994 to December 2007, the
patients with CLM who underwent curative intent sur-
gical treatment were investigated retrospectively. The
patients were divided into two groups: primary CLM
with primary surgical treatment (group 1) and recurrent
CLM with repeat surgical treatment (group 2). The sur-
vival and risk factors were analyzed.
Results: Total 393 patients were included: 349 patients
in group 1 and 44 patients in group 2. After median 40-
month (range 1–195) follow up, there was no significant
difference between the group 1 and 2 in disease free and
overall survival (OS) curves (p = 0.975, p = 0.252). In
recurrent CLM, the number of recurrence was a prog-
nostic factor in Cox regression test (p = 0.037).
Conclusions: Repeat surgical treatment for recurrent
CLM is effective as primary surgical treatment for pri-
mary CLM.
PPL26-017
RECURRENCE PATTERN DEPENDS ON
THE LOCATION OF COLON CANCER
IN THE PATIENTS WITH
SYNCHRONOUS COLORECTAL LIVER
METASTASIS
Huisong Lee1, Dong Wook Choi1, Yong Beom Cho1,
Seong Hyeon Yun1, Hee Cheol Kim1, Woo Yong Lee1,
Jin Seok Heo1, Seong Ho Choi1, Kyung Uk Jung2 and
Ho-Kyung Chun2
1Samsung Medical Center, Sungkyunkwan University,
Korea; 2Gangbuk Samsung Medical Center, Korea
Introduction: The veins from the lower rectum drain
into the systemic venous system, while those from other
parts of the colon drain into the portal venous system.
The aim of this study was to investigate recurrence pat-
tern and survival according to the anatomical differ-
ences in patients with colorectal liver metastases
(CLM).
Method: From October 1994 to December 2009, syn-
chronous CLM patients who underwent R0 or R1 sur-
gery were identified from our prospectively collected
database. The patients were excluded if there had been
extrahepatic metastases. The patients were divided into
two groups according to the location of the primary
colorectal cancer: lower rectal cancer (group 1) and
upper rectal or colon cancer (group 2). The recurrence
patterns and survival were investigated.
Results: A total of 316 patients were included: 78
patients in group 1 and 238 patients in group 2. After
a median follow-up of 37 months, the extrahepatic
recurrence rate in group 1 (37 patients, 47%) was sig-
nificantly superior to that of group 2 (69 patients,
29%) (p = 0.003). The disease-free and overall survival
curves of group 1 were inferior to those of group 2
(p = 0.011) (p = 0.002). Lower rectal cancer was a sig-
nificant risk factor for extrahepatic recurrence in multi-
variate analysis (HR = 1.603, p = 0.037).
Conclusions: The extrahepatic recurrence rate is high in
lower rectal cancer patients after surgical treatment for
synchronous CLM. If there is CLM from lower rectal
cancer, a short-term follow up and detailed work up
are necessary.
PPL26-018
EARLY CUTANEOUS METASTASIS
POST HEPATOCELLULAR
CARCINOMA RESECTION – CASE
REPORT
Boon Koon Yoong, Jun Kit Koong, Peng Soon Koh
and Khoon Leong NG
Mr, Malaysia –> 확인중
Introduction: Hepatocellular carcinoma (HCC) with
cutaneous metastasis is rare, occuring in 2.7–3.4% of
HCCs and accounts for <0.8% of all known cutaneous
metastasis. Majority of the cutaneous metastasis origi-
nate from needle track or surgical wound contamina-
tions. Spontaneous cutaneous metatasis is very rare.
The median survival time and 1 year survival rate for
these patients are very poor.
Method: We report a case of an elderly gentleman who
was diagnosed with hepatocellular carcinoma and
developed cutaneous metastasis after surgery.
Results: The patient presented to our institution with
loss of appetite, loss of weight and a palpable liver
mass. Multiphasic computed tomography (CT) scan of
the liver showed a large right lobe liver tumor and int-
rahepatic duct dilatation. Staging CT scan does not
show distant metastasis. Right portal vein embolisation
was done to obtain adequate liver volume for resection.
A right hepatectomy, with an en bloc resection of the
diaphragm was subsequently done. Histopathological
examination (HPE) confirmed hepatocellular carcinoma
with adquate resection margins. Upon follow up
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3 months later, firm nodular swellings over the chest
wall, arms and thighs were found. Incisional biopsy of
these lesions revealed metastatic hepatocellular carci-
noma. He was subsequently treated with Sorafenib but
was unable to tolerate it’s side effects. The patient suc-
cumbed to his illness 2 years after surgery.
Conclusions: Extrahepatic cutaneous metastases of
hepatocellular carcinoma is very rare and despite hav-
ing an operable tumour initially, post operative metas-
tases confers poor prognosis and survival rate.
PPL26-019
LIVER DAMAGE AFTER BLUNT
ABDOMINAL TRAUMA:
LAPAROSCOPIC APPROACH.
Igor Khatkov2, Aleksey Pankratov1 and Pavel
Tyutyunnik1
1MSUMD, Russia; 2Moscow Scientific Research
Institute of Gastroenterology, MSUMD, Russia
Introduction: To value our results of using a laparo-
scopic approach for patients with blunt traumatic liver
injuries.
Method: Single hospital experience: ten man and two
woman had a blunt abdominal trauma (BAT) resulted
in liver damage. Mean age 30.7 years (range 15–
53 years). The causes of BAT were: sport n = 1, falls
n = 2, motor vehicle accidents or car-pedestrian acci-
dents n = 4, unknown reason n = 5. Time before an
admission: in first 3 hours n = 6, 72 hours n = 1,
unknown period of time n = 5. BAT n = 7, combined
trauma n = 5. Laparoscopy was performed for hemodi-
namically stable patients with hemoperitoneum by
ultrasound ≤500 mL or 12 hours later trauma incident
with any volume of hemoperitoneum. Grade I n = 8,
grade II n = 2, grade III n = 1 and grade IV n = 1
[Moore]. Mean volume of hemoperitoneum 458.3 mL
(range 150–1100 mL).
Results: Treatment laparoscopy n = 9 (coagulation
n = 5, coagulation and laparoscopic spleenectomy
n = 1, exploration and drainage n = 3), conversion
n = 3. Reasons for conversion: severe bleeding (grade
IV [Moore] or combined injuries of liver and spleen),
paraduodenal hematoma. There were no lost injuries in
this study. Complications rate: 2 out of 12 patients
(right lobe of liver central hematoma was percutane-
ously drained; relaparoscopy without any finds). Mor-
tality rate 1 out of 12 patients (grade IV [Moore] with
conversion). Mean length of hospital stay 24.4 days
(range 5–105 days).
Conclusions: Laparoscopy could be an adequate and
informative alternative to laparotomy for hemodinami-
cally stable patients with liver damage after blunt
abdominal trauma.
PPL26-020
IMPACT OF HBV DNA LEVEL &
ANTIVIRAL AGENT ON THE
RECURRENCE OF PATIENTS AFTER
LIVER RESECTION FOR HEPATITIS B
VIRUS–RELATED HEPATOCELLULAR
CARCINOMA
Tae Yoo, Kyung-Suk Suh, Kwang-Woong Lee, Nam-
Joon Yi, Hae Woon Lee, Geun Hong, Young Rok
Choi, Sukwon Suh and Jeungmoo Lee
Seoul National University Hospital, Korea
Introduction: To investigate the significance of HBV
DNA levels & antiviral agent for predicting recurrence in
HCC patients who underwent curative liver resection.
Method: From 2005 to 2010, 341 HBV-related HCC
patients who underwent tumor resection in Seoul
National University Hospital were enrolled. HBV
DNA levels (pre-, postop. viral load) and antiviral
treatment were analyzed for association with HCC
recurrence, together with other clinical variables.
Results: Of the 294 patients, patients (n = 197) with low
preop. HBV DNA level (2.5 9 105 IU) had better recur-
rence outcome than those (n = 97) with high level
(5 year-RFS = 36.3 vs 26%, p = 0.01). Also in postop.
period, the group (n = 164) with low viral titer
(1 9 103 IU) had better outcome than those (n = 130)
with high viral load in recurrence (5 year-RFS = 43.2%
vs 22.2%, p < 0.001). In terms of Antiviral agents, un-
treatment group (n = 136) had worse outcome than
treatment group (n = 158) in recurrence (5 year-
RFS = 28.3% vs 56.3%, p < 0.001). In subgroup
analysis, if the treatment group had high HBV viremia
postoperatively, they had good recurrence free survival
(RFS) as group with low viremia (5 year-RFS = 54.1%
vs. 58.3%). But, even if untreated patients had low vire-
mia, they had poor outcomes as untreatment group with
high viremia (5-year RFS = 37.1% vs. 11.9%). More-
over, whether it is advanced stage (III) or not, low
postop. HBV viral load showed the better recurrence
outcome but, antiviral treatment did not present differ-
ence in advanced stage. Finally, postop AFP levels
(HR = 3.52, p < 0.001) as well as postop HBV DNA
(HR = 2.2, p < 0.001), antiviral therapy (HR = 2.28,
p < 0.001), tumor size (HR = 1.54, p = 0.025), micro-
vascular invasion (HR = 1.997, p = 0.005) were indepen-
dent risk factors for RFS in multivariated analysis.
Conclusions: Low HBV DNA load and antiviral ther-
apy may be important factors after the curative treat-
ment of HBV-related hepatocellular carcinoma in terms
of tumour recurrence.
PPL26-021
LOCALLY ADVANCED
HEPATOBLASTOMA IN CHILDREN:
OPTIMAL MANAGEMENT STRATEGY
Madhusudhan Chinthakindi1, R Pratap Reddy1, T
Ravimohan1, Moksha Prasuna1, Narayan Rao Dvl1, J
Vinod Kumar1, Leela Kumar2 and Narayana Dr2
1Osmania General Hospital, Hyderbad, Ap, India;
2Niloufer Hospital, Hyderabad, India
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Introduction: Hepatoblastoma is the most common pri-
mary liver tumour in children. Complete surgical
removal is the treatment of choice for cure; however, in
most cases the tumour is unresectable because of its
extensive hepatic involvement. This study aims to assess
the influence of the combination chemotherapy and
advanced surgical principles in hepatic resections on
the tumor resectability and the outcome of patients
with advanced hepatoblastoma.
Method: Ten pediatric cases of advanced Hepatoblas-
toma (8 boys, 2 girls) with ages ranging from 2 months
to 14 years were referred for the management to our
hospital from 2010 to 2013. All were conventional
hepatic resections, done with ipsilateral extra hepatic
inflow and out flow vascular control. Parenchymal
transection done with Kelly clysis and harmonic scal-
pel. Cisplatinum and adriamycin chemotheraphy regi-
men (preoperative/post operative) was used in
unresectable/residual tumor patients.
Results: All but one suffered from abdominal disten-
tion. Serum alpha-fetoprotein levels were elevated in all
patients. Right hepatectomy in 6, right extended hepa-
tectomy in 2, left hepatectomy in 1 and non anatomical
liver resection in 1 patient were done. Preoperative che-
motherapy (cisplatin + adriamycin) was given in 3
patients due to unresectability because of its extensive
hepatic involvement. One patient received post opera-
tive chemotherapy due to margin and lymph node
involvement. In 6 patients, no chemotherapy was given
and curative resection was done in them and kept on
regular follow up. 30 day hospital mortality was 10%.
One patient had minor bile leak managed conserva-
tively.
Conclusions: A combination of improved chemother-
apy and technical advances in anesthesia and hepatic
resection caused the obvious improvement in the sur-
vival of advanced hepatoblastoma. Preoperative chemo-
therapy resulted in an increased resectability of the
tumor, whereas postoperative chemotherapy played an
important role in the increased cure rate of cases with
either an incomplete tumor resection or metastasis.
PPL26-022
SELECTIVE GLISSONIAN PEDICLE
CONTROL: A USEFUL TECHNIQUE IN
LAPAROSCOPIC LIVER RESECTION
Rawisak Chanwat, Chairat Bunchaliew and Thiravud
Khuhaprema
National Cancer Institute, Thailand
Introduction: Laparoscopic liver resections are becom-
ing a common procedure and bleeding remains the
major concern during parenchymal transection. Prin-
gle’s maneuver can be performed but ischemic reperfu-
sion injury can lead to postoperative morbidity.
Selective hemihepatic inflow control can reduce the
severity of visceral congestion and total liver ischemia.
The purpose of this report was to describe our experi-
ence with laparoscopic selective Glissonian pedicle con-
trol for minor hepatic resection.
Method: Ten patients submitted to laparoscopic liver
resection in our institute due to malignant lesion.
Results: The technique was successfully performed
without complication. The tumor size was 4.3 cm
(range, 2.5–8.0 cm). Mean operative time consumed to
achieve complete control of right or left pedicle was
26.5 minutes (range, 18–46 minutes). Mean intraopera-
tive blood loss was 150 mL (range, 50–300 mL) and no
blood transfusion was needed. The postoperative
course of the patients was uneventful and they were
discharged an average of 4.8 days (range, 3–7 days)
after the operation.
Conclusions: Safe laparoscopic liver surgery requires
knowledge of the regular techniques of vascular occlu-
sion for on-demand use when necessitated to reduce
blood loss.
PPL26-023
ROBOTIC LAPAROSCOPIC
ASSOCIATING LIVER PARTITION
WITH PORTAL VEIN LIGATION FOR
STAGED HEPATECTOMY (ALPPS).
Evgeny Solomonov, Sigal Aizner, Eviatar Nesher,
Anton Kvasha, Ezra Shaharabani, Marius Brown,
Salomon Shtemer, Ofer Binyaminov and Eytan Mor
Tel Aviv University School of Medcine, Israel
Introduction: Associating Liver Partition with Portal
Vein Ligation for Staged Hepatectomy (ALPPS) is a
new procedure and a variant of two stages Hepatec-
tomy, allowing quick remnant hypertrophy and poten-
tial cure surgery with low incidence of postoperative
liver failure.
Trauma of the major liver surgery is a major concern
and may be decreased by minimally invasive approach.
Based on our experience in robotic liver surgery
accounting more than 50 cases with approximately
50% Major Liver Resections we proposed Robotic AL-
PPS.
Method: A 68-year-old male suffering 6 centimeters
hepatocellular carcinoma in the right lobe as per biopsy
and macrovesicular steatosis up to 30% and mild liver
fibrosis as per biopsy from the future remnant.
We proposed two-staged liver resection by ALPPS
technique and minimally invasive laparoscopic robotic
approach using Da Vinci surgical System.
Results: Both steps have been done fully robotically
with 14 days interval. Duration of the first stage was
390 minutes and the second 190. There was no blood
transfusion during the both steps of the surgery. The
patient was discharged 7 days after the first step and
on the day 3 after the second in good general condition
without complications.
Conclusions: Combination of two stages surgical strat-
egy with minimally invasive approach by using robotic
laparoscopic technique allowed uneventful recovery of
this patient with impaired liver parenchyma. Minimally
invasive robotic liver resection may have added value
in quick recovery process and should be used in spe-
cialized centers with expertise in both liver surgery and
robotics.
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PPL26-024
SPLENECTOMY: AN EFFECTIVE
ADJUVANT THERAPY FOR
HEPATOCELLULAR CARCINOMA?
Xin Long, Jian Wang, Jian-ping Zhao, Hui-fang Liang,
Peng Zhu, Qi Chen, Wang-guang Zhang, Bi-xiang
Zhang and Xiao-ping Chen
Tongji Hospital, Tongji Medical College, Huazhong
University of Science and Technology, China
Introduction: The role of spleen in the development of
hepatocellular carcinoma remains blurry. The aim of
this study was to clarify the effect of splenectomy on
growth and metastasis of hepatocellular carcinoma.
Method: Hepa1-6 and H22 cancer cells were injected
subcutaneously behind the anterior forelimb of C57
and Balb/c mice respectively. The tumors were sliced
into 1 mm3 nodules which were implanted in the left
lobe of mice liver when they grew into 1 cm3. The can-
cer cells were inoculated into the lateral tail vein of
C57 and Balb/c mice separately to establish metastatic
models. Mice were divided into splenectomy group and
control group. The size of implanted tumors and meta-
static nodules, overall survival rates, metastatic state
and MDSCs from the periphery blood were compared.
Results: The size of implanted tumors was significantly
smaller in splenectomy group than control group in
both type of mice. The lung metastatic rate was lower
in splenectomy group than control group (0% vs 20%,
p < 0.05) in C57 mice. For Balb/c tumor-implanted
mice models, lung metastasis (0% vs 20%, p < 0.05),
diaphragm invasion (0% vs 20%, p < 0.05), abdominal
cavity implantation (25% vs 40%, p < 0.05), abdomi-
nal wall invasion (50% vs 60%), intrahepatic metastasis
(0% vs 20%, p < 0.05), and ascite rates (0% vs 20%,
p < 0.05) were different between the two groups. For
tail vein injection of Balb/c mice models, the nodules in
lungs were smaller and fewer in splenectomy group
than control group, liver metastasis (20% vs 50%,
p < 0.05) and overall survival rates were also significant
between the two groups. MDSCs from periphery blood
in all mice models decreased in splenectomy group.
Conclusions: Splenectomy inhibited the hepatocellular
carcinoma growth and metastasis, which could be
involved with decreases in the periphery blood of
MDSCs induced by splenectomy. The deeper mecha-
nisms are being invested and clinical data are being col-
lected.
PPL26-025
APPRAISAL OF INDICATION AND
TECHNIQUE OF COUINAUD’S
SECTORIECTOMIES FOR
HEPATOCELLULAR CARCINOMA IN
THE LEFT LIVER
Masahiko Kainuma, Keiji Sano, Yutaka Ikeda,
Yoshiko Aoyagi, Hiromichi Ito, Naoyuki Toyota,
Keita Wada, Fumihiko Miura, Hodaka Amano and
Tadahiro Takada
Teikyo University School of Medicine, Japan
Introduction: Hepatocellular carcinoma (HCC) should
fundamentally be anatomically resected under portal
venous ramification (Couinaud’s classification) since
HCC potentially metastasize via portal vein. Therefore,
‘left lateral sectoriectomy (segment 2) ‘and ‘left parame-
dian sectoriectomy (segment 3 and 4)’ are oncologically
recommended for HCC in the segment 2, and segment
3 and 4, respectively, if the background liver function
is insufficient for left hemihepatectomy. However, in
the liver resection guidelines based on the classification
of liver anatomy defined in IHPBA Brisbane 2000 ter-
minology, the second-order division based on portal
vein is treated to be “alternative” in “addendum”. In
this study we appraised precise indication and tech-
nique of Couinaud’s sectorinectomies for HCC in the
left liver.
Method: In the latest 3 years, 120 hepatectomies for
HCC were performed in our institution. Among them
left lateral sectoriectomy was carried out in two cases,
and left paramedian sectoriectomy in one case. In the
former sectoriectomy, Glisson of segment 2 was ligated
at first, and transection was done along the demarca-
tion line. In both cases, the main trunk of the left hepa-
tic vein was exposed over an approximately whole
length on the transection surface. In the latter sectoriec-
tomy, hepatic artery to segment 3 and 4, and umbilical
portion of portal vein were ligated, followed by transec-
tion along the demarcation line exposing the main
trunk of the left and middle hepatic veins. Intraopera-
tive cholangiography showed preserving of the segment
2 biliary branch.
Results: In all three cases, operative bleeding amount
was under 1254 mL, and perioperative transfusion of
RCC was not needed. Postoperative serum bilirubin
value was all under 2 mg/dL. Postoperative course was
satisfactory.
Conclusions: Oncologically-recommended Couinaud’s
sectoriectomies in the left liver can be done safely
under the precise indication and the established opera-
tive procedures.
PPL26-026
ROLE OF SHUNT SURGERY IN BUDD
CHIARI SYDROME – 20 YEARS
EXPERIENCE OF A SINGLE TERTIARY
CARE CENTER
Nabi Prithiviraj1, Shyam K Thingam4, Arunanshu
Behera1, Radhakrishnan Dhiman2, Ajay Duseja2,
Dheepakkumar Bhasin3, Rakesh Kochar3, Surinder
Rana3, Kartar Singh3 and Yogeshwar Chawla2
1PGIMER, Chandigarh, India; 2PGIMER, India;
3PGIMER, India; 4PGIMER, India
Introduction: Decompressive shunt surgery, liver trans-
plantation and transjugular stenting are the accepted
modes of treatment in Budd Chiari syndrome (BCS).
The aim of the study was to evaluate the effectiveness
and outcome of shunt surgeries.
Method: This is a retrospective study of 146 patients
who underwent shunt surgery for BCS between January
1994 to August 2013, in PGIMER, Chandigarh, a ter-
tiary referral centre in India. All the patients underwent
Doppler and Magnetic Resonance Venography (MRV)
510 Poster Panel [Liver]
© 2014 The Authors
HPB © 2014 Americas Hepato-Pancreato-Biliary Association HPB 2014, 16 (Suppl. 2), 406–549
to establish the diagnosis and the level of occlusion.
Patients with obstructed and partially thrombosed infe-
rior vena cava (IVC) further underwent IVC graphy
and pressure gradient measurements.
Results: One hundred and forty-six patients underwent
148 shunt procedures which included 85 mesoatrial, 36
mesocaval, 18 cavomesoatrial, 3 cavoatrial, 1 portocav-
al, 1 cavoatrial combined with a separate splenorenal
shunt, 1 peritoneovenous shunting, 1 revision of throm-
bosed mesoatrial shunt and 1 redo mesocaval for shunt
thrombosis. A hypercoagulable haematological disorder
could be identified in 32 patients. There were 6 (4.1%)
deaths within 30 days of surgery (perioperative period).
Late complications included subdural haematoma in 2
patients, reversible encephalopathy in 6 patients and
meningitis in 1 patient. Three late deaths occurred due
to liver failure during follow up.
Conclusions: Decompressive shunt surgery in BCS is a
good option with acceptable morbidity and mortality.
Long term anticoagulation is important to maintain
patency of these shunts.
PPL26-027
SIMULTANEOUS COLORECTAL
SURGERY IN SYNCRHONOUS LIVER
METASTASES, YET NOT CONSENSUS
ABOUT SAFETY, WILL SEUL 2014
REACH IT? AN UPDATED LITERATURE
REVIEW
Victor Manuel Correa Santillan1 and Henri Bismuth2
1Instituto Jalisciense de Cancerologia & Hospital Civil
de Guadalajara “Fray Antonio Alcalde”, Mexico; 2Henri
Bismuth Hepatobiliary Institute, France
Introduction: Of all patients with colorectal cancer,
more than 50% will eventually develop liver metastases.
Around 15–25% of patients with colorectal cancer will
have metastases in their liver at the time of initial diag-
nosis of the colorectal cancer (synchronous liver metas-
tases, SCRLM). Nowadays defining the optimal
treatment strategy for patients presenting with CRLM
remains difficult, especially regarding to synchronous
metastases. Complete surgical removal of all liver dis-
ease remains the only potentially curative treatment
option, with 5-year survival rates of up to 50%, how-
ever, optimal timing of liver surgery for synchronous
metastases remains controversial.
Method: A sistematic updated review was performed in
the published medical literature in order to clarify if
consensus is reached already about simoultaneous colo-
rectal surgery in the syncrhonous setting.
Results: In favour of combining hepatic and colorectal
surgery it has the advantage of a single operation in
which all tumoral disease can be resected, more other
studies prefer to do colorectal surgery first and then try
chemotherapy, even more, some recomend the “liver
first aproach.” Overall perioperative morbidity of
simultaneous resection of colorectal cancer and hepa-
tectomy in patients with SCRLM has been reported in
several international series between 5% and 53%, but
only three (USA) have assessed complications accord-
ing to a severity-oriented score.
Conclusions: Actually, there is no clear recommenda-
tion in the literature regarding the optimal surgical
strategy in patients with SCRLM. More studies which
assess and stratify perioperative complications accord-
ing to a severity-oriented score in the simultaneous
strategy for colorectal and major hepatectomy surgery
in patients with SCRLM are needed in order to clarify
the safty of this complex procedure. These controver-
sies have contributed to preserve the challenge among
surgeons involved in the treatment of metastatic colo-
rectal cancer. The need of finding the best timing strat-
egy for treating this disease is mandatory, due to
impaired rate of mortality and especially of morbidity.
PPL26-028
BIOIMPEDANCEMETRY OF THE LIVER
AS A METHOD OF ESTIMATION OF
HEPATIC FUNCTIONAL RESERVE
Dmitry Panchenkov1, Sergey Leonov1, Ruslan
Alikhanov2, Yulia Stepanova4, Olga Zhavoronkova4,
Mikhail Efanov4, Yuri Ivanov3, Fedor Zabozlaev3,
Dmitry Astakhov1 and Viacheslav Chugunov1
1A.I. Evdokimov Moscow State University of Medicine
and Dentistry, Russia; 2M.V. Lomonosov Moscow State
University, Russia; 3Federal Research Clinical Center of
Specialized Medical Care and Medical Technologies
FMBA, Russia; 4A.V. Vishnevsky Institute of Surgery,
Russia
Introduction: Aim of the study: estimation of hepatic
functional reserve by liver parenchyma full electric
impedance measurement.
Method: The study included experimental and clinical
part. The experimental part based on examination of 27
white rats Vistar, which has undergone laparotomy and
measurement of bioelectric impedance of liver paren-
chyma. The invasive bioimpedancemetry (BIM) per-
formed with bipolar needle electrodes and the original
device for measurement of full electric impedance of
biological tissues “BIM II” (patent ¹ 2366360). Major
hepatectomy performed (about 70% of the liver) and
measured bioelectric impedance of residual liver paren-
chyma. In 72 hours after the procedure was performed
relaparotomy and measured liver impedance one more
time. After relaparotomy animals were taken out of the
experiment and the fragment of the liver sent to mor-
phological examination. The clinical part based on bio-
impedancemetry of liver by percutaneous approach
under US control (n = 15), laparoscopic (n = 48), dur-
ing laparotomy (n = 23). For the control in all cases
hepatic functional reserve was estimated by traditional
methods (biochemical data, cirrhosis class according
Child scale ets.)
Results: In the experiment the electric impedance of
intact liver was 3.18  0.12 kI^m. Immediately after
major hepatic resection parameters slightly decreased to
3.04  0.17 kI^m (differences are not significant,
p > 0.05). After 72 hours the electric impedance of the
liver significantly increased to 4.00  0.2 kI^m (n = 14,
p < 0.05). The microscopic examination of residual
liver in all survived animals showed fatty hepatosis. In
clinical study in all cases the results of bioimpedance-
metry matched with control.
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Conclusions: The results of bio impedancemetry reflect
the changes of functional activity of liver parenchyma
and could be used for the assessment of liver function
for liver surgery.
PPL26-029
PRIMARY SQUAMOUS CELL
CARCINOMA OF THE LIVER:
PRESENTATION AS LIVER ABSCESS
Madhusudhan Chinthakindi, R Pratap Reddy, T
Ravimohan, Moksha Prasuna, Narayan Rao Dvl and J
Vinod kumar
Osmania General Hospital, Hyderbad, Ap, India
Introduction: Primary squamous cell carcinoma (SCC)
of the liver is rare. It has a high malignancy rate and
poor prognosis and survival is typically no longer than
1 year. The pathogenesis of the disease is unclear, but
is generally considered to be correlated with the long-
term inflammation or metaplasia of biliary epithelial
cells and congenital cyst of the liver. We report here, a
case of primary SCC of the liver presenting as liver
abscess.
Method: A 42 year female presented with complains of
pain upper abdomen of 20 days associated with fever.
She gives history of being evaluated elsewhere and
diagnosed to have liver abscess. She underwent percu-
taneous catheter drainage of liver abscess 9 months
back. Abdominal examination revealed discharging
sinus at epigastric region with tender hepatomegaly.
Ultrasound abdomen reveals a large lobulated, hyper
echoic mass with cystic areas in the left lobe displacing
the porta hepatis and gallbladder. Triphasic CT liver
shows a large cyst with hyper intensity areas in the left
lobe of liver extending into segment 8 and 5. Mild dilata-
tion of intrahepatic biliary radicals was seen. No plane
between the mass and IVC, middle and left hepatic veins.
Spleenomegaly was present. Pus culture was sterile.
Results: A left extended hepatectomy with caudate lobe
excision and Hepaticojejunostomy was done. A
10 9 12 cm solid cystic mass involving the segments 2–
5, 8 and 1. Gallblader and hepatic hilum were densely
adherent to the mass. Hepatic veins and ivc were insep-
arable from the mass. Histopathology shows keratin
producing squamous cell carcinoma (SCC) in a non
parasitic liver cyst. Immuno histochemistry confirmed
the SCC.
Conclusions: Primary SCC of the liver presenting as
liver abscess is rare. Few cases were reported in the lit-
erature. Primary SCC of the liver has been reported to
be associated with hepatic teratoma, hepatic cyst, he-
patolithiasis/caroli and cirrhosis. It requires multimo-
dality treatment.
PPL26-030
RISK FACTORS AND PROGNOSIS OF
HEPATIC FAILURE AT SURGICAL
TREATMENT OF LIVER CIRRHOTIC
PATIENTS
Vasyl Syplyviy, Olexiy Petiunin, Volodymyr
Markovskiy, Dmytro Ievtushenko and Pavlo Petiunin
Kharkiv National Medical University, Ukraine
Introduction: The most dangerous complication of sur-
gical treatment in patients with liver cirrhosis is a post-
operative hepatic failure. The purpose of our research
was to improve the results of surgical treatment in
patients with liver cirrhosis based on the determination
of risk factors and prognosis of hepatic failure at
choice of surgical treatment method.
Method: The results of surgical treatment of 137
patients with liver cirrhosis were analysed. In 81 cases
was performed the distal splenorenal shunt by Warren,
in 56 – devascularization surgery. Clinical and bio-
chemical blood examinations, mophological examina-
tions with morphometry of intraoperative liver
biopsies, doppler ultrasound of portal blood were done.
Results: It was established, that hepatic failure occures
in 33.9% patients with liver cirrhosis and is a reason of
their death in 11.57% cases. The highest risk of it’s
occurrence is after shunting operations, at presence of
ascities, combination of ascities and hemorrhage from
esophageal and gastric variceal veins. Hepatic failure is
accompanied by hypoproteinemia, hypoalbuminemia,
hyperfibrinogenemia, increased concentration of biliru-
bin, urea, creatinine, hyperactivity of the asparaginea-
minotransferase, alaninaminotransferase, alcalain
phosphatase, increase of anemia, leucocytosis, lymp-
hopenia. Morphological changes in liver at liver cirrho-
sis reflects it’s functional reserves, and risk of the
hepatic failure is the highest at C-type cirrhosis.
Decrease of the hepatic blood supply, linear portal
velocity, increase in diameter of portal and splenic
veins indicates the deterioration of functional liver
reserves. The Child-Turcotte-Pugh score may be used
for the complex prognosis of the hepatic failure in
patients with liver cirrhosis and choice of treatment tac-
tics.
Conclusions: The preoperative prognosis of the hepatic
failure at surgical treatment of liver cirrhotic patients,
based on mathematical analysis of clinical, laboratory,
morphological and instrumental parameters, is possible.
PPL26-031
THE EXPRESSION OF DNA
METHYLTRANSFERASE DNMT3A IN
CONVENTIONAL AND
FIBROLAMELLAR VARIANT OF
HEPATOCELLULAR CARCINOMA
Ewa Wilczek, Tomasz Ilczuk, Dominika Wolosz,
Grzegorz Szparecki, Krzysztof Zieniewicz and Barbara
Gornicka
Medical University of Warsaw, Poland
Introduction: The epigenetic regulation of DNA-tem-
plated processes has been studied extensively during the
last 15 years. As was revealed, DNA modification such
as methylation possess great impact on cell fate and
can result in abnormal protein expression patterns what
can lead to the induction of carcinogenesis. DNA
(cytosine-5)-methyltransferases are enzymes that cataly-
ses the transfer of methyl groups to specific CpG struc-
tures in DNA. The methylation of these sequences can
lead to inappropriate gene expression such as the
silencing of tumor suppressor genes in cancer cells.
DNMT3a gene encodes a DNA methyltransferase that
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is thought to function mainly in de novo methylation.
In the normal liver DNMT3a is usually expressed on
the medium level, as was described in literature. Hepa-
tocellular carcinoma (HCC) still remains one of the
most common cause of death among patients with can-
cer. Fibrolamellar hepatocellular carcinoma (FL) repre-
sents rare subtype, which affects usually young people
(an onset between 20 and 30 years) and its etiology is
poorly understood. In our study we compared the pres-
ence of DNMT3a protein between two different types
of HCC – conventional and fibrolamellar one.
Method: Immunohistochemical staining of formalin
fixed paraffin embedded tissue sections obtained from
30 patients (22 HCC and 8 FL).
Results: We found that DNMT3a immunoreactivity is
significantly more pronounced in the typical variant of
HCC than in the fibrolamellar one. The DNMT3a
immunoreactivity was predominantly localized in can-
cer cell nuclei in a form of separate large granules spot-
ted in proximity to heterochromatin region.
Conclusions: The reduced presence of DNMT3A in the
fibrolamellar variant of HCC may suggest that different
epigenetic mechanisms are involved in development of
this particular type of liver cancer. Improving our
understanding the roles of DNMT proteins in hepato-
carcinogenesis can benefit in the development of epige-
netic – based therapy designed for specific HCC
subtype.
PPL26-032
WHAT LOCAL ABLATIVE TREATMENT
OF COLORECTAL LIVER METASTASE
NEEDS TO ACCOMPLISH TO BE AN
ALTERNATIVE TO RESECTION
Silja Karlgren1, Henrik Nilsson1, Rene Adam3, Eduard
Jonas2 and Jacob Freedman1
1Karolinska Institutet at Danderyd Hospital, Sweden;
2Karolinska Hospital, Sweden; 3Ho^pital Paul Brousse,
Villejuif, Paris, France
Introduction: Liver metastasis of colorectal cancer will
occur in 25–30% of patiens, two-thirds at diagnosis of
the primary (synchronous) and one-third at follow-up
(metachronous). Ablative treatment is typically reserved
for patients not fit for surgery or as an adjunct to
resection to achieve a tumour free liver at time of sur-
gery, where residual liver volume is an issue. Micro-
wave ablation is effective with tumours <30 mm in
diameter and away from central biliary ducts. It has
the added benefit of activating local and systemic
immune response to denaturated tumour antigens.
Microwave ablation has in several studies showed a
local recurrance rate of 5–10%. Minimal invasive abla-
tion (percutaneous or laparoscopic) of a single lesion
typically involves 1 day of hospitalisation.
It is very difficult to perform a randomised non-inferi-
ority study of resection versus ablation as such a study
would need to include around 1600 patients in each
arm (90% power, alpha = 5%, 60% survival at
3 years).
Method: With kind permission of the Liver Met Survey
register, all patients with a complete registry and single
metasis of <3 cm where analysed regarding survival,
liver recurrance, complications and postoperative hospi-
talisation, stratified by type of surgery defined as wedge
resection (non-anatomical, 1–2 segments), minor resec-
tion (anatomical 1–2 segments) and major resection (>2
segments).
Results: There is no difference in survival with the
three different treaments. Major resection has higher
30-day mortality than the other resections, the other
parameters are not significantly different between
groups.
Conclusions: Non-anatomical resection of a single liver
metastasis compares favourably to an anatomical resec-
tion. There is a need for a multicentre trial comparing
ablative treatment with resection, as a minimal invasive
approach could be as effective but with less complica-
tions and shorter hospitalisation, generating much
lower costs.
PPL26-033
VALIDATION OF OUR POLICY OF
LONG-TERM DRAINS MAINTENANCE
AFTER HEPATIC RESECTION:
RESULTS OF A PROSPECTIVE
COHORT ANALYSIS.
Matteo Donadon, Guido Costa, Fabio Procopio,
Matteo Cimino, Daniele Del Fabbro, Angela
Palmisano, Andrea Gatti and Guido Torzilli
Humanitas Clinical And Research Center, Italy
Introduction: The utility of drains after hepatic resec-
tion is still debated. The aim of this study was the vali-
dation of our definition, and management of biliary
fistula after hepatic resection. We also sought to review
the main literature, in particular the definition by the
International Study Group of Liver Surgery (ISGLS).
Method: Data on abdominal drains and on clinical,
pathological and short-term outcome were reviewed in
a prospective cohort of patients who underwent hepatic
resection between 2004 and 2013. Drains were main-
tained at least 7 days, and the bilirubin levels were
measured in POD 3, 5, and 7. Drains were removed if
the bilirubin level in POD7 was inferior than in POD5,
and less than 10 mg/dl. Statistical analysis on prognos-
tic factors for biliary fistula was performed.
Results: Among 475 consecutive patients, 39 (8%) had
biliary fistulas. Only 8 (1.7%) patients required inter-
ventional procedures. The area under the receiver-oper-
ating-characteristic curve on POD7 had the highest
predictive value (0.81, p < 0.001). The multivariate
analysis found a protective role for cirrhosis
(OR = 0.56, p = 0.045), while a Pringle’s maneuver
>90 minutes (OR = 3.45, p < 0.001), extended resec-
tions (OR = 6.45, p = 0.007), blood transfusions
(OR = 2.4, p = 0.035), and resections including seg-
ment-I (OR = 1.94, p = 0.033), and segment-V
(OR = 1.87, p = 0.024) were found to be associated
with increased risk. Using the definition proposed by
the ISGLS 66% of our patients would have received a
diagnosis of biliary fistula.
Conclusions: The maintenance of abdominal drains up
to POD7 reduces the risk of biliary fistulas after hepa-
tic resection. The greater is the complexity of hepatic
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resection the greater is the risk of biliary fistula, which
may effectively managed with drains maintenance.
PPL26-034
HALPPS: A MODIFIED ALPPS
TECHNIQUE FOR TWO-STAGE LIVER
RESECTION
Tamara Gall, Adam Frampton, Mikael Sodergren,
Paul Tait, James Jackson, Madhava Pai, Duncan
Spalding, Nagy Habib and Long Jiao
Hammersmith Hospital, UK
Introduction: Patients with primary or secondary liver
tumours require hepatic resection for long-term sur-
vival. The future liver remnant (FLR) must be at least
25–30% of the liver volume to avoid liver failure and
mortality. Portal vein embolization (PVE) is used to
increase the size of the FLR, allowing for hepatic resec-
tion. More recently the associating liver partition and
portal vein ligation for staged hepatectomy (ALPPS)
procedure has been used allowing for a greater increase
of the FLR volume but with a high morbidity. The
HALPPS technique involves a laparoscopic first stage
in situ liver splitting using ablation only without com-
plete transection. We hypothesise that this will rapidly
increase the size of the FLR without the associated
morbidity from liver transection.
Method: We prospectively reviewed three patients who
had HALPPS and compared them to three age-, sex-,
and liver function- matched PVE patients. The primary
endpoint was the increase in FLR volume. Secondary
endpoints were morbidity, mortality, and postoperative
liver function.
Results: There were two males and one female in each
group with a median age of 66 (HALPPS) and 68
(PVE) years. All patients underwent a second-stage
right hepatectomy. The mean% increase in the FLR
volume was 59.05  8.87 measured after a mean of
16  6.2 days following the first procedure for HAL-
PPS. This compared to a% increase of 22.81  23.32
after 57  13.9 days following PVE. There was no 30-
day mortality or morbidity. There was no difference in
postoperative liver function between the two groups.
Conclusions: The HALPPS procedure is a feasible tech-
nique, with a greater increase in FLR volume in a
shorter time period compared to the PVE group in this
series. Larger studies are required to fully evaluate
postoperative outcome and morbidity.
PPL26-035
SINGLE-INCISION TRANSUMBILICAL
LAPAROSCOPIC UNROOFING OF
SYMPTOMATIC GIANT SPLENIC CYST
Takeyuki Misawa1, Nobuhiro Tsutsui2, Yuki
Fujiwara1, Hiroaki Shiba2 and Katsuhiko Yanaga2
1The Jikei University Kashiwa Hospital, Japan; 2The
Jikei University School of Medicine, Japan
Introduction: The report of single-incision laparoscopic
surgery (SILS) for unroofing of splenic cyst (USC) is lim-
ited. We report an efficacy and our techniques of SILS-
USC in patients with symptomatic giant splenic cyst.
Method: Two patients, a 31-year-old male and a 33-
year-old female, respectively, with a symptomatic sple-
nic cyst were underwent SILS-USC. The patient was
positioned in the right semi-lateral decubitus position
with left arm fixed over the head. A 2.5-cm mini-lapa-
rotomy was made in the umbilicus for placement of a
SILSTM Port with three 5-mm trocars as a single access
site. Under the pneumoperitoneum, a flexible 5-mm
laparoscope and an articulating grasper were used in
addition to standard laparoscopic equipment. Under
laparoscopic ultrasonography, the cyst was percutane-
ously aspirated and decompressed. Then the cyst wall
was widely resected using LigaSure
TM.
Results: SILS-USC was successfully performed in both
cases without any intra- or post-operative complica-
tions. The operation times were 285 and 120 minutes,
respectively, with minimal blood loss (uncountable).
The meal was started on postoperative day 1, and the
patients were discharged uneventfully on postoperative
day 4. Postoperative follow-up at 33 and 14 months,
respectively did not reveal recurrence or any complica-
tions, and the incisions were almost invisible in both
cases.
Conclusions: SILS was safely applied in USC in the
current cases. However, the indication and limitation of
SILS-USC should be investigated.
PPL26-036
MORPHOLOGICAL AND CLINICAL
ANALYSIS OF A RARE CASE OF HCC
WITH STEM CELL FEATURES
Piotr Malkowski, Barbara Gornicka, Dariusz Wasiak,
Ewa Wilczek, Maciej Kosieradzki, Maurycy Jonas and
Andrzej Chmura
Medical University of Warsaw, Poland
Introduction: Recent findings showed that within the
group of HCC a small fraction of tumors with stem/
progenitor cells immunohistochemical profile can be
found. According to few current reports such tumors
are characterized by poorer prognosis and more aggres-
sive biology in comparison to conventional HCC.
Method: A 37-year-old, healthy woman with no evi-
dence of liver disease was incidentally diagnosed with 3
adjacent liver tumors (8 cm in total diameter) in left
lateral segments of the liver and serum AFP of
5700 ng/mL. A resection of segments 2 and 3 was per-
formed without complications. AFP levels returned to
normal 4 months following surgery. Two and a half a
year later, the patient has no sign of recurrence in a 4-
phase CT and her AFP remains normal. Histologically
all 3 tumors shared the same morphology. They were
heterogeneous and composed mainly of hepatocyte-like
cells, with areas of pleomorphic cells and cells with
clear cell cytoplasm. Most of them were positive with
HepPar 1. Immunohistochemistry revealed 7% of cells
with stem/progenitor cell phenotype, positive for CK19,
nuclear cell adhesion molecule (NCAM/CD56) and
KIT. These cells appeared mainly within clear cell areas
and were not recognizable in routine HE stain.
Results: The case of this patient is unique in some fea-
tures: despite evident stem cell component the clinical
course so far has been benign. Progenitor cells were
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identified in a tumor that occurred in a healthy liver.
Stem/progenitor cells, not distinguishable with classical
HCC stains could have been identified with multiple
specific immunohistochemical stains.
Conclusions: We believe some HCC tumors can share
stem/progenitor cell morphology, even in cases with no
liver disease, and hence routine immunohistochemical
staining is encouraged. In spite they are thought to
have poor prognosis, clinical course of such cases needs
further investigation.
PPL26-037
RESECTION OF LIVER METASTASES
FROM COLORECTAL CANCER AFTER
METALLIC STENT PLACEMENT FOR
COLORECTAL OBSTRUCTION
Hiroshi Matsukiyo, Manabu Watanabe, Koji asai,
Tomoaki Saito, Hajime Kodama, Toshiyuki Enomoto,
Yoichi Nakamura, Jiro Nagao, Shinya Kusachi and
Yoshihisa Saida
Toho University Medical centre Ohashi Hospital, Japan
Introduction: Colorectal stent placement is a procedure
to treat colorectal obstruction using self-expandable
metallic stent (SEMS). Traditionally, obstructive colo-
rectal cancer was treated by emergent operation to per-
form temporary colonostomy. However, this technique
has decreased patients’ quality of life (QOL). In this
study, we analyzed the patients with simultaneously
liver metastasis from obstructive colorectal cancer,
which treated using SEMS avoiding the temporary col-
onostomy.
Method: From 1993 to 2013, 114 cases with obstructive
colorectal cancer were inserted SEMS at our depart-
ment. Among these cases, 6 cases with simultaneously
liver metastases were operated with one stage or two
stage hepatectomies after SEMS placement for obstruc-
tion.
Results: The duration between colorectomy and hepa-
tectomy was 94  83.4 days. Preoperative percutaneous
transhepatic portal embolization (PTPE) was per-
formed in 2 cases. Hepatectoies included 3 cases of
right hepatectomy, one case of medial sectionectomy,
and 2 cases of partial resection. Regarding to the recur-
rence after hepatectomies, 3 cases were occurred hepa-
tic recurrence, which were operated re-hepatectomies,
and 2 cases were occurred lung metastasis, which were
operated peunectomy. Chemotherapy was introduced
after surgery in 5 cases, and chemotherapy regimens
were followed; FU/LV in 2 cases, FOLFOX in 2 cases,
and XELOX in 1 case.
Conclusions: Regarding to the therapeutic strategy of
the obstructive colorectal cancer, SEMS is a preferable
management, which is possible to perform one stage
colorectomy avoiding to the temporary colostomy. This
management seems to perform hepatetomies in short
interval and may improve the patient’s QOL. Further-
more, this strategy is able to introduce the chemother-
apy after surgery.
PPL26-038
TRANSARTERIAL
CHEMOEMBOLIZATION FOR
INTRAHEPATIC MULTIPLE
RECURRENT HCC AFTER LIVER
RESECTION OR TRANSPLANTATION
Chung-Bao Hsieh, Yi-Chiao Cheng, Teng-Wei Chen,
Hsiu-Ling Fan, Chih-Yung Yu and An-Chieh Feng
National Defense Medical Center, Taiwan
Introduction: Transarterial chemoembolization (TACE)
can reduce tumor progression rate in HCC patients to
achieve good locoregional effect even after liver resec-
tion (LR) with multiple intrahepatic multiple recur-
rences (IHMR). The effect of TACE for HCC with
IHMR after liver transplantation (LT) remains unclear.
The purpose of this study is to investigate the effect of
TACE for IHMR after LR or LT.
Method: A hospital-based retrospective study was con-
ducted, in which 968 and 180 HCC patients undergoing
LR and LT in past decade were included. There were
101 and 11 patients diagnosed IHMR during follow-
up. The parameters were recorded from the computer-
ized data bank included clinical characteristics, AFP
level, Child classification, tumor size in recurrence, the
tumor stage in first treatment, recurrent and survival
status. Univariate and multivariate factors were ana-
lyzed by t-test or chi-square test. Survival and recur-
rence were analyzed by Kaplan–Meier method.
Differences were significant at P < 0.05.
Results: There are 112 patients diagnosed IHMR after
LR or LT. There are statistics differences in age, gen-
der and HCV infection in clinic characteristics. All
patients underwent LT had HCC recurrence occurred
with 36 months after LT. The risk factors of death
from tumor recurrence are the larger tumor size in
recurrence, poor Child classification in tumor recur-
rence, hyperbilirubinemia, hypoalbuminemia, and no
TACE treatment. In Cox regression analysis, only ves-
sel invasion, Child C and no TACE treat are the inde-
pendent factors for death from tumor recurrence.
Conclusions: TACE is beneficial to IHMR, either LR
or LT.
PPL26-039
ENHANCED RECOVERY PROGRAMME
FOR LIVER SURGERY. EFFECT ON
LONG TERM SURVIVAL
Zaria Ali1, Kariem Elhadd1, Anton Kriege1, Shorab
Jangar2, Lindsay Pearce2, Elaine Atkinson1, David
Chang1, Collin Harris1 and Daren Subar1
1East Lancashire Teaching Hospitals, UK; 2Manchester
Royal Infirmary, UK
Introduction: Several studies have demonstrated that an
enhanced recovery programme for liver surgery (ER-
PLS) shortens hospital stay without compromising
morbidity and mortality. However to date no study has
reported on the effect of ERPLS on survival. The aim
of this study was to assess the effect of the ERPLS on
patient survival.
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Method: This is a retrospective study comparing
patients who experienced a ERPLS to those who expe-
rienced standard care following liver resection. The out-
come measures assessed were morbidity, mortality,
length of hospital stay and long term survival. Fifty
patients in the ERPLS group were compared to sixty
patients in the standard care group.
Results: The mean age of the patients was 66 years
(range 25–88 years). 58% of patients in the ERPLS
group were male, and 59% in the standard care group.
There was no difference between the groups in terms of
indication for resection, type of resection, age or sex.
There was no difference in morbidity (p = 0.31) or
mortality (p = 0.49) between the groups. Patients on
the ERPLS had a decreased length of hospital stay
compared to those receiving standard care (8 days vs
9 days, p = 0.15). The 2 year survival was 73% and
77% for the ERPLS and the standard group respec-
tively with no statistical difference (p = 0.422).
Conclusions: The multi-modal enhanced recovery pro-
gramme for liver surgery can improve length of stay
following liver resection without adverse impact on the
overall quality of care. In addition the ERPLS does
not appear to have a negative impact on survival. Long
term results in terms of its effect on 5 year disease free
and overall survival are needed.
PPL26-040
INITIAL EXPERIENCE OF ROBOTIC
LIVER SURGERY IN A LIVER
TRANSPLANTATION CENTER
Paolo Reggiani, Barbara Antonelli, Daniele
Dondossola and Giorgio Rossi
Fondazione IRCCS Ospedale Maggiore Policlinico di
Milano, Italy
Introduction: Nine hundred and ninety liver transplants
have been performed at our institution and more than
one hundred laparoscopic liver resections were carried
out mainly in cirrhotic patients with hepatocellular car-
cinoma (HCC).
During the last year, after the completion of a training
period in a well known Italian school of robotic sur-
gery, we start a program of robotic liver surgery with
the aim to evaluate the safety profile and the impact on
a liver transplantation program of this new technology.
Method: Nine patients underwent to robotic surgical
resection: one for benign lesion and one for a metastatic
nodule. Seven patients were cirrhotic with resectable
HCC according the BCLC classification. We will report
demographics, type of liver resection, complications,
lenght of hospital stay and outcomes of all patients.
Results: The median operative time was 190 minutes
and one case was converted to open surgery for pru-
dential care in our initial learning curve due to diffucult
management of a lesion at the biliary biforcation for
an HCC nodule located between segments III and IV.
During the followup, our first patient experienced the
new onset of unresectable HCC and he is now in our
waiting list for liver transplantation. No perioperative
mortality was observed.
Conclusions: In conclusion we consider robotic liver
resection a feasible and safe procedure that potentially
could expand the application of minimally invasive
approach to the liver surgery, above all, in liver trans-
plantation centers in order to complete and potentiate
the conventional cure of hepatocellular carcinoma and
limits the allocation of the few organs avalaible to the
patients that really have a benefit from liver transplan-
tation.
PPL26-042
PREVENTION AND TREATMENT OF
COMPLICATIONS IN LIVER
RESECTIONS FOR FOCAL DISEASES
Mikhail Zarivchatskiy1, Ildar Mugatarov2, Ekaterina
Kamenskikh1, Alexander Kosyak2, Oleg Gavrilov2,
Konstantin Malginov2 and Arkadiy Kolevatov2
1Perm State Academy of Medicine, Russia; 2Perm
Territory Clinical Hospital &1, Russia
Introduction: Improvement of the results of surgical
treatment in patients with focal lesions of the liver.
Method: The results of treatment of 260 patients with
focal lesions of the liver are presented. The indication
for surgery were metastatic colorectal cancer in 118
(45.38%) cases, cancerous metastasis of other abdomi-
nal organs – in 29 (11.15%), hepatocellular carcinoma
– in 20 (7.69%), hepatic hemangiomas – in 75
(28.85%), parasitic hepatic cysts – in 18 (6.92%). Liver
resection was performed to 205 patients (78.85%).
including large liver resections (≥3 segments) – 87
(42.44%) patients, and small – 118 (57.56%).
Results: Intraoperative blood loss was reduced at the
expense of applying blood-accumulating technologies
from 2700  250.3 to 1100  200.5 mL for large resec-
tions, from 683  43.3 to 356  45.4 mL for small
resections. Biliary complications occurred in 4 (1.95%)
cases: lobar bile-duct stump failure – 1 (0.49%), choled-
ochal wall necrosis – 1 (0.49%), biloma – 2 (0.98%).
Hepatic stump bleeding developed in 4 (1.95%) cases.
Abdominal abscesses formed in 4 (1.95%) patients,
reactive pleurisy – in 5 (2.44%), thrombosis of IVC ret-
rohepatic segment – in 1 (0.49%). Postoperative mor-
tality was 1.46% (n = 3).
Conclusions: Observance of fundamental technological
approaches for liver resection can significantly reduce
the number of postoperative hemorrhagic complica-
tions. In case of extensive resections of the liver, it is
preferable to perform ligation of the lobar bile ducts in-
traparechimally so as to prevent bile-duct wall necrosis
and subsequent biliary complications. Implementation
of adequate hemostasis and cholestasis during surgery
permits to avoid septic complications in the postopera-
tive period. Hepatoprotectors are important for preven-
tion of liver failure.
PPL26-043
CLINICAL PATHOLOGY OF HEPATIC
HYDATID CYST EVALUATED BY
CONTRAST ENHANCED CT-SCAN
Xinyu Peng, Shijie Zhang, Xiangwei Wu and
Hongqiang Yang
The First Affiliated Hospital, Shihezi University School
of Medicine, China
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Introduction: To investigate the correlation between CT
images and the clinical pathological changes of Hepatic
hydatid cyst and to understand the natural history by
CT images.
Method: Five hundred and fifty-eight cases with 691
hepatic hydatid cysts which had been confirmed by CT
diagnosis and pathology were collected. The CT
appearances and intra-operative findings were analyzed
retrospectively.
Results:
1. The variability of the CT value of the different
types of mother cyst and daughter cyst was sta-
tistically significant (p < 0.001). The CT value
of mother cyst was increased from type CL to
type CE5.
2. According to CT characteristic findings in the
cases with biliary fistula, 36 cases with dilated
bile duct, 67 cysts with “crescent-like” apophysis,
25 cysts with calculus, 29 cysts with “concentric
circles sign”, 24 cysts with gas-fluid level, 42 cysts
with daughter cyst eccentric arrangement.
3. Intrahepatic rupture: 158 cysts, the incidence of
22.9%. CT showed by “gourd-like” lesions, the
prominent cystic wall was thinner than original
one. Extrahepatic rupture: 92 cysts, the incidence
of 13.3%.
4. According to CT characteristic findings in 267
cysts, which indicated by “liver capsule annular
depressed”, of 454 cysts which with an exophytic
component or adjacent liver edge. The variability
of the CT characteristic images of the different
types was statistically significant (p < 0.001).
5. 273 cysts had calcification in varying degrees,
and the calcification rate was 38.4%. The vari-
ability of the calcification rate of only cyst wall
or content of two kinds of cyst (no daughter-cyst
and daughter-cyst) was statistically significant
respectively (p < 0.001).
Conclusions: The CT images had an important role in
reflecting the cystic content, shrink and the calcification
trend in natural history of Hepatic hydatid cyst. And
it’s useful for determine biliary fistula and rupture of
hydatid cyst. According to CT characteristic findings,
growth state of hydatid cyst could be acknowledged.
PPL26-044
SURGICAL MANAGEMENT OF
COMPLICATED HYDATID CYSTS OF
THE LIVER
Xinyu Peng, Shijie Zhang, Xiangwei Wu and
Hongqiang Yang
The First Affiliated Hospital, Shihezi University School
of Medicine, China
Introduction: In terms of surgical treatment of liver
hydatid cysts, complication and recurrence rates seem
to be higher with conservative surgical procedures com-
pared to more radical treatment, but indiscriminate
application of total pericystectomy or major liver resec-
tion may be followed by a higher incidence of major
postoperative complications and mortality. Therefore,
radical surgery is performed with exorbitantly strict
indications and contraindications, especially for some
complicated cases.
Method: We revisited a series of patients who under-
went an evolving approach to radical surgery for com-
plex hydatid cysts over a period of 10 years at our
single center to determine the evolution of the surgical
treatment.
Results: The evolving approach to treatment of compli-
cated hydatid cysts is, at least in our center, the most
effective and reliable treatment procedure in the
selected cases. Although the surgical approach to liver
hydatid cyst have been well developed, surgical tech-
niques still have a broad space for development and
evolution.
Conclusions: In terms of radical treatment of compli-
cated hydatid cysts, our experience is summarized as
follows: (1) Preoperatively, contrast-enhanced CT is
extremely useful to evaluate the cyst status such as the
viability of the parasite, and the relationship between
the cyst and intrahepatic vessel. (2) Pericyst wall should
remove as much as possible because it is the major
incentives of the recurrence. (3) It is indeed possible to
separate the pericyst from the liver without damaging
the surrounding parenchyma along an interspace
observed in our practice. (4) The concept of “func-
tional” vessel and “non-functional” vessel has to be
kept in mind during the removal of pericyst, which
guides the choice of ligation or not; (5) Adscititious
operation such as biliary-digestive tract reconstruction
for cyst with large biliocystic fistula, probably increas-
ing the difficulty and risk, is worth considering because
it benefits the decrease of biliary complications.
PPL26-045
1 CASE OF ALPPS FOR INITIALLY
UNRESECTABLE MULTIPLE AND
BILOBAR SYNCHRONOUS
COLORECTAL LIVER METASTASES
In-Sang Song, Kwang-Sik Chun, Younghoon Sul and
Yong-Woo Yune
Chungnam National University School of Medicine,
Korea
Introduction: Associating liver partition and portal vein
ligation for staged hepatectomy(ALPPS) has been
recently devised to improve resectability and to mini-
mize the risk of liver failure.
Method: We reports a case of associating liver parti-
tion and portal vein ligation for staged hepatectomy
(ALPPS) and low anterior resection simultaneously for
initially unresectable multiple and bilobar synchronous
colorectal liver metastases.
Results: A 64-year-old male, with rectal cancer and ini-
tially unresectable multiple hepatic metastases received
8 cycle neoadjuvant chemotherapy with FOLFOX regi-
men. After 6 months, we performed the procedure in
two steps. During the first operation, two wedge resec-
tion of metastatic nodules in the left liver, right portal
vein ligation and in situ splitting as a right hepatectomy
were performed. A CT scan on POD 7 showed FLR
hypertrophy. At POD 12, complete right hemihepatec-
tomy and low anterior resection (for rectal cancer) was
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performed simultaneously. Postoperative course was
uneventful and patient was discharged at POD 23.
Conclusions: ALPPS can be a feasible and safe treat-
ment option to provide curative resection to unresec-
table patients with multiple and bilobar colorectal liver
metastases because of insufficient volume of FLR.
PPL26-046
HEPATOCELLULAR ADENOMA IN A
YOUNG MALE – A RARE CASE
REPORT
Surya Ramachandra Varma Gunturi, Venu Madhav
Thumma, Prakash Valse, Bodaiah T, Rajendra Prasad,
Abhijot Singh Parmar, Akheeluddin Dr and Bheerappa
Nagari
Nizams Institute of Medical Sciences, India
Introduction: Hepatocellular Adenoma is rare benign
liver neoplasm strongly associated with oral contracep-
tive use. It is even rare in men with a sex ratio of 1:9.
Here we are presenting a rare case of Hepatocellular
Adenoma in an young male without any metabolic dis-
ease of liver.
Method: Sixteen year old young male presented with
history of sudden severe pain Right upper quadrant
1 month ago and since then he had continuous pain of
less intensity. There is no history of Trauma, blood
transfusions or anabolic steroid usage. No history of
any metabolic liver disease.
Results: He was evaluated, CECT Abdomen revealed
heterogenous mass lesion in segment 5 and 6 of liver of
size 8 9 6 cm. Bisegmentectomy was performed and
Histopathology revealed as Hepatocellular Adenoma.
Conclusions: Hepatocellular adenoma is very rare in an
young male without any history of anabolic steroid use
and without metabolic diseases of liver and this case is
being presented for its rarity.
PPL26-047
COMPLICATION PROFILES AND
OUTCOME AFTER SYNCHRONOUS
LIVER AND BOWEL RESECTION FOR
COLORECTAL CANCER PRESENTING
WITH HEPATIC METASTASES
Michael Jones, Paul Shuttleworth, Santhalingam
Jegatheeswaran, Saurabh Jamdar, Angus Watson,
James Hill, Aali Sheen and Ajith Siriwardena
Manchester Royal Infirmary, UK
Introduction: Synchronous hepatic and bowel resection
for colorectal cancer with liver metastases (CRLM)
avoids the need for two major operations for the same
cancer episode. However, the cumulative morbidity
may be appreciable. This study assesses complication
profiles and outcome after synchronous surgery.
Method: A consecutive series of 28 patients undergoing
synchronous liver/bowel resection for metastatic colo-
rectal cancer in a regional liver surgery unit during the
period 17/4/2008 to 8/2/2013 constitute the study popu-
lation. Data were collected prospectively and analysed
in retrospect.
Results: Median (range) age was 67 (29–85) years, 18
(64%) male. Median BMI was 26 (19–35), 21 were
ASA grades 1 or 2 pre-op. The primary was right/
transverse colon in 13, left 7 and rectum 8. The median
(range) number of metastases was 2 (1–8), median size
1.9 (0.8–13.0) cm and 7 bi-lobar. Neoadjuvant chemo-
therapy was used in 8 of 20 non-rectal tumours (40%),
chemoradiotherapy in 5 (63%) rectal tumours. Median
operative time was 375 (217–642) minutes. Eight (28%)
received blood transfusion. 27 had a colonic anastomo-
sis [6 (21%) de-functioned]. Major liver resection (two
or more Brisbane 2000 sections) was undertaken in 10
(36%). Post-operatively 4 (14%) required intensive care
[median stay 0 (0–12) days] and 27 High dependency
(level II) support for 3 (0–18) days. Median in-patient
stay was 14 (7–133) days. There were no 30-day re-
admissions and in-hospital mortality was 0. Complica-
tions scored by the Clavien-Dindo system were: Grade
0-2 in 19 (68%), Grade 3 in 6 (22%) and Grade 4 in 2
(7%). Histologically, an R0 margin was achieved in 17
(61%). Adjuvant chemotherapy administered to 71%.
Conclusions: Synchronous liver and bowel resection is
associated with low mortality but a high complication
rate (although the majority were grade 1 or 2) and this
may compromise uptake of adjuvant chemotherapy.
Important questions remain about long-term outcome.
PPL26-048
EARLY RECURRENCE IN ALPPS
PROCEDURE. PRELIMINARY DATA
Alejandro Serrablo1, Luis Tejedor2, Dario Martınez-
Baena3 and Vicente Borrego1
1Miguel Servet University Hospital, Spain; 2Punta
Europa Hospital, Algeciras, Spain; 3Nuestra Se~nora de
Valme Hospital, Spain
Introduction: Since Schnitzbauer and coworkers pub-
lished an article about associating liver partition and
portal vein ligation for staged hepatectomy (ALPPS),
there have been an increasing interest for this technique
in literature. Discussion have mainly focused on mor-
bidity and mortality and on technical variations but
only one issue about recurrence rate in short-term out-
come.
Method: We analized the patients with liver metastases
operated on ALPPS technique from October 2011 to
December 2012.
Results: Eight patients were operated on in this period.
Median age was 58.5 years (46–51). All patients had
previous chemotherapy with 6 cycles of FOLFOX plus
bevacizumab. Every case had at least one metastasecto-
my of the liver remnant during the first procedure. Five
patients were operated as “first liver” surgery (67.5%);
one of them has not had the primary rectal cancer
resected yet. There was no mortality; one patient had a
postoperative liver failure and another one, with S7
and S8 as the sole remnant, had a biliary fistula, trea-
ted by percutaneous drainage and endoscopic. sphinc-
terotomy. Time span between both procedures of the
ALPPS was 11.5 days (7–14), obtaining a median vol-
ume increase of the liver remnant of 56.7%. The point
that we want to emphasize is the early local recurrence
found in 3 patients (37.5%), which appeared at 4, 5
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and 6 months. None of the recurrences were in the
resection margin. Patients with just one tumor were res-
cued with a new hepatectomy. Early recurrences
appeared after extended right hepatectomies.
Conclusions: For these patients, the ALPPS technique
can be the only chance to allow resection at all but,
concerning the oncologic benefit of this new approach,
we should be cautious and try to analize minutely
mainly about this possible early liver recurrence.
PPL26-049
ASSOCIATING LIVER PARTITION AND
PORTAL VEIN LIGATION FOR STAGED
HEPATECTOMY (ALPPS) – SINGLE
CENTRE EXPERIENCE
Soumil Vyas, Charles Imber, Anamaria Schipor, Lee
Grant, Dipok Dhar, Dinesh Sharma, Guiseppe Fusai,
Brian Davidson and Malago Massimo
Royal Free Hospital, UK
Introduction: PVE has been used for FRL volume
enhancement to offer a curative hepatectomy in
patients with insufficient FRL. ALPPS is a procedure
of great potential and promise to promote a rapid FRL
hypertrophy and perform R0 resection. We present
herewith our experience with this technique.
Method: Over 24 months, 23 patients underwent an
ALPPS procedure. The mean age was 57.60 years. The
disease distribution was as follows: CRC = 17,
NET = 2, CCA = 2 HCC = 2. The pre-ALPPS mean
FRL/TLV was 28.45%.
Results: All 23 patients underwent an ALPPS proce-
dure combined with resection of disease from left lobe
(n = 17) (FRL) or purely to enhance liver volumes. 2
patients had a colorectal resection combined with the
ALPPS procedure, for synchronous liver metastases. 2
patients underwent a liver first approach for synchro-
nous liver metastases. 1 patient could not have comple-
tion hepatectomy due to progressive disease. The
absolute FRL increment as a result of ALPPS was
obtained at a mean of 67.78% which equated to a
volume increment between 16–519 mL,
mean = 282.82 mL. Mean time to FRL increase was
13.72 days. Mortality was 1/23 = 4.34%. Overall mor-
bidity was 13/23 (56.52%). Grade 3 and 4 complica-
tions were noted in 6/23 (26.08%). R0 resection was
achieved in 21 patients (95.45%).
Conclusions: ALPPS can be performed with an accept-
able morbidity and mortality in patients with border-
line disease or those with borderline liver volumes. It
can be performed in the same hospital admission and is
achieves quicker hypertrophy with greater efficacy as
compared to PVE. This has significant impact on costs
as well as may influence survival due to lesser time to
initiation of adjuvant chemotherapy. ALPPS should be
offered wherever possible and should be considered as
a viable substitute for PVE.
PPL26-050
INTRAOPERATIVE RADIOFREQUENCY
ABLATION AND PERITONEAL LAVAGE
WITH DISTILLED WATER FOR
SPONTANEOUSLY RUPTURED
HEPATOCELLULAR CARCINOMA
Ho Joong Choi1 and Young Chul Yoon2
1Catholic University of Korea Bucheon St. Mary’s
Hospital, Korea; 2Catholic University of Korea Incheon
St. Mary’s Hospital, Korea
Introduction: Spontaneous rupture of hepatocellular
carcinoma (HCC) is a rare but life threatening compli-
cation by causing a hemoperitoneum and worse prog-
nosis. Prognosis of patients with ruptured HCC has
not been fully evaluated.
Method: Data of 4 consecutive patients who underwent
intraoperative radiofrequency ablation and peritoneal
lavage with distilled water for spontaneously ruptured
HCC was evaluated. Patients with ruptured HCC that
accompany neither distant metastasis nor existence of
tumor thrombus at PV or HV were targeted. Bleeding
control was performed by gently packing gauzes on the
cancer lesion and applying ablation with RFA probe at
corresponding site. Blood transfusion was also applied
at the same time. Depending on the consequences,
resection was done if needed. After the operation,
lavage with 10L of distilled water was followed for
20 minutes to prevent tumor seeding.
Results: Between Jan. 2012 and Oct. 2012, 4 patients
were operated using RFA on ruptured HCC. Among
these, 3 patitents had hepatitis B related LC and the
other was alcoholic LC. 1 patient ended the operation
after RFA only and 3 patients went through partial
hepatectomy in addition to bleeding control with RFA.
Amount of intraoperative PRC transfusion was 37
units for RFA + Rt. Hepatectomy, 2 and 7 unit for
RFA + Lt. lateral sectionectomy (LLS) patients,
respectively and 7 unit for RFA only patient. Average
length of hospital days in ICU was 5.5 days and aver-
age hospital days in general ward were 22 days.
6 month survival rate for all patients were 100% but 1
patient died of lung metastasis, 7 months after the
operation. All patients had no peritoneal metastasis.
Conclusions: Intraoperative RFA and peritoneal lavage
with distilled water for spontaneously ruptured HCC is
easy to perform and theoretically safe method,
although further study is needed after accumulation of
more cases.
PPL26-051
SURGICAL TREATMENT FOR
HEPATOCELLULAR CARCINOMA
LOCATED IN THE CAUDATE LOBE
Masahiko Sakoda, Shinichi Ueno, Satoshi Iino,
Kiyokazu Hiwatashi, Koji Minami, Hiroshi Kurahara,
Yuko Mataki, Kousei Maemura, Hiroyuki Shinchi and
Shoji Natsugoe
Kagoshima University School of Medicine, Japan
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Introduction: Surgical treatment remains difficult for
hepatocellular carcinoma (HCC) originating in the cau-
date lobe. Resection of the caudate lobe combined with
an adjacent segment or lobe can be reasonable if the
patient’s liver function permits. However, various prob-
lems are encountered because of the complicated anat-
omy. In this report, we evaluated the safety of and
problems associated with caudate lobectomy combined
with other types of hepatectomy.
Method: We performed caudate resection for primary
HCC in 14 patients from January 1995 to December
2010. Clinical and operative characteristics and survival
were analyzed.
Results: Tumors were located in the Spiegel lobe in
four patients, the caudate process in six and the para-
caval portion in four. The procedure performed most
was isolated partial caudate lobe resection (7 patients).
Three patients underwent partial caudate lobe resection
combined with other hepatectomy and the remainder
underwent subtotal caudate lobe resection combined
with other hepatectomy. Tumors of those patients who
underwent combined subtotal caudate lobe resection
were mainly in the paracaval portion. The median
operation time of the seven patients who underwent
combined resection was 446 min and their median in-
traoperative blood loss was 2.086 mL. There was no
postoperative complication in patients who underwent
combined subtotal caudate lobe resection, except one
case of subtotal resection combined with central biseg-
mentectomy; the remaining right posterior sector was
twisted after liver extraction, causing blockage of the
outflow of the right hepatic vein. The overall and the
recurrence-free survival rates did not differ between iso-
lated and combined resection.
Conclusions: For removal of HCC located in the cau-
date lobe, especially the paracaval portion, partial or
subtotal caudate lobe resection with other types of hep-
atectomy contributes to safe and curative surgery, if
the liver functional reserve and complications associ-
ated with surgery are well understood.
PPL26-052
A MULTIPLE ABLATION STRATEGY IN
PATIENTS WITH BORDERLINE
RESECTABLE OR IRRESECTABLE
COLORECTAL CANCER LIVER
METASTASES
Eduard Jonas1, Jennie Engstrand2, Henrik Nilsson2,
Bengt Isaksson1, Anders Jansson1, Lars Lundell1 and
Jacob Freedman2
1Karolinska University Hospital, Sweden; 2Danderyd
Hospital, Stockholm, Sweden
Introduction: In patients with colorectal cancer liver
metastases liver resection is indicated when a complete
(R0) resection with preservation of a sufficient future
liver remnant (FLR) is achievable. Some patients, ini-
tially irresectable can be converted to resectable with
combinations of chemotherapy, local ablation or liver
volume manipulation. We present results of an aggres-
sive treatment strategy using multiple microwave abla-
tion (MWA) in patients where curative intended
treatment is precluded by absence of a tumour-free
FLR due to extensive segmental tumour engagement.
Method: In patients where the whole liver or a FLR
could be rendered macroscopically tumour-free with
multiple ablations, MWA was performed at laparot-
omy, using ultrasound guidance or computer-assisted
navigation. In cases where a FLR was identified and
cleared, resection was performed as a second proce-
dure, whereas an ablate-and-wait approach was
adopted in patients with total liver clearance. Mortality
and morbidity was recorded and the overall and dis-
ease-free survival of the ablated patients was compared
to the survival data of two historic cohorts.
Results: Twenty patients were treated with the multiple
MWA strategy. There was no perioperative mortality
and complications associated with the MWA was
mostly mild to moderate. After a median follow-up of
640 days 11 patients were alive, of which 5 were dis-
ease-free. The MWA group showed a 3-year overall
survival of 33%, compared to 60% for the historic
cohort representing the best-case scenario (resected
patients) and 15% for the worst-case scenario cohort
(patients treated palliatively).
Conclusions: Results of the multiple MWA approach
in the defined population suggest that a favourable dis-
ease-free outcome with potential cure can be achieved
in a small number of patients. Patients where curative
efforts with this strategy fail seem to benefit from an
increased survival, compared to palliative chemother-
apy only.
PPL26-053
POSTOPERATIVE BUT NOT
PREOPERATIVE TREATMENT WITH
SORAFENIB INHIBITS LIVER
REGENERATION IN RATS.
Kasper Jarlhelt Andersen, Anders Riegels Knudsen,
Anne-Sofie Kannerup, Jens Randel Nyengaard,
Stephen Hamilton-Dutoit, Morten Ladekarl and Frank
Viborg Mortensen
Aarhus University Hospital, Denmark
Introduction: Sorafenib, a tyrosine multikinase inhibi-
tor, has been shown to halt the growth of hepatocellu-
lar carcinoma. The aim of the present study was to
investigate the effect of sorafenib on liver regeneration
in healthy rats.
Method: In two sub-studies, we examined the effect of
pre- or post-operative treatment with sorafenib (15 mg/
kg/day). 120 Wistar rats received either sorafenib or
placebo. Following 70% partial hepatectomy, the rats
were euthanized on postoperative days (PODs) 2, 4 or
8. Body weight and liver weight were recorded and
regeneration rate was calculated. Hepatocyte prolifera-
tion was estimated by immunohistochemistry for Ki-67
antigen using unbiased stereological methods.
Results: Eleven animals (9%) died following surgery.
In the Post-Op sub-study, significantly lower values of
liver weight gain, liver regeneration rates and hepato-
cyte proliferation were found in the S group. In the
Pre-Op sub-study, lower body weight gains during the
gavage period in the S group were found. No differ-
ences were found between the groups regarding liver
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weight gain, liver regeneration rates and hepatocyte
proliferation on PODs 2 and 4.
Conclusions: In our rat model, sorafenib did not seem
to increase post-hepatectomy mortality. Postoperative
treatment significantly impaired liver regeneration. Pre-
operative treatment impaired body weight gain during
the gavage period, but did not affect liver regeneration.
PPL26-054
PERIOPERATIVE OUTCOMES OF
LAPAROSCOPIC AND ROBOTIC
MAJOR HEPATECTOMIES: A
MULTICENTER COMPARATIVE STUDY
Marcello Spampinato1, Andrea Coratti2, Luigi Bianco2,
Fabio Caniglia4, Francesco Puleo5, Andrea Laurenzi3,
Giuseppe Maria Ettorre3 and Ugo Boggi4
1Policlinico di Abano Terme, Italy; 2Misericordia
General Hospital Grosseto, Italy; 3San Camillo Hospital
Rome, Italy; 4University of Pisa, Italy; 5Erasme
University Hospital, Belgium
Introduction: Laparoscopic major hepatectomies
(LMH) have been showed to be a valid alternative to
open surgery when performed in highly specialized cen-
ters. Recently, the robotic approach to minimally-inva-
sive liver surgery has been proposed as an alternative
to the laparoscopy. Aim of this study was to compare
short term perioperative outcomes of LMH versus
robotic major hepatectomies (RMH).
Method: A retrospective analysis was made comparing
RMH (n = 25) and LMH (n = 25) performed at four
Italian hepatobiliary centers (two robotics and two lap-
aroscopic) between January 2009 and December 2012.
Demographic data, operative, and postoperative out-
comes were collected from prospectively mantained da-
tabases and compared.
Results: Demographic characteristics and operation
type of RMH and LMH group were similar. The were
no significant differences in operative outcomes includ-
ing operating time, estimated blood loss and blood
transfusions between the two groups. Patients undergo-
ing LMH had more need for intermittent vascular
clamping (32% vs 0%, p = 0.001). Overall conversion
rate was 1/25 cases (4%) in both groups. There was no
difference in ICU and total hospital stay but the LMH
group had a faster postoperative recovery including
first flatus (LMH = 1 vs RMH = 3 days, p = 0.001)
and first liquid diet (LMH = 1 vs RMH = 2 days,
p = 0.001). There were no significant differences in
complication rates, 90-day mortality and readmission
rates.
Conclusions: In this retrospective multicenter study the
robotic approach leads to similar short term periopera-
tive outcomes compared to the laparoscopic one. More
studies are needed to validate these results and to clar-
ify the role of minimally invasive liver surgery for
major hepatectomies.
PPL26-055
WEIGHT LOSS AT TIME OF CANCER
DIAGNOSIS PREDICTS SHORTER
SURVIVAL
Thorhallur Agustsson, Cecilia Str€omberg and Bengt
Isaksson
Karolinska Institutet, Sweden
Introduction: The syndrome cancer cachexia causes
many metabolic changes in cancer patients and the
most obvious change is weight loss. We studied a
cohort of cancer patients that at the time of diagnosis
were divided into three groups: Cancer cachexia (CC),
weight loss caused by obstruction (WLO) and weight
stable (WS). After a minimum of 5 years follow up,
difference in survival between the groups was investi-
gated.
Method: All patients with a newly diagnosed cancer in
the upper gastrointestinal tract referred to the Karo-
linska University Hospital in Sweden were consented
for the study. Nutritional status was evaluated and
weight loss assessed. Weight loss was defined as >5%
in the last 3 months or > 10% in the last 6 months.
Patients with weight loss were allocated to CC or WLO
depending on the presence of obstruction. Therapy
conference management plan operations results, patho-
logical reports and time of death were recorded pro-
spectively. Survival was defined as the time from
inclusion into the study to time of death. Statistics were
performed with ANOVA, Spearman correlation, Kap-
lan–Meier survival and Cox regression.
Results: There were 17 patients in the CC group, 22 in
WS and 12 in WLO group. Nutritional status was
poorest in WLO and best in WS (p < 0.05). There was
significant difference in survival between all groups,
both at the time of diagnosis and in patients assessed
curable following therapy conference, WLO survival
shortest and WS longest. Patients in WLO had 3.5
times shorter survival than WS and all patients with
weight loss had 2.5 times shorter survival than WS
patients. There was significant correlation between %
weight loss and survival (R = 0.57).
Conclusions: Weight loss at time of cancer diagnosis
predicts shorter survival, especially if obstruction is
present and is not related to estimated curability.
PPL26-056
EARLY EXPERIENCE WITH INTRA-
OPERATIVE IRREVERSIBLE
ELECTROPORATION IN THE
TREATMENT OF LIVER METASTASES
Shaila Merchant, Hans Schoellhammer, Joseph Kim,
Lily Lai, Jonathan Kessler, John Park and Gagandeep
Singh
City of Hope Comprehensive Cancer Center, USA
Introduction: Irreversible electroporation (IRE) is an
emerging treatment option that may effectively control
hepatic malignancies that abut upon major vascular
and biliary structures. We present our early experience
with IRE.
Method: Medical records of patients who underwent
IRE in a single institution between June 2011 and July
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2013 were reviewed. IRE was performed in the operat-
ing room via laparotomy, usually in conjunction with
hepatic resection. IRE treatment was undertaken when
lesions were deemed unresectable (proximity to major
vascular structures or concerns regarding size of future
liver remnant) or for margin ablation after hepatic
resection. All patients received post-operative imaging
within 6 months of surgery except for 2 patients who
had their surgery recently.
Results: Fifteen patients (male = 9; female = 6) under-
went IRE treatment. Patients underwent ablation of
hepatic lesions (n = 2), hepatic resection followed by
margin ablation (n = 9) or both (n = 4). The histologies
included colorectal cancer (n = 11), hepatocellular car-
cinoma (n = 1), angiosarcoma (n = 1), prostate cancer
(n = 1), and cholangiocarcinoma (n = 1). Most patients
(n = 12 of 15) had bilobar disease and a majority
(n = 12 of 15) had undergone pre-operative chemother-
apy. Complications within a 30-day period occurred in
4 patients and included intra-abdominal collection
requiring drainage (n = 1), wound infection (n = 2), re-
admission for pain (n = 1) and pleural effusion requir-
ing drainage (n = 1). Complications at 60 days
occurred in 2 patients and included readmission for
pain (n = 1) and Clostridium difficile colitis (n = 1).
Post-operative imaging within 6 months indicated
patency of major arterial, venous and biliary structures
in all patients.
Conclusions: Our early experience shows that IRE is
safe for the treatment of hepatic metastases that are
close to or abutting major hepatic vasculature; further-
more, IRE can be used to ablate the hepatic paren-
chyma around major vascular structures when resection
margins are microscopic. Our short term results suggest
that IRE may be effective in the multidisciplinary man-
agement of hepatic malignancies.
PPL26-057
LONG TERM RESULTS AND
PROGNOSTIC FACTORS IN 185
PATIENTS WITH HEPATOCELLULAR
CARCINOMA TREATED BY
RADIOFREQUENCY ABLATION,
10 YEARS EXPERIENCE
Andrew, Sheung-Hey Ng, Ting Pong Fung, Derek, Tak
Lap Tam and Siu Ho Lam
United Christian Hospital, Hong Kong, China
Introduction: Radiofrequency ablation (RFA) has
gained widespread popularity in the treatment of hepa-
tocellular carcinomas (HCC). However, uncertainties
remain concerning favorable patient and tumor charac-
teristics.
Method: In this single-center retrospective study, from
2003 to 2013, the local recurrence-free survival, overall
survival, and prognostic factors for 185 patients under-
going RFA as primary treatment were assessed.
Results: There were 185 patients undergoing RFA in
10 years. Patients with up to three lesions, 3 cm or
smaller, or one lesion up to 5 cm, were considered for
ablation. 49% of our patients received percutaneous
RFA, while others received open or laparoscopic
assisted RFA. 4 patients (2.2%) suffered from
incomplete tumor ablation, requiring further treatment.
Two-year local recurrence free survival was 68%, with
a median of 43 months (95% CI: 33.5–52.5). On multi-
variate analysis, four independent favorable prognostic
factors were identified: patients with tumors 3 cm or
smaller (HR: 0.527; p = 0.021), without symptoms
(HR: 0.412; p = 0.024), with an AFP < 8 (HR: 0.548;
p = 0.023), and without ascites (HR: 0.477; p = 0.039).
Median overall survival was 58 months (95% CI: 39.3–
76.7), with a 5 year overall survival of 49%. On multi-
variate analysis, independent favorable prognostic fac-
tors for overall survival include solitary tumors (HR:
0.575; p = 0.038), absence of Hepatitis C infection
(HR: 0.448; p = 0.009), and Child Pugh score of A
(HR: 0.478; p = 0.005). The median hospital stay was
7 days, and 24 patients (13%) suffered from complica-
tions requiring intervention. The 30-day mortality rate
was 3.8%.
Conclusions: RFA achieves good local control of HCC,
especially in asymptomatic patients with small tumors,
no ascites, and low AFP. Overall survival is worse in
Hepatitis C affected patients with multifocal HCC, and
decompensating cirrhosis.
PPL26-058
USEFULNESS OF KYOTO CRITERIA AS
EXPANDED SELECTION CRITERIA FOR
LIVER TRANSPLANTATION FOR
HEPATOCELLULAR CARCINOMA
Toshimi Kaido, Kohei Ogawa, Akira Mori, Yasuhiro
Fujimoto, Koji Tomiyama, Etsuro Hatano, Hideaki
Okajima and Shinji Uemoto
Kyoto University, Japan
Introduction: We previously proposed expanded selec-
tion criteria for liver transplantation (LT) for hepato-
cellular carcinoma (HCC), the Kyoto criteria, involving
a combination of tumor number ≤10, maximal diameter
of each tumor ≤5 cm, and serum des-gamma-carboxy
prothrombin levels ≤400 mAU/mL, and we have used
these criteria since January 2007. In the present study,
the usefulness of the criteria was prospectively as well
as retrospectively validated.
Method: One hundred and ninety-eight patients with
HCC who underwent living donor LT (LDLT) at our
institute between February 1999 and December 2011
were enrolled in this study. Overall survival and the
recurrence rate were investigated in patients classified
according to the Kyoto criteria, the Milan criteria, or
previous treatments for HCC. Tumor biological aggres-
siveness, including microvascular invasion and histolog-
ical differentiation, according to selection criteria was
also examined.
Results: The 5-year overall survival rate for patients
within the Kyoto criteria (n = 147, 82.3%) was signifi-
cantly higher than that for the 49 patients exceeding
them (n = 49, 42.2%) (p < 0.001). The 5-year recur-
rence rate for patients within the Kyoto criteria (4.4%)
was significantly lower than that for patients exceeding
them (51.0%) (p < 0.001). Intention-to-treat analysis of
the 62 patients who underwent LDLT after implemen-
tation of the Kyoto criteria showed that the 5-year
overall survival rate and the recurrence rate were
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81.5% and 6.5%, respectively. Tumor biology was sig-
nificantly less aggressive in patients within the Kyoto
criteria.
Conclusions: The Kyoto criteria are useful expanded
criteria for LDLT for HCC and could help achieve
favorable outcomes.
PPL26-059
USEFULNESS OF THE THREE-
DIMENSIONAL (3D) PRINTED LIVER
MODEL IN HEPATIC SURGERY: A NEW
SIMULATION AND NAVIGATION
SYSTEM
Yasuji Seyama1, Masaki Matsuda1, Keigo Tani1,
Yoshiaki Hara2, Yasuhiro Morita2, Kijuro Takanishi2,
Masanao Kurata2, Goro Honda2 and Nobutaka
Umekita1
1Tokyo Metropolitan Bokutoh Hospital, Japan; 2Tokyo
Metropolitan Hospital, Japan
Introduction: Three-dimensional (3D) analysis has
enabled preoperative simulation and intraoperative
navigation in liver surgery. However, the 3D images
were demonstrated only on the 2D monitor. Recently,
we became able to make a 3D liver model with vascu-
lar structures and tumors by a 3D printer. Herein, we
present simulation and navigation using 3D printed
liver models in liver surgery.
Method: Preoperative CT images were reconstructed in
a 3D configuration, including the liver parenchyma,
portal vein, hepatic vein, and tumors. A transparent
liver model with precise internal structures was made
by a 3D printer. Preoperatively, the surgeons simulate
surgical procedures using the 3D model for a hand and
acquire a real image inside the liver. Intraoperatively,
liver resection is performed according to navigation
using the 3D liver model in a sterilization bag.
Results: Two types of 3D model were made by 3D prin-
ter, i.e. whole liver type and detachable type. Whole liver
type was adapted to extended right hepatectomy for a
patient with large metastatic tumors in the right live and
the caudate lobe. Preoperatively, we could get the 3D
position of the tumors and vessels and image of the liver
transection surface. A detachable type was adapted to
anatomical liver resection of the segment 8 for a patient
with hepatocellular carcinoma. Preoperatively, we could
detach the segment 8 from the 3D liver model and
observe the transection surface. In both types, planed
liver resections were successfully carried out by the simu-
lation and navigation using 3D printed model.
Conclusions: 3D printed liver model is useful in liver
surgery, and it can be a new system for pre-operative
simulation and intra-operative navigation.
PPL26-060
LAPAROSCOPIC MANAGEMENT OF
CYSTIC DISEASE OF THE LIVER
Adam Hauch, Lee Seeyuen, Kane Erika, Kandil Emad
and Buell Joseph
Tulane Transplant Institute, Tulane University School of
Medicine, USA
Introduction: Cystic disease of the liver can occur in
isolation or in combination with polycystic disease of
the kidney. The treatment of symptomatic liver cysts
has evolved from an open surgical procedure to a lapa-
roscopic approach.
Method: Retrospective review of 58 patients managed
by a single surgeon from 2000 to 2013. Analysis was
performed to compare and contrast with the previously
reported Pittsburgh series.
Results: All surgically resected patients underwent
either subtotal cystectomy or a total resection for
lesions with suspicious cyst linings. Median age of
patients was 61 years of age, BMI of 27, with 19%
being obese (>35) with an ASA of 3. The median cyst
size was 10.8 cm. In the 54 laparoscopic patients, 42%
underwent major hepatic resection (formal lobe) with a
median resection of 3 segments in the full cohort.
Resection required hand-assist in 60% of cases with a
median operative time of 120 min, 100 cc blood loss
and 12 staple loads. A total of 5 cystadenomas were
encountered. Four cases early in the cohorts experience
were approached via an open technique for suspected
cystadenoma and complexity. Incidence of complica-
tions was 11% (bile leak n = 3, pulmonary n = 2, ileus
n = 2).
Conclusions: This experience confirms laparoscopic
resection is the gold standard for the management of
hepatic cysts. In our experience open resection was rap-
idly abandoned for laparoscopy. An early incidence of
bile leak was identified and addressed by deployment
of staplers for cyst wall transection. Both series confirm
a laparoscopic approach can be utilized with a low inci-
dence of complications and recurrence.
PPL26-061
EFFECT OF PERIOPERATIVE
GLUTAMINE ON C – REACTIVE
PROTEIN AND LIVER FUNCTION
TESTS IN PATIENTS UNDERGOING
HEPATIC RESECTION – A
RANDOMIZED CONTROLLED TRIAL
Vijay Richard, Divya Dahiya, Lileswar Kaman,
Prithivi Raj and Arunanshu Behera
Pgimer, Chandigarh, India
Introduction: Hepatic resections are commonly associ-
ated with high morbidity and mortality. Nutrition plays
an important role in reducing postoperative complica-
tions besides improvement in intensive care and periop-
erative management. We evaluated the role of
glutamine as an immunonutrient in patients undergoing
hepatic resection.
Method: We present a prospective randomized con-
trolled trial which included 22 patients who underwent
hepatectomy. Patients were randomized into two equal
groups wherein group A patients received perioperative
glutamine and group B patients served as controls. Pri-
mary outcome measures were level of serum albumin,
C- reactive protein (CRP), liver function tests and
absolute neutrophil count in the postoperative period
while secondary outcome included post operative com-
plications.
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Results: Glutamine decreased the CRP response in
liver resection in a statistically significant manner
(p = 0.028) on the fifth post operative day. This may
signify that glutamine decreases the post operative
inflammatory response associated with liver resection.
Glutamine did not have any significant effect on liver
function tests. Postoperative morbidity was less in
patients who received glutamine.
Conclusions: CRP response was blunted in patients
who received glutamine postoperatively. Decrease in
morbidity following glutamine administration is an
attractive area of prospective research and requires fur-
ther trials involving larger patient groups along with
consideration of additional immunoreactive-nutritional
parameters.
PPL26-062
OPEN VERSUS LAPAROSCOPIC
TREATMENT FOR CYSTIC HYDATID
DISEASE OF LIVER: A 6-YEAR SINGLE-
CENTER EXPERIENCE
Tuxun Tuerhongjiang, Jin-hui Zhang, Jin-ming Zhao,
Qin-wen Tai, Tuerganali Aji, Abudurexiti Mierxiati
and Hao Wen
The first Affiliated Hospital of Xinjiang Medical
University, China
Introduction: Recently, with the introduction of mini-
mal invasive technique into hydatid surgery, increasing
number of laparoscopic surgical practice was reported
with promising results. But there are still some contro-
versies in terms of the safety and efficacy of laparo-
scopic treatment. Herein, we present a comparative
result of both open and laparoscopic treatment in the
context of a 6-year single-center experience.
Method: A Total number of 686 patients with cystic
hydatid disease underwent surgery in our center during
May 2005 to December 2011. Among them, 353
patients were eligible for this study with the following
exclusion criteria: unfit for general anesthesia, previous
upper abdominal surgery, intra-biliary ruptured cyst,
intra-parenchymal located cyst, recurrent cyst, multi-
organ cyst, cyst located in segment 1 and 7, and cyst
larger than 15 cm in size. Operative morbidity and
mortality, hospital stay, and recurrence rate were mea-
sured.
Results: Among 353 eligible patients, 60 were consid-
ered for laparoscopic approach and 293 for open
approach. In laparoscopic group, 24 cystectomies, 26
pericystectomy and hepatectomy in 10 patients. How-
ever, 181 cystectomies, 101 pericystectomies and 11
hepatectomies were carried out in open group. Opera-
tive time was significantly decreased in laparoscopic
group. Postoperative hospital stay was significantly
short in laparoscopic group (3.8  1.2 days) than that
in open group (7.4  1.4 days). The overall morbidity
was 13.3% (8/60) in laparoscopic and 19.8% (58/293)
in open group without significance. Neither major
blood loss nor blood transfusion occurred. Both con-
version rate and mortality was 0%. One recurrence in
laparoscopic and 5 in open group was occurred during
follow-up.
Conclusions: Laparoscopic treatment of liver hydatid
disease seems to be safe and effective in selected
patients and offers all the advantages of laparoscopic
surgery. Large, prospective and randomized trails are
strongly needed to determine a universally accepted
standard technique.
PPL26-063
CASE REPORT AND LITERATURE
REVIEW OF NONALCOHOLIC FATTY
LIVER DISEASE ASSOCIATED
HEPATOCELLULAR CARCINOMA
Haidong Tan and Zhiying Yang
A-PHPBA, China
Introduction: NAFLD is a metabolic stress-induced
liver injury that is closely related to insulin resistance
and genetic susceptibility. It has now become one of
the most common liver diseases. Recent studies found
that, as the disease evolves, NAFLD may gradually
progress into nonalcoholic steatohepatitis (NASH)
related liver fibrosis, cirrhosis and HCC. Two cases of
NAFLD associated HCC were encountered in China-
Japan Friendship Hospital during the period from
December 2010 to September 2011. To analyze the clin-
ical characteristic of non-alcoholic fatty liver disease
(NAFLD) associated hepatocellular carcinoma (HCC).
Method: The clinical features, imaging presentation,
pathological types and treatment outcome of two cases
with NAFLD associated HCC were studied.
Results: The two cases were both young and obese
male, with different CT findings from typical HCC and
both reported well-differentiated adenocarcinoma path-
ologically. Both patients underwent surgical resection
and were followed-up post-operatively for 24 months
and 14 months respectively, with no sign of recurrence
or metastasis.
Conclusions: NAFLD associated HCC has different
clinical presentation from the typical HCC. Incidental
finding of any liver occupying lesions in NAFLD
patients should warrant immediate clinical attention.
PPL26-064
DUAL TREATMENT: A NOVEL
STRATEGY FOR HIGHLY-ADVANCED
HEPATOCELLULAR CARCINOMA
Shinichi So, Masahiro Kido, Takumi Fukumoto,
Atsushi Takebe, Motofumi Tanaka, Hisoka Kinoshita,
Kaori Kuramitsu, Daisuke Tsugawa, Kenji Fukushima
and Yonson Ku
Kobe University, Japan
Introduction: The selection criteria for the treatment of
highly-advanced hepatocellular carcinoma (HCC) is still
controversial, and its therapeutic efficacy is unsatisfac-
tory. Conversely although survival benefit of surgical
resection for these cases have not been reported yet,
portal vein (PVTT) or IVC (IVCTT) tumor thrombus
is an life-limiting factor and accordingly surgery is
selected as a treatment option in the hope of long-term
survival. Previously we aggressively performed surgical
resection and thrombectomy for these patients.
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However with longer survival time after surgery,
intra-hepatic recurrence often developed in the rem-
nant liver. From this experience, we developed a
novel strategy for highly-advanced HCC patients;
dual treatment.
Method: At the first stage, we performed surgical resec-
tion including thrombectomy (reduction surgery).
Within a month we performed percutaneous isolated
hepatic perfusion (PIHP) as the second stage for the
prevention of recurrence. PIHP is a high-dose regional
chemotherapy we developed at our facility. With PIHP,
we could administer cytotoxic agents at a dose up to 10
times while reducing the side effect of the agents from
the entire body.
Results: Until December 2012, we treated 95 cases with
dual treatment and completed in 85 cases. Among them
32 cases were categorized in vp4 stages. More than
70% patients were performed lobectomy at the first
stage. Twenty-three (27.1%) patients showed complete
response, 36 (42.4%) showed a partial response, 15
(17.6%) showed no response, and 11 (12.9%) showed
progressive disease. Response rate was 69%, and sur-
vival rate of the 85 patients were 73% (1-year), 31%
(3-year), and 24% (5-year) respectively.
Conclusions: Dual treatment could achieve median and
long-term prognosis, indicating that this would be a
novel strategy for highly-advanced HCC.
PPL26-065
NEO-ADJUVANT CHEMOTHERAPY
AND PRIMARY-FIRST APPROACH FOR
RECTAL CANCER WITH
SYNCHRONOUS LIVER METASTASES
Tamara Gall, Mohamed Basyouny, Adam Frampton,
Nagy Habib, Duncan Spalding and Long Jiao
Hammersmith Hospital, UK
Introduction: Up to a quarter of patients with rectal
cancer have synchronous liver metastases at the time of
diagnosis. This is a predictor of poor outcome. There
are no standardized guidelines for treatment. We
reviewed the outcomes of our patients with synchro-
nous rectal liver metastases treated with a curative
intent by neo-adjuvant chemotherapy with or without
chemoradiotherapy followed by resection of primary
tumor and then liver metastases.
Method: Between 2004 and 2012, patients who pre-
sented with rectal cancer and synchronous liver metas-
tasis were treated with curative intent with
perioperative systemic chemotherapy as the 1st line of
treatment. Responders to chemotherapy underwent
resection of the primary tumor with or without preop-
erative chemoradiotherapy (CRT) followed by hepatic
resection.
Results: Fifty-three rectal cancer patients with 152 syn-
chronous liver lesions were identified. After a median
follow-up of 29.6 months (range, 6.07–107.6 months)
30 patients (57%) were alive (9 patients alive with dis-
ease) and 23 (43%) had died. Overall survival (OS) was
59% at 3 years and 39% at 5 years. OS was similar in
patients with no recurrence to those with liver recur-
rence only, but worse in patients with extra-hepatic and
hepatic recurrence.
Conclusions: Rectal resection before hepatic resection,
combined with perioperative chemotherapy is associ-
ated with promising clinical outcome. It allows down-
staging of liver lesions and removal of the primary
tumor before the progression of further micrometasta-
ses. Furthermore, patients that do not respond to che-
motherapy can be identified and may avoid major
surgical intervention.
PPL26-066
A MODIFIED SUGIURA PROCEDURE
FOR CONTROL OF VARICEAL BLEED
Feilong Liu, Qi Wang, Zhiwei Zhang and Bin Bin
Tongji Hospital, Tongji Medical College, Huazhong
University of Science and Technology, China
Introduction: A proportion of patients with variceal
bleed need surgical intervention. This study evaluated a
modified gastro-esophageal decongestion combined
with esophageal stapling (MGEDEST) procedure in
controlling variceal bleed after endoscopic therapy.
Method: A MGEDEST procedure was performed in 62
patients with acute variceal bleeding that could not be
controlled by endoscopic therapy or with a history of
massive bleed after endoscopic therapy.
Results: Perioperative mortality occurred in 1.6% (1/
62) patient. No esophageal leak or stenosis occurred.
Six months after operation, esophageal varices disap-
peared in 78.7% (48/61) patients, diminished in size in
18% (11/61), remained unchanged in 3.3% (2/61); Fun-
dal gastric varices disappeared in 98.4% (60/61)
patients, diminished in size in 1.6% (1/62). The rebleed
rate was 0, 3.27% (2/61) and 6.56% (4/61) in 6 months,
3 years and 5 years, respectively.
Conclusions: The MGEDEST procedure is safe and
effective for long-term control of variceal bleed after
endoscopic therapy.
PPL26-067
SHORT-TERM POSTOPERATIVE
OUTCOME OF CENTRAL
HEPATECTOMY FOR CENTRALLY
LOCATED HEPATOCELLULAR
CARCINOMA
Hiroaki Terajima, Taku Iida, Sena Iwamura, Hiroshi
Kawamoto, Rei Toda, Yoshikage Inoue, Mami
Yoshitomi, Yoichiro Uchida, Shugo Ueda and
Akiyoshi Kanazawa
Kitano Hospital, Japan
Introduction: For the treatment of centrally located
hepatocellular carcinoma (HCC) at Couinaud’s seg-
ment 4, 5, and 8, central hepatectomy including central
bisectionectomy, right anterior sectionectomy, and left
medial sectionectomy can preserve more nontumorous
parenchyma than conventional hemihepatectomy or tri-
sectionectomy. However, meticulous surgical techniques
are indispensable in central hepatectomy to perform 2-
sided broad hepatic parenchymal transection and to
reduce the risks of intraoperative bile duct injury or
postoperative bile leakage attributable to the extended
exposure of Glisson’s pedicle at the hepatic hilum.
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Method: From a single institution liver surgery data-
base for HCC between January 2006 and June 2013, 17
patients undergoing central hepatectomy (Central
group) and 41 patients undergoing other types of ana-
tomical resection (Non-central group) were identified,
and perioperative variables were retrospectively ana-
lyzed and compared between the 2 groups.
Results: The Central group consisted of 4 central biseg-
mentectomy, 11 right anterior sectionectomy and 2 left
medial sectionectomy. As for preoperative liver func-
tion, the Non-central group had a higher Child–Pugh
score (5.4 vs. 5.0, p = 0.01) and lower KICG value
(0.137 vs. 0.159, p = 0.047). The Central group had an
increased operative time (503 minutes vs. 400 minutes,
p = 0.014), but blood loss, transfusion rate, postopera-
tive liver function, and complication rates including
posthepatectomy liver failure and bile leakage were
equivalent between the 2 groups, resulting in the similar
hospital stay.
Conclusions: Although central hepatectomy is techni-
cally more demanding, it provides a similar short-term
postoperative outcome as other types of anatomical
resection.
PPL26-068
A CASE OF PRIMARY
CARCINOSARCOMA OF THE LIVER
UNDERGOING CENTRAL
BISECTIONECTOMY.
Hidejiro Urakami1, Jo Tokuyama1, Koji Osumi1, Shiko
Seki1, Atsushi Shimada1, Akira Matsui1, Takashi
Oishi1, Yo Isobe1, Yuya Murata2 and Sumio
Matsumoto1
1National Hospital Organization Tokyo Medical Center,
Japan
Introduction: Carcinosarcoma of the liver is a very rare
malignant tumor worldwide containing an intimate
mixuture of carcinomatous and sarcomatous elements.
The terminology and pathogenesis of hepatic carcino-
sarcoma remain controversial issues.
Method: We experienced a case of 70-year-old male
who complained of GERD with liver dysfunction and
jaundice. Hepatitis B and C markers showed negative.
CT and MRI demonstrated a well-vascularized multi-
lobular huge mass combined with calcification of 15 cm
in size at segments 4–5 and 8 as well as intrahepatic
bile duct dilatation. Neither clear distant metastases
nor vessel thrombi were observed. Tumor marker such
as AFP and PIVKA-II were extremely high level, and
diagnosed hepatocellular carcinoma. Child-Pugh score
was B at the diagnosis and the risk of liver failure was
expected after surgery, although patient desired to be
done a surgery.
Results: We underwent central bisectionectomy as sur-
gically curative operation. Child–Pugh score was chan-
ged to C during the evaluation period for a month,
though. Pathological findings revealed a tumor con-
tained a carcinomatous element showing positive
immunohistochemical (IHC) markers of CK, Hepato-
cyte and AFP, and a sarcomatous element showing
positive IHC markers of Vimentin, CD68 and SMA,
and diagnosed carcinosarcoma of the liver. Ki-67
labeling index was 20% at carcinomatous element and
80% at sarcomatous element. Moderate and mild grade
of infiltration to portal vein and hepatic vein were
observed, respectively. No clear complication was
occurred during hospitalization, however, local recur-
rence, pleural and peritoneal dissemination were
observed on CT 64 days following surgery. The patient
died 72 days after surgery. Autopsy revealed all recur-
rence and metastases lesions were consisted of sarcoma-
tous element.
Conclusions: The prognosis of this neoplasm is extre-
mely poor which may be largely due to the advanced
stage of disease at the time of clinical presentation.
Early detection and treatment with radical resection
may improve the outcome of this disease.
PPL26-069
SURGICAL STRATEGY FOR
PERITONEAL DISSEMINATION OF
HEPATOCELLULAR CARCINOMA
(HCC)
Noriaki Nakamura, Takumi Irie, Satoshi Matsumura,
Daisuke Ban, Takanori Ochiai, Atsushi Kudo, Shinji
Tanaka and Minoru Tanabe
Tokyo Medical and Dental University, Shuuwa General
Hospital, Japan
Introduction: Even in the patients with advanced stage,
peritoneal dissemination of HCC is rare. Although the
recent improvements of the treatment for HCC such as
surgical operation and radiofrequency ablation are
remarkable, the proper treatment for peritoneal dissem-
ination has not been established. In this paper, we
would focus on the nine cases and discuss on the par-
ticular features of HCC with peritoneal dissemination.
Method: Five hundred and eight cases of HCC were
treated from April, 2000 to August, 2013 in our depart-
ment, Tokyo medical and dental university hospital.
The nine cases (9/580; 1.5%) of peritoneal dissemina-
tion were treated with the surgical operation. The five
of nine was male and others were female. The average
age was 66.4 years old. Tumor markers were elevated
in all cases.
Results: Seven of 9 cases had previous treatment
including 2 cases of ruptured HCC, one had lung
metastasis to be resected and the other has multiple
resections. Only one case has no previous treatment. In
7 cases, there was no intrahepatic lesion at the end of
the surgical procedure for peritoneal disseminations.
Case Report; A 74-year-old male diagnosed with rup-
tured HCC in the right lobe was underwent emergency
TACE followed by right hepatectomy. After initial
treatment, repeat operation was performed during sev-
eral years. In the latest operation, the upper mediasti-
nal lymph nodes metastasis was resected followed by
resection of peritoneal dissemination.
Conclusions: Even in cases of peritoneal dissemination,
repeat surgical procedure is also possible and one of
the effective strategies. Peritoneal dissemination of
HCC has some clinical features different from other GI
cancers in terms of growth rate. Since it’s difficult to be
enclosed in a single category, it is necessary to carefully
consider the strategy of treatment for each case.
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PPL26-070
SPONTANEOUS NECROSIS OF
HEPATOCELLULAR CARCINOMA
Hiroshi Tanaka, Satomi Saeki, Kiyoshi Hiramatsu,
Takeshi Amemiya, Hidenari Goto, Takashi Seki,
Sakurako Suzuki, Shizuki Sugita and Toshiyuki Arai
Anjo Kosei Hospital, Japan
Introduction: We present a rare case of hepatocellular
carcinoma (HCC) in which spontaneous necrosis was
confirmed with surgical resection.
Method: A 64-year-old man began to be treated with
PEG-Interferon and Ribavirin because of chronic hepa-
titis C on October 2011, and HCV-RNA was turned
negative 12 weeks later. When he stopped the treatment
because of pancytopenia 53 weeks after, abdominal CT
scan revealed a hypovascular mass measuring 41 mm
at anterior segment of liver. We diagnosed the lesion as
HCC and performed a right hemihepatectomy on
December 2012.
Results: On macroscopic examination, the tumor was
yellow, firm with fibrous capsule. Histopathological
examination showed that the tumor in cirrhotic liver
had been completely replaced by central coagulative
necrosis infiltrated by inflammatory cells. This tumor
was surrounded by capillary vessels and was fed with
several thick arteries, but organized thrombi in the
hepatic artery were not detected. No viable HCC cells
were found in this tumor. The patient was discharged
20 days after the operation.
Conclusions: Spontaneous regression of HCC was
reported to be a rare event with a rate of 1 in 14,000
cases of HCC. It is said that thrombosis of feeding ves-
sels, deprivation of oxygen or noxious agents have rela-
tion to this change, but the mechanism is still unclear.
PPL26-071
PROLONGED CHEMOTHERAPY AND
OXALIPLATIN IMPAIR LIVER
HYPERTROPHY AFTER PORTAL VEIN
OCCLUSION
Nadia Russolillo1, Francesca Ratti2, Alessandro
Ferrero1, Luca Vigano’1, Federica Cipriani2, Luca
Aldrighetti2 and Lorenzo Capussotti1
1Mauriziano “Umberto I” Hospital, Italy; 2Sant
Raffaele Hospital, Italy
Introduction: The volume of the future liver remnant
(FLR) is clearly a predictor of postoperative hepatic
dysfunction. The rate of liver hypertrophy after portal
vein occlusion (PVO) predicts FLR function, represent-
ing an important “liver stress test”. The aim of the
study is to identify factors affecting liver hypertrophy
after PVO.
Method: Inclusion criteria were patients affected by
metastatic liver disease scheduled for preoperative PVO
(portal vein embolization or ligation) between 01/2000
and 06/2013 at the two institutions. Patients scheduled
for ALPPS procedure were excluded. PVO was sched-
uled whenever FLR volume was <30%. The standard-
ized FLR volume was assessed by volumetric CT-scan.
Liver hypertrophy was assessed by volumetric increase
[(FLR post% – FLR pre%)/FLR pre %].
Results: 118 patients were analyzed (71 males, median
age 62.5 years); 63 (53%) were scheduled for a two-
stage hepatectomy. The median FLR before PVO was
23.6  6.2%. PVO included 82 (69%) right portal vein
embolizations (extended to Sg4 in 4) and 36 (31%)
right portal vein ligations. 74 (63%) patients received
chemotherapy before PVO (median 6 cycles) and 14
(19%) after PVO (median 3.5 cycles). Chemotherapy
included oxaliplatin in 36 (49%) patients, irinotecan in
28 (38%), both in 4 (5%) and other drugs in 6 (8%).
Bevacizumab was associated with chemotherapy in 32
(43%) patients. The median FLR after PVO was
34.6  7.8% and the median volumetric increase was
0.46  0.38. Five (4.2%) patients didn’t undergo the
planned operation because of disease progression. At
univariate analysis, volumetric increase negatively cor-
related with prePVO chemotherapy, prePVO chemo-
therapy ≥8 cycles, oxaliplatin-based regimen and FLR
prePVO >20%. Bevacizumab and postPVO chemother-
apy didn’t affect liver hypertrophy. At multivariate
analysis prePVO chemotherapy ≥8 cycles (OR 5.3,
p = 0.025), oxaliplatin-based chemotherapy (OR 3.5,
p = 0.040) and FLR > 20% (OR 0.023, p < 0.001) were
independent predictors of lower hypertrophy.
Conclusions: Prolonged chemotherapy (≥8 cycles) and
oxaliplatin-based regimen impair liver hypertrophy
after PVO. Small FLR before PVO doesn’t preclude an
adequate liver hypertrophy.
PPL26-072
LAPAROSCOPIC VERSUS OPEN LIVER
RESECTION FOR ELDERLY PATIENTS
WITH MALIGNANT LIVER TUMORS: A
SINGLE CENTER EXPERIENCE.
Albert Chan, Ronnie Poon, Kenneth Chok, Tan To
Cheung, Jeff Dai, See Ching Chan, Sheung Tat Fan
and Chung Mau Lo
The University of Hong Kong, Hong Kong, China
Introduction: It remains unclear if the short-term bene-
fits of laparoscopic liver resection could be safely
applied to elderly patients with medical co-morbidities.
The aim of our study was to evaluate the perioperative
outcomes of laparoscopic liver resection in patients
with advanced age.
Method: Patients aged ≥70 years old who received liver
resections for malignant liver tumors between Jan 2002
and Dec 2012 were included. The perioperative out-
comes of 17 patients with laparoscopic approach were
matched and compared with 34 patients with conven-
tional open approach in a 1:2 ratio.
Results: There was no significant difference with regard
to age, gender, incidence of co-morbid illness, hepatitis
B positivity and Child grading of liver function. The
median tumor size was 3 cm for both groups. The
types of liver resection were similar between the two
groups with no significant difference in the duration of
operation (laparoscopic: 195 minutes vs open: 210 min-
utes, p = 0.436). The perioperative blood loss was
150 mL in the laparoscopic group and 330 mL in the
open group (p = 0.046) with no significant difference in
the number of patients with blood transfusion. The rate
of recovery in liver function between the two groups
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was also not significantly different in terms of the
serum levels of bilirubin and aspartate aminotransfer-
ase, which tended to be normalized from postoperative
day 3 onwards. The duration of hospital stay was
6 days (3–15 days) for the laparoscopic group and
8 days (5–105 days) for the open group (p = 0.005).
Conclusions: Laparoscopic liver resection is safe and
feasible for elderly patients with lesser blood loss and
shorter hospital stay when compared with the open
approach.
PPL26-073
LIGATING THE CORRESPONDING
INFLOW AND OUTFLOW VESSELS
DURING HEPATECTOMY: A
PROSPECTIVE RANDOMIZED
CONTROLLED TRIAL AND ANIMAL
STUDY
Binhao Zhang, Bixiang Zhang and Xiaoping Chen
Tongji Hospital of Huazhong University of Science and
Technology, China
Introduction: Innovation of the surgical procedure for
improving prognosis of primary hepatocellular carci-
noma (HCC) is under emergency request. We have
devised a simple bleeding control technique ligating the
corresponding inflow and outflow vessels without hilus
dissection before the parenchyma transection during
hepatectomy, and have identified its feasibility, security
and efficacy. However, the prognosis of this technique
is still unknown. The main objective of this study is to
investigate the role of this simple technique on postop-
erative metastasis and long term survival.
Method: During the past 10 years, 330 patients with
primary HCC were performed hepatectomy with the
new hemorrhage control technique, and prospective
randomized controlled trial (RCT) was applied. We
further applied a mice model ligating the pedicle of the
lesion-located hepatic lobe before hepatectomy to imi-
tate the clinic practice, and evaluated the role of the
new technique on postoperative metastasis and sur-
vival.
Results: The new technique prolonged postoperative
overall and disease-free survival for patients with pri-
mary HCC. In the animal model, hepatectomy with the
new technique showed lower intrahepatic metastasis,
lung metastasis, abdominal implantation metastasis and
incision metastasis, and longer overall and disease-free
survival when compared with conventional surgery.
Tumour thromboses were detected either in the portal
veins or bronchial arteries. Human specific-AFP
expressed at a high level in the serum of the metastasis
bearing mice, but not expressed in metastasis-free mice.
Conclusions: Ligating the inflow and outflow vessels of
the lesion-located hepatic lobe before hepatectomy
reduces postoperative metastasis and prolongs survival
of primary HCC. These results also indicate a potential
mechanism that the new technique prevents hematoge-
nous metastasis owing to its coincidence to principles
of oncological surgery to avoid the intraoperative
spread of tumour cells during hepatectomy.
PPL26-074
EVALUATION AND ANALYSIS OF THE
DEPARTMENT OF HEPATOBILIARY
SURGERY, ICU NURSING WORKLOAD
BY USING TISS-76
Qinghua Zhao
PLA General Hospital, China
Introduction: To evaluate the nursing workload in the
department of hepatobiliary surgery ICU by using the
TISS-76.
Method: The total TISS score for the 7 day of the
week and every different shifts of TISS score were mea-
sured and compared.
Results: There was no significant difference in the nurs-
ing workload between different working days for
1 week; there was no significant difference between day
and night work (p > 0.05), there was significant differ-
ence between eve night shift and before dawn shift and
there was significant difference between day shift and
before dawn shift (p < 0.01).
Conclusions: Nursing managers should adjust the nurs-
ing human resources in the weekend and at night
according to the characteristics of special ICU in order
to meet the needs of nursing workload.
PPL26-075
OPEN AND LAPAROSCOPIC
RESECTION OF HEPATOCELLULAR
ADENOMAS: A 20-YEAR SURGICAL
EXPERIENCE AT A SINGLE
INSTITUTION
Daniel Azoulay1, NicolaDe Angelis1, Gerard Pascal1,
Riccardo Memeo1, Julien Calderaro2, Emmanuelle
Felli1, Alain Luciani2 and Alexis Laurent1
1Henri Mondor Hospital – Creteil France, France;
2Henri Mondor Hospital, France
Introduction: Hepatocellular adenoma (HCA) is a rare
benign tumor of the liver, which may require surgical
management. This retrospective study compares the
indications and clinical outcomes of open and laparo-
scopic liver resections.
Method: Patients with a histological diagnosis of HCA
were included in this analysis. Indication for surgery
was for symptomatic patients and for those with lesions
>5 cm. All types of liver resections were performed by
either open or laparoscopic approach, in both elective
and emergency settings.
Results: Between 1989 and 2012, 62 patients (59 females)
underwent surgery for HCA. Of these, 26 patients were
operated by laparotomy (14 major resections, 3 biseg-
mentectomies, 1 unisegmentectomie, 8 wedges), and 36
by laparoscopy (9 major resections, 12 bisegmentecto-
mies, 3 unisegmentectomies, 12 wedges). Overall, 96.6%
of female patients had taken oral oestrogen-based con-
traceptive pills. Comorbidity was similar between the
two groups. Thirty-four patients (54.8%) were symptom-
atic with abdominal pain. Seven patients (11.2%) pre-
sented HCA-related hemorrhage. Among them, 6
patients were first treated with selective arterial emboli-
zation then operated under hemodynamic stability,
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whereas one patient underwent surgery in emergency
setting.
Patients treated by laparoscopy were younger, pre-
sented smaller hepatic lesions and underwent mainly
minor resections. Operatively, open and laparoscopic
liver resections did not differ, except for the number of
pedicular clamping that was significantly higher in the
open resection group (50% vs 27%; p = 0.04). Three
laparoscopic right hepatectomies (8.3%) were converted
to open due to technical difficulties. Post-operative
complication rate was similar between open versus lap-
aroscopic groups. Mortality was nil. In two patients,
atypical lesions borderline HCA/hepatocellular carci-
noma were found.
Conclusions: Open and laparoscopic liver resections are
alternative approaches for the surgical management of
HCA. Open resection is indicated for major hepatec-
tomy whereas laparoscopy is safe and feasible for iso-
lated lesions requiring limited resections.
PPL26-077
STREAMLINE FLOW OF PORTAL VEIN
AFFECTS THE LOBAR DISTRIBUTION
OF COLORECTAL LIVER METASTASES
AND HAS A CLINICAL IMPACT ON
SURVIVAL
Choon Hyuck David Kwon, Jin Soek Heo, Seong Ho
Choi, Dong Wook Choi, Jong Man Kim and Jae-Won
Joh
Samsung Medical Center, Sungkyunkwan University,
Korea
Introduction: There is an understanding that blood flow
from superior mesenteric vein and splenic vein mix
incompletely in the portal vein and maintain a stream-
line flow influencing its anatomic distribution.
Although, several experimental studies demonstrated
the existence of streamlining, clinical studies showed
conflicting results. We investigated whether streamlin-
ing of portal vein affects the lobar distribution of colo-
rectal liver metastases and estimated its impact on
survival.
Method: Data of histologically verified colorectal liver
metastases were retrospectively collected from Samsung
medical center database. Chi-square test and Cox
analysis were used to analyze the difference in lobar
distribution and risk factors for survival, respectively.
Fisher’s exact test was additionally used for analyzing
the difference in hepatic recurrence in the remnant liver
after right hemihepatectomy for solitary liver metasta-
sis.
Results: A total of 410 patients underwent hepatectomy
for colorectal liver metastases. Right to left ratio of liver
metastases were 2.20:1 in right-sided colon cancer and
1.39:1 in left-sided colorectal cancer (p = 0.017). Cox
analyses showed that margin<5 mm (p < 0.001,
HR = 2.837), age ≥ 60 (p = 0.004, HR = 2.149), N2 sta-
tus (p < 0.001, HR = 2.595), tumor size ≥ 45 mm
(p = 0.014, HR = 2.087) and additional distant metasta-
sis (p = 0.012, HR = 2.722) were risk factors for sur-
vival, while primary tumor location was not (p = 0.485).
However, subgroup analysis including 70 patients who
underwent right hemihepatectomy for solitary metastasis
showed that left-sided cancer was a risk factor for sur-
vival (p = 0.019, HR = 4.818). Fisher’s exact test
revealed that patients with left-sided cancer had more
hepatic recurrence than right-sided cancer (43.1% and
15.8%, respectively, p = 0.049) in these 70 patients.
Conclusions: This study showed significant difference in
lobar distribution of colorectal liver metastasis. Fur-
thermore, survival of left-sided colorectal cancer was
poorer than the right in patients who underwent right
hemihepatectomy for solitary metastasis. These findings
can be helpful for clinicians plan the treatment
strategy.
PPL26-078
SINGLE SMALL LIVER SIMPLE CYST
INCREASED IN A SHORT PERIOD AND
MIMICKED A COMPLEX TYPE A CASE
REPORT
Kazuhiro Hiramatsu, Taro Aoba, Seiji Natsume and
Takehito Kato
Toyohashi Municipal Hospital, Japan
Introduction: Liver simple cyst is benign disease, partic-
ularly single small cyst is thought it never grow up in
decade. But very rarely it become large (>4 cm), which
sometimes present several symptoms and problems in
distinguishing from pathological cystic diseases of liver.
We experienced a single small cyst had become large
one in only 5 years without any symptoms, which mim-
icked a complex type.
Method: Case report.
Results: A 64-year-old female was diagnosed as having
cholecystolithiasis and a single liver simple cyst of 2 cm
in diameter in lateral sector by CT in 2005. She had no
other congenital cystic disease. Until 2007, CT revealed
no change of cyst in size and shape. In 2012, in order
to observe asymptomatic cholecystolithiasis, CT and
MRCP were done. This CT demonstrated the cyst
apparently increased to more than 6 cm in diameter.
MRCP revealed heterogeneous content and septum for-
mation of cyst and small mural nodules inside. Ultra-
sound couldn’t show neither mural nodule nor septum
formation. Although these discrepancies among imag-
ing diagnoses were existed, we performed surgical resec-
tion because this simple cyst apparently increased
during only 5 years and had possibility of neoplastic
potential. Due to its proximity of umbilical portion of
left portal vein, left liver resection was done. Macro-
scopically it was 6 9 593 cm unilocular cyst contain-
ing clear liquid, and had no mural nodule. Histological
examination revealed single columnar epithelium with-
out any cellular atypia of cyst wall, which diagnosed it
simple cyst.
Conclusions: Simple small cyst could grow up to large
one in only 5 years without any symptoms and etiol-
ogy. Moreover, there is seldom that the evolutional
change in a short period from small to large simple cyst
like our case had been reported.
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PPL26-079
FOLATE-PEI600-CYCLODEXTRIN
NANOPOLYMER VECTOR IMPROVES
THE THERAPEUTIC EFFICACY OF
ALPHA-FETOPROTEIN PROMOTER-
MEDIATED TBID GENE THERAPY IN
HEPATOCELLULAR CARCINOMA
(HCC)
Paul Lai, Baoguang Hu and George Chen
The Chinese University of Hong Kong, Hong Kong,
China
Introduction: Treatment for advanced HCC remains
suboptimal. We previously reported the application of
Ad/AFPtBid, which over-expresses tBid controlled by
the human alpha-fetoprotein (AFP) promoter, was
effective against AFP-producing HCC cells in vitro and
in vivo. However, due to the potential safety issues of
the adenovirus vector, we have to search for safer and
more effective gene constructs and delivery systems.
Method: A total of 15 different AFP genotype tran-
scriptional regulatory sequences were cloned based on
human AFP promoter variants found. We then chose
the promoter variant (EA4D) with the highest lucifer-
ase activity to construct a new gene therapy agent using
Folate-PEI600-cyclodextrin nanopolymer vector (H1),
pGL3-Basic and the tBid sequence. Such agent is
named in short as ‘H1-pGL3-EA4D-tBid’. The effects
of H1-pGL3-EA4D-tBid were tested in 6 cell lines
including Hep3B, HepG2, Huh-7, Bel7402, SK-Hep-1
and A549 as well as HCC xenograft-bearing nude mice.
Results: H1-pGL3-EA4D-tBid was effective against
AFP-producing HCC cells. In the cell culture, H1-
pGL3-EA4D-tBid was able to significantly reduce HCC
cell growth and proliferation by inducing apoptosis. In
HCC xenograft-bearing nude mice, H1-pGL3-EA4D-
tBid markedly inhibited the growth of HCC tumor
compared with the control. Importantly, in all these
experiment, we did not observe any obvious toxicity
towards normal cells and there were no damage to liver
and renal function. Furthermore, H1-pGL3-EA4D-tBid
significantly sensitized cultured HCC cells to sorafenib.
In the presence of H1-pGL3-EA4D-tBid, the dose of
sorafenib can be significantly reduced when compared
to sorafenib alone; in achieving the same cytotoxic
effect to HCC cells.
Conclusions: H1-pGL3-EA4D-tBid, a novel nanoparti-
cle-based delivery system that coupled with a construct
with the improved AFP promoter activity, can be used
to specifically target and effectively suppress the AFP-
producing HCC. By sensitizing the HCC cells to sorafe-
nib, H1-pGL3-EA4D-tBid may help minimize the side
effects through the use of smaller dose of sorafenib.
PPL26-080
SURVIVAL AFTER REHEPATECTOMY
OR RADIOFREQUENCY ABLATION
(RFA) FOR RECURRENT
HEPATOCELLULAR CARCINOMA
(HCC) – A RETROSPECTIVE COHORT
STUDY
Hon Chi Yip, Charing CN Chong, Anthony KW
Fong, Sunny YS Cheung, John Wong, Kit Fai Lee and
Paul BS Lai
The Chinese University of Hong Kong, Hong Kong,
China
Introduction: Optimal management of post-hepatec-
tomy recurrence of HCC is yet to be determined. This
study aims to review the outcomes after rehepatectomy
or RFA in this group of patients.
Method: This is a retrospective review of patients with
recurrent HCC <5 cm after initial hepatic resection
who underwent rehepatectomy or RFA. Data was
retrieved from a prospectively collected database of
HCC treated from April 2004 to July 2012. Survival
between the cohorts were compared and multivariate
analysis performed to identify factors associated with
recurrence.
Results: Eighteen and 20 patients underwent rehepatec-
tomy and RFA respectively, with median follow-up of
32 months. The mean age was 57.4 with male predomi-
nance (4.4:1). The ASA score were similar between the
two groups. All but four patients in RFA group were
hepatitis B carrier, and all had Child-Pugh grade A cir-
rhosis. During the first operation, 77.8% and 75.0% of
patients underwent minor hepatectomy (≤2 segments)
in the rehepatectomy and RFA groups respectively
(p = 0.841). Most patients had solitary intrahepatic
recurrent HCC (83.3% vs 80.0% for rehepatectomy
and RFA respectively, p = 0.791) with median size of
2.0 cm in both groups (p = 0.649). Percutaneous
approach was used in 80% of patients in RFA group.
Only two patients in the rehepatectomy group experi-
enced post-operative pleural effusion, there was no
complication in the RFA group. There is a non-signifi-
cant trend towards improved disease free survival after
rehepatectomy (Median DFS – 28.4 months vs
10.7 months, Log Rank test p = 0.051). There was also
an apparent improvement in overall survival but the
median survival has not been reached yet. Upon multi-
variate analysis, treatment allocation to RFA was the
only independent predictor of further disease recurrence
(p = 0.049).
Conclusions: With appropriate patient selection, rehep-
atectomy can improve the long term outcome of the
recurrent HCC by reducing further recurrence as com-
pared with RFA, with low morbidity and mortality.
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PPL26-081
THE EFFECT OF TRANSARTERIAL
RADIOEMBOLIZATION WITH
YTTRIUM 90 FOR UNRESECTABLE
HEPATOCELLULAR CARCINOMA
Ka Wing Ma, Moon Tong Cheung, Nam Hung Chia,
Chong Hei Kwok, Sandas Chou, Angus Leung and
Ting Wa Lam
Queen Elizabeth Hospital, Hong Kong, China
Introduction: To study the effect of transarterial radio-
embolization with Yttrium 90 for unresectable hepato-
cellular carcinoma (HCC).
Method: From 1-12-2006 to 31-12-2012, all patients
referred for Yttrium 90 (Y90) treatment due to unresec-
table HCC were reviewed. Patient’s demograpphic data,
Child-Pugh’s score, tumour characteristics, portal vein
status and treatment outcome of Y90 were analysed.
Results: There were 46 patients in our series and the
mean age was 65.3. Majority (37 patients) of our
patients had Child’s A liver disease and most (24
patients) of our patients had diffuse tumour involve-
ment. The mean sum of the diameters in the 2 biggest
tumors was 12.0 cm (SD 6.3 cm). Absence of portal
vein invasion was seen in 27 patients, right or left por-
tal vein invasion in eleven patients and main portal
vein invasion in eight patients. Yttrium was given to 30
patients. Coil embolization was performed in thirteen
patients. After Y90, the mean survival and standard
error were 679 days (148 days) in Child’s A patients,
and 168 days (100 days) in Child’s B patients
(p = 0.023). The survival was 776 days (197 days) for
patients without portal vein invasion, and 299 days
(133 days) for patients with portal vein invasion
(p = 0.036). For those with portal vein invasion, the
survival after MAA assessment date was 311 days
(132 days) if Y90 could be given, it became 114 days
(16 days) if Y90 was contraindicated. Child Pugh’s
score, portal vein status and Y90 treatment were inde-
pendent variables affecting survival. Complications of
treatment included 3 irradiation induced gastritis, 1
arterial dissection making Y90 not possible, and 1 alco-
hol withdrawal syndrome and death 9 days after Y90.
Conclusions: Y90 is able to prolong survival in patients
suffering from unresectable HCC. The complication
profile was acceptable. Child Pugh’s score, portal vein
status and treatment with Y90 were shown to be the
independent variable affective survival.
PPL26-082
SHOULD NODAL STATUS OF THE
PRIMARY TUMOR CONTRAINDICATE
RESECTION OF SYNCHRONOUS
COLORECTAL LIVER METASTASES?
Francois Paye, Mircea Chirica, Morgan Anyla, Magali
Svreck, Pierre Balladur, Yann Parc, Emmanuel Tiret
and Francois Paye
Hopital Saint Antoine – Assistance Publique Hopitaux
de Paris, France
Introduction: A poor survival has been reported after
simultaneous resection of colorectal primaries with 4 or
more lymph node metastases and synchronous liver
metastases with no 5-year survival. But primary’s nodal
status is not available preoperatively. This study
focused on preoperative criteria that could select candi-
dates for simultaneous resection.
Method: From 1998 to 2012, 163 patients underwent
both primary resection and liver resection for synchro-
nous liver metastases at our institution, either simulta-
neous (n = 57) or delayed (n = 106), with available
complete pathological examination. Studied preoperative
criteria included age, sex, carcinoembryonic antigen
level, number of liver metastases at diagnostic, maximal
size of liver metastases, site of primary cancer (colon or
rectum), uni- or bilateral metastases, prehepatectomy
chemotherapy and performance of a major hepatectomy.
Pathological characteristics of the primary tumor were
also collected, such as depth of wall invasion, presence of
lymph node metastases, vascular and perineural inva-
sion. Uni- and multivariate analyses were performed.
Results: At univariate analysis on the whole popula-
tion, resection of two or more liver metastases was the
only preoperative predictive factor with a 37% 5-year
survival compared to 68% for single metastasis
(p = 0.007), but was neither significant on multivariate
analysis nor predictive in the simultaneous resection
group. Regarding primary tumor, the number of lymph
node metastases was not significantly correlated with 5-
year survival, seeing that patients with 4 or more lymph
node metastases had a 51% 5-year survival versus 48%
(ns) for the whole population as well as for the simulta-
neous resection group (63% vs 73%, ns).
Conclusions: The number of lymph node metastases of
the primary cannot be used to contraindicate simulta-
neous or delayed resection of synchronous liver metas-
tases since this histological data is not available pre-
operatively and does not seem to significantly impact
overall survival when upfront liver resection is techni-
cally possible.
PPL26-083
INCIDENCE OF CLINICALLY
SYMPTOMATIC DEEP VEIN
THROMBOSIS (DVT) AND
PULMONARY EMBOLISM (PE) IN
LIVER RESECTION PATIENTS
WITHOUT PHARMARLOGICAL
PROPHYLAXIS
Bin Chet Toh1, Winston Woon2, Sameer P Junnarkar3
and Jee Keem Low4
1MBChB (Dundee), MRCS (Edinburgh), Singapore;
2MBBS, BSc (med), UNSW Australia, FRACS,
Singapore; 3MBBS, MS (Gen Surgery), FRCS
(Glasgow), FRCS Gen Surg (UK), MD (Res),
Singapore; 4MBChB, MD, FRCS (Eng, Edin), FRCS
Gen Surgery (Eng), Singapore
Introduction: The perceived risk of bleeding after liver
resection has limited the use of medical pharmacologic
thromboprophylaxis to prevent deep vein thrombosis
(DVT). Recently, it is evident that liver resection can
unbalance haemostatic equilibrium towards hypercoag-
ulable state and cirrhotic patient is not protective from
thrombotic risk.
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Method: A retrospectively reviewed of all patients
undergoing liver resection operations in Tan Tock Seng
Hospital, Singapore from January 2010 to August 2013
was performed and those developing DVT and PE was
highlighted. In addition, the radiology database (RAD-
WED) was reviewed to ensure or computed tomogra-
phy. Patients with pharmalogical prophylaxis were
excluded from the study.
Results: Eighty-eight patients (67 male and 21 female)
with a mean age of 62 years underwent liver resection
operations either wedge resection, segmentectomy (up
to 2 segments) or hemihepatectomy during the study
period. A major hemihepatectomy was performed in 35
patients (39.7%). 18 patients had wedge resection
(20.5%) and 35 patients had segmentectomy (39.8%).
Indication of liver resection are hepatocellular carci-
noma 49 patients, colorectal liver metastases 29
patients, 2 Klatskin Tumour, 2 gallbladder carcinoma,
1 gastric carcinoma with liver invasion, 1 pancreatic
neuroendocrine tumour, 3 hepatic haemangioma and 1
focal nodular hyperplasia. Thrombotic complications
were seen in 1 patient in hemihepatectomy group
(2.86%) with radiologically evident. There is no DVT
or PE in wedge resection or segmentectomy group
(0%). All patients have TED stocking post-operatively.
Conclusions: Majority of liver resection patients with-
out pharmacological prophylaxis do not have clinically
symptomatic thromboembolism events despite on TED
stocking only. It is still uncertain whether the benefits
of pharmacologic prophylaxis outweigh risk of bleeding
in liver resection patients especially in Asian population
and further case-control study is suggested.
PPL26-084
RECURRENT PYOGENIC
CHOLANGITIS: VARIOUS TYPE OF
SURGICAL MANAGEMENT IN
HOSPITAL SELAYANG, SELANGOR,
MALAYSIA.
Mohd Sharifudin Sharif, Harjit Singh, Krishnan
Raman and Lim kin Foong
Ihpba & A-Phpba, Malaysia
Introduction: Recurrent Pyogenic Cholangitis (RPC) is
a common problem in Eastern Asia, It comes with vari-
ous names and terminology e.g. Intra-hepatic Stones,
hepatolithiasis, Oriental cholangitis or Cholangio-hepa-
titis. The present study reviews the outcome of various
type of surgical management this disease.
Method: A total of 90 patients were suspected to have
Hepatolithiasis were retrospectively reviewed. Nineteen
patients were excluded because of tumors, had previous
bilio-enteric anastomosis stricture from previous bile
duct injury and biliary cyst.
Results: Patients included 28 men and 43 women with
median age of 47 years. Race distributions showed
Malay (65%), Chinese (19%), Indian (12%) and Others
(3%). Almost half (49.3%) of the patients had left
intra-hepatic stone (IHD), 33.6% had bilateral stone
disease and 16.1% had right IHD. Types of surgery
included, Liver resection alone (32.4%), Liver resection
with drainage procedure (49.3%) and drainage proce-
dure alone (18.3%). The overall incidences of residual
stones, stone recurrence, mortality and morbidity were
12.7%, 11.3%, 2.8% and 33.8% over a median follow-
up of 12 months. In the Drainage procedure alone
group, the incidences of residual stone, stone recur-
rence, mortality and morbidity were 18.2%, 18.2%,
9.1% and 63.6%. In the liver resection alone group the
incidences of residual stone, stone recurrence, mortality
and morbidity were 17.4%, 4.8%, 0% and 26.1%. In
the liver resection with drainage procedure group, the
incidences of residual stone, stone recurrence, mortality
and morbidity were 8.6%, 14.3%, 2.9% and 31.4%.
Conclusions: Operative treatment for RPC is safe and
should be mainstay of treatment. Liver resection with
or without drainage procedure give better result in term
of residual stone and stone recurrence than drainage
procedure alone.
PPL26-085
ALPPS IN DIFFERENT CONTEXTS
Bergthor Bj€ornsson, Thomas Gasslander and Per
Sandstr€om
County Council of €Osterg€otland, Link€oping University,
Sweden
Introduction: Since the introduction of ALPPS, the
technique has been applied in various clinical settings
in our department. The indications, effect, complica-
tions and results are reported.
Method: A retrospective study of all patients where the
ALPPS technique was used during a 9 months period
was conducted. The study included demographic fac-
tors, indications for treatment, growth of future liver
remnant (FLR), complications and results.
Results: During the period Oct 31 2012 to Aug 1 2013
six patients were selected for ALPPS. They were 5
males and 1 female, median age was 67.5 (62–80) years.
Indications were colorectal liver metastases (n = 3),
HCC (n = 2) and Klatskin tumour (n = 1). The median
size of the FLR was 465 mL (250–707) corresponding
to 19% (17–31%) of the total liver volume before stage
one operation. Three patients had portal vein emboliza-
tion (PVE) before ALPPS treatment. The second stage
operation was done 8 days (7–9) after procedure one
and the median volume of the FLR was 890 mL (352–
1164) at that time. This corresponds to a 91% (35–129)
increase in FLR size. The resections were right sided
hemihepatectomy (n = 3) and extended right sided
hemihepatectomy (n = 3). Hepaticojejunostomi was
done in the second operation in 1 case. Resections were
performed in the FLR in 2 cases. Post-operative com-
plications occurred in 3 patients, with the highest Cla-
vien-Dindo score 3a (in 2 patients). All patients stayed
in hospital between the two operations and median stay
after the second operation was 11 days (4–19).
Conclusions: The ALPPS procedure is applicable to a
wide variety of hepatic- and biliary tumours were
strong growth of the FLR is necessary. This includes
bilateral colorectal liver metastases, large HCCs and
Klatskin tumours and may be specially indicated when
PVE fails to induce the growth needed in the FLR.
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PPL26-086
PURE LAPAROSCOPIC HEPATECTOMY
FOR THE PATIENTS WITH UPPER
ABDOMINAL SURGICAL HISTORY
Masashi Isetani, Zenichi Morise, Norihiro Kawabe,
Hirokazu Tomishige, Hidetoshi Nagata, Jin Kawase,
Satoshi Arakawa and Rie Yoshida
bantane hospital, Japan
Introduction: With the expanding indication of laparo-
scopic hepatectomy, there is increasing number of lapa-
roscopic hepatectomy performed in patients with a
surgical history. The aim of this study was to assess the
clinical outcomes of laparoscopic hepatectomy in
patients with a history of upper abdominal surgery.
Method: Of 69 pure laparoscopic hepatectomies, 15
patients underwent laparoscopic hepatectomy after pre-
vious upper abdominal surgery, excluding laparoscopic
cholecystectomy. Previous surgeries included hepatec-
tomy (n = 5), pancreatectomy (n = 3), cholecystectomy
and common bile duct excision (n = 1), splenectomy
(n = 1), distal gastrectorny (n = 1), ovarian carcinoma
with extensive lymph-node dissection (n = 1), and co-
lectomy with the involvement of transverse colon
(n = 3). Out of 15 previous surgeries, 3 hepatectomies,
1 splenectomy, 1 gastrectomy, and 1 colectomy had
been performed laparoscopically. Clinical indicators of
perioperative course were examined.
Results: In 11 out of 15 patients (73.3%), there were
severe adhesions in the area around the liver. However,
there was no conversion to a laparotomy in this group.
In 54 patients without a history of upper abdominal
surgery, the median operative time was 390 minutes
and blood loss was 200 mL. On the other hands, the
operative time was 334 minutes and blood loss was
143 mL in 15 patients with the history. Complication
occurred in 1 patient (7.1%) and the median hospital
stay was 14 days in patients with the history. There
were no differences in the perioperative results between
two groups.
Conclusions: Laparoscopic liver resection in patients
with a history of upper abdominal surgery is feasible
and safe. However, since there is no case of anatomical
liver resection after the history of anatomical liver
resection, further investigations are needed for such
cases.
PPL26-087
EPIDURAL ANALGESIA IN LIVER
SURGERY – IS IT SAFE AND
EFFECTIVE?
Senthil Ganapathi, Gemma Roberts, Susan Mogford,
Barbara Bahlmann, Bazil Ateleanu and Nagappan
Kumar
University Hospital of Wales, UK
Introduction: Epidural analgesia is the reference stan-
dard for the provision of postoperative pain relief in
patients recovering from major abdominal operations.
However a failure rate of 20–32% has been reported.
The aim was to analyse the effectiveness of epidural
analgesia and the outcome in patients who underwent
liver surgery.
Method: Data were collected from a prospectively
maintained database of 70 patients who underwent
open liver surgery by a bilateral sub-costal incision dur-
ing a period of 20 months (Feb 2009 to Sep 2010).
Consultants with expertise in anaesthesia for liver sur-
gery performed the epidural catheter placement. A ded-
icated pain team assessed the postoperaive pain scores
using the Verbal Descriptor Scale. The outcome was
measured in terms of success rates, complications and
length of stay.
Results: The study group included 43 males and 27
females. The indication for resection was liver second-
aries (70%), primary tumours (19%), and benign dis-
ease (11%). While major (≥3 segments) and minor (≤2
segments) resections were performed in 44% and 47%
respectively, 9% were inoperable. Epidural analgesia
was successful in 64 patients (91%). Among the
patients with successful epidural only 9 patients (13%)
reported moderate or severe pain at 1 or more tome
intervals in the first 3 days. All other patients reported
either mild or no pain. Bacterial colonisation of the
epidural tip without neurological complications was
noticed in 2 patients. Five patients (7%) had radiologi-
cally confirmed chest infection. Four patients (6%) had
wound infection. One patient died due to liver failure.
The median length of stay was 6 days (3–27 days). The
extent of liver resection (p = 0.026) and postoperative
chest infection (p = 0.012) had a significant influence
on the length of stay.
Conclusions: Our experience shows that epidural anal-
gesia is safe, successful and effective in providing ade-
quate pain relief following open liver surgery.
PPL26-088
HEPATOCELLULAR CARCINOMA
WITH INVASION OF SURROUNDING
ORGANS: IS EN-BLOC RESECTION
JUSTIFIED?
Siu Ho Kenneth Chok, Ka Kin Ng, Tan To Cheung,
Albert Chan, Jeff Dai, Simon Tsang, Tiffany Wong,
See Ching Chan, Ronnie Poon and Chung Mau Lo
The University of Hong Kong, Hong Kong, China
Introduction: T4 hepatocellular carcinoma (HCC) car-
ries poor prognosis. This study aims to determine the
survival outcomes after en-bloc resection of HCCs with
invasion of surrounding organs at a tertiary referral
center.
Method: Data of the 59 patients (Group 1) who under-
went en-bloc resection of HCCs with surrounding
organs (invasion confirmed by histology) in the period
from 1989 to 2010 were reviewed. A control group of
118 patients (2:1 match) (Group 2) without HCC inva-
sion of surrounding organs was matched to age, tumor
size, tumor number, and TNM staging (AJCC 5th edi-
tion). Survival was estimated by the Kaplan–Meier
method and compared by the log-rank test. A p < 0.05
were regarded as statistically significant and all p values
were two-tailed.
Results: The two groups had no statistical difference in
demographics, postoperative complication rate, and
survival rates. The 5-year and 10-year overall survival
rates in Group 1 were 21.7% and 16.7% respectively
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and those in Group 2 were 25.1% and 18.2% respec-
tively (p = 0.430). The 5-year and 10-year disease-free
survival rates in Group 1 were both 14.8% and those
in Group 2 were 13.4% and 10.9% respectively
(p = 0.459).
Conclusions: The survival outcomes of patients with
HCC with and without direct invasion are comparable.
At centers with expertise, en-bloc resection should be
attempted for clinical T4 disease if the patient is fit for
operation.
PPL26-089
DILI-CHOLESTATIC AND ALERGIC
REACTION FROM VALPROIC ACID –
CASE REPORT
Pranvera Kristani1, Floreta Kurti2, D Qerimi1 and
Adriana Babameto2
1Durresi Hospital, Albania; 2UHC “Mother Theresa”,
Tirana, Albania
Introduction: Drugs are an important reason of hepato-
toxicity. In general more than 1000 drugs, toxins and
herbs have been reported to cause hepatotoxicity.
Acute hepatitis with or without cholestasis is the usual
histological pattern of DILI (drug – induced liver
injury). Most cases of DILI resolve on discontinuation
of the drug, but recovery can take months or rarely dis-
ease can progress despite drug withdrawal. In elderly
patients DILI is more frequent than in younger. DILI
is a potencial complication, because of central role of
the liver in drug metabolism and elimination. Generaly,
hepatotoxicity caused by drugs is known to be: type A
dose dependent (intrinsic toxicity) or type B idiosyn-
cratic. It can be accompanied with imunoallergic fea-
tures such as eosinophillia, rash, antibody titer.
Method: We report a case of valproic acid (VPA)
induced hepatotoxicity and to discuss the incidence
rates, risk factors, possible etiologies, preventive mea-
sures, and treatment courses for this severe reaction.
Results: A 62-year-old male patient presented to the
emergency department in an altered condition, con-
fused with severe jaundice without transaminase eleva-
tion, itching and cutaneus rash. He was treated with
antihypertensive drugs (aprovel) and valproic acid for
2 years for epilepsia. He denied any drug reactions
before. The ultrasound and CT Scan of the liver was
normal, also there was no viral hepatitis (B, C). Other
cholestatic diseases were excluded. He was treated suc-
cessfully with UDCA and cortisone in high doses.
Conclusions: The exact mechanism of VPA – associated
hepatotoxicity has not been clearly established. Major
risk factors include age, sex, and concomitant treatment
with more than one anticonvulsivant. Other significant
risk factors include metabolic or serious neurologic dis-
orders. Older age is a determinant factor for cholesta-
tich DILI with a male predominance, whereas younger
age is associated with cytolitic damage and a female
predomination.
PPL26-090
HEPATOCELLULAR CARCINOMA:
INTEREST OF MICROVASCULAR
INVASION AS A FACTOR WITH
IMPACT IN PROGNOSIS AFTER
SURGICAL TREATMENT
J. Guilherme Tralhao1, Ricardo Martins1, Beatriz
Costa1, Monica Martins1, Henrique Alexandrino1, M.
Augusta Cipriano3, F. Caseiro Alves2 and Francisco
Castro Sousa1
1Faculdade de Medicina da Universidade de Coimbra,
Portugal; 2Servico de Imagiologia, Portugal; 3Servico de
Anatomia Patologica, Portugal
Introduction: Hepatocellular carcinoma (HCC) is the
third cause of cancer-related death, and the incidence is
growing worldwide. Survival without surgical treatment
does not exceed, in most series, the 10 months. The
option between Resection (HR) and Transplantation
(HT), the only options with curative potencial, remains
controversial. The aim of this study is to evaluate the
results os HR of HCC in our department and the inter-
est of microvascular invasion as a factor with impact in
prognosis after surgical treatment.
Method: 95 patients with medium age of
64  11.7 years (34–85) underwent HR for HCC in
our department. 85% were male, 69% had chronic
hepatic disease and 90% were classified as Child–Pugh
A. Medium size of lesions was 66  48 mm (17–280),
75 were solitaire (79%) and 39% of patients were
within the Milan Criteria. Five patients underwent
hepatic arterial chemoembolization and ten to portal
vein embolization before surgery. Forty-three patients
underwent major liver ressection and 52 a minor. Prog-
nostic factors were evaluated using univariate and mul-
tivariate analyses.
Results: Per-operative mortalitu (3 months) was 5.5%
and morbidity 43.1%. Thirteen patients underwent new
surgical treatment due to recurrence, HT in 4 and HR
in 9. Overall survival was 58% (5 years) and 36.4%
(10 years); disease free survival was 42.3% (5 years)
and 26.4% (10 years). In patients with tumours without
microvascular invasion overall survival was respectively
at 5 and 10 years 75.9% and 56.4%.
Conclusions: HR of HCC can be performed with accept-
able morbi-mortality, increasing significantly survival in
these patients; particulary in those with tumours without
microvascular invasion, allowing a better selection of
patients taht can be treated with HR.
PPL26-091
PREOPERATIVE PERIPHERAL BLOOD
NEUTROPHIL COUNT PREDICTS
LONG-TERM OUTCOMES AFTER
HEPATIC RESECTION FOR
COLORECTAL LIVER METASTASES
Koichiro Haruki, Hiroaki Shiba, Yuki Fujiwara, Kenei
Furukawa, Tomonori Iida, Masaichi Ogawa, Yuichi
Ishida, Takeyuki Misawa and Katsuhiko Yanaga
The Jikei University School of Medicine, Japan
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Introduction: Preoperative systemic inflammatory
response is associated with a poor long-term prognosis
after resection for malignant tumors. Several markers
of systemic inflammation were reported to be a predic-
tor of outcomes, but have not been fully investigated.
Therefore, we retrospectively investigated the relation
between preoperative peripheral blood neutrophil count
and disease-free as well as overall survival after hepatic
resection for colorectal liver metastasis (CRLM).
Method: The study comprised 89 patients who had
undergone hepatic resection for CRLM between Janu-
ary 2000 and March 2010. We retrospectively investi-
gated the relation between preoperative peripheral
blood neutrophil count and disease-free as well as over-
all survival.
Results: In multivariate analysis, presence of neo-adju-
vant chemotherapy (p = 0.015), bilobar distribution
(p = 0.015) and neutrophil count ≥3.500/lL (p = 0.025)
were independent and significant predictors of disease-
free survival, while significant predictors of overall sur-
vival were consisted of more than 4 lymph node metasta-
ses (p = 0.001), presence of neo-adjuvant chemotherapy
(p = 0.003), bilobar distribution (p = 0.039) and neutro-
phil count ≥3.500/lL (p = 0.040). Moreover, tumor
diameter (p = 0.021) and monocyte count (p < 0.0001)
were significantly greater in elevated neutrophil count
group.
Conclusions: Preoperative peripheral blood neutrophil
count is an independent and significant indicator of
long-term outcomes in patients with CRLM after hepa-
tic resection.
PPL26-092
PURE LAPAROSCOPIC HEPATECTOMY
FOR HCC PATIENTS WITH CHRONIC
LIVER DISEASE
Jin Kawase, Zenichi Morise, Norihiko Kawabe,
Masashi Isetani, Rie Yoshida, Satoshi Arakaw,
Hidetoshi Nagata and Hirokazu Tomishige
Fujita Health University School of Medicine Banbuntane
Houtokukai Hospital, Japan
Introduction: The indications of laparoscopic hepatec-
tomy are expanding. We discuss the features of pure
laparoscopic hepatectomy for HCC patients with
chronic liver disease in present study.
Method: 40 patients with HCC and chronic liver dis-
ease, including 9 Child B/C patients, underwent pure
laparoscopic hepatectomy. The numbers of the tumors
are 1–4 and the sizes are in 1.1–7.8 cm. Anatomical
resections were applied to 11 patients and 5 underwent
resections of 1 or more sectors. 4 patients underwent
combined microwave ablation therapy. 10 patients had
the history of treatments for HCC and 7 had the his-
tory of precedent upper abdominal surgeries (hepatec-
tomy: 3, pancreatectomy: 2, splenectomy: 1,
exploration and lithotomy of common bile duct: 1).
Results: The operating time was 140–710 (median:
288) minutes, the intraoperative blood loss was uncount-
able-2400 (median: 50) mL, and the postoperative hospi-
tal stay was 8–254 (median: 15) days. Two patients
needed conversion to open surgery, and 1 to HALS. Five
patients developed postoperative complication of
Clavien Grade II or III. There was no post-operative
mortality. There was no statistically significant difference
in the perioperative factors between Child B/C patients
and the others, and also, between patients with upper
abdominal surgical history and the others.
Conclusions: We considered that the advantages of the
procedure were; 1. For severe cirrhotic patients, it mini-
mizes destruction of the collateral blood/lymphatic flow
from laparotomy and mobilization, and mesenchymal
injury from compression. The fact leads to less refractory
ascites, which trigger fatal complications. 2. Repeat lapa-
roscopic hepatectomy for patients with multicentric/
metachronous HCCs was facilitated with less post-oper-
ative adhesion and good vision/manipulation in the
small operative field between adhesions. 3. The partial
resection of the liver, in the area of subphrenic space,
around IVC or next to the attachment of retro-perito-
neum, is also facilitated in pure laparoscopic surgery
with appropriate patient positioning and port arrange.
PPL26-093
COLORECTAL CANCER LIVER
METASTASIS: RADIOLOGISTS DOING
MORE THAN JUST IMAGING.
Thiago Penachim2, Daniel Lahan-Martins2 and
Antonio Roberto F. Teixeira1
1State University of Campinas – Sao Paulo- Brazil,
Brazil; 2Consultant Radiologist, Brazil
Introduction: Colorectal cancer is the second most pre-
valent tumor worldwide. Half of the patients will have
metastasis diagnosed during the course of their dis-
eases. Actually metastatic disease is no longer consid-
ered incurable. Invasive treatment is the modality of
choice for liver colorectal metastasis and every effort
must be done to make it possible. Several approaches
are used to increase overall long term survival and the
radiologist plays a pivotal role in multiple levels, such
as diagnosis, staging, surgical planning and therapy.
Method: To review how the radiologist can contribute
to optimize the treatment of liver colorectal metastasis
in multiple steps, such as diagnosis, staging, surgery
planning, conversion of patients from inoperable to
operable (by selective portal vein embolization), treat-
ment (ablative therapy) and surveillance of local or sys-
temic relapse. Review of appropriate epidemiologic
data, reinforcing the importance of aggressive and inva-
sive treatment for liver metastasis from colorectal can-
cer.
Results: There is a strong benefit for the patients with
colorectal liver metrastasis when radiologists and sur-
geons worked together. Possibility of mistreatment is
ruduced. Surgical planning on pre-op CAT scans can
help in avoid bleeding and can find aditional lesions
during the surgery. Volumetry may help in order to
avoid a too-small remnant.
Conclusions: Radiologists must work very close to sur-
geons in the setting of colorectal liver metastasis
patients. They should help on the diagnosis, but also
thy can help in: Imaging findings and technical consid-
erations (US, CT, MRI and PET-CT), therapeutic
planning, surgical planning, response measurement
after chemotherapy, conversion of patients from inop-
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erable to operable, selective portal embolization and
liver volumetry, ablative therapy, and surveillance of
local and systemic relapse.
PPL26-094
AMEBIC ABSCESS OF THE LIVER
PENETRATING INTO THE RIGHT
HEMITHORAX – A CASE STUDY
Michael Wacha and Andreas Shamiyeh
Surgeon, Austria
Introduction: This poster shows the interesting case of
a young male with amebic disease of the liver.
Method: Case study.
Results: We are discribing the case of a 40-year-old
male patient presenting himself with increasing dysp-
noea after a holiday on the Maledives. He was sent to
the departement of pneumology. A chest x-ray showed
a big pleural effusion on the right side and a B€ulau
drainage was placed. A CT-scan of the thorax and
abdomen revealed a pleural effusion on the right side
with complete atelectasis of the right lung and 3 big
abscesses in the right lobe of the liver. The patient
showed increasing septicemia and had to be intubated.
An emergency surgery was performed. We could find
big necrotizing abscesses in segments IVa, VI and VIII
with penetration into the right thoracal cavity via a
perforation of the diaphragm. The abscesses were
drained, the pleural empyema – 2 L of pus- was evacu-
ated and the diaphragm which was partially necrotic
was sutured. As the patient was cardiorespiratorily
instable, a perihepatic packing was done. After stabil-
ization we did return to the OR 2 days later in order
to remove the packing. There was no bleeding but most
parts of the right lobe were necrotic. Therefore a right
hemihepatectomy was performed.
Histologic workup of the specimen proved the suspi-
cion of amebiasis. The further history of the patient
was complicated by atrial fibrillation, pneumothorax
on both sides, pleural effusions and bilateral pneumo-
nia. Nevertheless he survived and could be sent to reha-
bilitation where he fully recovered.
Conclusions: Amebic disease of the liver is well known in
tropic regions such as Asia and uncommon in Middle
Europe. In most cases it is treated antibiotically with
metronidazole. Rarely surgical treatment is required.
PPL26-095
COMPLICATIONS OF LIVER
RESECTIONS OF COLORECTAL
METASTASES IN UNIVERSITY
HOSPITAL OF PILSEN
Tomas Skalicky, Vladislav Treska and David Smid
Single, Czech Republic
Introduction: Liver resection now means the only possi-
bility of curative treatment for patients with metastases
of colorectal carcinoma of liver.
Method: The aim of this work was to evaluate the
group of patients in a retrospective way liver resection
had been performed in due to metastases of colorectal
carcinoma at the Surgery Department of Faculty of
Medicine of Charles University and University Hospital
in Pilsen between May 2009 and March 2013. Only the
patients multistage resection, combined surgeries or
RFA had been performed were eliminated.
Results: There were thirty patients altogether having
gone through the given resection in this period. The
whole morbidity of this group was 63.7%. The mortal-
ity of the group was 0%. The most frequent postopera-
tive complication was fluidothorax – 42.9%, loss of
blood more than 500 mL was considered to be the
most frequent preoperative complication – 3.9%. Col-
lections by the resection area/hematoma, bilioma/
belonged among other frequent postoperative complica-
tions – 33.8%. Fortunately, we noticed susceptible liver
failure only in two patients, which means 2.6%. In
comparison with the same evaluation in the group of
patients between 2000 and 2005, we determined the
decrease of the occurence of postoperative bleeding by
4.5% and liver failure by 3.8%. On the contrary, the
amount of collections appeared at the resection area
increased by almost 6.9%.
Conclusions: Curative liver resections for metastases of
colorectal carcinoma mean a high occurence of postop-
erative complications for patients but it is necessary to
solve only a small percentage of these in an invasive
way. The effect of the surgery considerably exceeds
possible risks for patients.
PPL26-096
PRIMARY HEPATIC
NEUROENDOCRINE TUMOR OF LIVER
Shivendra Singh and Nikhil Gupta
Rajiv Gandhi Cancer Institute, Delhi, India
Introduction: Primary hepatic neuroendocrine tumor of
the liver is a rare entity with only few case reports in
the literature. Its clinical features and treatment out-
comes are not well understood.
Method: We retrospectively analyzed the data of three
patients diagnosed with primary hepatic neuroendo-
crine tumors.
Results: Three patients were diagnosed with primary
neuroendocrine tumor of liver between 2011 and 2013.
Two were males and one female. Mean age was
45.3 years (29–69 years). Pain in abdomen was the pre-
senting complaint in all the patients and physical exami-
nation was normal. Diagnosis of primary
neuroendocrine tumor of liver was preoperatively made
in two patients and in the third patient it was based on
postoperative histology of the resected specimen. Serum
CEA, CA19.9, AFP, UGI endoscopy and colonoscopy
were normal. Serum chromogranin A was elevated in
two patients and the DOTANOC PET scan showed dis-
ease only in the liver. DOTANOC PET CT done postop-
eratively in third patient showed no residual disease. One
patient underwent right hepatectomy with middle hepa-
tic vein excision. Other patient underwent central hepa-
tectomy and third left hepatectomy with excision of
MHV. All the patients had negative margins. Patients
had grade 1, 2 and 3 neuroendocrine histology. Patient
with grade 1 histology had recurrence in the liver and
which was managed by radiofrequency ablation and was
put on octreotide analogue. Patient with grade 2 histol-
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ogy had recurrence in the nodes and was also treated
with octreotide analogue. Patient with the grade 3 histol-
ogy was given adjuvant chemotherapy. All the patients
are alive.
Conclusions: Primary hepatic neuroendocrine tumors
are rare. Multimodality treatment involving surgery, che-
motherapy and targeted therapy provides best results.
PPL26-097
INDICATION OF HEPATIC RESECTION
FOR HEPATOCELLULAR CARCINOMA
Yoichiro Uchida, Hiroaki Terajima, Taku Iida, Sena
Iwamura, Hiroshi Kawamoto, Rei Toda, Yoshikage
Inoue, Mami Yoshitomi, Shugo Ueda and Akiyoshi
Kanazawa
Tazuke Kofukai Medical Research Institute, Kitano
Hospital, Japan
Introduction: As the preoperative index of hepatic
resection for hepatocellular carcinoma (HCC), Makuu-
chi’s criteria which means the presence or absence of
ascites, the serum total bilirubin level, and the indocya-
nine green retention rate at 15 minutes (ICGR-15) has
been widely used in Japan. However, we have experi-
enced some cases beyond the criteria in clinical settings.
Method: We examined a total of 50 consecutive
patients who underwent hepatic resection for HCC
from December 2008 to December 2012, and compared
between “Within” or “Beyond” Makuuchi’s criteria
group. In our institution, ICG Krem (≧0.05) which is
calculated by multiplication of disappearance rate of
ICG and remnant liver volume ratio to total liver vol-
ume has been adopted for indication of hepatectomy.
Results: Anatomical resection was performed in 39
cases, 16 patients were in beyond group. There were no
significant differences in age, operation time, blood
loss, tumor size, postoperative complications (Clavien-
Dindo Classification: over grade III, 5 in within group
and 4 in Beyond group), bile leak, hospital stay, overall
survival and disease free survival rates. In Beyond
group, ICGR-15, disappearance rate of ICG, and the
frequency of posthepatectomy liver failure (ISGLS
Classification: 6 in within group, 8 in Beyond group)
were significantly higher, compared to within group.
Conclusions: The possibility to perform hepatectomy
exists in cases beyond the criteria, although there is no
doubt that Makuuchi’s criteria is reliable index. A cri-
teria, ICG Krem≧0.05 may be one of useful indexes for
promising safe hepatectomy in patients with HCC.
PPL26-098
IS PRINGLE MANEUVER NEEDED IN
THE MODERN ERA OF LIVER
RESECTION? 153 CONSECUTIVE LIVER
RESECTIONS WITHOUT LIVER
INFLOW OCCLUSION USING CUSA
AND AQUAMANTYS.
Athanasios Petrou1, Kyriakos Neofytou3 and
Evangelos Felekuras2
1Consultant HPB Surgeon, Cyprus; 2Ass. Profesor of
Surgery, Greece; 3Clinical Fellow, UK
Introduction: Hemorrhage is undoubtedly one of the
main factors of morbidity and mortality in liver resec-
tions. Vascular occlusion techniques are effective to
control intraoperative bleeding, but they cause liver
damage due to ischemia. We evaluated the effectiveness
and safety of using a combined technique for hepatic
parenchymal transection without liver inflow occlusion.
Method: 153 consecutive patients who underwent liver
resection in two Hepato-Pancreato-Biliary (HPB) units.
Hepatic parenchymal transection was carried out using
a combined technique of saline-linked radiofrequency
precoagulation and ultrasonic aspiration without liver
inflow occlusion. Endpoints were overall amount of in-
traoperative blood loss (IBL), amount of blood loss
during parenchymal transection (PTBL), parenchymal
transection time (PTT), the amount of packed red
blood cells (PRBC) transfused, the postoperative mor-
bidity and the 30-day mortality.
Results: During the study period 55 minor and 98
major hepatic resections were performed. The mean
amount of intraoperative blood loss was 349 mL (SD
259 mL, range 50–1800 mL) and the blood transfusion
rate was 11.1%. The median amount of blood loss dur-
ing parenchymal transection and parenchymal transec-
tion time were 227 mL (SD 211, range 40–1500) and
63 minutes (range 14–146 minutes) respectively. There
was one post-operative death (0.65%). Complications
occurred in 42 patients (27.45%) and most complica-
tions were minor.
Conclusions: Combined technique of saline-link radio-
frequency ablation and ultrasonic aspiration appears to
be comparable to other techniques and should be con-
sidered as an alternative. Crucially, this combined tech-
nique eliminates the need for liver inflow occlusion
during parenchyma transection.
PPL26-099
EXPRESSION LEVELS OF INSULIN-
LIKE GROWTH FACTORS AND
RECEPTORS IN HEPATOCELLULAR
CARCINOMA
Yun Shin Chun1, Min Huang2 and Lori Rink1
1Virginia Piper Cancer Institute, USA; 2Fox Chase
Cancer Center, USA
Introduction: The insulin-like growth factor (IGF)
pathway is implicated in the pathogenesis of hepatocel-
lular carcinoma (HCC) and may be particularly impor-
tant in patients with non-alcoholic fatty liver disease
(NAFLD) and the metabolic syndrome, which is asso-
ciated with insulin resistance and increased levels of
bioavailable IGF-1. The aim of this study was to deter-
mine expression levels of IGFs and their receptors in
patient with NAFLD-associated HCC.
Method: Tissue microarrays were constructed from
patients who underwent hepatectomy for HCC. Immu-
nohistochemistry was performed using antibodies for
IGF-1, IGF-2 and their receptors, IGF-1R and IGF-
2R. Slides were read by a pathologist blinded to clinical
data. Median follow-up was 26 months (range, 2–
136 months).
Results: Among 27 patients with HCC, the most com-
mon underlying liver diseases included NAFLD
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(n = 13, 48%), hepatitis C (n = 7, 26%), and alcoholic
hepatitis (n = 2, 7%). Expression levels of IGFs and
their receptors were not associated with patients’ under-
lying liver disease. In all patients, IGF-2 expression was
upregulated in both tumor and adjacent non-tumorous
liver. IGF-1 expression was low in adjacent non-tumor-
ous liver in 6 of 10 patients (60%) with cirrhosis, com-
pared to 2 of 17 patients (12%) without cirrhosis
(p = 0.008). Higher expression of IGF-1 in adjacent
liver relative to tumor was associated with significantly
poorer median survival of 22 months, compared to
72 months with equal or lower IGF-1 expression in
adjacent liver relative to tumor (p = 0.006).
Conclusions: Our preliminary results demonstrate signif-
icant associations between IGF-1 expression and liver
cirrhosis and survival after resection in patients with
HCC, independent of their underlying liver disease.
PPL26-100
A NOVEL ALGORITHM FOR
HEPATECTOMY BASED ON THE
FIBROSIS STAGE
Kaori Kuramitsu, Takumi Fukumoto, Kenji
Fukushima, Masahiro Kido, Atsushi Takebe,
Motofumi Tanaka, Hisoka Kinoshita, Ippei
Matsumoto, Tetsuo Ajiki and Yonson Ku
Hepato-biliary and pancreatic surgery, Japan
Introduction: In Japan, Makuuchi criteria is widely
accepted as a decision tree for hepatectomy. Although
the criteria are regulated by only three parameters:
presence or absence of uncontrollable ascites, serum
bilirubin level, and the indocyanine green retention rate
at 15 minutes (ICG15), hepatectomy can be safely per-
formed to several cases outside the criteria. We have
previously reported that posthepatectomy liver failure
(PHLF) significantly associates with overall and recur-
rence free survival, and also that the incidence of
PHLF concomitantly increased with extent of resection
and fibrosis stage. In this study, we searched for the
preoperative factor which can assess fibrosis stage most
accurately.
Method: We retrospectively analyzed 114 consecutive
patients who underwent curative hepatectomy for hepa-
tocellular carcinoma from 2010 to 2012. 1) Correlation
with preoperative and final fibrosis stage, 2) correlation
with preoperative, intraoperative, and final fibrosis
stage, and 3) a role of fibrosis stage as an algorithm
factor for hepatectomy were evaluated.
Results: 1) Preoperative fibrosis stage>2 (p = 0.0094),
presence of ascites (p = 0.0458), decrease of the recep-
tor index LHL15 (liver 15/heart 15 + liver 15) mea-
sured by TcGSA scintigram (p = 0.0851), and PT<79%
(p = 0.0458) significantly associated with final fibrosis
stage>2 in univariate analysis. In multivariate analysis,
preoperative fibrosis stage>2 was identified as an inde-
pendent risk factor for final fibrosis stage>2
(p = 0.0336). 2) Sensitivity/specificity of pre and intra-
operative fibrosis stage>2 for final fibrosis stage>2 were
100/45% and 92/73% respectively. 3) Combination of
PT<79% or presence of ascites and preoperative fibro-
sis stage>2 increased sensitivity/specificity for final
fibrosis stage>2 up to 100/55%.
Conclusions: Assessment of fibrosis stage might be a
key component to constitute a novel algorithm for hep-
atectomy which directly associates with lower incidence
of PHLF and longer patient survival.
PPL26-101
MASPIN IS A MARKER FOR EARLY
RECURRENCE IN PRIMARY STAGE III
AND IV COLORECTAL CANCER
Benjamin Emmink1, Nikol Snoeren1, WinanVan
Houdt1, Eric Belt3, Hein Stockmann2, RichardVan
Hillegersberg1, Connie Jimenez4, Remond Fijneman3,
Onno Kranenburg1 and Inne Borel Rinkes1
1University Medical Centre, Netherlands; 2Kennemer
Gasthuis, Haarlem, Netherlands; 3VU University
Medical Centre, Amsterdam, Netherlands; 4VU
University Medical Centre, Netherlands
Introduction: Little is known about the factors that
drive metastasis formation in colorectal cancer (CRC).
Here, we set out to identify genes and proteins in
patients with colorectal liver metastases that correlate
with early disease recurrence. Such factors may predict
a propensity for metastasis in earlier stages of CRC.
Method: Gene expression profiling and proteomics
were used to identify differentially expressed genes/pro-
teins in resected liver metastases that recurred within
6 months following liver surgery versus those that did
not recur for >24 months. Expression of the identified
genes/proteins in stage II (n = 243) and III (n = 176)
tumours was analysed by immunohistochemistry on tis-
sue microarrays. Correlation of protein levels with
stage-specific outcome was assessed by uni- and multi-
variable analyses.
Results: Both gene expression profiling and proteomics
identified Maspin to be differentially expressed in colo-
rectal liver metastases with early (>6 months) and pro-
longed (>24 months) time to Recurrence.
Immunohistochemical analysis of Maspin expression on
tumour sections revealed that it was an independent
predictor of time to recurrence (log-rank p = 0.004)
and CRC-specific survival (p = 0.000) in stage III
CRC. High Maspin expression was also correlated with
mucinous differentiation. In stage II CRC patients,
high Maspin expression did not correlate with survival
but was correlated with a right-sided tumour location.
Conclusions: High Maspin expression correlates with
poor outcome in CRC after spread to the local lymph
nodes. Therefore, Maspin may have a stage-specific
function possibly related to tumour cell dissemination
and/or metastatic outgrowth.
538 Poster Panel [Liver]
© 2014 The Authors
HPB © 2014 Americas Hepato-Pancreato-Biliary Association HPB 2014, 16 (Suppl. 2), 406–549
PPL26-102
LAPAROSCOPIC PARTIAL LIVER
RESECTION FOR THE TREATMENT OF
HEPATOCELLULAR CARCINOMA
PATIENTS WITH UNDERLYING
CHILD–PUGH B AND C LIVER
CIRRHOSIS
Mitsuo Miyazawa, Masayasu Aikawa, Katsuya Okada,
Yukihiro Watanabe, Kojun Okamoto and Isamu
Koyama
Saitama Medical University International Medical
Center, Japan
Introduction: Liver resection by open surgery remains
the treatment of choice for hepatocellular carcinoma
(HCC). Currently, laparoscopic liver resection is pre-
ferred to avoid postoperative liver failure and severe
ascites in these circumstances. Laparoscopic partial
liver resection (LLR) for the treatment hepatocellular
carcinoma with Child- Pugh B and C cirrhosis was
compared to open partial liver resection (OLR) per-
formed in our institution and examined validity of the
LLR.
Method: Seventeen LLRs performed for HCC at the
Saitama Medical University International Medical Cen-
ter from 2007 to 2012 were prospectively analyzed. Sev-
enteen cases LLRs performed included Child-P B 15
and C 2 cases. These data were compared with an
equivalent group of 9 consecutive OLRs (C-P B: 9
cases) undertaken immediately prior to the introduction
of LLR. Outcomes were evaluated for differences in
perioperative morbidity and hospital length of stay.
Results: There were no differences between LLRs and
OLRs in demographics, pathology, cirrhosis, tumour
location or extent of resection. There were no LLRs
underwent conversion to an open approach and no
deaths. LLRs had significantly decreased intraoperative
blood loss (60 mL vs 553 mL, p < .001), postoperative
complications (6% vs 33%, p < .05), and length of stay
(7.1 days vs 16.1 days, p < 0.001) compared with
OLRs. There were no differences in operating time for
LLRs compared to OLRs (199 minutes vs 152 minutes,
respectively).
Conclusions: Laparoscopic resection of HCC with
underlying Child-Pugh B and C liver cirrhosis is feasi-
ble and safe. In patients with severe liver cirrhosis,
LLR minimizes the disturbance in collateral blood and
lymphatic flow caused by laparotomy and liver mobili-
zation, as well as the mesenchymal injury caused by
compression of the liver. It limits complications such as
massive ascites, which can lead to severe postoperative
liver failure.
PPL26-103
EFFICACY OF NEO-ADJUVANT
CHEMOTHERAPY FOR PATIENTS
WITH LOCALLY ADVANCED
INTRAHEPATIC
CHOLANGIOCARCINOMA
Yuki HIROSE, Jun Sakata, Tomohiro Katada,
Natsuru Sudo, Taku Ohashi, Kazuyasu Takizawa,
Kabuto Takano, Takashi Kobayashi, Masahiro
Minagawa and Toshifumi Wakai
Niigata University Graduate School of Medical and
Dental Sciences, Japan
Introduction: The aim of this study was to evaluate effi-
cacy and perioperative outcomes of neo-adjuvant che-
motherapy for patients with locally advanced
intrahepatic cholangiocarcinoma (ICC).
Method: A retrospective analysis was conducted of 5
patients who were treated with neo-adjuvant chemo-
therapy prior to surgical resection for initially unresec-
table locally advanced ICC. Indications for neo-
adjuvant chemotherapy included direct invasion to
adjacent extrahepatic structures (i.e., abdominal wall,
diaphragm, stomach) alone (n = 4) and direct invasion
plus paraaortic lymph node involvement (n = 1). The
regimens of neo-adjuvant chemotherapy included gem-
citabine (GEM) alone (n = 2), Tegafur-Gimeracil-Ot-
eracil Potassium (S-1) alone (n = 1), GEM plus S-1
(n = 1), and GEM plus S-1 converted to GEM plus cis-
platin (n = 1). The response to neo-adjuvant chemo-
therapy was evaluated according to Response
Evaluation Criteria in Solid Tumors (RECIST) guide-
lines.
Results: The response rate was 20% in 5 patients. One
patient who received GEM plus S-1 achieved partial
response (68% tumor reduction rate). Three patients
showed stable disease, and the remaining one patient
showed progressive disease (PD). Surgical procedures
planned before administration of neo-adjuvant chemo-
therapy were performed in all 5 patients. All patients
underwent R0 resection. According to the UICC TNM
classification, one patient had pStage I tumor, 3 had
stage IVA, and one had stage IVB. Perioperative com-
plications included intraabdominal abscess (n = 2), rup-
ture of pseudoaneurysm (n = 1), enteritis (n = 1), and
lymphorrhea (n = 1). There was no in-hospital death.
Two patients had died of tumor recurrence 9 and
14 months after surgical resection. One patient was
alive with recurrent disease, and 2 patients were alive
with no evidence of disease. The cumulative 1- and 2-
year overall survival rates were 72% and 50%, respec-
tively.
Conclusions: Neo-adjuvant chemotherapy for locally
advanced ICC was well tolerated and did not impair
planned surgical resections.
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GAS JET LIVER RESECTION.
EXPERIMENTAL RESEARCH
Denys Skoryi, Oleksandr Tyshchenko, Oleksandr
Maloshtan, Rostyslav Smachylo and Tatiana Kozlova
Institute of General and Urgent Surgery, Ukraine
Introduction: There exists a great variety of liver paren-
chyma dissection techniques. The original method of
gas jet dissection was developed in our institute. The
objective of this research lies in comparing gas jet dis-
section technique with the existing ones.
Method: Efficiency comparison of gas-jet (original
apparatus “Pneumojet”, Ukraine), ultrasonic («SON-
OCA 300», Soring, Germany), water-jet («Hydrojet»,
Erbe, Germany) methods of dissection and Clamp
crushing technique was carried out on 24 mini-pigs.
Depending on the liver parenchyma dissection tech-
nique, the animals have been divided into 4 groups. We
did not use Pringle maneuver.
We performed biopsy of the resection surface for exam-
ining damage and regeneration on days 7 and 21 after
surgery.
Results: The sizes of the resected section of liver and,
accordingly, wound surfaces that were formed as a
result of operation, did not differ in the investigated
groups. The mean blood loss at the resection stage was
the smallest in the group of animals that had a gas jet
dissection (3.5  0.15 mL/cm²) and the highest in the
Clamp crushing technique group – 5.5  0.46 mL/cm²
(Indicators have statistically authentic differences
p < 0.05). The dissection speed was the highest in the
Clamp crushing technique group – 2.9  0.25 cm²/min-
utes and was credibly higher than in the gas jet
(2.4  0.16 cm²/minutes), ultrasonic (2.4  0.13 cm²/
minutes) and water-jet (2.5  0.14 cm²/minutes) dissec-
tion groups.
Visually empty vacuoles extending necrosis zone are
identified in the area of resection surface after gas-jet
dissection without being identified in other dissection
types. Nonetheless, all inflammation components
appear in the wound evolution at any type of dissec-
tion. In spite of the high damage depth, healing dynam-
ics and cicatrix size at later stages were the most
favorable in gas-jet dissection.
Conclusions: Gas jet dissection is not accompanied by
thermal damage of hepatocytes, ensures minimal
trauma and fast restoration of hepatocytes. Therefore,
it can be recommended for further clinical applica-
tion.
PPL26-105
ROLE OF SPECTRAL CT IN THE
DIFFERENTIAL DIAGNOSIS OF
METASTATIC AND REACTIVE LYMPH
NODES
Yong-bo Yang1, Yu-Fang Chen2, Yan-zhuo Li3, Na
Gao4, Guo-liang Shao1 and Hong-Yan Cheng3
1Zhejiang Cancer Hospital, China; 2Hangzhou First
People’s Hospital, China; 3Eastern Hepatobiliary
Surgery Hospital, China; 4GE China, China
Introduction: To investigate the value of spectral CT
imaging in the differential diagnosis of metastatic and
reactive lymph nodes.
Method: A total of 25 patients with swelling lymph
nodes in the hilar region received spectral CT imaging
(Discovery CT750 HD), including 13 hepatocellular
carcinoma (HCC), 5 gallbladder carcinoma (GC) and 7
non-neoplastic deseases (NND, containing 3 cirrhosis,
2 intrahepatic calculus, 1 cholecystitis and 1 hepatic
haemangioma), which were certified in the postopera-
tive pathology. Normalized iodine concentration (NIC,
the ratio of iodine concentration of lymph nodes and
aorta from the iodine-based material-decomposition
image), and slope of Spectral Curve (SSC, the differ-
ence of CT value of lymph nodes on 40 keV and
100 keV divided by 60), were obtained from images
during the arterial phase (AP), portal venous phase
(PVP) and delayed phase (DP). The one-way analysis
of variance and area under the receiver operating char-
acteristic curve were performed.
Results: Both the mean NIC (0.15  0.03) in HCC
and the mean NIC (0.16  0.06) in GC were signifi-
cantly higher than that (0.11  0.03) in NND during
AP (p = 0.022, 0.041, respectively). Similarly, both the
mean SSC (1.82  0.40) in HCC and the mean SSC
(1.83  0.66) in GC were significantly lower than that
(2.66  0.38) in NND during AP (p = 0.014, 0.046,
respectively). However, there was no significant differ-
ence in either NIC or SSC in lymph nodes between
HCC and GC (p = 0.991, 0.828). The area under the
curve of the NIC and SSC during AP was 0.794 and
0.762, respectively. The combination of NIC and SSC
showed high sensitivity (77.8%) and specificity (100%)
for distinguishing metastatic lymph nodes from reactive
lymph nodes. In addition, there was no significant dif-
ference in either NIC or SSC of different lymph nodes
during PVP or DP.
Conclusions: Spectral CT provided several quantitative
methods and showed a potential value in the differen-
tial diagnosis of metastatic and reactive lymph nodes.
PPL26-106
THE CORRELATION STUDY OF
POSTOPERATIVE PLATELET COUNTS
WITH LIVER FUNCTION RECOVERY
AFTER PARTIAL HEPATECTOMY IN
PATIENTS WITH HEPATOCELLULAR
CARCINOMA
Ke Wang, Xiaofeng Wu, Xiangcheng Li and
Chuanyong Zhang
The First Affiliated Hospital of Nanjing Medical
University, China
Introduction: To investigate the correlation of postop-
erative platelet counts with liver function recovery after
partial hepatectomy in patients with hepatocellular car-
cinoma.
Method: Two hundred and twelve patients with hepa-
tocellular carcinoma were enrolled in this study. The
relation between postoperative platelet counts and
serum levels of ALT, AST, TB and PT after operation
was analyzed.
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Results: There were 78 patients with a low
(<100 9 109/L) immediate postoperative platelet count
in this series of 212 patients who underwent partial
liver resection for hepatocellular carcinoma, and 134
patients with a normal platelet count (≥100 9 109/L).
Based on the criteria, 27 patients were categorized as
having delayed postoperative liver function recovery.
There were no death cases in this study. Postopera-
tively, peak levels of ALT, AST and TB were signifi-
cantly higher in the patients with a low postoperative
platelet count than patients with normal platelet counts
(p < 0.05). Statistical analysis showed that patients with
a low immediate postoperative platelet count after par-
tial liver resection for hepatocellular carcinoma had sig-
nificantly increased risk of delayed postoperative
recovery than patients with normal platelet count
(v2=9.112, p = 0.003).
Conclusions: Low postoperative platelet counts was
associated with delayed liver function recovery after
partial hepatectomy in patients with hepatocellular car-
cinoma, suggesting that platelet was a new target for
preventing liver function failure after hepatectomy in
patients with hepatocellular carcinoma.
PPL26-107
SURGICAL TREATMENT COMBINED
LIVER DAMAGED
Bahtiyar Rakhimov, Igor Galkin, Alexander Morosov,
Andru Solovgev, Vladimir Kolesnikov and Andru
Kalugin
GBUZ 5 Togliatti Clinik Hoapital, Russia
Introduction: The purpose: improvement of results of
damages of a liver by use of modern technologies of
diagnostics and interventions.
Method: Two hundred and seventy-eight victims at the
age from 16 till 70 years with a liver trauma are saved
up. Wounds were available at 116, the closed damages
for 162 patients. Liver damages are divided into five
groups. At 153 suffered damages of a liver are carried
to light and average. To 83 patients it is made lap
exam. At all the diagnosis of damage of a liver is con-
firmed, thus at 23 patients the diagnostic laparoscopy
has passed in surgical operation. In this group com-
bined damages had 14 patients from them 5 persons a
craniocerebral trauma; 3 trauma of a chest; 6 fracture
bones. At receipt the condition as heavy is regarded at
17. Victims, at whom the diagnostic laparoscopy is fin-
ished by surgical operation, had superficial ruptures ii –
iii segment – 9; IV seg – 2; V and VI seg – 10 patients.
For performance lap operations considered as the indi-
cation hemoperitoneum no more than 500 mL absence
of intestinal contents, and absence of a proceeding
intensive bleeding from a liver wound. At surgical pro-
cessing it is deleted alien bodies, small scraps of a hepa-
tic fabric, we tie up bleeding vessels. Somtimes produce
resection, with heavy damage plugging for damage con-
trol.
Results: Complications were observed at 23 patients,
including specific, in connection with damage of the
liver 3 patients. 38 patients have died. After a heavy
trauma died 24, and wounds – 14. At the isolated dam-
ages have died 16, and at combined 22.
Conclusions: Diagnostics improvement, working out of
new surgical tactics, introduction of a resection of a
liver at a trauma, has allowed to improve results of
liver damages.
PPL26-108
COLORECTAL CARCINOMA LIVER
METASTASIS WITH BILE DUCT
INVOLVEMENT: REPORT OF TWO
CASES
Natsuru Sudo, Jun Sakata, Yuki Hirose, Hirosuke
Ishikawa, Tomohiro Katada, Kazuyasu Takizawa,
Kabuto Takano, Takashi Kobayashi, Masahiro
Minagawa and Toshifumi Wakai
Niigata University Graduate School of Medical and
Dental Sciences, Japan
Introduction: Although bile duct involvement is recog-
nized behavior of colorectal carcinoma liver metastasis
(CRLM), this behavior may make it difficult to dis-
criminate CRLM from primary intrahepatic cholangio-
carcinoma (ICC) by radiological examination.
Method: We herein report two cases of CRLM with
bile duct involvement, mimicking ICC, and review of
the literature to evaluate the usefulness of immunohis-
tochemical examination for discrimination between
CRLM and ICC.
Results: Two patients with a past history of surgical
resection for colorectal adenocarcinoma presented with
a liver tumor. Computed tomography of both patients
depicted a mass with dilatation of the intrahepatic bile
ducts. Although past history of colorectal adenocarci-
noma suggested the diagnosis of CRLM, primary ICC
was not ruled out by radiological findings. The two
patients underwent a hepatectomy and histological
examination of the resected specimens revealed the
tumors involving the intrahepatic bile ducts. In the
both patients, immunohistochemical examination
showed that the tumors were positive for cytokeratin
(CK) 20 and negative for CK7. After confirming the
diagnosis of CRLM with bile duct involvement, they
received adjuvant chemotherapy, and remain alive and
well with no evidence of disease 48 and 4 months after
hepatectomy. In reviewing the literature, studies of bile
duct involvement in CRLM vary widely with respect to
cited incidence from 6.1% to 42%. Several authors
demonstrated that CK 7 (specific for biliary epithelium)
and CK20 (specific for intestinal epithelium) immuno-
phenotype is useful for discrimination between CRLM
and primary ICC. CK20-positive/CK7-negative immu-
nophenotype is highly characteristic for CRLM,
whereas CK7-positive/CK20-negative immunopheno-
type is highly suggestive of ICC.
Conclusions: Immunohistochemical combination of
CK7 and CK20 appears to be useful for discriminating
between CRLM with bile duct involvement and ICC.
To make firm histological diagnosis with knowledge of
the clinical details is of importance for making a deci-
sion regarding chemotherapy regimen.
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PPL26-109
RADIO FREQUENCY ABLATION FOR
HCC RESULTED FROM HEPATITIS B
AND LIVER CIRRHOSIS INDUCED
INSUFFICIENT CELLULAR IMMUNE
RESPONSES TO VIRAL LOAD AND
TUMOR RECURRENCE
Yuesi Zhong, Meihai Deng, Ruiyun Xu and Zhaofeng
Tang
Third Affiliated Hospital, Sun Yat-Sen University, China
Introduction: Radio frequency ablation (RFA) for
hepatocellular carcinoma (HCC) can induce tumor-spe-
cific immune responses; however, whether the anti-
immune responses are sufficient for affecting HCC
recurrence remains controversial.
Method: 28 cases with HCC resulted from hepatitis B
and liver cirrhosis were included. Each case was with
tumor number ≤2, diameter of each tumor ≤3 cm.
Serum samples were collected with written consent pre-
RFA, and 1, 2 and 3 weeks post-RFA, which subse-
quently were tested for hepatitis B virus DNA
(HBVDNA) load with real time polymerase chain reac-
tion, and CD4+, CD8+ T cells and natural killer (NK)
cells with flow cytometer respectively. All cases were
followed up until the end point of HCC recurrence
according to tumor markers and contrast-enhanced
ultrasound or computed tomography. Student′s t-test
and Pearson Correlation were used for statistical analy-
sis.
Results: There were 4 cases with no HCC recurrence
during 3-year follow-up. The HBVDNA loads of pre-
RFA and 1 week, 3 weeks post-RFA were not signifi-
cantly different (p > 0.05), except for HBVDNA load
of 2 weeks post-RFA which was significant lower than
that of pre-RFA (p = 0.03). The proportions of CD4+
T cells, NK cells and ratios of CD4+/CD8+ T cells of
pre-RFA and 2, 3 weeks post-RFA were significantly
different (41.30  6.52 vs 36.32  2.36 for proportions
(%) of CD4+ T cells of pre-RFA vs 3 weeks post-
RFA, 7.43  4.62 vs 18.42  7.56 for proportions (%)
of NK cells, 2.01  0.84 vs 1.75  1.06 for ratios of
CD4+/CD8+ T cells). Pearson Correlation revealed
that correlation between changes of serum immune cells
pre- and 3 weeks post-RFA and disease-free survival
time (median: 13 months) was not significant (related
coefficient 0.088, p = 0.49).
Conclusions: RFA for HCC can induce cellular
immune responses from 2 weeks post-RFA; however,
which was insufficient for decreasing HBVDNA load
and HCC recurrence.
PPL26-110
EARLY GOAL DIRECTED
RESUSCITATION AFTER MAJOR
HEPATECTOMY IMPROVES LIVER
FUNCTION AND MAY DECREASE
HOSPITAL LENGTH OF STAY
Achilleas Ntinas, Dimitrios Kardassis, Panagiotis
Kottos, Antonios Manias, Ioannis Konstantinopoulos
and Dionisios Vrochides
"Euromedica Geniki Kliniki" General Hospital, Greece
Introduction: The concept of goal directed treatment is
well established and applied in critically ill patients.
This study evaluates the impact of early goal directed
resuscitation after major hepatectomy.
Method: This is a retrospective case control study of
62 consecutive patients who underwent major hepatec-
tomy. Laparoscopic procedures (n = 5) were included,
whereas cases with caval reconstruction were excluded.
All patients underwent a fast-track recovery pathway.
The first 35 patients received standard post-operative
resuscitation (control group), whereas the rest 27 (study
group) were enrolled to the early goal directed resusci-
tation protocol. Early goals included (but not restricted
to): mean blood pressure (>65 mmHg), central venous
pressure (<5 cmH2O), cardiac index (>2.5 L/minutes/
m2), urine output (>0.25 mL/kg/minutes), oxygen
extraction fraction (<27%) and lactic acid (<20 mg/dL).
Primary endpoints included postoperative (30-day)
mortality, morbidity and length of hospital stay. Sec-
ondary endpoints included lactic acid clearance, liver
biochemistry values and coagulation profile during the
postoperative period.
Results: Central venous pressure goal was reached by
the 6th postoperative hour in 88.9% and 57.1% of the
study and control group, respectively (p = 0.006). Lac-
tic acid goal was reached by the 6th postoperative hour
in 85.9% and 60.0% of the study and control group,
respectively (p = 0.028). There was no postoperative
mortality in either group. The SGPT value on the 2nd
postoperative day was 221  142 IU/L and
312  160 IU/L for the study and control group,
respectively (p = 0.024). The lactic acid value on the 1st
postoperative day was 14  6 mg/dL and 18  mg/dL
for the study and control group, respectively
(p = 0.015). Length of hospital stay was 6.9  1.8 and
7.7  1.7 days for the study and control group, respec-
tively (p = 0.091).
Conclusions: Early goal directed resuscitation after
major hepatectomy improves liver function and may
decrease hospital length of stay.
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PPL26-111
RADIOFREQUENCY-ASSISTED LIVER
RESECTIONS: COMPARISON OF OPEN
AND LAPAROSCOPIC TECHNIQUES
Petr Vavra1, Jana Nowakova2, Petr Jelinek1, Martin
Hasal2, Jana Jurcikova5, Peter Ihnat1, Petr Ostruszka1,
Michaela Vavrova4, Nagy Habib3 and Pavel Zonca1
1University Hospital Ostrava and Ostrava Medical
Faculty, Czech Republic; 2V SB – Technical University
of Ostrava, Czech Republic; 3Hammersmith Hospital,
Imperial College London, UK; 4Novy Jicin Hospital,
Czech Republic; 5University Hospital Ostrava, Czech
Republic
Introduction: Twenty years after the first reported lapa-
roscopic liver resection (LLR), it is still one of the last
areas of resistance to the offensive of laparoscopic sur-
gery. Laparoscopic radiofrequency assisted liver surgery
has been recently developed technique for treatment of
primary and secondary liver tumors. In this study, we
successfully used the radiofrquency device to carry out
laparoscopic hand-assisted liver surgery.
Method: Over a 5-year period, a total of 134 laparo-
scopic and open radiofrequency assisted operations
were performed on patients with liver tumors: laparo-
scopic liver resections or ablations in 47 patients and
open liver resections or ablations (OLR) in 87 patients.
Results: The selection criteria for study were met by
134 patients, 14 of whom had benign lesions and the
remaining 120 patients had malignant disease. The
mean operative time for the LLR was 151 minutes
(median 145 minutes), while the mean operative time
for the OLR was 167.9 min (median 165 minutes). The
mean blood loss for LLR was 68.7 mL, the difference
between the groups was significant with lower median
of blood loss using laparoscopy (p = 0.046). Of the134
patients 17 (12.7%) had postoperative complications:
14 complications (16.1%) in the open surgery group
(n = 87), and 3 complications (6.4%) in the laparos-
copy group (n = 47). The 5- year survival rate was
67.0% after laparoscopic surgery and 63.8% after open
surgery. The mean survival time was longer for a lapa-
roscopic approach than for an open approach
(49.3 months vs 46.9 months, respectively). None of
the statistical tests showed the difference between
groups to be significant.
Conclusions: Laparoscopic liver resection is safe and
feasible procedure. For selected patients, the hand-
assisted radiofrequency technique can be applied safely
and effectively to laparoscopic liver surgery. The lapa-
roscopic approach can be recommended for peripheral
lesions requiring limited hepatectomy or left lateral sec-
tionectomy.
PPL26-112
THE SIGNIFICANCE OF ANTI-VIRUS
TREATMENT FOR PATIENTS OF
HEPATOCELLULAR CARCINOMA
WITH POSITIVE EXPRESSION OF HBV-
DNA
Zhigong Zhang, Xiaoping Geng, Huagang Zhu and
Hongchuan Zhao
1st Affiliated Hospital of Anhui Medical University,
China
Introduction: To investigate the effect of anti hepatitis
B virus treatment to the prognosis of patients accepted
hepatectomy with hepatocellular carcinoma combined
positive expression of HBV DNA.
Method: Analysed patients accepted hepatectomy with
hepatocellular carcinoma combined positive expression
of HBV DNA in General Surgery Department of 1st
Affiliated Hospital of Anhui Medical University from
January 2007 to December 2012. Totally 68 patients
were divided into non-antiviral group (33 cases) and
antiviral group (35 cases) which protocol was lamivu-
dine + adefovir or entecavir alone. The clinical/patho-
logical parameters, HBV DNA level in serum,
postoperative total and tumor free survival time were
compared in these two groups respectively.
Results: The clinical/pathological parameters and pre-
operative HBV DNA level in two groups didn’t show
the significant difference (p > 0.05), while postoperative
HBV DNA level in antiviral group was decreased sig-
nificantly than in non-antiviral group (p < 0.05). The
patients in antiviral group had a significantly greater
total and tumor free survival time than in non-antiviral
group after hepatectomy.
Conclusions: The anti hepatitis B virus treatment can
decrease the HBV DNA level in serum and prolong the
total and tumor free survival time in patients with
hepatocellular carcinoma combined positive expression
of HBV DNA after hepatectomy.
PPL26-113
A NEW TECHNIQUE FOR LIVER
RESECTION – SEMI-SPHERICAL
RADIOFREQUENCY BIPOLAR DEVICE:
EXPERIMENTAL IN VIVO STUDY
Petr Vavra1, Marek Penhaker2, Jana Jurcikova3,
Michal Crha4, Martina Skrobankova1, Patricie
Delongova1, Nagy Habib5, Jan Grepl2, Pavel Zonca1
and Dana Salounova6
1University Hospital Ostrava and Ostrava Medical
Faculty, Czech Republic; 2Faculty of Electrical
Engineering and Computer Science, V SB – Technical
University of Ostrava, Czech Republic; 3University
Hospital Ostrava, Czech Republic; 4University of
Veterinary and Pharmaceutical Sciences Brno, Czech
Republic; 5Hammersmith Hospital, Imperial College
London, UK; 6Faculty of Economics, V SB-Technical
University of Ostrava, Czech Republic
Introduction: The role of radiofrequency energy in liver
surgery has expanded in recent years from simple tumour
ablation to its use in the technique of RF-assisted liver
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resection. The present study assessed the feasibility and
safety of liver resection by a new semi-spherical bipolar
radiofrequency device (RONJA). The primary hypothe-
sis of the study was to evaluate whether this new device
is able to consistently produce homogeneous and pre-
dictable areas of coagulation necrosis without the Pringle
maneuver. Performing liver resection using the new semi-
spherical device (RONJA), we aim to confirm that this
new method is effective and safe.
Method: In vivo testing was conducted on a set of 12
pigs (Sus scrofa domestica) randomly divided into two
groups. The whole experiment was made up of three
parts. During the first part the animals in both groups
underwent middle laparotomy and radiofrequency-
assisted liver resection under general anaesthesia. The
second part of the study followed 14 days after inter-
vention, and it was focused on control laparoscopy. In
the last part, 30 days after the operation, all pigs were
euthanized and samples were pathologically evaluated.
Results: For comparison and statistical evaluation data
were collected including results of blood samples, the
values recorded during surgery and postoperatively and
also the histopathological evaluation. Examination of
thermal changes at the resection margin showed strong
thermal alteration in both groups. Statistical analysis
using the median test (p-value was computed by Fish-
er’s exact test) didn′t show significant difference
between the groups.
Conclusions: This experimental study demonstrated the
feasibility and safety of the newly developed semi-
spherical bipolar device for liver ablation and resection.
RONJA device shows promise in the effort to reduce
healthy tissue liver parenchyma resection during liver
surgery in a porcine model. Performing liver resection
using the new semi-spherical device, we have confirmed
this new method is effective and safe.
PPL26-114
ROBOT-ASSISTED LAPAROSCOPIC
HEPATECTOMY: THE HENRI-MONDOR
EXPERIENCE.
Chady Salloum, Claude Tayar, Alexis Laurent,
Alexandre Malek, Philippe Compagnon, Riccardo
Memeo, NicolaDe Angelis, Gerard Pascal and Daniel
Azoulay
Henri Mondor Hospital, France
Introduction: Laparoscopic hepatectomy remains tech-
nically challenging. The recent introduction of robotic
surgical systems has revolutionized the field of mini-
mally invasive surgery in regards to 3-dimensional
images and better instrumentations. It offers solutions
to the fundamental limitations of conventional laparo-
scopic liver resection.
Method: Between Mars 2011 and June 2013, we per-
formed 24 hepatic resection for both benign and malig-
nant lesions by robot-assisted laparoscopic approach
(left lateral sectionectomy n = 11, atypical resection
segment 2 n = 2, atypical resection segment 3 n = 4,
atypical resection segment 4 n = 3, atypical resection
segment 5 n = 1, atypical resection segment 6 n = 3). A
Da Vinci Robotic Surgical System (Intuitive Surgical)
with three arms was used and two additional laparo-
scopic ports for the assistant surgeons were added. No
Pringle maneuver was used. The dissection was carried
out with the bipolar forceps on the left arm of the sur-
geon and the Harmonic curved shears on the right
arm. In case of left lateral sectionectomy, the division
of the vascular pedicles for segments 2 and 3 was per-
formed with EndoGIA staplers. Prospectively collected
data was analysed retrospectively.
Results: Overall mean operative time was
164.2  75.5 minutes (range: 60–300). Overall mean in-
traoperative blood loss was 169.6  165.2 mL (range:
20–700). One open conversion was needed. Two
patients (8.3%) had postoperative complications (par-
tial thrombosis in the right anterior portal branch and
enterocutaneous fistula treated conservatively). There
was no mortality and no reoperations. Mean hospital
stay was 6  3.6 days (range: 2–16). All patients had
R0 resection with a mean margin of 13  10 mm
(range: 1–45 mm).
Conclusions: In experienced hands, robot-assisted lapa-
roscopic hepatectomy is feasible and safe. Further eval-
uation with clinical trials is required to assess for
improvement in outcomes and to validate its real bene-
fits. Long-term oncologic outcomes are still pending.
Further research on its cost-effectiveness is required.
PPL26-115
LYMPH NODE RATIO AND
METACHRONOUS LIVER METASTASES
IN COLORECTAL CANCER
Roberto Scilletta, Gaetano La Greca, Giovanni Li
Destri, Antonio Pesce, Teresa Portale, Erminia Conti
and Stefano Puleo
Univeriity of Catania, Italy
Introduction: The goal of sampling 12 nodes for proper
staging colorectal neoplasia is often “uncommon” and
the lymph node ratio (LNR), rather than the overall
number of lymph nodes, would allow a better selection
of patient prognosis. The authors wanted to assess
whether the distribution of patients according to the
LNR can predict the risk of developing metachronous
liver metastases from colorectal cancer.
Method: It was retrospectively evaluated a homoge-
neous group of 280 patients, classified according to the
staging of Astler-Coller and followed in follow-up for
at least 5 years. In order to highlight the groups at
greatest risk of metachronous liver metastases subjects
were divided into four quartiles in relation to LNR.
Results: The number of lymph nodes sampled in the
B1 group was statistically significantly lower than the
groups B2 and C2 (p 0.021 and p 0.013, respectively).
As has not been reached statistical significance between
the LNR global and the development of liver metasta-
ses, the subdivision into quartiles allowed to highlight
that in the more advanced (LNR3 LNR4) was regis-
tered a higher incidence of metachronous liver metasta-
ses (70% vs 30%, p 0.028) and that there is a different
distribution of patients with or without liver metastasis
in function of quartiles (p = 0.010).
Conclusions: Considering these data, the LNR allows
to prognosticate patients at greater risk of developing
metachronous liver metastases.
544 Poster Panel [Liver]
© 2014 The Authors
HPB © 2014 Americas Hepato-Pancreato-Biliary Association HPB 2014, 16 (Suppl. 2), 406–549
The lower sampling lymph node staging in the patients
with less advanced (B1) and in patients with negative
nodes-(B1 B2) who developed liver metastases leads us
to believe that some patients with less advanced stages
have been understaged. We believe that further studies
are needed in order to be able to determine which is
the cut-off of LNR that allows to discriminate on the
risk of disease relapse.
PPL26-116
COMPARATIVE ANALYSIS OF
CLINICAL OUTCOMES IN PATIENTS
WITH LIVER RESECTION FOR
COLORECTAL HEPATIC METASTASES
AFTER NEOADJUVANT
CHEMOTHERAPY
Roberto Scilletta1, Marco Spada2, Duilio Pagano2,
Sebastiano Mongiovi3, Antonio Pesce1, Teresa Portale1,
Stefano Puleo1 and Salvatore Gruttadauria2
1University of Catania, Italy; 2ISMETT Palermo, Italy;
3Humanitas, Italy
Introduction: The aim of this study was to identify the
incidence of surgical site infections and postoperative
complications, as defined by the Clavien-Dindo Classifi-
cation, after hepatic resection for metastatic colorectal
cancer in patients with and without associated neoadju-
vant chemotherapy.
Method: A total of 181 patients were studied retrospec-
tively. Patients were divided into two groups: the first
composed of patients with associated neoadjuvant che-
motherapeutic treatment for liver metastases with a
latency time of less than 8 weeks; the second composed
of patients without associated chemotherapy.
Results: Variables of duration of liver surgery, length
of total hospital stay, and length of post-operative hos-
pital stay seem to be correlated with surgical site infec-
tions and post-operative complications, p < 0.005 and
<0.0001, respectively. Duration of surgery is a risk fac-
tor for surgical site infections, with an odds ratio of
1.15, and an odds ratio of 1.35 for Clavien- Dindo
Classification complications.
Conclusions: Neoadjuvant chemotherapy was not a sig-
nificant risk factor for surgical site infections, while
total length of hospital stay, length of post-operative
hospital stay, and duration of surgery were independent
predictors of surgical site infections and Clavien-Dindo
Classification complications.
PPL26-117
ALPPS RESULTS IN GROWTH OF THE
FUTURE LIVER REMNANT AFTER
FAILED PORTAL VEIN
EMBOLIZATION
Ernesto Sparrelid, Lars Lundell and Bengt Isaksson
Hepatobiliary Surgery, Sweden
Introduction: After the first report describing ALPPS
(associating liver partition with portal vein ligation for
staged hepatectomy) in 2012 there has been an interest
for this surgical technique. However, the technique has
also been subjected to critique for high morbidity and
mortality, heterogeneous patient diagnosis, different
surgery performed and using ALPPS upfront when
portal vein embolization (PVE) is a more established
method.
Method: This is a phase I study with the aim of includ-
ing 10 patients (7 included so far since study start in
December 2012) with bilobar colorectal liver metastases
and previous right-sided PVE without sufficient effect
for subsequent safe extended right-sided hemihepatecto-
my. Stage 1 operation is performed transecting the
parenchyma between segment 2/3 and 4, and right por-
tal vein is ligated. The effect is evaluated with CT volu-
metry on day 6 and stage 2 operation is performed day
7 resecting segments 4–8.
Patients are studied with multimodal liver function tests
consisting in repeated: 4-phase CT liver, hepatobiliary
scintigraphy with SPECT/CT, ICG and blood samples.
In addition bilobar liver biopsies are taken at both
operations and blood collected for further study.
Results: All patients underwent the first operation
without major intraoperative complications. On CT
volumetry day 6 there was an increase of FLR with in
median 64% (range 41–105) despite previous PVE. In
all cases the effect was considered sufficient (FLR/BW-
ratio > 0.5) for completion surgery the day after. No
patient developed postoperative liver failure. There was
no mortality and no serious complications leading to
significant morbidity.
Conclusions: ALPPS seems to be a safe procedure in
selected patients, and could be used if previous PVE is
unsuccessful. The mechanisms behind the powerful and
fast growth of the FLR after ALPPS are unknown, but
further analysis of the performed liver function tests
and collected tissue samples will hopefully contribute to
increased knowledge about this.
PPL26-119
IS HEPATIC RESECTION FOR
COLORECTAL LIVER METASTASES IN
OVERWEIGHT AND OBESE PATIENTS
SAFE? OUR EXPERIENCE
Samuele Vaccari, Mariateresa Mirarchi, EmilioDe
Raffele, Silvia Palumbo, Ferdinando Lecce, Barbara
Dalla Via, Dajana Cuicchi, Roberto Bellusci, Antonino
Cavallari and Bruno Cola
U.O. Chirurgia Generale e d’Urgenza – Prof. Cola, Italy
Introduction: The current increase in incidence of obes-
ity and colorectal liver metastases (CRLM) will soon
bring an equal increasing in obese and overweight
patient candidates for liver resection (LR). The aim of
this study was to clarify the perioperative outcome of
hepatectomy in obese (OB) and overweight (OW)
patients with CRLM in comparison with normal
weight patients (NW).
Method: Complete perioperative parameters were avail-
able in 207 LR performed for CRLM between October
2000 and June 2013 by one of the authors and were
reviewed; 78 were performed in NW, 96 in OW, and 33
in OB. These groups were comparable for age, sex and
distribution of minor LR, major LR and synchronous
colorectal resection and hepatectomy. ANOVA and
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Student’s t tests were used for statistics; significance
was defined as p ≤ 0.05.
Results: The demographic data were similar among the
three groups. Intraoperative blood transfusions were
328.2  600.9 mL [0–3300], 189.6  400.9 mL [0–2100]
and 137.9  396.1 mL [0–1800] in NW, OW and OB,
respectively (p = 0.0833). Duration of surgical proce-
dure was 361  154 minutes [115–800], 368  166 min-
utes [90–820] and 368  152 minutes [180–705] in NW,
OW and OB, respectively (p = 0.9542). Postoperative
complications were 14.10%, 15.63% and 21.21% in
NW, OW and OB, respectively (p = 0.6414). Postopera-
tive mortality was 1.28%, 0% and 3.03% in NW, OW
and OB, respectively (p = 0.2883). Postoperative hospi-
tal-stay was 11.29  8.06 days [6–68],
10.31  3.63 days [6-29] and 9.64  3.50 days [4–23] in
NW, OW and OB, respectively (p = 0.3161).
Conclusions: The favourable perioperative outcomes
observed in our experience prove that obesity is not a
deterrent for liver resection and also for simultaneous
colorectal resection and hepatectomy; however these
patients should be approached cautiously by specialist
surgeons in centers with experience in hepatobiliary
and bariatric surgery. In this context, surgery should be
the treatment of choice also in obese or overweight
patients with CRLM.
PPL26-121
LAPAROSCOPIC VERSUS OPEN LIVER
RESECTION FOR METASTATIC
COLORECTAL CANCER: A META-
ANALYSIS OF 610 PATIENTS
Suzanne Schiffman, Kevin Kim, Allan Tsung, J. Wallis
Marsh and David Geller
University of Pittsburgh, USA
Introduction: The feasibility and safety of laparoscopic
liver resection (LLR) have been demonstrated in multi-
ple reports. LLR for malignant pathology has been
slower to gain acceptance. The aim of this study was to
systematically analyze the clinical evidence for LLR
and open liver resection (OLR) in patients with hepatic
colorectal metastases (mCRC) and compare periopera-
tive and oncologic outcomes. In addition, we sought to
analyze the long-term OS and DFS in these patient
cohorts.
Method: A PubMed search identified 2.122 articles.
When filtered for case-matched articles comparing LLR
to OLR for mCRC, 8 articles were identified consisting
of 610 total patients (242 LLR matched to 368 OLR
patients). A random effects meta-analysis was per-
formed.
Results: The two groups were well-matched for age,
gender, BMI, ASA score, tumor size, number of CRC
hepatic metastases, extent of major hepatectomy, and
use of neadjuvant/adjuvant chemotherapy. EBL was
significantly less in LLR compared to OLR (262 cc vs
385 cc; p = 0.049). Transfusion rate was significantly
less in LLR (9.9% vs 19.8%; p = 0.004). There was not
a significant difference in operative time (248.7 minutes
vs 262.8 minutes; p = 0.85). R1 margin positivity was
significantly lower in the LLR (6.5% vs 16%;
p = 0.01). LOS was significantly shorter in LLR
compared to OLR (6.5 days vs 8.8 days; p = 0.007).
The overall complication rate was significantly less in
LLR group (20.3% vs 33.2%; p = 0.03). There was no
difference in the 1-, 3- and 5-year disease-free survival
(DFS) or overall survival (OS) rates.
Conclusions: In carefully selected patients with mCRC,
LLR provides significant peri-operative benefits without
compromising oncologic outcomes or long-term sur-
vival. Specifically, LLR offers decreased EBL, need for
transfusion, R1 positive margin, LOS, and overall com-
plication rate compared to OLR. 5-year DFS and OS
rates are comparable.
PPL26-122
ASSOCIATING LIVER PARTITION AND
PORTAL VEIN LIGATION FOR STAGED
HEPATECTOMY (ALPPS) PROCEDURE
–A TRUE BREAKTHROUGH IN
HEPATIC SURGERY? – A SYSTEMIC
REVIEW.
Bhavin Vasavada
Fellow Liver Surgery and Transplant, India
Introduction: To induce rapid hepatic hypertrophy and
to reduce post-hepatectomy liver failure (Phlf), associ-
ating liver partition and portal vein ligation for staged
hepatectomy (Alpps) has been recently developed for
patients with a limited future liver remnant. The aim of
this study was to systemically review the literature to
further validate its usefulness.
Method: Medline search conducted and studies con-
taining outcome of Alpps procedure were systemically
reviewed. primary endpoint was increase in size of
future liver remnant (Flr) secondary endpoints were
morbidity and mortality associated with this procedure.
Results: Total data of 112 patient from 8 studies done
until now showed mean percentage increase of 79.15%
In Flr (future liver remnant) in mean period of 8.2 days
after first stage making second stage resection feasible
with adequate Flr (future liver remnant). 38 patients
developed grade 3 gade 4 complication. And 5 patients
died peiopratively.
Conclusions: Alpps is a feasible options for inadequate
future remnant liver with acceptable morbidity and
mortality.
PPL26-123
SURGICAL TREATMENT FOR
HEPATOCELLULAR CARCINOMA
WITH PORTAL VEIN TUMOR
THROMBUS: A NOVEL
CLASSIFICATION
Jiang-Feng Xu
The Yiwu Affiliated Hostpital of Zhejiang University
School of Medicine, China
Introduction: The hepatic resection for hepatocellular
carcinoma (HCC) with portal vein tumor thrombus
(PVTT) which are not uncommon at clinic are contin-
ues to be debated. This study aimed to explore the effi-
ciency of surgical treatment for hepatocellular
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carcinoma (HCC) with portal vein tumor thrombus
(PVTT).
Method: From January 2008 to December 2012, a total
of 56 cases of HCC with portal vein tumor thrombus
(PVTT) underwent liver resection combined with
thrombectomy. Clinical pathological features and surgi-
cal data of these patients were retrospectively studied.
The patients were divided into two groups. Group A,
tumor thrombi involving the main portal vein trunk or
both the left and right portal vein. Group B, tumor
thrombi involving only one branch (left or right) of
portal vein. Cumulative overall survival curves of
patients were compared according to the different
groups.
Results: 16 patients (28.6%) belong to group A com-
pared to 40 patients (71.4%) belong to group B. The
rates of capsular formation and tumor number showed
differences between two groups (p = 0.047, p = 0.032).
Group A had more liver cirrhosis than group B
(p = 0.047). The patients with large blood loss (≥1000)
were more in group A, as well. There was no significant
difference in complications between two groups except
the ascites (p = 0.028). The 1-year overall survival rates
of group A after liver resection was 31.5%. The 1-, 3-,
5-year overall survuval rates of group B were 62.3%,
16.1%, 5.2% respectively. For further study, group B
have the significantly better overall survival than group
A (p = 0.033).
Conclusions: Liver resection combined with thrombec-
tomy for HCC with PVTT can get better outcome in
patients with PVTT involving the main portal vein
trunk or both the left and right portal vein, compared
to the HCC patients with PVTT involving only one
branch (left/right) of portal vein.
PPL26-124
SURGICAL LIVER RESECTION FOR
SEGMENT V, VII, AND VIII COMBINED
WITH INFERIOR VENA CAVA TUMOR
THROMBUS IN HEPATOCELLULAR
CARCINOMA: REPORT OF A CASE
Sheng Tai and Sheng Tai
The Second Affiliated Hospital of Harbin Medical
University, China
Introduction: Hepatocellular carcinoma (HCC) with
inferior vena cava (IVC) tumor thrombosis is rare, and
its prognosis is extremely poor. Non-surgical treatment
for these patients causes tumor invasion to right atrium
leading to heart failure and sudden death. The surgical
treatment of this disease can prevent the unfortunate
heart failure and invasion of tumor in the right atrium.
We report the case of this surgery to investigate the
preoperative planning, surgical techniques and postop-
erative efficacy of this disease.
Method: A 45-year-old man who suffered from HCC
with IVC tumor thrombus was admitted to our hos-
pital. To prevent liver functional insufficiency or liver
failure at postoperative period, we decided to reserve
the Couinaud’s segment sixth (VI) via reserving the
inferior right hepatic veins (IRHV). Thus the patient
underwent resection of the huge hepatic tumor in the
right lobe with reservation of segment VI and Infe-
rior Vena Cava tumor thrombus (IVCTT) removal
surgery.
Results: The patient showed great recovery with nor-
mal liver function and AFP level without any signifi-
cant complications after surgery. Computed
tomography shows no metastasis and no signs of recur-
rence during the follow-up after 11 months operatively.
Conclusions: Liver resection and IVC tumor thrombo-
sis removal Surgery can be safely performed on the
case of HCC with Tumor Thrombosis in IVC; surgical
treatment can relieve the patient from the risk of sud-
den death caused by heart failure and pulmonary;
When the IRHV existing, resection the segment V, VII,
VIII, reserving the segment VI of the liver can prevent
functional insufficiency of liver or liver failure at post-
operative period.
PPL26-125
MESENCHYMAL STEM CELLS INDUCE
THE GENERATION OF A NOVEL
TOLEROGENIC DENDRITIC CELLS
THROUGH IL-6/STAT3/SOCS1/TLR4
SIGNALING NETWORK
Guo-Ying Wang, Yi-nan Deng, Wei Meng, Wei Liu,
Min-Ru Li, Qi Zhang, Yang Yang and Gui-Hua
Chen
The Third Affiliated Hospital of Sun Yat-Sen University,
China
Introduction: Mesenchymal stem cells (MSC) display a
striking immunoregulatory property. This property has
been used in several clinical settings; particularly, MSC
infusion could resolve severe, acute graft-vs-host dis-
ease. Most of the data suggest that this property
involves secretion of specific cytokines and mechanisms
mediated by cell-cell contact. In addition, MSC are also
likely to modulate the differentiation and function of
dendritic cells (DC). However, the underlying mecha-
nisms are still poorly understood.
Method: The MSC from human umbilical cord (huc-
MSC) was identified by flow cytometric analysis and
the differentiation of mesenchymal lineage. After
9 days of coculture, we evaluated the influence of MSC
on the morphology and function of DC by FACS
analysis, ELISA, and Western blot.
Results: We found that huc-MSC induced immature
dendritic cells (iDC) to differentiate into a novel tolero-
genic DC subset (MSC-DC) with a stable phenotype
and function when cocultured. MSC-DC display the
low immunogenicity and immune tolerance by trigger-
ing a T helper type 2–polarizing program and down-
regulating the pro-inflammatory factor production.
Further study demonstrates that huc-MSC induce the
tolerogenic MSC-DC generation through the IL-6/
STAT3/SOCS1/TLR4 signaling network. Huc-MSC
induced the higher expression of SOCS1 in MSC-DC,
which were activated by secreting a larger number of
IL-6 through the JAK–STAT pathway, repressing toll
like receptor 4 (TLR4) signaling pathway, and ulti-
mately inducing the generation of novel tolerogenic
dendritic cells. Moreover, Huc-MSC could increase
phophorylation of Akt, but inhibit phophorylation of
IRF3.
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Conclusions: Our data proposed a new molecular
mechanism of MSC in regulating tolerogenic DC
production and promote the clinical application of
MSC in new and broader immune applications, includ-
ing treatment of allograft rejection and graft-vs-host
disease in organ transplantation and autoimmune liver
diseases.
PPL26-126
LOW POWER LASER IRRADIATION
IMPROVES REGENERATION OF THE
LIVER REMNANT AFTER PARTIAL
HEPATECTOMY IN RATS.
Antonio Roberto F. Teixeira1, Tiago Araujo2,
Gracinda Jorge2, Edmyr Reis2, Rodolfo Tartaro2,
Luciana Moreira2, Ilka Boin1, Ester Nicola2 and Mario
Saad2
1State University of Campinas- Sao Paulo- Brazil,
Brazil; 2State University of Campinas, Brazil
Introduction: A simple, easy, and safe procedure aim-
ing to improve liver regeneration could be of great clin-
ical benefit in critical situations. Efforts are dedicating
to improve remnant liver regeneration by changing por-
tal flow. Nevertheless other mechanisms are related to
regeneration processes, such as light stimulation. Low-
power laser irradiation (LPLI) has been used to rene-
nerate oral mucosa after chemo and radioterapy, but it
has not been tested in the liver remnant yet. The aim
of this study was to investigate the main molecular
mechanisms involved inliver regeneration of partially
hepatectomized rats exposed to LPLI.
Method: We used Wistar male rats, which had their
remaining liver irradiated or not with LPLI (wave-
length of 632.8 nm and fluence of 65 mW/cm2) for
15 minutes after a 70% hepatectomy. We investigated
hepatocyte growth factor (HGF), Met, Akt, and Erk 1/
2 signaling pathways through protein expression and
phosphorylation analyses along with cell proliferation
(proliferating cell nuclear antigen (PCNA) and Ki-67)
using immunoblotting and histological studies.
Results: LPLI can improve liver regeneration as shown
by increased HGF protein expression and the phos-
phorylation levels of Met, Akt, and Erk 1/2 accompa-
nied by higher levels of the PCNA and Ki-67 protein
in the remnant livers. It might be useful in clinical prac-
tice since it is a completely innofensive method to the
liver remnant, and may be applied intraoperatively.
Conclusions: Low power laser irradiation may play a
clinical role as a simple, fast, and easy-to-perform strat-
egy in order to enhance the liver regenerative capacity
of a small liver remnant after hepatectomy.
PPL26-127
A PROSPECTIV E RANDOMIZED
CONTROLLED TRIAL TO COMPARE
PRINGLE MANOEUVRE WITH HEMI-
HEPATIC VASCULAR INFLOW
OCCLUSION IN LIVER RESECTION
FOR HEPATOCELLULAR CARCINOMA
WITH CIRRHOSIS
Jun-sheng Ni1, Wan Yee Lau2, Yuan Yang1, Ze-Ya
Pan1, Zhen-guang Wang1, Hui Liu1, Meng-chao Wu1
and Wei-ping Zhou1
1Eastern Hepatobiliary Surgery Hospital, Second
Military Medical University, Shanghai, CHINA, China;
2The Chinese University of Hong Kong, Hong Kong,
SAR, People’s Republic of China, Hong Kong, China
Introduction: The duration of hepatic vascular inflow
occlusion and the amount of intraoperative blood loss
have significant negative impacts on postoperative mor-
bidity, mortality and long-term survival outcomes of
patients who receive partial hepatectomy for hepatocel-
lular carcinoma (HCC) with cirrhosis.
This study aimed to compare the perioperative out-
comes of partial hepatectomy for HCC superimposed
on hepatitis B-related cirrhosis using two different
occlusion techniques.
Method: A randomized controlled trial was carried out
to evaluate the impact of two different vascular inflow
occlusion techniques. The postoperative short-term
results were compared.
Results: During the study period, 252 patients received
partial hepatectomy for HCC with cirrhosis. Of these
patients, 120 were randomized equally into two groups:
the Pringle manoeuvre group (n = 60) and the hemi-
hepatic vascular inflow occlusion group (n = 60). The
number of patients who had poor liver function on
postoperative day 5 with ISLGS grade B or worse was
24 and 13, respectively (p = 0.030). The postoperative
complication rate was significantly higher in the Pringle
manoeuvre group (40% vs 22%, p = 0.030). However,
the Pringle manoeuvre group had significantly shorter
operating time (116 minutes vs 136 minutes, p = 0.012)
although there was no significant difference in intraop-
erative blood loss between the two groups [200 mL
(range 10–5000 mL) vs 300 mL (range 100–1000 mL);
p = 0.511]. There was no perioperative mortality.
Conclusions: The results indicated that for patients
with HCC with cirrhosis, hemi-hepatic vascular inflow
occlusion was a better inflow occlusion method than
Pringle manoeuvre.
PPL26-128
MAJOR HEPATIC RESECTION IN
HEPATIC HYDATIDOSIS
Ibrahim Abdelkader Salama, Mohamed Abou shady,
Osama Hegazy, Sherif Saleh, Hany Shorem, Mohamed
Houseni and El-Amir Amir
National Liver Institute, Menophyia University, Egypt
Introduction: Ecchinococcal disease is still a serious
problem in certain parts of the world, with liver as the
most affected organ. Surgery remains the main stay of
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treatment of hydatidosis, but the optimal surgical pro-
cedure remains unsettled.
Method: Objective: Safety and efficacy of major hepa-
tic resection in multiple and giant hepatic hydatidosis.
Patients & Methods: Sixty-three patients had hepatic
hydatidosis associated with lung, spleen, and suprarenal
hydatidosis were managed between April 2005 to April
2011 at National Liver institute, Menophyia University.
43 (68%) males and 20 (32%) females, age range 8–
56 years. Cysts were found in the liver only in 51
(81%) patients, liver with spleen in 5 (8%), liver, spleen
and lung in 2 (3.1%), liver and lung in 4 (6.3%), liver
and suprarenal in one patient (1.6%).
Results: Multiple cysts were found in 38 (60%) and
solitary cyst in 25 (40%) with cysts diameter ≤ 5 cm in
22 (35%), 5–10 cm in 16 (25%), and 10–38 in 25
(40%). Right hepatectomy in 24 (38%), Right trisec-
tionectomy in 2(3.2%), right hepatectomy with segment
III in 4 (6.3%), right hepatectomy with segment I in 2
(3.2%), left hepatectomy in 12 (19%), left lateral sec-
tionectomy in 6 (9.5%), left hepatectomy with segment
VI in 3 (4.8%), left lateral sectionectomy with Right
posterior sectionectomy in 2 (3.2%), right hepatectomy
with splenectomy in 7 (11%) and right hepatectomy
with right suprarenal in one (1.6%) patient were per-
formed. Hospital stay was 4.2 (3–13 days), there was
one mortality and 12 (19%) morbidities. No recurrence
on follow up period (8–60 months) was observed.
Conclusions: Radical procedure is safe and effective
option for hepatic hydatidosis and should be performed
when the entire lobe is diffusely involved by huge or
multiple hydatidosis with little healthy liver tissue.
PPL26-129
LIVER SURGERY FOR NON-
MALIGNANT DIAGNOSES: OUR
EXPERIENCE
Matthew Mortimer and Nagappan Kumar
Cardiff Liver Unit, UK
Introduction: Advances in surgical technique, anaesthe-
sia, and peri-operative care have led to an increase in
the number of patients undergoing liver surgery for
non-malignant diagnoses, and cases where malignancy
cannot be fully ruled out. We reviewed this patient
group at our unit, looking at demographics, pre-opera-
tive radiological diagnosis, post-operative diagnosis,
outcomes and length of stay to establish current trends
in the surgical management of patients with non-malig-
nant liver pathology and to see if this service is feasi-
ble.
Method: We reviewed our prospectively maintained
database to identify patients who had undergone liver
surgery for non-malignant pathologies. We then
reviewed the case notes to elicit the required informa-
tion.
Results: Between 2003 and 2011, 52 liver resections
were carried out for non-malignant conditions,
accounting for 16% of liver resections at the unit. 81%
of these patients were female, and the mean age was
55. The most common procedure was a formal hemi-
hepatectomy, accounting for 30% of all procedures car-
ried out. The most common pre-operative diagnosis
was simple cyst, followed by adenoma. Overall pre-
operative diagnosis was accurate in 69% of patients.
There was no in hospital mortality. Six percent of
patients developed post-operative complications (Cla-
vien-Dindo 3 or more). The median post-operative stay
of all patients was 7 days.
Conclusions: Liver resection for benign conditions can
be performed safely with minimum morbidity.
Although it could be argued that liver biopsy will avoid
major surgery in these patients, it can make the condi-
tion inoperable if the biopsy turns out to show malig-
nancy. There is a high rate of needle tract seeding.
Also, a core biopsy may not give a clear diagnosis. We
would strongly recommend, based on our outcomes
and the literature that all patients with incidental
masses in the liver are referred to the liver unit for fur-
ther assessment.
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